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Abstract
During the development of a multicellular organism, different cell types with specific functions
have to be generated, although the cells contain the same genetic information. This is achieved
by a cell type specific expression of genes. The gene expression pattern and the identity of the cell
have to be maintained for several rounds of cell division. The growing field of epigenetics deals
with the inheritance of traits, which are not determined in the underlying DNA sequence. The
long-term maintenance of gene expression patterns, which can be described as a kind of a cellular
memory, is counted among epigenetic mechanisms. Different epigenetic inheritance systems like
chromatin remodeling exist. For instance, the chromatin structure can be altered by the histone
modifying Polycomb Group (PcG) proteins. The PcG proteins are responsible for the inheritance
of the repressed state. Many genes, which are controlling development, differentiation and the
cell cycle, are regulated by PcG proteins. The proteins have been shown to act as large multipro-
tein complexes, so-called Polycomb Repressive Complexes (PRCs).
In the scope of this thesis, PcG and associated proteins have been characterized in the freshwater
polyp Hydra. The PcG genes Scm and Pho/YY1 could be identified in the Hydra genome and have
been cloned. Together with the already identified proteins of the PRC1 and PRC2 complexes, Hy-
dra possesses a complete set of PcG proteins. A comparison with homologous proteins of other
species could demonstrate that the functional domains of the Hydra PcG proteins are highly con-
served.
Interestingly, the genes of the PRC2 complex are exclusively expressed in one of the three cell
lineages of Hydra. The genes are expressed in the so-called interstitial cell lineage. Studies with
sexual polyps could show that the genes are also expressed in the gonads of the animals. The cell
line specific expression of the genes in Hydra seems to separate interstitial cells from the epithelial
cell lineages.
The DNA binding protein HyYY1 has been of special interest in this study. It is a homolog of the
Drosophila protein Pho and of the human transcription factor YY1. Pho can be found in a PcG
complex termed PhoRC (Pleiohomeotic Repressive Complex) in combination with dSfmbt. This
complex is responsible for the recruitment of the other PcG complexes to their target genes in the
fruit fly. YY1 acts as a ’molecular adapter’ and links the PcG complexes to so-called Polycomb
Response Elements (PREs). These cis-regulatory elements can be found close to target genes and
are important for the recruitment of the PcG complexes. The Hydra protein has both a zinc fin-
ger domain, which is responsible for the DNA binding, and a so-called REPO domain, which is
necessary for the interaction with the PRCs. With the help of gel retardation assays, it could be
demonstrated that HyYY1 can effectively interact with the DNA in a sequence-specific manner.
The consensus sequence is equivalent to the CCAT-motif found in Drosophila and mammals. In
the fruit fly, this sequence can be found within PREs.
A polyclonal antibody against recombinantly expressed HyYY1 has been generated during this
study - making immunohistochemical analyses and immunoprecipitations (IPs) possible. An in-
dication of the interaction of HyYY1 with other PcG proteins could be provided by a Co-IP. How-
ever, this preliminary result has to be verified. In addition, it should be kept in mind that the
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recruitment of PcG complexes in Hydra is not necessarily dependent on Pho/YY1 and PRE sites.
At least for mammals, other recruiting mechanisms are known.
The existing antibodies against HyYY1 and otherHydra PcG proteins render chromatin-IPs to
identify target genes possible. In a preliminary experiment, sequences of the Hydra genome could
be precipitated. Next-generation sequencing technologies will enable large-scale ChIP-Seq exper-
iments and the future identification of PcG target genes in Hydra.
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Zusammenfassung
Während der Entwicklung eines vielzelligen Organismus müssen unterschiedliche Zelltypen mit
spezifischen Funktionen gebildet werden, obwohl alle Zellen dieselbe Erbinformation enthalten.
Dies wird durch eine zelltypspezifische Expression von Genen erreicht. Das Genexpressionsmu-
ster - und damit die Identität der Zelle, muss über viele Zellteilungen hinweg aufrecht erhalten
werden. Das wachsende Feld der Epigenetik beschäftigt sich mit der Vererbung von Merkmalen,
die nicht in der DNA-Sequenz festgelegt sind. Darunter fällt auch die langfristige Aufrechter-
haltung von Genexpressionsmustern, welche auch als eine Art ’Zellgedächtnis’ bezeichnet wer-
den kann. Es existieren verschiedene epigenetische Vererbungssysteme, wie beispielsweise der
Chromatinumbau (’chromatin remodeling’). Die Chromatinstruktur kann unter anderem durch
die Histon-modifizierenden Polycomb Group (PcG) Proteine derart verändert werden, dass die
Transkription verhindert wird. PcG Proteine sind für die Vererbung des reprimierten Zustandes
verantwortlich. Viele Gene, welche die Entwicklung, die Differenzierung und den Zellzyklus
kontrollieren, werden durch PcG Proteine reguliert. Die Proteine agieren dabei als große Multi-
proteinkomplexe, sogenannte Polycomb Repressive Complexes (PRCs).
Im Rahmen dieser Arbeit wurden Polycomb Group (PcG) und assoziierte Proteine im Süßwas-
serpolypen Hydra näher untersucht. Im Laufe dieser Arbeit konnten die PcG Gene Scm und
Pho/YY1 im Hydra-Genom identifiziert und kloniert werden. Zusammen mit den in früheren
Studien identifizierten PcG Proteine der PRC1 und PRC2 Komplexe besitzt Hydra damit einen
vollständigen Satz an PcG Proteinen. Durch den Vergleich mit homologen Proteinen anderer Or-
ganismen konnte gezeigt werden, dass vor allem die funktionellen Domänen der PcG Proteine in
Hydra hoch konserviert sind.
Interessanterweise werden die Gene des PRC2 Komplexes ausschließlich in einer der drei Zell-
linien von Hydra exprimiert. Die Gene werden in der sogenannten interstitiellen Zelllinie expri-
miert. Anhand von Studien an geschlechtlichen Polypen konnte außerdem gezeigt werden, dass
die Gene in den Gonaden der Tiere exprimiert werden. Die zelllinienspezifische Expression der
Gene in Hydra scheint eine Abgrenzung der interstitiellen Zellen von den beiden Epithelzelllinien
darzustellen.
Von besonderem Interesse war das DNA bindende Protein HyYY1, welches ein Homolog des Dro-
sophila Proteins Pho und des humanen Transkriptionsfaktors YY1 ist. In der Fruchtfliege bildet
Pho zusammen mit dSfmbt einen PcG Komplex namens PhoRC (Pleiohomeotic Repressive Com-
plex), welcher für die Rekrutierung der anderen PcG Protein-komplexe zu den Zielgenen verant-
wortlich ist. YY1 agiert als ein ’molekularer Adapter’ und verbindet die PcG Komplexe mit soge-
nannten Polycomb Response Elements (PREs). Diese cis-regulatorischen Elemente werden in der
Nähe von Zielgenen gefunden und sind für die Rekrutierung der PcG Proteine von Bedeutung.
Das Hydra Protein besitzt sowohl vier Zinkfinger, welche für die DNS-Interaktion verantwortlich
sind, als auch eine REPO-Domäne, welche für die Interaktion mit den PcG Komplexen notwen-
dig ist. Anhand von Gelretardations-Analysen konnte gezeigt werden, dass HyYY1 tatsächlich
sequenzspezifisch mit der DNS interagieren kann. Die Konsensussequenz entspricht dem CCAT-
Motiv von Drosophila und Säugern. In der Fruchtfliege wird diese Sequenz in PREs gefunden.
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Während dieser Arbeit wurde ein polyklonaler Antikörper gegen rekombinant exprimiertes HyYY1
hergestellt, welcher immunhistochemische Analysen und Methoden wie die Immunpräzipitation
(IP) erlaubt. Durch eine Co-IP konnte ein anfänglicher Hinweis auf die Interaktion von HyYY1
mit anderen PcG Proteinen erbracht werden. Dieses vorläufige Ergebnis muss allerdings verifi-
ziert werden. Desweiteren sollte bedacht werden, dass die Rekrutierung der PcG Komplexe in
Hydra nicht zwangsläufig über Pho/YY1 und PREs erfolgen muss. Zumindest in Säugern wur-
den weitere Mechanismen der Rekrutierung gefunden.
Die vorhandenen Antikörper gegen HyYY1 und weitere Hydra PcG Proteine ermöglichen zu-
dem Chromatin-IPs zur Identifizierung von Zielgenen. In einem Vorexperiment konnten bereits
Sequenzen des Hydra-Genoms präzipitiert werden. Sequenziertechniken der neuen Generation
erlauben die zukünftige Durchführung von ChIP-Seq Experimenten im größeren Maßstab und
die Identifizierung von PcG-Zielgenen in Hydra.
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11. Introduction
1.1. The freshwater polyp Hydra as a model organism
The freshwater polyp Hydra was first described at the beginning of the 18th century by
Antony van Leeuwenhoek in "Philosophical Transactions of the Royal Society" in 1702 as
a kind of "animalcule": "[...] Further, I discovered a little animal whose body was at times long,
at times drawn up short, and to the middle of whose body (where I imagined the undermost part
of its belly was) a still lesser animalcule of the same make seemed to be fixed fast by its hinder end.
[...]" (van Leeuwenhoek, 1702).
Some years later the Swiss naturalist Abraham Trembley studied Hydra in detail. In 1744
he published his findings in his book "Mémoires pour servir à l’histoire d’un genre de
polypes d’eau douce, à bras en forme de cornes" which was translated into German in
1791 ("Abhandlungen zur Geschichte einer Polypenart des süssen Wassers mit hörnerför-
migen Armen"). Not sure whether Hydra is an animal or plant, Trembley cut the polyp in
two halves and discovered that it can regenerate a complete head with tentacles. There-
fore he compared the freshwater polyp with the serpent-like water beast called Lernaean
Hydra of the greek mythology. The mythological beast possessed nine heads which grew
again after cutting them. It was a guardian of the entrance to the Underworld and was
killed by Herakles as second task of his Twelve Labours. Trembley coined the name Hy-
dra for the freshwater polyp. Furthermore, he was the first one to describe the locomotion
of Hydra, its asexual reproduction by budding and he discovered a positive phototactic
behavior in this eyeless animal. More remarkably, Trembley performed the first regener-
ation and transplantation experiments in Hydra: he discovered that Hydra can regenerate
a whole animal from a piece of tissue and that a piece of tissue can be grafted from one
polyp to another one (Trembley, 1744). In figure 1.1 an illustration of the ancient Greek
mythological Hydra and drawings of Hydra from the 18th century are depicted.
FIGURE 1.1 The appearance of Hydra. A Ancient black-figure water jar depicting the Greek hero
Herakles battling the Lernaean Hydra (date: about 525 B.C.; museum collection: The J. Paul Getty Museum,
Malibu, California, USA). B Hydra as drawn by van Leeuwenhoek in 1702. C Observations made on the
appearance of Hydra by Trembley in 1744. D A photograph of Hydra.
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In 1766 Peter Simon Pallas described in his book "Elenchus Zoophytorum" some more
Hydra species. He distinguished between Hydra oligactis, Hydra vulgaris, Hydra viridis-
sima and Hydra attenuata (Pallas, 1766).
About one and a half century later - in 1909, Ethel Nicholson Browne published her ob-
servations on grafting green Hydra (Browne, 1909). She was the first person who could
demonstrate that a transplant of hypostomal tissue could induce a secondary axis in Hy-
dra (figure 1.2). Some years later, Hans Spemann and Hilde Mangold did a very similar
experiment in amphibian embryos: a part of the blastopore lip of a gastrula stage embryo
induced a secondary axis when grafted into another gastrula stage embryo. The grafted
tissue ’organized’ its surrounding tissue (Spemann and Mangold, 1924). For their obser-
vation on the amphibian organizer, Spemann was awarded the Nobel Prize for Physiol-
ogy or Medicine in 1935.
FIGURE 1.2 Induction of secondary axes of polarity in Hydra and amphibians. (The induced secondary
axes are marked by an asterisk.) A A transplant of hypostomal tissue (white) can induce a secondary axis in
Hydra viridis (modified after Browne, 1909). B An eplant of a part of the blastopore lip of the newt Triturus
cristatus can induce a secondary neural tube and a secondary embryo in Triturus taeniatus. The figure shows
an embryo at the neural stage with primary and secondary axis (modified after Spemann and Mangold,
1924).
In the mid-20th century, the apparently simple freshwater polyp has been studied further.
Studies on Hydra’s stem cell lines and on the structure of its stinging cells, the nemato-
cysts - have been performed (Chapman and Tilney, 1959a,b; David and Campbell, 1972;
Campbell and David, 1974; David and Gierer, 1974). The high regenerative capacity and
pattern formation of Hydra became more and more interesting for developmental biolo-
gists (for a review see Bode (2003); Fujisawa (2003); Holstein et al. (2003); Bosch (2007);
Bosch et al. (2010)). Also its nerve net, which is one of the most simple neuronal systems
in the animal kingdom - is of special interest for revealing the basic principles of neuronal
differentiation (Davis, 1969; Dunne et al., 1985; Koizumi and Bode, 1986; Koizumi et al.,
1988, 1990). In the 2000th the genome of Hydra has been sequenced (Chapman et al., 2010)
and Hydra can be easily cultured in the laboratory in artificial Hydra Medium (Lenhoff,
1983) making it an ideal model organism. However, compared to other classical model
organisms like Drosophila, C. elegans, zebrafish or mice, Hydra has some major disad-
vatages as to functional studies:
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• No Hydra cell culture system exists. Cells can be kept in culture for some month
but they cannot be manipulated and they are not proliferating.
• There is still no possibility for knocking out genes. Although RNAi has been de-
scribed in Hydra, the technique could not be reproduced efficiently (Lohmann et al.,
1999; Galliot et al., 2007).
• Producing transgenic animals is feasible by now but still difficult (Wittlieb et al.,
2006). To obtain homozygous transgenic lines is laborious and transgenic lines are
often fragile in culture.
In the following sections, the characteristics of Hydra are described.
1.1.1. The position of Hydra in the metazoan phylogeny
Hydra belongs to the phylum Cnidaria. Besides the Porifera (sponges) and the Ctenophora
(comb jellies), the Cnidaria belong to the most basal metazoan animals (figure 1.3). Both
Ctenophora and Cnidaria are encompassed in the term Coelenterata. This term refers to
the hollow body cavity of the animals. The phylum Cnidaria has evolved over 700 mil-
lion years ago at the Precambrian time before the Cambrian explosion (Galliot and Miller,
2000; Chen et al., 2002). The following four classes belong to this phylum: Cubozoa (box
jellyfish), Scyphozoa (true jellyfish), Anthozoa (sea anemones and corals) and Hydrozoa
which includes Hydra. The phylum is one of the most species rich in the animal king-
dom. It consists of about 9000 species whose animals are exclusively found in acquatic
environments; most of the animals are marine. A common feature of all cnidarians are
the eponymous cnidocytes. They are also called ’nettle cells’ and are mainly used for
catching prey. These specialized cells are exclusively found in the cnidarian phylum.
The classification of the Cnidaria within metazoan evolution is however discussed con-
troversly (for a review see Ball et al., 2004; Martindale, 2005). There is a big discrep-
ancy between morphological data which describes the animals as radially symmetric
and molecular data describing them as bilateral symmetric. Interestingly the cnidarians
already have a large subset of genes which is found in bilaterian animals. The simple, ra-
dial symmetric body of cnidarians is not reflected by the level of gene expression. Based
on molecular data, the cnidarian phylum is classified to be a sister group to the Bilateria
(Kim et al., 1999; Medina et al., 2001). In order to better understand metazoan evolution,
the cnidarians are an interesting phylum to study.
Within the Cnidarian phylum, the Anthozoans are the most basal class (Kim et al., 1999).
The Hydrozoans are a sister group and have diverged from the Anthozoans at least 560
million years ago (Chen et al., 2002). Wheras the Anthozoan species have a bilateral sym-
metric body, the Medusozoa (Scyphozoa, Cubozoa and Hydrozoa) have a radial symmet-
ric body. Based on morphological data, it was proposed that the genus Hydra consists
of four species groups: viridissima, braueri, vulgaris and oligactis group (Campbell, 1989).
This classification was recently supported by molecular phylogenetic studies based on
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mitochondrial DNA (Kawaida et al., 2010). The model organism used during this thesis,
Hydra magnipapillata 105 belongs to the vulgaris group.
FIGURE 1.3 Overview of metazoan phylogeny. The cnidarians (in red) are placed as a sister group
to the Bilateria. They represent one of the most basal phylum in metazoan evolution. The position of the
placozoans (dashed line) in metazoan evolution is discussed controversely. This phylogenetic tree refers to
studies which position the placozoans basal relative to all other diploblast groups (Schierwater et al., 2009).
The length and distances of the branches of the depicted tree have been chosen at random and do not allow
a chronological or spacial classification. Innovations during evolution are indicated by grey dots.
1.1.2. Characteristics of the Hydra genome
The genome of Hydra magnipapillata 105 has been fully sequenced and published in 2010
(Chapman et al., 2010). It has been sequenced at the Joint Genome Institute using a
whole genome shotgun approach. The genome has been assembled into contigs and can
be accessed online at: http://hydrazome.metazome.net/cgi-bin/gbrowse/hydra/.
The Hydra genome is about 1.3 mega base pairs in size. It is very (A+T)-rich (over 70 %)
and includes a large number of transposable elements (over 50 %); the most abundant
is a non-long-terminal-repeat retroelement of the chicken repeat 1 family (CR1). Hydra
probably contains about 20000 protein coding genes based on EST data, homology and
gene prediction analysis (Table 1.1). An interesting feature of Hydra is the fact that genes
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TABLE 1.1 Some features of Hydra and its genome.
Features Hydra magnipapillata
class Hydrozoa
symmetry radial
medusa state no (secondarily lost)
polyp state solitary
habitat fresh water ponds, lakes and streams
reproduction asexual by budding and sexual
eggs per female 1 - 2
cell number in the adult polyp 50000 - 100000
diploid chromosome number 30
genome size 1.3 x 109 base pairs
protein coding genes ca. 20000
GC content 29 %
transposable elements 57 % of the genome size
mitochondrial genome two 8 kb linears
of Hydra undergo trans-splicing: A short trans-spliced leader sequence is added to the
5’ end of the messenger RNA which provides the opportunity to combine genes into
operons (Stover and Steele, 2001). 32 potential operons are found in the Hydra genome.
Amazingly, genes for all major bilaterian signaling pathways like Wnt (wingless/int-1),
TGF-β (transforming growth factor beta), Hedgehog, RTK (receptor tyroseine kinase) and
Notch are present in Hydra. There have also been found some non-metazoan, bacterial
genes which are candidates for horizontal gene transfer.
1.1.3. Morphology of Hydra
Like all cnidarians Hydra has one oral-aboral body axis and two body layers: ectoderm
and endoderm which are seperated by a acellular, jelly-like layer called mesoglea. The
mesoglea of Hydra is similar to the vertebrate basement membrane and has the charac-
teristics of an extracellular matrix (ECM). All major ECM proteins like collagen, laminin,
fibronectin and heperan sulfate proteoglycans have been found in the mesoglea (Sarras
et al., 1991a,b, 1993). The mesoglea is secreted by both epithelia. The column-like body
can be arranged into a ’head’ including the hypostome and tentacles and a body column
which can be subdivided into a gastric region, a budding region and the peduncle. Typ-
ically, an adult polyp has about 4 - 6 tentacles. The basal disc of Hydra is considered to
be its ’foot’. It can secrete a mucous by its ectodermal epithelial cells which allows the
polyp to stick to the underground. It can also secrete a gas bubble which allows floating
to the surface. Hydra is a rather small animal of about 0.5 - 2 centimetres in length. An
overview of Hydra’s morphology is depicted in figure 1.4.
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FIGURE 1.4 Morphology of Hydra. A Schematic picture of Hydra. The two body layers are depicted in
green (ectoderm) and blue (endoderm). The mesoglea is coloured in grey. The oral-aboral main body axis is
indicated by a dashed line. The different regions of the body are marked. The arrows indicate the direction
of Hydra’s constant cell flow. B Dark field image of an adult polyp of Hydra magnipapillata 105. Scale bar: 500
µm.
1.1.4. Cell types and capsules of Hydra
Hydra has three main stem cell lineages which are comprised by ectodermal epithelial
stem cells, endodermal epithelial stem cells and interstitial stem cells, which are often
abbreviated to I cells (for a review see Holstein, 1995). For an overview of the cellular
organization of the two body layers see figure 1.5.
The different cell types of Hydra are well described. A technique called maceration can
be used to separate the cells and to study the structure of the cells (Mundie, 1926; David,
1973). A maceration preparation and a schematic overview of Hydra’s cells is depicted in
figure 1.6.
Epithelial cells
The ectodermal epithelium secretes a glycocalyx made up of glycoproteins and polysac-
charides and has a protective function. The ectodermal epithelial cells are responsible
for osmoregulation (Prusch et al., 1976). The endodermal epithelial cells are used for in-
gestion by phagocytosis or pinocytosis and digestion. They possess two flagella to whirl
food particles inside the gastric cavity. Both epithelial cell lines have muscle protrusions
at their ends which are essential for contraction and elongation of the animal (Mueller,
1950; Haynes et al., 1968). Despite the fact that cnidarians are diploblastic animals that
lack an obvious mesoderm, many of the animals have muscle formation and mesoderm
marker genes like mef2, twist and snail (Martindale et al., 2004). The epithelial stem cell
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lines of Hydra are proliferating permanently generating a flow of cells from its body col-
umn to both the proximal and distal end of the animal and into its budding zone (Camp-
bell, 1967; Otto and Campbell, 1977). Their mean cell cycle time is about three days
(David and Campbell, 1972). Old cells are shedded at the tentacle tips and the basal disc.
The ectodermal epithelial stem cells can differentiate into basal disc cells and so-called
battery cells that can be found in the tentacles. The endodermal epithelial stem cells can
differentiate into tentacle endodermal cells and foot endodermal cells.
Interstitial cells
The third pluripotent stem cell line of Hydra, the I cells are of special interest. They can ei-
ther undergo germline differentiation into egg and sperm or somatic differentiation into
neurons, Hydra’s characteristic nematocytes and gland (zymogen) cells (Campbell and
David, 1974; David and Gierer, 1974; Bode and Flick, 1976; Bode et al., 1976). The gland
cells secrete proteolytic enzymes for digestion (Haynes and Burnett, 1963; Schmidt and
David, 1986). The I cells constitute about 75 % of Hydra’s cells. The mean cell cycle time of
I cells is about one day. The interstitial stem cells are found throughout the gastric region
of Hydra and seem to stay at their initial position, whereas the differentiating cells like
nematoblasts and neuroblasts seem to migrate rapidly to their final destination (Bosch
and David, 1990; Khalturin et al., 2007).
In Hydra one can distinguish between two classes of neurons: the ganglion cells and
the sensory cells (Davis, 1969, 1971; David and Gierer, 1974). Ganglion cells are bipolar
or multipolar nerve cells which are found throughout the body column and tentacles,
sensory cells are unipolar and can be found in the body column. The nerve cells differ-
entiate from neuronal precursor cells. After neural commitment, half of the cells migrate
towards the proximal and distal end, whereas the other half stays at their position and is
integrated into the nerve net (Bode and David, 1978; Heimfeld and Bode, 1985; Koizumi
and Bode, 1986; Koizumi et al., 1988, 1990). The exact mechanisms of neural differen-
tiation in Hydra are still unknown, but neuropeptides seem to play an important role
(Takahashi et al., 2000; Hayakawa et al., 2007; Takahashi et al., 2008).
The nematocytes or cnidocytes are a characteristic feature of cnidarians. The nemato-
cytes or stinging cells are regarded as mechanosensory or chemosensory neural cells
(Hausmann and Holstein, 1985). The interstitial cells divide synchronously into clus-
ters of 4, 8, 16 or 32 cells, the nematoblasts (David and Gierer, 1974). These cells are
connected by cytoplasmic bridges and each cell produces a capsule inside a secretory
vesicle (Holstein, 1981; Engel et al., 2002). After the capsule formation is completed, the
cell clusters break into single cells and migrate into the tentacles. Four types of cap-
sules can be distinguished in Hydra: stenoteles, atrichous isorhizas (stereoline glutinant),
holotrichous isorhizas (streptoline glutinant) and desmonemes (volvent) (Chapman and
Tilney, 1959a,b). In the tentacles, they are engulfed by specialized ectodermal epithelial
cells, the battery cells. Normally, there are about 1 - 2 stenoteles in a battery cell, which
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are surrounded by isorhizas and desmonemes. The stenotele is the most striking capsule
of Hydra. Its stylet apparatus is armed with spines and it is used for penetrating and
capturing prey. The holotrichous isorhiza has a tube populated with spinules and is sup-
posedly used for defense. The atrichous isorhiza is used for attaching to the substrate
during locomotion; the tube is devoid of spinules. Like stenoteles, the desmonemes are
used for capturing prey. However, their tubes are unarmed and coiled after discharge.
For an overview of Hydra nematocytes see figure 1.7.
FIGURE 1.7 Nematocytes of Hydra. In A a picture and a schematic overview of a battery cell are
depicted. A section of a tentacle with battery cells is shown in different magnifications in both pictures on
the left. The different capsule types can be easily distinguished. On the right, a schematic overview of a
battery cell is shown (modified after Hufnagel et al., 1985; Hobmayer et al., 1990). In B, pictures of isolated
capsules are shown. Both intact and discharged capsules are displayed. (Scale bar: 10 µm) (The capsule
preparation for taking the pictures in B has been kindly provided by Anna Beckmann, Holstein lab.)
The nematocyst is discharged upon mechanosensory or chemosensory stimulus; it is in a
complex with a cnidocil apparatus which can be compared to a ciliary receptor. The dis-
charge of nematocytes has been studied further in stenoteles (Tardent and Holstein, 1982;
Holstein and Tardent, 1984; Nüchter et al., 2006). The process is completed within three
milliseconds and the acceleration of the stilet is about 40000 g - which can be compared to
a technical bullet. The wall of the Hydra nematocytes has to resist an enourmous internal
osmotic pressure of 12.5 megapascals (Weber, 1989). To achieve its high tensile strength,
the capsule wall is built up of a special type of collagens: the minicollagens (Kurz et al.,
1991; Engel et al., 2001).
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1.1.5. The life cycle of Hydra - living forever?
Hydra belongs to a family of hydrozoans which secondarily lost its medusa state. The
solitary polyp state is its only appearance. It can proliferate either asexually by budding
or sexually. However, not all Hydra species develop gonads. For an overview of Hydra’s
life cycle see figure 1.8.
FIGURE 1.8 The life cycle of Hydra. Hy-
dra can either proliferate asexually by budding or
sexually. Asexual reproduction by budding is the
normal condition. Sexual reproduction is subjected
to environmental influence.
Polyps that reproduce asexually are potentially immortal. Asexual or vegetative repro-
duction takes place by budding. The budding process involves the simultaneous evagi-
nation of both ectodermal and endodermal layer. Tissue of the body column of the adult
Hydra polyp gets transformed into tissue of the novel forming bud by morphallaxis (Hol-
stein et al., 1991). The budding process is exclusively controlled by the epithelial stem cell
lines. Polyps that lost their interstitial stem cell line were still able to form buds (Camp-
bell, 1976; Sugiyama and Fujisawa, 1978). The buds form at the budding region of an
adult polyp. An adult polyp can bear more than one bud at a time, whereat the oldest
bud is next to the peduncle. The permanent proliferation of the epithelial cells and the
constant cell flow of Hydra render the asexual reproduction by budding possible. Figure
1.9 illustrates the process.
FIGURE 1.9 The asexual or vegetative reproduction of Hydra by budding is depicted schematically.
The arrangement of the different bud stages is adapted from Otto and Campbell (1977). In stages 1 - 5 the
ectoderm and endoderm evaginate, in stage 6 - 8 the evagination of the tentacles occurs. In the last two
stages (9 - 10) the peduncle region and the basal disc differentiate.
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Sexual reproduction in Hydra is possible but does not represent its standard form of re-
production. Normally, in higher metazoan animals a seperate germ line exists. However,
Hydra is considered to be a metazoan lacking a distinct germ line. There is evidence
that the interstitial stem cell line gives rise both to somatic cells and germ cells (Bosch
and David, 1987). Cloning experiments showed that an interstitial cell population ex-
ists which could only differentiate into eggs (Littlefield, 1991) or sperm (Littlefield, 1985;
Nishimiya-Fujisawa and Sugiyama, 1993). The sexual phenotype of Hydra is exclusively
determined by the I cell line (Bosch and David, 1986); No sex chromosome was found in
Hydra. There are Hydra species that are gonochroistic or hermaphroditic. In some Hydra
species sex reversal can occasionally be observed. Figure 1.10 provides an overview of
the sexual reproduction.
FIGURE 1.10 Schematic overview of the sexual reproduction of Hydra. In the upper part, an
overview of oogenesis and embryogenesis is given, the lower part depicts the spermatogenesis. At the
beginning of oogenesis, numerous I cells accumulate in the inter-cellular space of the ectoderm (stage 1/2).
One central I cell is commited to become the future oocyte (red), the surrounding I cells become nurse cells
(green). A so-called egg patch becomes visible (stage 3). The oocyte increases in volume and phagocytizes
adjacent apoptotic I cells. The mature oocyte breaks through the ectodermal layer and rests in the so-called
egg cup (stage7). At this stage, the oocyte is ready to be fertilized. The different stages are adapted from
Miller et al. (2000). The first cleavages after fertilization are unilateral, which means that the blastomeres
are still interconnected by plasma bridges. During gastrulation, a small number of cells immigrates into the
blastocoel to form the endodermal layer. After gastrulation (64-cell stage), the ectodermal embryonic cells
secrete a two-cell layered cuticle to protect the embryo from dehydration (spike stage embryo). After an
arrested stage which can last up to 12 month, the young polyp is hatching. Spermatogenesis in Hydra begins
with a proliferatio of I cells in the region of the emerging gonad. After 3-4 days a mature gonad has formed
in which the developmental stages of the spermatozoans exist in different layers. The mature sperms are
released into the surrounding medium.
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1.1.6. Regeneration in Hydra - some remarkable features
Due to its highly dynamic tissue composition and the stem cell character of its cells, the
freshwater polyp Hydra has a remarkable regenerative capacity: it can regenerate ’head’
or ’foot’ after amputation, and it can regenerate a whole animal from a small piece of
tissue (figure 1.11). This exceptional high regenerative capacity was already detected 250
years ago by Abraham Trembley. During regeneration, the original polarity of the animal
is retained: a head will regenerate at the apical end and a foot at the basal end. Hydra’s
epithelial stem cell lines are responsible for regeneration; Experiments with animals lack-
ing interstitial cells showed normal regeneration (Holstein et al., 1991).
Even more striking is the fact that dissociated Hydra cells can reaggregate, reorganize and
regenerate a normal animal after a short time (Noda, 1970; Gierer et al., 1972). In disso-
ciated cell of Hydra, all positional information is lost and the process of regeneration and
pattern formation can be studied from the very beginning (for a reviw see Holstein et al.
(2003); Bode (2003, 2009). During Hydra regeneration no dedifferentiation or blastema
formation occurs like in vertebrates. Instead, the process of regeneration is a morpho-
genetic process that involves subsequent cell adhesion, ecto-endo sorting, formation of
the two epithelia and differentiation of head and foot (Technau and Holstein, 1992).
FIGURE 1.11 Hydra has an almost unlimited regeneration capacity (after Bode (2003)). From A - D the
regeneration of missing body parts is illustrated. Hydra can regenerate a new head or foot when bisected. It
can regenerate both head and foot or even can regenerate from a small piece of tissue. In E the time course of
head regeneration is depicted. Hydra can regenerate a new head within 48 hours. Head regeneration and the
formation of a new organizing center is strongly dependent on the wnt pathway. F illustrates the process of
reaggregation. Cell adhesion is followed by the formation of the two epithelial layers and the differentiation
of head and foot structures.
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Alfred Gierer and Hans Meinhardt (Gierer and Meinhardt, 1972; Meinhardt and Gierer,
1974) set up a theoretical model for pattern formation processes: the activator/inhibitor
model. This model is based on an auto-catalytically regulated activator, which also reg-
ulates the expression of its own inhibitor. A minimal excess of the activator can shift
the balance, and both activator and inhibitor are expressed at elevated levels. Since the
inhibitor has a longer diffusion range, the activator expression in the surrounding tis-
sue is repressed and a defined signaling center/organizer is established. A version of
this model can be applied to Hydra head formation and especially regeneration (figure
1.12). It has been proposed that a so-called ’head activator’ is the key factor triggering
head formation (Schaller and Gierer, 1973; Schaller, 1973). However, the ’head activator’
molecule remains elusive. More recent studies provide evidence that the pattern forma-
tion process and the formation of new head organizing centers is controlled by the Wnt
signaling pathway, which has been shown to be important for the function of vertebrate
organizers (Hobmayer et al., 2000; Lengfeld et al., 2009). MacWilliams (1982) could show
that the head regeneration is a two step process which is in accordance with the activa-
tor/inhibitor model. The simulation of Meinhardt (1993) assumes that the signals for the
formation of the head, tentacles and foot are generated by seperate activator/inhibitor
systems. A so-called source density gradient links the systems together. According to
the model, tentacles are forming in the region of the highest source density/morphogen
concentration that is not occupied by the head signal. Upon decapitation, the concen-
tration begins to rise and temporarily reaches the threshold level of the tentacle zone.
New tentacles are forming, the concentration increases further and reaches the hypos-
tome level. Bode et al. (1988) could visualize the process by means of antibody stainings
with a tentacle specific antibody (TS-19). The described setting comes true for an ampu-
tation at 80% body length. If the animal is amputated at 50% body length, the hypostome
level is reached first, followed by the tentacle level.
FIGURE 1.12 ’Activator/inhibitor’ model for pattern formation in Hydra. Different activator/inhibitor
systems are responsible for the formation of the head, tentacles and foot. The systems are coupled by the
source density gradient(blue). Whereas the source density gradient is increased by the head system (green),
it is decreased by the foot system (pink). The tentacles (red) are built in the region of the highest source
density that is not occupied by the head signal. After amputation, the signals are regenerated with the
correct polarity. The figure on the right depicts the process of head regeneration and tentacle formation as
visualized by TS-19 monoclonal antibody (Bode et al., 1988). The signal appears at the most apical part of
the tip and shifts to the tentacles at later stages. The figure was adapted from Meinhardt (1993, 2009)
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1.2. Polycomb Group proteins and epigenetics
1.2.1. What are epigenetics?
The term ’epigenetics’ originates from the theory of ’epigenesis’, which was described by
Aristotle in the book "On the Generation of Animals". The term describes the develop-
ment of an organism through a sequence of unfolding steps in which new structures and
organs will differentiate which have not been existing in the original egg or spore. This
definition of ’epigenesis’ was used by developmental biologists and embryologists in the
17th century and was opposed by the theory of ’preformationism’. The preformationists
held the view that the later form of an organism is already existing in the egg.
A more recent concept of epigenetics was first characterized by Conrad Hal Waddington
to describe the entire developmental process from the fertilized egg to the mature organ-
ism as an interplay between genes and their surroundings to produce a phenotype. He
coined the term ’epigenetics’ to link the field of developmental biology and genetics.
"But the difference between an eye and a nose, for instance, is clearly neither genotypic nor phe-
notypic. It is due, as we have seen, to the different sets of developmental processes which have
occurred in the two masses of tissue; and these again can be traced back to local interactions be-
tween the various genes of the genotype and the already differentiated regions of the cytoplasm in
the egg. One might say that the set of organizers and organizing relations to which a certain piece
of tissue will be subject during development make up its "epigenetic constitution" or "epigeno-
type"; [...]" (Waddington, 1939).
However, this concept of ’epigenetics’ is still very broad and differs substantially from
today´s acception of the word. In 1996, Riggs and Porter described epigenetics as "the
study of mitotically and/or meiotically heritable changes in gene function that cannot be
explained by changes in the DNA sequence" (Riggs and Porter, 1996). This definition can
be seen as a working definition of epigenetics. Many apparently unexplainable phenom-
ena contributed to this definition over time, like position effect variegation in Drosophila
(Müller, 1930), transposable elements in maize (McClintock, 1950), X-chromosome inacti-
vation (Lyon, 1961), genomic imprinting (Cattanach and Kirk, 1985) or DNA methylation
(Holliday and Pugh, 1975).
1.2.2. Epigenetic modifications
Several epigenetic inheritance systems exist, including chromatin remodeling, RNA tran-
scripts (e.g. RNAi), prions and cellular structures like ciliary rows in paramecium. Chro-
matin remodeling and epigenetic modifications on the chromatin level are further de-
scribed in this section. Epigenetic modifications can be found on different levels of chro-
matin organization. The genetic information (DNA) in higher eukaryotes is about two
meters long and needs to fit into a nucleus of about 10 micrometers. The secret lies in
packaging: The DNA is wrapped around protein complexes, the histones, and is thus
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maximally condensed (Kornberg, 1974; Luger et al., 1997). 147 base pairs of DNA are
wrapped around a histone octamer, composed of two histone H2A/H2B dimers and one
H3/H4 tetramer. This basic unit of chromatin is called nucleosome. Repeating units of
nucleosomes constitute the so-called 10 nm-fiber, which is further compacted in the pres-
ence of the linker histone H1 and other scaffolding proteins. However, chromatin has
not only packaging functions, but it plays an important role in gene regulation. Within
the cell, chromatin is existent in two different states. Whereas actively transcribed genes
can be found in open regions of euchromatin, the less active or repressed genes are at
regions of more densly packed heterochromatin (Weintraub and Groudine, 1976). Mech-
anisms regulating the accessibility of the DNA template by stably altering higher-order
chromatin structure have to exist. The chromatin structure is highly dynamic and modi-
fications can be found on different levels of chromatin organization (figure 1.13):
• DNA modification (methylation of cytosine residues)
• histone modifications (methylation, acetylation, phosphorylation, ubiquitination)
• histone variants
• proteins that bind to histone or DNA modifications.
FIGURE 1.13 Overview
of chromatin modifications
involved in epigenetic mech-
anisms.
Modifications of the histone tails by chromatin modifying enzymes are of special inter-
est in the context of epigenetic inheritance and gene regulation. In 1950, Stedman and
Stedman proposed that histones could play a role in gene regulation. Allfrey et al. (1964)
were the first ones to observe the relationship between histone modifications and gene
activation or repression. The importance of histone modifications and histone modify-
ing enzymes in gene regulation began to reveal. The first modification which was linked
to gene activation was the acetylation of histones (Brownell et al., 1996). In the same
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year, the first eukaryotic histone deacetylase (Rpd3) was discovered in yeast. In 1999,
histone methyltransferases and their role in transcriptional regulation were described
(Chen et al., 1999). All these discoveries led to the ’histone code’ hypothesis of Jenuwein
and Allis. They proposed that modifications of histone tails form a kind of language or
cross-talk, which is read by other proteins facilitating distinct events like transcriptional
activation or repression of target genes (figure 1.14).
One of the repressive histone marks is the trimethylation of histone H3 at lysine 27, which
is set by the Polycomb Group (PcG) proteins. These proteins are introduced further in
the next sections.
FIGURE 1.14 The histone code: sites of histone tail modifications (adapted from Allis et al. (2006)).
In the left corner a 2.5 Å structural model of a nucleosome is depicted. 147 base pairs of DNA (gray) are
wrapped around a histone octamer composed of two copies of histones H2A (yellow), H2B (red), H3 (blue)
and H4 (green), respectively. The picture was generated using a molecular graphics visualisation tool based
on RasMol (by Roger Sayle). The underlying nucleosome structure was retrieved from the Protein Data Bank
entry 3AFA (www.pdb.org/). The histone tails of the core histones with known sites of covalent modifica-
tions are illustrated. Active marks include acetylation, arginine methylation and some lysine methylations.
Repressed marks include methylations on H3K9, H3K27 and H4K20.
1.2.3. The identification of Polycomb Group (PcG) and Trithorax Group
(TrxG) proteins
In a developing organism some genes have to be active whereas other genes have to be in-
active to assure proper development. In multicellular organisms, different cell types have
to perform varying functions, despite holding the same genetic information encoded in
their DNA. The difference lies in the variable gene expression patterns. The particular
challenge exists in maintaining the gene expression patterns during cell division after
the initial stimulus has disappeared. A cellular or transcriptional memory system which
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ensures the long-term maintenance of transcriptional states has to exist (Paro and Harte,
1996). The PcG and TrxG proteins have been first identified in the context of long-term
maintenance of HOX (homeobox) gene expression in Drosophila. In metazoans, HOX
gene expression defines the anterior-posterior axis of the animal and PcG mutants show
severe homeotic transformations. In figure 1.15 mutant phenotypes caused by homeotic
transformations are depicted.
FIGURE 1.15 Examples for homeotic transformations in PcG mutants. Left: Homeotic transformations
in a Drosophila Pc-mutant. A wild-type Drosophila larva with the correct sequence of segments is shown on
the left. On the right site, a Pc-mutant larva is depicted. The segments are transformed and the larva
shows severe brain defects (Müller et al., 1995). Middle: The axial skeleton of newborn wild-type (left) and
homozygous bmi1 mutant (right) mice are shown. The mutant mouse shows defects in the sacral vertebra.
The first sacral vertebra is transformed to the sixth lumbar vertebra (Alkema et al., 1995). Right: A wild-type
(top) and a clf-2 mutant flower (bottom) of Arabidopsis. In the mutant flower, the petals are absent (Goodrich
et al., 1997).
In 1978 Lewis identified the Polycomb (Pc) gene as a negative trans-regulator of the Drosophila
bithorax complex. Heterozygous and homozygous mutants were caused by ectopic ex-
pression of HOX genes. Some years later, in 1985, the Trithorax (Trx) gene has been
identified as a trans-regulator of the Drosophila bithorax and Antennapedia complex (In-
gham, 1985). Genes of the Trithorax Group have been shown to counteract the Poly-
comb Group genes (Kennison and Tamkun, 1988). PcG proteins propagate repressed
chromatin states, whereas TrxG proteins propagate the active states. The first evidence
for the direct interaction between Pc and homeotic loci was the binding pattern of Pc
on Drosophila polytene chromosomes (Zink and Paro, 1989). Due to similarities to the
Drosophila heterochromatin-associated protein HP1, it was hypothesized that the mech-
anism of action of the PcG proteins is an epigenetic mechanism by nature (Paro and
Hogness, 1991). It has been discovered that PcG and TrxG proteins act in multimeric
protein complexes to regulate higher order chromatin structure (Franke et al., 1992). The
first mammalian PcG gene which has been discovered was the oncogene Bmi-1. It could
be shown that Bmi-1 is a member of a vertebrate PcG complex and is involved in HOX
gene repression as well (Brunk et al., 1991; Bunker and Kingston, 1994; Alkema et al.,
1995). By substituting the Drosophila Pc protein for its mammalian counterpart, it could
be demonstrated that the protein is functionally conserved (Müller et al., 1995). In 1997,
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the first PcG member was identified in plants: CURLY LEAF (Goodrich et al., 1997).
In the following years, the PcG and TrxG proteins have been linked to various epige-
netic phenomena like cosuppression, X-inactivation, genomic imprinting and RNAi (Pal-
Bhadra et al., 1997; Wang et al., 2001; Mager et al., 2003; Plath et al., 2003; Silva et al., 2003;
Grimaud et al., 2006). Furthermore the interaction of PcG proteins with general transcrip-
tion factors and histone modifications has been shown (Cavalli and Paro, 1999; Breiling
et al., 2001; Saurin et al., 2001).
1.2.4. The Polycomb Group response elements (PREs)
In Drosophila many of the genes regulated by PcG proteins are controlled by a so-called
Polycomb response element (PRE) or cellular memory module (CMM). PREs are cis-
regulatory elements that direct the genes to be active or repressed; a switch between the
ON and OFF state can occur (reviewed in Ringrose and Paro (2001, 2004, 2007)). Besides
genes involved in cell cycle regulation and senescence, developmental regulators, among
which the homeotic genes can be found - have been shown to be regulated by PcG and
TrxG proteins and controlled by PREs (Mihaly et al., 1998). Not only the homeotic genes
are controlled by PREs, but also their initial transcriptional regulators, the segmentation
genes (gap, pair rule and segment polarity genes).
PREs are switchable elements that can be turned from a silent to an active state during
development. The new state can be maintained over several rounds of cell division. Bus-
turia et al. (1997) showed that the PRE itself is directly involved in keeping the silent state
during cell cycle. Removal of the PRE caused a derepression of its controlled gene. To
further identify and study the nature of Polycomb response elements, PRE maintenance
assays based on transgene reporter constructs have been performed in many classical
studies. In figure 1.16 the assembly of such a transgene assay in Drosophila is depicted
schematically.
FIGURE 1.16 PRE maintenance assay in Drosophila based on a transgenic reporter construct. A
potential PRE fragment is flanked by an enhancer and a reporter gene. As reporter, lacZ or the Drosophila
mini-white gene may be used. The transgene construct can be tronsformed into Drosophila by P-element
transformation. In case the used PRE fragment functions as PRE, the PcG complex can bind and lacZ or mini-
white are silenced. The resulting phenotype shows white eyes and no lacZ expression pattern, respectively.
In case the potential PRE fragment shows no PRE function, the reporter genes are activated and expressed.
The fly has wild-type red eyes or shows a lacZ expression pattern dependent on the enhancer used.
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It could be demonstrated that the initial configuration of a PRE is not necessarily persis-
tent. PRE-directed gene silencing can be relieved and the resulting active state persists
during cell division (Cavalli and Paro, 1998, 1999). By using a transgene carrying the
Fab7-PRE from the Drosophila Bithorax complex flanked by a lacZ reporter gene driven
by the GAL4 transcriptional activator, it could be shown that a burst of GAL4 transcrip-
tion can switch the PRE from a silent configuration to an active one. Whether this active
state is transient or persistent depends on the time point during development at which
the transcriptional burst occurs. At least, for the transient activation, a memory system
has to exist, allowing the PRE to ’remember’ its initial state and to become inactivated
again after several rounds of cell division.
PREs do not act alone but in groups. For instance it has been shown for the homeotic
genes that one gene is controlled by two or more PREs (Simon et al., 1993). To identify
the minimal required PRE, a reporter construct containing a PRE fragment flanking a
tissue-specific enhancer for the Ubx gene followed by the Ubx promoter and a LacZ re-
porter gene has been used (Horard et al., 2000). In case the fragment has PRE activity, it
should maintain the correct pattern of lacZ expression. Yet, a universal minimal PRE has
not been identified up to now.
It has been shown that PcG proteins need to interact with the PRE to maintain its inactive
configuration (Beuchle et al., 2001; Poux et al., 2001a). After knocking-out the PcG genes,
a dramatic loss of silencing occurs.
1.2.5. The Polycomb Repressive Complexes (PRCs)
It has been suggested that the PcG proteins act in different complexes (Beuchle et al.,
2001). There has to exist one complex forming the memory mark for maintaining silence
during cell division and another, true repression complex which is responsible for gene
silencing. These complexes have been termed Polycomb repressive complexes (PRCs).
In Drosophila three major Polycomb Repressive Complexes (PRCs) have been described:
PRC1, PRC2 and PhoRC. There is evidence that the composition of these complexes is
dynamic and is dependent on tissue and target genes (Strutt and Paro, 1997; Orlando
et al., 1998; Satijn and Otte, 1999). For most of the members of the complexes, mammalian
homologues have been identified (Levine et al., 2002). For an overview of the members
of the repressive complexes see table 1.2.
PRC2
The Drosophila PRC2 complex is a 600 kDa complex composed of the proteins E(z), Esc,
Su(z)12 and the histone-binding protein p55. Tie et al. (2001) reported that the histone
deacetylase Rpd3 co-fractionates with the PRC2 members. The PRC2 complex methy-
lates histone H3 via the SET domain of its catalytic subunit E(Z) (Cao et al., 2002; Czer-
min et al., 2002; Müller et al., 2002; Kuzmichev et al., 2002). Proteins with SET domains
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TABLE 1.2 Drosophila PcG complexes and associated factors.
Drosophila PcG gene functional domain Mus musculus homologue
Polycomb Repressive Complex 1 (PRC1)
Pc Polycomb chromodomain Cbx2 / M33
Cbx4 / MPc2
Cbx6
Cbx7
Cbx8 / MPc3
Ph-p, Ph-d Polyhomeotic zinc finger,
SAM/SPM domain
Edr1 / Mph1 / Rae28
Edr2 / Mph2
Psc Posterior Sex Combs zinc finger, HTH do-
main
Bmi1
Rnf110 / Zfp144 /
Mel18
dRing / Sce dRing / Sex combs
extra
RING zinc finger Ring1 / Ring1a
Rnf2 / Ring1b
Scm Sex Combs on Mid-
leg
SAM domain, MBT
domain, zinc finger
Scmh1
Polycomb Repressive Complex 2 (PRC2)
E(z) Enhancer of zeste SET domain Ezh2 / Enx2
Ezh1 / Enx1
Esc
Escl
Extra sex combs WD40 repeats Eed
Su(z)12 Suppressor of zeste
12
zinc finger, VEFS box mSU(Z)12
p55 / Nurf-55
(Caf1)
p55 histone-binding
domain
RbAp48
RbAp46
Pleiohomeotic Repressive Complex (PhoRC)
Pho Pleiohomeotic zinc finger Yy1
Phol Pleiohomeotic-like zinc finger Yy2
dSfmbt Scm-related gene
containing four mbt
domains
MBT domain, SAM
domain
L3mbtl2
PcG recruiters
Dsp1 Dorsal switch protein HMG-box Hmgb1|1
Grh Grainyhead CP2 domain Grhl2
Gaf / Trl Gaga factor /
Trithorax-like
BTB domain, zinc fin-
ger
Zbtb7b
Lolal Lola-like BTB domain ?
Psq Pipsqueak HTH-psq domain ?
Zeste Zeste ? ?
PRC2 associated factors
Pcl Polycomb-like PHD zinc finger Phf1
Rpd3 Rpd3 Histone deacetylase
domain
Hdac2
Sir2 Sirtuin SIR2 domain Sirt1
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have been discovered to possess a histone lysine methyltransferase (HKMT) activity (Rea
et al., 2000). The PRC2 complex has been shown to methylate histone H3 at two lysine
residues via E(z): at lysine 27 and to a lesser extent at lysine 9 (Cao et al., 2002; Czer-
min et al., 2002; Müller et al., 2002; Kuzmichev et al., 2002). Both methylation marks
are associated with transcriptional silencing. However, E(z) cannot act on its own. The
minimal PRC2 complex displaying HKMT activity is composed of E(z), Su(z)12 and Esc.
In addition to its HKMT activity, the PRC2 complex could also possess other chromatin-
modifying activities. In some variants, the histone deacetylase Rpd3/HDAC2 has been
found (Tie et al., 2001).
Additional PRC2 related complexes like PRC3 and PRC4 have been identified. The PRC3
and PRC4 complexes can be distinguished from the PRC2 complex by their Eed isoforms
(Kuzmichev et al., 2004, 2005). The PRC3 complex is composed of E(z), Su(z)12, p55 and
two shorter Eed isoforms. This complex has been shown to methylate lysine 27 on hi-
stone 3 (H3K27), whereas the PRC2 complex with the longest isoform of Eed has been
shown to methylate lysine 26 on histone H1 (H1K26).
Interestingly, the PRC2 complex can also be linked to gene silencing dependent on DNA
methylation. Mammalian DNA can be modified by methylation at CpG dinucleotides.
DNA methylation patterns are heritable epigenetic marks which are associated with gene
silencing (for a review see Bird (2002)). For example X-inactivation and genomic imprint-
ing have been linked to DNA methylation. Viré et al. (2006) could demonstrate that the
Enhancer of zeste subunit in the context of PRC2/3 complexes can serve as a platform
for the recruitment of DNA methyltransferases (DNMTs). It could be shown that E(z) is
needed for the DNA methylation of its own target genes. Both histone methylation and
DNA methylation could be connected with each other. This mechanism displays another
possibility for PcG mediated gene silencing, which is only dependent on PRC2.
PRC1
The PRC1 complex was first purified from Drosophila and contains Pc, Psc, Ph-p, Ph-d,
Scm and Sce/dRing (Shao et al., 1999). The complex is 1-2 MDa in size. A functional core
complex composed of Pc, Psc, Ph and dRing could be reconstituted in vitro and has been
shown to block transcription and nucleosome remodelling mediated by the SWI/SNF
ATPase complex (Francis et al., 2001). The PRC1 complex can recognize the epigenetic
methylation mark set by the PRC2 complex via the chromodomain of PC (Min et al., 2003;
Fischle et al., 2003).
A human Polycomb Repressive Complex 1-like (hPRC1L) composed of Ring1, Ring2,
Bmi1 and HPH2 has been shown to possess E3 ubiquitin ligase activity which is specific
for lysine 119 on histone H2A. The monoubiquitination of H2AK119 could be dramat-
ically decreased by knocking down Ring2 or Bmi1 leading to a derepression of target
genes (Wang et al., 2004a; Cao et al., 2005). The E3-ligase activity seems to be critical for
PcG-mediated silencing and the establishment of a repressed chromatin state.
1.2. POLYCOMB GROUP PROTEINS AND EPIGENETICS 23
General transcription factors like TBP and dTAFIIs have been co-purified with PRC1
(Breiling et al., 2001; Saurin et al., 2001). Apart from altering higher-order chromatin
structure, one functional aspect of the PcG proteins is the direct inhibition of the tran-
scriptional apparatus (Dellino et al., 2004).
PhoRC
The exact mechanism of interaction between the PcG proteins and their mode of action
is still unclear. But it has been shown that PC (PRC1) and ESC (PRC2) need to interact
transiently with each other to establish gene silencing (Poux et al., 2001b). Whereas the
PRC2 complex is responsible for setting up the histone mark for a silent transcriptional
state, the PRC1 complex is responsible for the establishment of the silent state. However,
none of the members of the PRC1 and PRC2 complexes has been shown to bind to DNA
in a sequence-specific manner. Consequently the question arises: How do PcG proteins
find their target genes?
Several candidate proteins with a sequence-specific DNA binding activity have been
linked to the targeting of the PcG complexes: Pleiohomeotic (Pho), Trithorax-like (Trl),
Dorsal switch protein (Dsp1), Pipsqueak (Psq) or Zeste. Pleiohomeotic and the redun-
dant Pleiohomeotic-like are the most promising candidates. Pho is the Drosophila homo-
logue of the mammalian transcription factor Yin Yang-1 (YY1) and belongs to the PcG
genes. Pho has been shown to interact with a number of PREs, like the Drosophila en-
grailed and Ultrabithorax PRE (Brown et al., 1998; Fritsch et al., 1999; Brown et al., 2003). It
has been suggested that Trl or Dsp1 assist Pho in binding to PRE sites (Mahmoudi et al.,
2003; Déjardin et al., 2005) Additionally, it could be demonstrated that the C-terminal
binding protein (CtBP) plays a role in controlling the binding of Pho/YY1 and the re-
cruitment of PcG proteins to PREs (Srinivasan and Atchison, 2004; Basu and Atchison,
2010).
Even though identified as a PcG protein, Pho could neither be found in the PRC1 nor the
PRC2 complex. In lieu thereof, Pho could be detected in assemblies containing a dINO80
complex or dSfmbt. Following the terminology of the other repressive complexes, the
Pho-dSfmbt complex was termed Pleiohomeotic Repressive Complex (PhoRC) (Klymenko
et al., 2006). Besides PRC1 and PRC2, the PhoRC complex can be seen as the third major
PcG complex with the following subunits: Pho, Phol and dSfmbt. Wang et al. (2004b)
reported that Pho can directly interact with the PRC2 complex via E(z) and Esc and that
Pho is required for PRE binding by E(z). Yet, in this study neither the PRC2 complex nor
the PhoRC complex could recruit PRC1.
A hierarchical model of PcG mediated gene silencing can be set up: In a first step, the
PhoRC complex binds to a PcG target site and recruits the PRC2 complex which methy-
lates histone H3 on lysine 27. In a second step, the methylation mark is recognized by
the PRC1 complex, which is recruited. Figure 1.17 illustrates the mechanism of action.
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FIGURE 1.17 Cartoon illustration the PcG dependent silencing mechanism in Drosophila. A To
maintain the inactive transcriptional state, the PcG complexes have to inactivate the target gene PRE site. In
a first step, the PhoRC complex with its subunits Pho, Phol and dSfmbt binds to the PRE site. B Through the
interaction with PhoRC, the PRC2 complex composed of E(z), Esc, Su(z)12 and p55 is recruited to the target
gene. The PRC2 complex establishes the H3K27me3 epigenetic mark via the histone methyltransferase E(z).
In turn, the histone mark is recognized by the PRC1 complex. The PRC1 complex consists of Pc, Ph, Psc
and Sce/dRing. Pc can interact with H3K27me3 via its chromodomain and thereby recruit the complex. C
The PRC1 complex can establish transcriptional silencing of the target gene by ubiquitination of H2AK119
followed by chromatin remodeling.
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1.2.6. Transmission of the H3K27me3 epigenetic mark through the cell cycle
A big question concerns the transmission of the H3K27 epigenetic mark through the cell
cycle. The silent chromatin state needs to persist during cell division for an effective
long-term repression and the maintenance of cell identities. It has been proposed that
the PRC2 complex can recognize and bind to its own methylation mark (H3K27me3)
and copies this mark to neighbouring histones during DNA replication (Hansen et al.,
2008; Hansen and Helin, 2009; Margueron et al., 2009). Another study suggested that
the Polycomb core complexes are retained on their DNA templates during passage of the
replication fork and that the H3K27me3 mark is not essential (Francis et al., 2009); the
PRC1 complex remains continuously bound. Hence, the transmission of the epigenetic
mark during cell cycle seems to be dependent on the Polycomb repressive complexes
themselves.
Another question concerns the removal of the H3K27me3 epigenetic mark. Since pro-
liferation and development are highly dynamic processes and genes are differentially
expressed, a possibility to reset the H3K27me3 epigenetic mark has to exist. For a long
time, no possibility for removing the epigenetic mark has been known. The mark seemed
to be irreversibly bound. In 2007 a H3K27me3 demethylase has been discovered (Ag-
ger et al., 2007; Santa et al., 2007; Hong et al., 2007; Lan et al., 2007; Lee et al., 2007).
The JmjC-domain-containing proteins UTX and JMJD3 have been shown to catalyze the
demethylation of H3K27me3/2.
1.2.7. PcG targeting mechanisms in Drosophila and mammals
PRE-dependent PcG protein targeting in Drosophila
In Drosophila, PcG proteins are recruited to their target genes in a PRE-dependent manner.
The PRE site is recognized by the PhoRC complex, which recruits the other repressive co-
molexes.
To predict and identify PcG target genes in Drosophila, the PRE elements were identified.
About 100 PREs have been assumed in the Drosophila genome. The search has been ex-
ceedingly difficult in the beginning due to the lack of a PRE consensus sequence. The
identification of PREs and PcG target genes was dependend on functional assays like
transgene analysis or chromatin immunoprecipitation. With these classical approaches,
the PREs at the following loci have been found in Drosophila: homeotic genes at the bitho-
rax (BX-C) and Antennapedia complexes (ANT-C), the engrailed, polyhomeotic and hedge-
hog genes (Simon et al., 1993; Strutt and Paro, 1997; Brown et al., 1998; Americo et al., 2002;
Maurange and Paro, 2002; Bloyer et al., 2003; DeVido et al., 2008). However, stainings on
Drosophila polytene chromosomes revealed over 100 sites (Zink and Paro, 1989; Rastelli
et al., 1993). In 2003 Ringrose et al. defined sequence criteria to distinguish PRE sites from
non-PRE sites based on previously identified PREs. Binding motifs for GAF/Trl, Zeste
and Pho have been shown to be required for the function of several PREs. A genome-
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wide prediction identified 167 PRE sites in Drosophila which have been further analyzed
concerning their functionality. PREs have been found in the vicinity of genes involved
in development and cell proliferation like hunchback, knirps, giant, even skipped, engrailed,
hedgehog, armadillo, wingless, eyes absent, proliferation disrupter or lethal(2) giant larvae. Five
significant PRE sequence motifs have been identified in that study (table 1.3):
TABLE 1.3 Left: DNA binding proteins which are known to play a role in PRE binding and their
consensus motif. Right: motifs which have been found to be significantly enriched at PRE sites and DNA
binding proteins known to interact with these sequences.
DNA binding
protein
Sequence motif
Pleiohomeotic/
Yin Yang-1
GCCAT
Trithorax-like/
GAGA factor
GAGAG
Zeste (C/T)GAG(C/T)GAG
PRE motif DNA binding
protein
AGAGAGAGAGAG Trxl/GAF
GGCCGCCATTTT Pho/YY1
GTGTGTGTGTGT ?
TTTTTTTTGCTT hunchback?
TGCTGCTGCTGC ?
Initially, PREs have been discovered in Drosophila (Simon et al., 1993). PREs in other
species remained elusive for a long time. The first vertebrate PREs have been identified
recently. Sing et al. (2009) identified a vertebrate PRE which regulates the MafB/Kreisler
segmentation gene in mice. Inversion of kreisler (kr) shifts the MafB expression in the
embryonic hindbrain anteriorly. It is postulated that the kr inversion antheriorizes MafB
expression by affecting a PRE site. In M33 mutant mice the MafB expression is affected.
By examining the kr inversion breakpoint, a conserved region, several Pho/YY1 binding
sites and GAGAG motifs could be identified. Even a palindromic double Pho-binding
site as in conserved Drosophila core elements has been found. The PRE was termed PREkr.
Functional transgene assays with PREkr in Drosophila and mice revealed that the identi-
fied PRE can repress gene expression of a reporter gene. Knocking-down Pho or PRC1
components derepressed the reporter gene. A second mammalian PRE was identified by
Woo et al. (2010). A region between HOXD11 and HOXD12 (D11.12) which is associated
with PcG proteins has been identified. The D11.12 element has been shown to repress
luciferase expression in a reporter construct. For a full repression of the reporter gene, a
cluster of YY1 binding sites and a highly conserved region have been necessary. The con-
served region seems to be required for the recruitment and/or stability of the Polycomb
repressive complexes. After the knock-down of the PcG genes, the silencing function
was lost. However, only isolated vertebrate PREs have been identified so far. In 2010
Liu et al. have followed a computational approach to predict PcG target genes in mouse
embryonic stem cells. Surprisingly the YY1 motif could not be found in murine PREs at
this approach. There is growing evidence for additional mechanisms in PcG recruitment
in mammals.
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PcG protein targeting by long non-coding RNAs in mammals
Mammalian PcG proteins are associated with X-inactivation. In female mammals, one
of the two X chromosomes within a cell gets inactivated. Dosage compensation involves
the silencing of almost all genes on the inactivated X chromosome (Xi). It has been shown
that X inactivation is regulated by a locus called XIC (X inactivation center). This locus
produces a long non-coding RNA molecule which accumulates at the future Xi. The Xist
(X inactive specific transcript) RNA initiates gene silencing by nucleosome remodeling
and DNA methylation. X inactivation may occur randomly or in some mammals like
rodents, X inactivation has been shown to be imprinted.
It has been shown that the inactivation of one X chromosome in female cells is accom-
panied by H3K27 methylation mediated by the PRC2 complex (Wang et al., 2001; Plath
et al., 2003; Silva et al., 2003). The recruitment of PRC2 to the future Xi appears to be
dependent on Xist RNA. The association of PRC2 with the inactive X chromosome is
transient and only required for establishing the epigenetic mark to maintain the silent
state. Interestingly, PRC1-mediated H2A ubiquitination has been found associated with
Xi, as well. This indicates that PRC1 may be involved in X inactivation, too (Fang et al.,
2004; de Napoles et al., 2004).
PcG proteins are not only involved in X inactivation, but also in the process of genomic
imprinting of autosomal genes. There are about 60 genes in mammals which have been
shown to be paternally or maternally repressed. Mager et al. (2003) could show that in
homozygous Eed mutant mouse embryos transcripts from paternally repressed genes are
present. Changes in the DNA methylation state of the differentially methylated regions
(DMR) on affected genes could be detected. The following paternally repressed genes got
activated in the PcG mutant mice: Cdkn1c, Ascl2, Grb10 and Meg3. Hence PcG silencing
mechanisms are required for the regulation of autosomal imprinted loci.
Several studies showed that PcG mediated gene silencing of imprinted genes is depen-
dent on the interaction of PRC2 with non-coding RNAs. Umlauf et al. (2004) and Ter-
ranova et al. (2008) revealed that the PRC2 complex is involved in silencing the pater-
nally imprinted Kcnq1 locus via its interaction with the Kcnq1ot1 non-coding RNA. Rinn
et al. (2007) demonstrated that an interaction between PRC2 and the HOTAIR non-coding
RNA is needed for gene silencing. HOTAIR is a non-coding RNA in the HOXC locus
and represses transcription along the HOXD locus in trans. The silencing mechanism
of dosage compensation and genomic imprinting by PcG proteins in mammals can be
compared with the mechanism of HOX gene repression in Drosophila.
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2. Goals of this study
The present study was designed to identify and characterize PcG and associated pro-
teins in the cnidarian Hydra. Special emphasis was placed on the PRC2 complex and
the identification of DNA binding proteins which are important for targeting of the PcG
complexes. Very little was found in the literature on PcG proteins in this ’basal’ metazoan
animal. In a phylogenetic study of Schuettengruber et al. (2007) the existence of an al-
most complete set of PcG proteins has been reported. However, the findings of this study
are only based on in silico data. In a study by Genikhovich et al. (2006), two genes of the
PRC2 complex from Hydra vulgaris AEP have been cloned and further characterized.
In the ’classical’ Drosophila model, the PcG proteins are clustered into multimeric com-
plexes which are recruited to their target genes in a hierarchical manner. The PRC2 core
complex consisting of the proteins E(z), Esc, Su(z)12 and p55 is recruited to the target
gene by the PhoRC complex consisting of the DNA binding protein Pho and dSfmbt.
Surrounding nucleosomes are trimethylated at histone H3K27. This epigenetic mark
is recognized by the PRC1 core complex consisting of Pc, Ph, Psc and dRing. Histone
H2A gets ubiquitinated at K119 followed by chromatin remodeling and transcriptional
silencing. However, recent studies on PcG proteins in mammals reveal a more complex
situation. First, there is emerging evidence for various recruiting mechanisms of the PcG
complexes to their target genes, in which long non-coding RNAs seem to play a role.
Second, it becomes apparent that the PcG complexes can be assembled combinatorially
depending on the target gene. Third, the actual process of gene silencing triggered by
PcG proteins is dependent on downstream events like DNA methylation.
PcG and associated genes were analyzed in Hydra to gain inside into PcG based mech-
anisms in lower animals, which could help to better understand the more complex sit-
uation in higher animals. The goals of this study can be summarized in the following
items:
1. The identification of PcG and associated genes in the Hydra genome, cloning of the
candidate genes and identification of conserved functional domains.
2. The identification of the expression patterns of PcG genes in the freshwater polyp
to get an idea of the processes, which might be regulated by PcG proteins: Common
processes like stem cell regulation and embryogenesis or Hydra-specific pattern for-
mation processes like budding and regeneration.
3. The identification of molecules, which are important for PcG recruitment and which
could help to identify target genes in Hydra.
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3. Materials and Methods
3.1. Materials
3.1.1. Chemicals and solutions
chemical formula MW (g/mol) company
acetic anhydride C4H6O3 102.9 Riedel-de-Haen;
Seelze (Germany)
acrylamide/bisacrylamide
(Rotiphorese Gel 40 (29:1))
- - Roth;
Karlsruhe (Germany)
agar - - AppliChem;
Darmstadt (Germany)
agarose - - Roth;
Karlsruhe (Germany)
ammonium acetate C2H3O2NH4 77.08 VWR International;
West Chester,
Pennsylvania (USA)
ammonium persulfate (NH4)2S2O8 228.2 Serva;
Heidelberg (Germany)
ampicillin C16H18N3NaO4S 371.39 Roth;
Karlsruhe (Germany)
aprotinin C284H432N84O79S7 6511.51 AppliChem;
Darmstadt (Germany)
β-mercaptoethanol C2H6OS 78.13 Roth;
Karlsruhe (Germany)
BCIP C8H6NO4BrCIP·C7H9N 433.6 Roche Diagnostics GmbH;
Mannheim (Germany)
benzamidine hydrochloride C7H8N2 · HCl 156.62 AppliChem;
Darmstadt (Germany)
BMPurple - - Roche Diagnostics GmbH;
Mannheim (Germany)
boric acid H3BO3 61.83 Merck;
Darmstadt (Germany)
bovine serum albumine,
fraction V
- - Sigma-Aldrich;
St. Louis, Missouri (USA)
bromophenol blue C19H10Br4O5S 692.0 Serva;
Heidelberg (Germany)
calcium chloride dihydrate CaCl2 ·H2O 147.02 Merck;
Darmstadt, Germany
CHAPS C32H58N2O7S 614.88 Sigma-Aldrich;
St. Louis, Missouri (USA)
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chemical formula MW (g/mol) company
chloramphenicol C11H12Cl2N2O5 323.1 Serva;
Heidelberg (Germany)
chrome alum CrK(SO4)2 · 12 H2O 283.24 Roth;
Karlsruhe (Germany)
Coomassie Brilliant Blue G 250 C47H48N3NaO7S2 877.0 Serva;
Heidelberg (Germany)
dimethylformamide C3H7NO 73.09 Serva;
Heidelberg (Germany)
disodium EDTA C10H14O8N2Na2 · 2
H2O
372.24 AppliChem;
Darmstadt (Germany)
disodium hydrogen phosphate Na2HPO4 141.96 AppliChem;
Darmstadt (Germany)
DMP C9H18N2O2 186.25 Sigma-Aldrich;
St. Louis, Missouri (USA)
DMSO C2H6OS 78.13 Serva;
Heidelberg (Germany)
DTT C4H10O2S2 154.3 Serva;
Heidelberg (Germany)
ethanol C2H6O 46.07 Sigma-Aldrich;
St. Louis, Missouri (USA)
ethanolamine C2H7NO 61.08 Roth;
Karlsruhe (Germany)
ethidium bromide C21H20BrN3 394.29 Serva;
Heidelberg (Germany)
ethyl carbamate C3H7NO2 89.09 Merck;
Darmstadt (Germany)
ficoll - ∼ 400000 Fluka Biochemika;
Buchs (Switzerland)
formaldehyde CH2O 30.03 Merck;
Darmstadt (Germany)
formamide CH3NO 45.04 Sigma-Aldrich;
St. Louis, Missouri (USA)
gelatin - - Merck;
Darmstadt (Germany)
gentamycin sulfate C19−21H39−43N5O7
· 2.5 H2SO4
694.75
- 723.75
AppliChem;
Darmstadt (Germany)
glacial acetic acid C2H4O2 60.05 Merck;
Darmstadt (Germany)
glucose monohydrate C6H12O6 · H2O 198.17 Merck;
Darmstadt (Germany)
glycerol C3H5(OH)3 92.09 AppliChem;
Darmstadt (Germany)
glycine C2H5NO22 75.07 AppliChem;
Darmstadt (Germany)
guanidin hydrochloride CH6ClN3 95.53 AppliChem;
Darmstadt (Germany)
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chemical formula MW (g/mol) company
guanidinium thiocyanate C2H6N4S 118.16 Merck-Schuchardt;
Hohenbrunn (Germany)
Heparin sodium salt - - Roth;
Karlsruhe (Germany)
HEPES C8H18N2O4S 238.3 Roth;
Karlsruhe (Germany)
hydrochloric acid HCl 36.46 VWR International;
West Chester,
Pennsylvania (USA)
hydrogen peroxide H2O2 34.01 Merck;
Darmstadt (Germany)
hydroxyurea CH4N2O2 76.05 Sigma-Aldrich;
St. Louis, Missouri (USA)
imidazole C3H4N2 68.08 Merck;
Darmstadt (Germany)
IPTG C9H18O5S 238.3 Serva;
Heidelberg (Germany)
isopropyl alcohol C3H8O 60.1 AppliChem;
Darmstadt (Germany)
kanamycin sulfate C18H36N4O11 · H2SO4 582.58 AppliChem;
Darmstadt (Germany)
leupeptin hemisulfate C20H38N6O4
· 0.5 H2SO4
475.60 AppliChem;
Darmstadt (Germany)
levamisol hydrochloride C11H12N2S · HCl 240.75 Sigma-Aldrich;
St. Louis, Missouri (USA)
lithium chloride LiCl 42.39 Roth;
Karlsruhe (Germany)
luminol C8H7N3O2 117.16 Fluka Biochemika;
Buchs (Switzerland)
magnesium chloride
hexahydrate
MgCl2 · 6 H2O 203.3 AppliChem;
Darmstadt (Germany)
maleic acid C4H4O4 116.07 Roth;
Karlsruhe (Germany)
methanol CH4O 32.04 J. T. Baker;
Phillipsburg,
New Jersey (USA)
milk powder (blotting grade) - - Roth;
Karlsruhe (Germany)
Mowiol 4-88 (-CH2CHOH-)n ∼ 31000 Roth;
Karlsruhe (Germany)
NBT C40H30Cl2N10O6 817.7 Roche Diagnostics GmbH;
Mannheim (Germany)
neutral red C15H17ClN4 288.7 Merck;
Darmstadt (Germany)
nickel sulfate NiSO4 154.75 Merck;
Darmstadt (Germany)
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chemical formula MW (g/mol) company
N-lauroyl-sarcosine C15H29NO3 271.4 Sigma-Aldrich;
St. Louis, Missouri (USA)
Nonidet P40 - - AppliChem;
Darmstadt (Germany)
paraformaldehyde OH(CH2O)nH (n = 8 -
100)
Sigma-Aldrich;
St. Louis, Missouri (USA)
p-coumaric acid C9H8O3 164.16 Sigma-Aldrich;
St. Louis, Missouri (USA)
pepstatine A C34H63N5O9 685.89 AppliChem;
Darmstadt (Germany)
PMSF C7H7FO2S 174.19 AppliChem;
Darmstadt (Germany)
polyvinylpyrrolidone (C6H9NO)n ∼ 24000 Roth;
Karlsruhe (Germany)
potassium acetate CH3CO2K 98.15 AppliChem;
Darmstadt (Germany)
potassium chloride KCl 74.56 J. T. Baker;
Phillipsburg,
New Jersey (USA)
pyruvic acid sodium salt C3H3NaO3 110.94 Roth;
Karlsruhe (Germany)
sodium acetate trihydrate CH3COONa · 3 H2O 136.08 Merck;
Darmstadt (Germany)
sodium azide NaN3 65.0 Serva;
Heidelberg (Germany)
sodium chloride NaCl 58.44 VWR International;
West Chester,
Pennsylvania (USA)
sodium deoxycholate C24H39NaO4 414.55 Sigma-Aldrich;
St. Louis, Missouri (USA)
sodium dihydrogen
phosphate dihydrate
NaH2PO4 · 2 H2O 156.01 Roth;
Karlsruhe (Germany)
sodium dodecyl sulfate NaC12H25SO4 288.4 Serva;
Heidelberg (Germany)
sodium hydrogen carbonate NaHCO3 84.01 J. T. Baker;
Phillipsburg,
New Jersey (USA)
TEMED C6H16N2 116.21 Roth;
Karlsruhe (Germany)
tetracyclin C22H24N2O8 · HCl 480.9 Serva;
Heidelberg (Germany)
triethanolamine hydrochloride C6H16CINO3 185.65 Merck;
Darmstadt (Germany)
Tris C4H11NO3 121.14 Roth;
Karlsruhe (Germany)
trisodium citrate dihydrate C6H5Na3O7 · 2 H2O 294.10 GERBU Biochemicals GmbH;
Gaiberg (Germany)
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chemical formula MW (g/mol) company
Triton X-100 C14H22O(C2H4O)n - Merck;
Darmstadt (Germany)
trypan blue C34H28N6O14S4 872.88 AppliChem;
Darmstadt (Germany)
trypton - - AppliChem;
Darmstadt (Germany)
Tween 20 C58H114O26 1227.54 Roth;
Karlsruhe (Germany)
urea CH4N2O 60.06 Roth;
Karlsruhe (Germany)
X-Gal C14H15BrClNO6 408.63 AppliChem;
Darmstadt (Germany)
xylene cyanol C25H27N2NaO6S2 538.6 Serva;
Heidelberg (Germany)
yeast extract - - Roth;
Karlsruhe (Germany)
yeast RNA - - Boehringer (Roche Diagnostics);
Mannheim (Germany)
zinc chloride ZnCl2 136.28 Merck;
Darmstadt (Germany)
3.1.2. Consumables
consumables specification company
12 ml polystyrene tubes PS- Tube Screw Cap 12 ml Greiner-Bio-One GmbH;
Frickenhausen (Germany)
15 ml polypropylene tubes tube, 15 ml, PP, conical bottom with blue
screw cap
Greiner-Bio-One GmbH;
Frickenhausen (Germany)
50 ml polypropylene tubes tube, 50 ml, PP, conical bottom with blue
screw cap
Greiner-Bio-One GmbH;
Frickenhausen (Germany)
active ester agarose for cou-
pling proteins
AffiGel 10 gel BioRad Laboratories GmbH;
München (Germany)
autoradiography films Amersham Hyperfilm ECL (18 x 24 cm,
24 x 30 cm)
GE Healthcare UK Ltd;
Little Chalfont,
Buckinghamshire (England)
columns for protein purifica-
tion
Econo-Pac, general purpose plastic col-
umn, 1-20 ml
BioRad Laboratories GmbH;
München (Germany)
columns for protein purifica-
tion
Poly-Prep, disposable plastic column, 2
ml
BioRad Laboratories GmbH;
München (Germany)
cover glass cover glass 24 x 32 mm VWR International; West
Chester, Pennsylvania (USA)
cuvettes cuvettes 10 x 4 x45 mm, polystyrene Sarstedt AG & Co.;
Nümbrecht (Germany)
desalting columns PD-10 desalting columns (packed with
Sephadex G-25)
GE Healthcare UK Ltd;
Little Chalfont,
Buckinghamshire (England)
36 3. MATERIALS AND METHODS
consumables specification company
dialysis tubing Dialysis-Membrane type 27; MWCO
12000-16000; pore size 25A
BIOMOL GmbH;
Hamburg (Germany)
dialysis tubing dialysis tubing Membra-Cel; MWCO
10000-14000; type 36/32
Roth; Karlsruhe (Germany)
FBS Fetal Bovine Serum Standard Quality PAA Laboratories GmbH;
Pasching (Austria)
Fixogum Fixogum rubber cement Marabu GmbH & Co.KG;
Bietigheim-Bissingen
(Germany)
folded filters folded filters 595 1/2; ∅ 185 mm Schleicher & Schuell BioScience
GmbH; Dassel (Germany)
Hydra culture dishes polystyrene dishes (Rotilabo-"Gerda"-
Frischhalteboxen)
Roth; Karlsruhe (Germany)
medium for insect cells TC 100 Insect Medium with L-glutamine Lonza Group Ltd.;
Basel (Switzerland)
membrane filter Minisart, single use syringe filter, sterile,
0.20 µm
Sartorius AG;
Göttingen (Germany)
membrane filter Rotilabo, single use syringe filter, sterile,
0.45 µm
Roth; Karlsruhe (Germany)
metal chelate affinity beads Ni-NTA agarose beads Qiagen GmbH;
Hilden (Germany)
microscope slides microscope slides 76 x 26 x 1 mm Paul Marienfeld GmbH &
Co.KG; Lauda-Königshofen
(Germany)
pasteur pipettes pasteur capillary pipettes, short size, 150
mm
WU; Mainz (Germany)
PCR tubes 0.2 ml PCR tubes with attached, flat cap BioRad Laboratories GmbH;
München (Germany)
Pen-Strep Penicillin/Streptomycin (100x) (Peni-
cillin 10.000 Units/ml; Streptomycin 10
mg/ml )
PAA Laboratories GmbH;
Pasching (Austria)
petri dishes petri dish 94 x 16 mm Greiner-Bio-One GmbH;
Frickenhausen (Germany)
pipette filter tips micro filter tip 10 µl, filter tip 100 µl, fil-
ter tip 1000 µl
Greiner-Bio-One GmbH;
Frickenhausen (Germany)
pipette tips micropipette tip 0.5 - 10 µl, pipette tip
10-200 µl, pipette tip 201-1000 µl
Greiner-Bio-One GmbH;
Frickenhausen (Germany)
positive charged nylon mem-
brane
Amersham Hybond-N+ GE Healthcare Europe GmbH;
Freiburg (Germany)
protein A-agarose matrix protein A-agarose Roche Diagnostics GmbH;
Mannheim (Germany)
protein A-sepharose matrix protein A Sepharose CL-4B GE Healthcare Europe GmbH;
Freiburg (Germany)
protein concentrator Vivaspin 2, 50000 MWCO PES Sartorius AG;
Göttingen (Germany)
protein concentrator Vivaspin 15, 10000 MWCO PES Sartorius AG;
Göttingen (Germany)
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consumables specification company
reaction tubes SafeSeal MicroTube 2 ml, polypropylene Sarstedt AG & Co.;
Nümbrecht (Germany)
reaction tubes MicroTube 1.5 ml, polypropylene Sarstedt AG & Co.;
Nümbrecht (Germany)
septa for sequencing sample
tubes
Genetic Analyzer septa for 0.5 ml Sam-
ple Tubes
Applied Biosystems; Carlsbad,
California (USA)
sequencing capillary 310 Genetic Analyzer Capillaries, 5-47
cm x 50 µm capillaries
Applied Biosystems; Carlsbad,
California (USA)
sequencing polymer POP-6, performance optimized polymer Applied Biosystems; Carlsbad,
California (USA)
sequencing running buffer 310 Running Buffer, 10X Applied Biosystems; Carlsbad,
California (USA)
sequencing sample tubes Genetic Analyzer 0.5 ml Sample Tubes Applied Biosystems; Carlsbad,
California (USA)
syringe luer slip syringe BD Discardit II: 10 ml,
20 ml
Becton Dickinson GmbH;
Heidelberg (Germany)
syringe luer-lok BD Plastipak: 50 ml Becton Dickinson GmbH;
Heidelberg (Germany)
tissue culture flasks CELLSTAR cell culture flask with filter
top: 250 ml (75 cm2), 650 ml (175 cm2)
Greiner-Bio-One GmbH;
Frickenhausen (Germany)
tissue culture multiwell plates CELLSTAR cell culture multiwell plate:
6 well (9.6 cm2), 24 well (1.9 cm2)
Greiner-Bio-One GmbH;
Frickenhausen (Germany)
transfection reagent cellfectin Invitrogen GmbH;
Darmstadt (Germany)
ultracentrifuge tubes Ultra-Clear centrifuge tubes, 14 x 95 mm Beckman Coulter GmbH;
Krefeld (Germany)
Western blotting membrane PVDF membrane Millipore GmbH;
Schwalbach (Germany)
Whatman paper Whatman chromatography paper, 46 x
57 cm x 3 mm
Whatman International Ltd.;
Maidstone (England)
3.1.3. Technical equipment
technical equipment specification company
autoclave steam-sterilizer type W Holzner Medizintechnik
GmbH; Nußloch (Germany)
autoradiography cassette Amersham Hypercassette Autoradiog-
raphy Cassettes (18 x 24 cm, 24 x 30 cm)
GE Healthcare UK Ltd;
Little Chalfont,
Buckinghamshire (England)
benchtop centrifuge Heraeus Biofuge pico Heraeus Instruments (Thermo
Fisher Scientific); Waltham,
Massachusets (USA)
centrifuge Beckman GS-6KR (swing-out rotor) Beckman Coulter GmbH;
Krefeld (Germany)
centrifuge for tissue culture Beckman GS-63 (swing-out rotor) Beckman Coulter GmbH;
Krefeld (Germany)
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technical equipment specification company
centrifuge Sorvall RC5C (fixed angle rotors:
GS-3, GSA, SA-600 and SS-34)
Sorvall Instruments (Thermo
Fisher Scientific); Hamburg
(Germany)
developer machine tabletop developer machine Agfa Curix
60
Agfa-Gevaert N.V.;
Mortsel (Belgium)
DNA gel system in-house production Institute of Zoology;
Heidelberg (Germany)
electroporation apparatus BioRad GenePulser II BioRad Laboratories GmbH;
München (Germany)
freezer -20 ◦C Liebherr Premium Liebherr-International Deutsch-
land GmbH; Biberach an der
Riss (Germany)
freezer -80 ◦C Forma -86C ULT Freezer Thermo Electron Corporation
(Thermo Fisher Scientific);
Waltham, Massachusets (USA)
gel documentation system GelJetImager Intas Science Imaging
Instruments GmbH;
Göttingen (Germany)
incubation shaker for cultiva-
tion of bacteria
Multitron Standard Infors HT; Bottmingen
(Switzerland)
incubator for cultivation of
bacteria
incubator type B50 Memmert GmbH + Co. KG
; Schwabach (Germany)
incubator for cultivation of Sf9
insect cells
Heraeus B-5060-EK-CO2 Heraeus; Hanau (Germany)
inverted confocal microscope Nikon A1R with Nikon Eclipse Ti Nikon Instruments Europe B.V.;
Kingston, Surrey (England)
inverted fluorescence micro-
scope
Nikon Eclipse 80i (camera: Nikon Digi-
tal Sight DS-U1)
Nikon Instruments Europe B.V.;
Kingston, Surrey (England)
magnetic stirrer magnetic stirrer type MR1 Heidolph Elektro GmbH & Co.
KG; Kelheim (Germany)
mixer intelli-Mixer neoLab; Heidelberg (Germany)
PCR machine GeneAmp PCR system 2400 Perkin Elmer;
Rodgau (Germany)
PCR machine MyCycler BioRad Laboratories GmbH;
München (Germany)
PCR machine PalmCycler CG1-96 Corbett Research;
Cambridge (England)
pH-meter Digital-pH-Meter 646 (pH-electrode:
Mettler Toledo inLab 417)
Knick Elektronische Messgeräte
GmbH & Co. KG;
Berlin (Germany)
pipettes 2 µl, 20 µl, 200 µl and 1000 µl Gilson Inc.; Middleton,
Wisconsin (USA)
pipetting aid pipetus-akku Hirschmann Laborgeräte
GmbH & Co. KG;
Eberstadt (Germany)
power supply for DNA and
protein gels
Gene Power Supply GPS 200/400 Pharmacia (GE Healthcare life
sciences); Uppsala (Sweden)
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technical equipment specification company
power supply for blotting Power Pac HC BioRad Laboratories GmbH;
München (Germany)
protein blotting cell Trans-Blot SD Semi-Dry Transfer Cell BioRad Laboratories GmbH;
München (Germany)
protein gel system PerfectBlue Twin S peqlab; Erlangen (Germany)
rocker Duomax 1030 Heidolph Elektro GmbH & Co.
KG; Kelheim (Germany)
roller mixer CAT RM5 CAT Ingenieurbüro M. Zipperer
GmbH; Staufen (Germany)
safety cabinet Heraeus HeraSafe HS Heraeus; Hanau (Germany)
sequencer ABI PRISM 310 Genetic Analyzer Applied Biosystems; Carlsbad,
California (USA)
spectrophotometer Nanodrop ND-1000 peqlab; Erlangen (Germany)
spectrophotometer SmartSpecPlus Spectrophotometer BioRad Laboratories GmbH;
München (Germany)
thermomixer Thermomixer comfort Eppendorf AG;
Hamburg (Germany)
ultracentrifuge L8-55 ultracentrifuge (swing-out rotor:
SW 40)
Beckman Coulter GmbH;
Krefeld (Germany)
UV cross-linker UV Stratalinker 1800 Stratagene Corporation; LaJolla,
California (USA)
UV transilluminator chromato-Vue Transilluminator Model
TM-20 (220/240 V, 50 Hz, 1.5 Amp)
UVP; San Gabriel, California
(USA)
vortexer vortexer type REAX-1 Heidolph Elektro GmbH & Co.
KG; Kelheim (Germany)
waterbath JULABO type A6/U3 JULABO Labortechnik GmbH;
Seelbach (Germany)
watersystem for ultrapure wa-
ter
MilliQ Millipore GmbH; Schwalbach
(Germany)
watersystem for Hydra culture Elix Millipore GmbH; Schwalbach
(Germany)
white light transilluminator white light transilluminator (220 V, 50
Hz)
Rex Messinstrumentebau
GmbH, Erlangen (Germany)
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3.1.4. Primers
All primers for cloning were obtained from Operon. The oligonucleotides used for gel retardation
assays are HPLC purified, all other primers are salt-free. Primer stock solutions of 100 pmol have
been stored at -20 ◦C.
TABLE 3.4 List of primers and oligonucleotides. (Tm = melting temperature; # = internal number)
name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
HyYY1
YY1 CF for CAA CCT TTG ATA
GCA CTA CAA
for 21 56,7 Amplification of HyYY1 core
fragment
203
YY1 CF rev GAG TCT CTT TTA
GAA TTT GAT TT
rev 29 53,9 Amplification of HyYY1 core
fragment
204
YY1 5´Race GAA TCT TCA AAG
AAC CCA TCT GAA
ACT GTT
rev 30 63,3 5’Race 199
YY1 5´Nested GAG AAT TAG GTT
GTA GTG CTA TCA
AAG GTT
rev 30 63,3 5’Race (Nested) 200
YY1 3´Race CAT TTG AGG GTT
GTG GTA AAA GAT
TTA GTC TA
for 32 63,4 3’Race 201
YY1 3´Nested CGC AAT CTA CCA
ACC TAA AAA GTC
ATA TCT
for 30 63,3 3’Race (Nested) 202
YY1 FL for ATG GCT GAC GAT
TTA ACG ATA GA
for 23 59,2 Amplification of HyYY1 FL
(translated region); Template for
YY1 riboprobe
205
YY1 FL rev CTA CAC AGC ATC
TTC TTC TAT GTC T
rev 25 61,3 Amplification of HyYY1 FL
(translated region, stop codon
included); Template for YY1
riboprobe
206
YY1 Rp 1 for GTT TGT GCT GAA
TGC GGG A
for 19 60,16 Template for YY1 riboprobe RP1 224
YY1 Rp 1 rev CTT CTA AGA TCG
CTT AAA GTT TGC
rev 24 59,44 Template for YY1 riboprobe RP1 225
YY1 Rp 2 for CGG TAC AAT TGG
ACC TAA GTT AAT
for 24 59,44 Template for YY1 riboprobe RP2 226
YY1 Rp 2 rev CAT TCC CAT CTG
AAG CCC ATA
rev 21 60,61 Template for YY1 riboprobe RP2 227
XhoI-YY1 FL 1
for
GGG AAC TCG AGA
TGG CTG ACG ATT
TAA CGA
for 30 68,73 Introducing XhoI restriction
site for cloning of HyYY1 into
pET15b(+) vector
230
BamHI-YY1 FL
rev
CCT TTG GAT CCC
TAC ACA GCA TCT
TCT TCT A
rev 31 67,29 Introducing BamHI restriction
site for cloning of HyYY1 into
pET15b(+) vector
248
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name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
YY1 FR-BamHI
rev
CCT TTG GAT CCT
GAA GCC CAT ACA
ATA ACT GA
rev 32 67,21 Introducing BamHI restriction
site for cloning of HyYY1∆ZnF
into pET15b(+) vector
231
HindIII-rbs-
YY1 FL
GGG AAA AGC TTA
GAA GGA GAT ATA
CAT ATG GCT GAC
GAT TTA ACG A
for 46 69,96 Introducing HindIII restriction
site and ribosomal binding
site for cloning of HyYY1 into
pET21(+) vector
YY1FL-His-
XhoI rev
CCT TTC TCG AGG
TGA TGA TGA TGA
TGA TGC ACA GCA
TCT TCT TCT ATG T
rev 49 72,26 Introducing XhoI restriction site
and 6His-tag for cloning of
HyYY1 into pET21(+) vector
YY1FR-His-
XhoI rev
CCT TTC TCG AGG
TGA TGA TGA TGA
TGA TGT GAA GCC
CAT ACA ATA ACT
rev 48 71,56 Introducing XhoI restriction site
and 6His-tag for cloning of
HyYY1∆ZnF into pET21(+) vec-
tor
EcoRI-Koz-YY1
FL for
GGG AAG AAT TCG
CCG CCA TGG CTG
ACG ATT TAA CGA
TAG AT
for 41 72,7 Introducing EcoRI restriction
site and Kozak sequence for
cloning of HyYY1 into pBac1
vector
YY1 FL-KpnI
rev
CCT TTG GTA CCC
TAC ACA GCA TCT
TCT TCT A
rev 31 67,28 Introducing KpnI restriction site
for cloning of HyYY1 into pBac1
vector
292
YY1 FL-His-
XhoI rev
CCT TTC TCG AGG
TGA TGA TGA TGA
TGA TGC TAC ACA
GCA TCT TCT TCT
ATG T
rev 52 72,63 Introducing XhoI restriction site
and 6His-tag for cloning of
HyYY1 into pBac1 vector
YY1 Seq for CGA TGT TCC TCG
TAA ATG GTC A
for 22 60,8 Sequencing 207
YY1 Seq rev CGC ATT CAG CAC
AAA CAT GAA CA
rev 23 61 Sequencing 208
HySCM
SCM CF for CTT ATC CCC CAT
CAA AT
for 17 52,37 Amplification of HySCM core
fragment
85
SCM CF rev CTT CAA ATC TTC
AAT CAA AT
rev 20 50,15 Amplification of HyYY1 core
fragment
86
SCM 5’Race GCT TCA AGT TTC
ATC CCA ACT GA
rev 23 60,99 5’Race 87
SCM 5’Nested CGC ATT TGA TGG
GGG ATA AGA A
rev 22 60,81 5’Race (Nested) 88
SCM 3’Race GAT GGT AAA GCC
CTA CTT CTT TT
for 23 59,2 3’Race 89
SCM 3’Nested CTC GGA CCA GCC
GTC AAA
for 18 62,18 3’Race (Nested) 90
SCM FL for 1 ATG GAA GTA CTT
ATA TCA AAC ATA GT
for 26 56,7 Amplification of HySCM FL
(translated region)
192
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name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
SCM FL for 2 ATG AGC TAC AGA
ATA TGG TTT
for 21 55,2 Amplification of HySCM FL
(translated region); Template for
SCM riboprobe RP1
193
SCM FL for 3 ATG GAA ATG ATT
AAC GCA A
for 19 48 Amplification of HySCM FL
(translated region)
SCM FL rev CTA TGG AGT CAA
ATA TCA ATA AA
rev 23 56 Amplification of HySCM FL
(translated region, stop codon
included); Template for SCM ri-
boprobe RP3
194
SCM Seq for 1 CTC GGA CTA ATA
ATG GTC ATT TTG A
for 25 59,66 Sequencing 133
SCM Seq for 2 CAG GCT ATA GGC
ATG ACC CAA
for 21 62,57 Sequencing; Template for SCM
riboprobe RP2
135
SCM Seq for 3 GAT ACT CCC CTA
ATC TTC TTC A
for 22 61 Sequencing 195
SCM Seq for 4 CAA TAG GTG ATG
AAG TCC ATG A
for 22 58,9 Sequencing 197
SCM Seq for 5 CGG AAA ACT AAT
GAA GAT AAA AGT
for 24 56 Sequencing 198
SCM Seq rev 1 GTT CAT GGA CTT
CAT CAC CTA T
rev 22 58,94 Sequencing 134
SCM Seq rev 2 CTG TGA GAC TGC
ATT TAT GAC TAA
rev 24 59,44 Sequencing 136
SCM Seq rev 3 GTT TTA GGC TTC
ATT GGA GTA AGT T
rev 25 59,66 Sequencing of SCM FL large 182
SCM Seq rev 4 GAC AAG AAG CAT
AAT TTC AGT TGA
rev 24 59,7 Sequencing; Template for SCM
riboprobe RP2
196
SCM Rp 1 rev GAG CCA CGA TCA
GTC CAA
rev 18 59,9 Template for SCM riboprobe
RP1
228
SCM Rp 3 for GAT GGT GAC ATT
CAT TCA GTT A
for 22 57,08 Template for SCM riboprobe
RP3
229
XhoI-SCM for GGG AAC TCG AGA
TGA GCT ACA GAA
ATA TGG T
for 31 67,28 Introducing XhoI restriction site
for cloning of HySCM into
pET15b(+) vector
265
SCM FL-
BamHI rev
CCT TTG GAT CCC
TAT GGA GTC AAA
GTA TCA ATA
rev 33 65,9 Introducing BamHI restriction
site for cloning of HySCM into
pET15b(+) vector
266
SCM FR-
BamHI rev
CCT TTG GAT CCG
AGA CTG CAT TTA
TGA CTA A
rev 31 65,96 Introducing BamHI re-
striction site for cloning of
HySCM∆MBT into pET15b(+)
vector
264
HyEZH2
EZH2 FL for GTT GAT GAT GAA
ACA GTT TTG CAT A
for 25 52,9 Amplification of HyEZH2 FL
(translated region)
57
EZH2 FL rev TCA CAC TGT CCA
TTT CTT TG
for 20 45,4 Amplification of HyEZH2 FL
(translated region)
60
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name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
EZH2 RP1 for CTG AAG AAG CAA
AGT CTA TTT ACA
for 24 57,3 Template for EZH2 riboprobe
RP1
EZH2 RP1 rev CAA TGT ATG GTA
AGA GTG CAT
rev 21 56,7 Template for EZH2 riboprobe
RP1
EZH2 RP2 for CAT GTG AAC ATC
CTG GGC A
for 19 60,16 Template for EZH2 riboprobe
RP2
EZH2 RP2 rev CTG TCC ATT TCT
TTG CAA CAC CT
rev 23 60,98 Template for EZH2 riboprobe
RP2
HyEED
EED FL for ATG GAT ACT GTT
AAT GAT TTT AT
for 23 52,07 Amplification of HyEED FL
(translated region); Template for
EED riboprobe RP1
219
EED FL rev TGT CTG CTT GTC
CCA T
rev 16 54,15 Amplification of HyEED FL
(translated region); Template for
EED riboprobe RP2
220
EED RP1 rev CTG TCT CAA GTG
ACC AAA AT
rev 20 56,3 Template for EED riboprobe RP1
EED RP2 for CAG TGC AAG TAA
AGA TCA CA
for 20 56,3 Template for EED riboprobe RP2
HySUZ12
SUZ FL for ATG ACT TCT TTA
AAT CAA AAG GTG
GAT CTT CAC TTG G
for 37 65,79 Amplification of HySUZ12 FL
(translated region)
306
SUZ FL rev CAT TTT TGG TAA
AAG TTC TTC TTT
CAA CTT GTA G
rev 34 62,25 Amplification of HySUZ12 FL
(translated region)
307
SUZ12 RP1 for ATG ACT TCT TTA
AAT CAA AAG GTG
GA
for 26 58,28 Template for SUZ12 riboprobe
RP1
SUZ12 RP1 rev CGA TGT AAT CCA
TTT TCT TCA GT
rev 23 57,42 Template for SUZ12 riboprobe
RP1
SUZ12 RP2 for CAG ACC GAA CTG
AAG AAA AT
for 20 56,3 Template for SUZ12 riboprobe
RP2
SUZ12 RP2 rev GTA AGG CCG TCC
AAC AAT A
rev 19 58 Template for SUZ12 riboprobe
RP2
Hyp55
P55 FL for ATG GCT GCT TTA
AGT GCT CCA AA
for 23 60,99 Amplification of Hyp55 FL
(translated region)
180
P55 FL rev AGG TTT CGA TTG
GTG CCT T
rev 19 58 Amplification of Hyp55 FL
(translated region); Template for
p55 riboprobe RP1
181
P55 RP1 for CAG GAC ATT TAT
TAA GTG CAT CT
for 23 57,42 Template for p55 riboprobe RP1
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name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
HyPC
PC FL for ATG CCT AAG GAC
ACT GGT
for 18 57,62 Amplification of HyPC FL
(translated region)
82
PC FL rev TCA TGC AAA AAA
ACC TTG GTC T
rev 22 57,08 Amplification of HyPC FL
(translated region)
83
HyPH
PH FL for ATG GCT GTT TCA
TTG GTG CAA
for 21 58,66 Amplification of HyPH FL
(translated region)
213
PH FL rev GGC GAT CTT AAA
ACT ATG GTG A
rev 22 58,94 Amplification of HyPH FL
(translated region)
215
HyPSC
PSC FL for ATG GAA GAA AAG
AAC TCA CAT AA
for 23 55,64 Amplification of HyPSC FL
(translated region)
277
PSC FL rev CTT TAT CTT TAA
CAA ACT ATT TCG A
rev 25 54,74 Amplification of HyPSC FL
(translated region)
278
HyRING
RING FL for ATG TCA CAG TCT
GCA CAA
for 18 55,34 Amplification of HyRING FL
(translated region)
51
RING FL rev TTA CCG ATT TTC
ACT TGA
rev 18 50,79 Amplification of HyRING FL
(translated region)
52
Gene race primers
5’ GeneRacer CGA CTG GAG CAC
GAG GAC ACT GAC
ATG GAC TGA AGG
AGT AGA AA
/ 23 66,3 5’ Race RNA oligo 210
5’ GR CGA CTG GAG CAC
GAG GAC ACT GA
rev 23 68,1 5’ Race primer 211
5’ GR Nested GGA CAC TGA CAT
GGA CTG AAG GAG
TA
rev 26 66,2 5’ Race nested primer 212
QtdT CCA GTG AGC AGA
GTG ACG AGG ACT
CGA GCT CAA GCT
TTT TTT TTT TTT TTT
T
/ 52 71,84 3’ Race oligo for ligation
Qo CCA GTG AGC AGA
GTG ACG
for 18 62,17 3’ Race primer
Qi GAG GAC TCG AGC
TCA AGC
for 18 62,17 3’ Race nested primer
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name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
Common primers
M13 for AGG GTT TTC CCA
GTC ACG ACG TT
for 23 64,55 Sequencing of pGEM-T
M13 rev GAG CGG ATA ACA
ATT TCA CAC AGG
rev 24 62,85 Sequencing of pGEM-T
pET rev GGA TAT AGT TCC
TCC TTT CAG CAA
rev 24 61,15 Sequencing of pET-vectors 119
pET for CCC GCG AAA TTA
ATA CGA CTC A
for 22 60,81 Sequencing of pET-vectors 120
pFastBac1 Seq
for
CAT ACC GTC CCA
CCA TCG GGC
for 21 68,42 Sequencing of pFastBac1 299
PFastBac1 Seq
rev
GAT CCT CTA GTA
CTT CTC GAC AAG
rev 24 62,86 Sequencing of pFastBac1 300
HyEF1alpha
for
GTT GGT CGT GTT
GAA ACT GG
for 20 57,3 Amplification of HyEF1alpha as
a control for semi-quantitative
RT-PCR
HyEF1alpha
rev
TCC AGC AGC AAC
ACC TGC TT
rev 20 59,4 Amplification of HyEF1alpha as
a control for semi-quantitative
RT-PCR
Oligonucleotides for binding site selection and gel retardation assays
EMSA random CGT GAT TGG CTA
CGC ATC GT CAG
CAG CAG CAG CAG
NNN NNN NNN NNN
NNN CAG CAG CAG
CAG CAG GTC ATA
CTC ACT CAC GGA
CT
/ 85 82,41 Oligo with random core for
HyYY1 binding site selection
Klenow rev AGT CCG TGA GTG
AGT ATG AC
rev’ 20 60,4 Primer used for annealing with
EMSA random primer to gener-
ate a double-stranded oligo for
binding site selection with the
Klenow enzyme
Klenow for CGT GAT TGG CTA
CGC ATC GT
for’ 20 62,4 Control primer for the Klenow
reaction
HyYY1 round 6
for
GAT TGG CTA CGC
ATC GTG TAA AGT
TTT CTT GAG TCA
TAC TCA CTC ACG
GA
for 50 74,3 Oligo used for biotin-labeling
and gel retardation assays; core
sequence obtained in binding
site selection with HyYY1 after
round 6
HyYY1 round 6
rev
TCC GTG AGT GAG
TAT GAC TCA AGA
AAA CTT TAC ACG
ATG CGT AGC CAA
TC
rev 50 74,3 Oligo used for biotin-labeling
and gel retardation assays; core
sequence obtained in binding
site selection with HyYY1 after
round 6
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name sequence (5’→ 3’) for/rev length Tm
(◦C)
use #
HyYY1 round 3
for
GAT TGG CTA CGC
ATC GTA GTT TTT
TGT TGA ATG TCA
TAC TCA CTC ACG
GA
for 50 73,5 Oligo used for biotin-labeling
and gel retardation assays; core
sequence obtained in binding
site selection with HyYY1 after
round 3
HyYY1 round 3
rev
TCC GTG AGT GAG
TAT GAC ATT CAA
CAA AAA ACT ACG
ATG CGT AGC CAA
TC
rev 50 73,5 Oligo used for biotin-labeling
and gel retardation assays; core
sequence obtained in binding
site selection with HyYY1 after
round 3
control for GAT TGG CTA CGC
ATC GTC CTG CAG
CAC TGT GTG TCA
TAC TCA CTC ACG
GA
for 50 ≥75 Control oligo used for biotin-
labeling and gel retardation as-
says; core sequence obtained
in binding site selection with
HyYY1∆ZnF after round 6
control rev TCC GTG AGT GAG
TAT GAC ACA CAG
TGC TGC AGG ACG
ATG CGT AGC CAA
TC
rev 50 ≥75 Control oligo used for biotin-
labeling and gel retardation as-
says; core sequence obtained
in binding site selection with
HyYY1∆ZnF after round 6
YY1 consensus
for
GAT TGG CTA CGC
ATC GTG CCG CCA
TTT TGG GCG TCA
TAC TCA CTC ACG
GA
for 50 ≥75 Oligo used for biotin-labeling
and gel retardation assays; core
sequence corresponds to the
known Drosophila and human
consensus motif
YY1 consensus
rev
TCC GTG AGT GAG
TAT GAC GCC CAA
AAT GGC GGC ACG
ATG CGT AGC CAA
TC
rev 50 ≥75 Oligo used for biotin-labeling
and gel retardation assays; core
sequence corresponds to the
known Drosophila and human
consensus motif
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3.1.5. Vectors
Cloning vectors
The pGEM-T vector is a linearized with 3’-T overhangs at both ends. The vector allows the ef-
ficient ligation of PCR products. A map of the pGEM-T vector and its multiple cloning site are
depicted in figure 3.1.
FIGURE 3.1 pGEM-T vector: map, features and multiple cloning sites.
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TABLE 3.6 List of cloning vectors. The genes that were cloned into the vector are indicated.
plasmid size (bp) insert cloning
pGEM-T 3000 - commercially available from
Promega
pGEM-T-HyYY1 4088 HyYY1 full length coding region Sonja Matt (Holstein lab)
pGEM-T-HyYY1 CF 3883 HyYY1 ’core fragment’ Sonja Matt (Holstein lab)
pGEM-T-HyYY1 5’-end 3212 HyYY1 fragment containing the 5’
UTR of the gene
Sonja Matt (Holstein lab)
pGEM-T-HyYY1 3’-end
small
3493 HyYY1 fragment containing the 3’
UTR of the gene including the polyA
signal
Sonja Matt (Holstein lab)
pGEM-T-HyYY1 3’-end
large
3634 HyYY1 fragment containing the 3’
UTR of the gene including the polyA
signal
Sonja Matt (Holstein lab)
pGEM-T-HyYY1 RP1 3761 HyYY1 template for ISH riboprobe Sonja Matt (Holstein lab)
pGEM-T-HyYY1 RP2 3480 HyYY1 template for ISH riboprobe Sonja Matt (Holstein lab)
pGEM-T-HySCM 5501 HySCM full length coding region Sonja Matt (Holstein lab)
pGEM-T-HySCM CF 4705 HySCM ’core fragment’ Sonja Matt (Holstein lab)
pGEM-T-HySCM
5’-end
3875 HySCM fragment containing the 5’
UTR of the gene
Sonja Matt (Holstein lab)
pGEM-T-HySCM
3’-end
3204 HySCM fragment containing the 3’
UTR of the gene
Sonja Matt (Holstein lab)
pGEM-T-HyPC 3678 HyPC full length coding region Anne Kuhn (Holstein lab)
pGEM-T-HyPH 3990 HyPH full length coding region Anne Kuhn (Holstein lab)
pGEM-T-HyPSC 3892 HyPSC full length coding region Anne Kuhn (Holstein lab)
pGEM-T-HyRING 3980 HyRIN full length coding region Volker Lauschke (Holstein lab)
pGEM-T-HyEZH2 5175 HyEZH2 full length coding region Christoph Herbel (Holstein lab)
pGEM-T-HyEZH2 RP1 3745 HyEZH2 template for ISH riboprobe Sonja Matt (Holstein lab)
pGEM-T-HyEH2 RP2 3713 HyEZH2 template for ISH riboprobe Sonja Matt (Holstein lab)
pGEM-T-HyEED 4263 HyEED full length coding region Christoph Herbel (Holstein lab)
pGEM-T-HyEED RP1 3744 HyEED template for ISH riboprobe Sonja Matt (Holstein lab)
pGEM-T-HyEED RP2 3753 HyEED template for ISH riboprobe Sonja Matt (Holstein lab)
pGEM-T-HySUZ12 4916 HySUZ12 full length coding region Volker Lauschke (Holstein lab)
pGEM-T-HySUZ12
RP1
3715 HySUZ12 template for ISH ribo-
probe
Sonja Matt (Holstein lab)
pGEM-T-HySUZ12
RP2
3764 HySUZ12 template for ISH ribo-
probe
Sonja Matt (Holstein lab)
pGEM-T-Hyp55 4305 Hyp55 full length coding region Christoph Herbel (Holstein lab)
pGEM-T-Hyp55 RP 3721 Hyp55 template for ISH riboprobe Sonja Matt (Holstein lab)
Prokaryotic expression vectors
The pET15b(+) vector is a prokaryotic expression vector that allows the expression of a fusion
protein with an N-terminal 6His-tag. The pET21(+) vector is a transcription vector that lacks the
ribosomal binding site and ATG start codon necessary for recombinant protein expression. It
carries a C-terminal 6His-tag. Maps of the vectors and their multiple cloning sites are depicted in
figures 3.2 and 3.3.
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TABLE 3.8 List of prokaryotic expression vectors. The expressed protein and the cloning vector are
indicated.
plasmid size (bp) insert cloning
pET15b(+) 5708 - available from Novagen
pET21(+) 5369 - available from Novagen
pET15b(+)-HyYY1 6795 HyYY1 full length coding region Sonja Matt (Holstein lab)
pET15b(+)-
HyYY1∆ZnF
6141 HyYY1 lacking its C-terminal zinc
finger domains
Sonja Matt (Holstein lab)
pET21(+)-HyYY1 6477 HyYY1 full length coding region Sonja Matt (Holstein lab)
pET21(+)-HyYY1∆ZnF 5826 HyYY1 lacking its C-terminal zinc
finger domains
Sonja Matt (Holstein lab)
FIGURE 3.2 pET15b(+) vector: map, features and multiple cloning sites.
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FIGURE 3.3 pET21(+) vector: map, features and multiple cloning sites.
Eukaryotic expression vectors
The pFastBac1 vector allows the generation of an expression construct containing the gene of
interest, which is controlled by the polyhedrin promoter. The expression cassette is flanked by
the left and the right arms of Tn7. A map of the pFastBac1 vector and its multiple cloning site are
depicted in figure 3.4.
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FIGURE 3.4 pFastBac1 vector: map, features and multiple cloning sites.
TABLE 3.10 List of eukaryotic expression vectors. The expressed protein and the cloning vector are
indicated.
plasmid size (bp) insert cloning
pFastBac1 4776 - available from Invitrogen
pFastBac1-HyYY1 5827 HyYY1 full length coding region Sonja Matt (Holstein lab)
pFastBac1-HyYY1-6His 5824 HyYY1 full length coding region
with a C-terminal 6His-tag
Sonja Matt (Holstein lab)
pFastBac1-HyEZH2 6941 HyEZH2 full length coding region Volker Lauschke (Holstein lab)
pFastBac1-HyEED 6039 HyEED full length coding region Volker Lauschke (Holstein lab)
pFastBac1-HySUZ12 6687 HySUZ12 full length coding region Volker Lauschke (Holstein lab)
pFastBac1-Hyp55 6070 Hyp55 full length coding region Volker Lauschke (Holstein lab)
52 3. MATERIALS AND METHODS
3.1.6. Enzymes
Restriction endonucleases
restriction
enzyme
recognition
sequence
temperature buffer manufacturer
ApaI GGGCC↓C 37 ◦C Buffer B Fermentas
BamHI G↓GATCC 37 ◦C NEBuffer 3 +
100 µg/ml BSA
NEB
EcoRI G↓AATTC 37 ◦C NEBuffer 1, 2, 3 or 4 NEB
HindIII A↓AGCTT 37 ◦C NEBuffer 2 NEB
SacI GAGCT↓C 37 ◦C Buffer B Fermentas
XhoI C↓TCGAG 37 ◦C NEBuffer 2, 3 or 4 NEB
Buffer composition:
NEBuffer 1: 10 mM Tris Propane-HCl, 10 mM MgCl2, 1 mM DTT (pH 7.0 at 25 ◦C)
NEBuffer 2: 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT (pH 7.9 at 25 ◦C)
NEBuffer 3: 100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT (pH 7.9 at 25 ◦C)
NEBuffer 4: 50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 1 mM DTT (pH 7.9
at 25 ◦C)
Buffer B: 10 mM tris-HCl, 10 mM MgCl2, 0.1 mg/ml BSA (pH 7.5 at 37 ◦C)
Polymerases and other enzymes
enzyme recognition
sequence
manufacturer
Phusion proofreading DNA polymerase Finnzymes (No. F530S)
EuroTaq DNA polymerase BioCat (No. EME010001)
Klenow DNA polymeraseI DNA polymerase lacking the 5’ - 3’
exonuclease activity
NEB (No. M0210S)
BigDye Terminator v3.1 ready reaction mix for
cycle sequencing
Applied Biosystems
(No. 4337457)
SP6 RNA polymerase RNA polymerase Roche (No. 10 810 274 001)
T7 RNA polymerase RNA polymerase Roche (No. 10 881 767 001)
DNaseI, RNase-free deoxyribonuclease Roche (No. 04 716 728 001)
RNaseA endoribonuclease Applichem (No. A3832)
RNaseH ribonuclease Invitrogen (No. 18080-051)
RNaseOUT recombinant ribonuclease
inhibitor
Invitrogen (No. 18080-051)
SuperScriptIII RT reverse transcriptase Invitrogen (No. 18080-051)
T4-PNK polynucleotide kinase Fermentas (EK0031)
TdT Terminal deoxynucleotidyl
transferase
Thermo Scientific
(No. 89818)
proteinase K serine protease Roche (No. 1 092 766)
T4 RNA ligase RNA ligase Invitrogen (No.)
T4 DNA ligase DNA ligase Promega (No. M1804)
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3.1.7. Antibodies
TABLE 3.12 Primary and secondary antibodies. (WB = Western Blot, IH = Immunohistochemistry, IP
= Immunoprecipitation, ChIP = Chromatin Immunoprecipitation)
antibody species application purity manufacturer
primary antibodies:
α-Penta-His mouse IgG1 WB, IP affinity pure Qiagen
(No. 34660)
α-H3K27me3 rabbit (polyclonal) WB, IH, ChIP affinity pure Millipore
(No. 07-449)
α-HyYY1 rabbit (polyclonal) WB, IH, IP,
ChIP
crude serum,
affinity pure
Holstein lab
(Sonja Matt)
α-HyEZH2 rabbit (polyclonal) WB, IH, IP,
ChIP
crude serum Holstein lab
(Christoph Herbel)
α-HyEED rabbit (polyclonal) WB, IH, IP,
ChIP
crude serum Holstein lab
(Volker Lauschke)
α-Hyp55 rabbit (polyclonal) WB, IH, IP,
ChIP
crude serum Holstein lab
(Volker Lauschke)
α-HyPC rabbit (polyclonal) WB, IH, ChIP crude serum Holstein lab
(Anne Kuhn)
α-HyRING rabbit (polyclonal) WB, IH crude serum Holstein lab
(Anne Kuhn)
α-Digoxigenin-AP sheep
(Fab fragments)
ISH AP-
conjugated
Roche
(No. 11 093 274 910)
secondary antibodies:
Goat-α-Mouse HRP goat IgG (H+L) WB HRP conju-
gate
Dianova
(No. 115-035-003)
Goat-α-Rabbit HRP goat IgG (H+L) WB HRP conju-
gate
Dianova
(No. 111-035-003)
Alexa Fluor 488
donkey-α-rabbit
donkey IgG (H+L) IH Alexa488-
conjugated
Molecular Probes
(No. A21206)
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3.2. Methods: Laboratory animals
3.2.1. Cultivation of Hydra
The animals were kept in artificial Hydra Medium at 18 ◦C in polystyrene dishes. The initial
culturing conditions of Hydra and the Hydra Medium recipe were described by Lenhoff in 1953.
The Hydra polyps were fed two to three times a week with freshly hatched Artemia salina nauplii.
The animals were washed twice after feeding and the medium was exchanged. Prior to RNA iso-
lation or protein extraction, the animals were starved for 48 hours. The following Hydra-strains
have been used to perform the experiments. Both strains belong to the vulgaris group:
Hydra magnipapillata 105: also known as Hydra magnipapillata B8. This strain is the standard wild
type strain whose genome was sequenced during the Hydra genome
project. It originates from a single polyp collected by Dr. Tsutomo
Sugiyama in a swamp adjacent to the National Institute of Genetics in
Mishima, Japan.
Hydra vulgaris AEP: This strain is a result of crosses of several American wild type strains.
The founder strains are a male strain called CA7 which was collected
from Boulder Creek (Susanville, California) and a female strain called
PA1 which was collected from a pond on the Haverford College cam-
pus (Haverford, Pennsylvania). This strain produces eggs and sperm
frequently. Its embryos are used for generating transgenic Hydra.
Hydra Medium (HM) 1 mM Tris-Cl pH 7.4
0.1 mM KCl
1 mM CaCl2
1 mM NaHCO3
0.1 mM MgCl2
Preparation of artemia
Artemia were prepared by incubating two spoons of Artemia cysts (Inve) in 2 litres of salt water
(32.5 g sea salt/l H2O, pH 8.2) in aerated flasks at 32 ◦C for 24 hours. The hatched Artemia were
seperated from unhatched cysts and loose eggshells. Hatched Artemia were kept in salt water at
18 ◦C in aerated flasks. Prior to feeding, the Artemia were washed with Hydra Medium to avoid
changing the salt concentration in the Hydra culture during feeding.
3.2.2. Regeneration experiments with Hydra
For regeneration experiments polyps without buds have been used. For head regeneration exper-
iments Hydra was cut with a scalpel just beneath its tentacle base. After decapitation the regen-
erating tip was transferred to a petri dish with fresh Hydra Medium. The polyp was allowed to
regenerate for different periods of time. For RNA isolation and in situ hybridization, the polyps
were allowed to regenerate for 1.5, 3, 6, 12, 24 and 48 hours.
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3.2.3. Treatment of Hydra with hydroxyurea
It has been shown by Bode et al. (1976) that Hydra can be treated with hydroxyurea (HU) to
selectively deplete its I-cell lineage. 50 polyps were transferred into a petri dish with fresh Hy-
dra Medium and fed daily for three days. The Hydra Medium was then replaced with Hydra
Medium containing 10 mM HU. The animals were kept in medium containing HU for four days
with exchanging the medium daily. They were fed on the first two days of the treatment and then
starved. On the fourth day, the animals were washed with normal Hydra Medium and used for
RNA isolation and in situ hybridization immediately. As a control, animals were kept in the same
way, except that the Hydra Medium was not exchanged with medium containing HU.
3.3. Methods: Microbiological techniques
3.3.1. Cultivation of E. coli
E. coli-strains were cultivated in LB-medium at 37 ◦C and 200 rpm in a shaker or on LB-agar
plates at 37 ◦C in an incubator for 12 to 16 hours. To select for the desired recombinant bacteria
antibiotics were added to the medium if necessary. During the thesis the follwing E.coli-strains
have been used:
DH5α: F− endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG φdlacZ∆M15
∆(lacZYA-argF)U169 hsdR17(rK - mK -) λ-
DH10Bac: F− mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 endA1
araD139 ∆(ara, leu)7697 galU galK λ- rpsL nupG/bMON14272/pMON7124
BL21(DE3): F− ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene1 ind1
sam7 nin5])
Rosettagami (DE3) pLysS: ∆(ara-leu)7697 ∆lacX74 ∆phoA PvuII phoR araD139 ahpC galE galK rpsL
(DE3) F’[lac+ lacIq pro] gor522::Tn10 trxB pLysSRARE (CamR, StrR, TetR)
Media, solutions and antibiotics
LB-medium: 10 g tryptone
5 g yeast extract
5 g NaCl
Adjust volume to 1 liter with H2O.
Sterilize by autoclaving.
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LB-agar plates: 10 g tryptone
5 g yeast extract
5 g NaCl
15 g agar
Adjust volume to 1 liter with H2O.
Sterilize by autoclaving.
Cool down to 50 ◦C and add the appropriate amount of antibiotic,
X-Gal and IPTG. Mix the medium gently and pour into sterile plates.
To remove air bubbles, flame the surface of the medium with a bun-
sen burner. After the medium hardened, the plates are stored at 4
◦C.
For AXI-plates 100 µg/ml ampicillin, 40 µg/ml X-Gal and 0.2 M
IPTG are added.
For DH10Bac-plates 50 µg/ml kanamycin, 7 µg/ml gentamycin, 10
µg/ml tetracyclin, 100 µg/ml X-Gal and 40 µg/ml IPTG are added.
SOC-medium: 20 g tryptone
5 g yeast extract
0.5 g NaCl
2.5 mM KCl
Adjust volume to 1 liter with H2O.
Sterilize by autoclaving.
Add MgCl2 to a final concentration of 10 mM and glucose to 20 mM.
CaCl2 solution: 60 mM CaCl2
15% glycerol
10 mM PIPES pH 7.0
X-Gal stock-solution: 20 mg/ml in dimethylformamide
Sore at - 20 ◦C.
IPTG stock-solution: 1 M in H2O
Store at - 20 ◦C.
Ampicillin stock-solution: 100 mg/ml in H2O
Sterilize by filtration. Store at - 20 ◦C.
Working concentration: 100 µg/ml.
Kanamycin stock-solution: 100 mg/ml in H2O
Sterilize by filtration. Store at - 20 ◦C.
Working concentration: 100 µg/ml.
Gentamycin stock-solution: 50 mg/ml in H2O
Sterilize by filtration. Store at 4 ◦C.
Working concentration: 7 µg/ml.
Tetracyclin stock-solution: 6.1 mg/ml in ethanol
Store at - 20 ◦C.
Working concentration: 10 µg/ml for liquid cultures and 12.5 µg/ml
for plates.
Chloramphenicol stock-solution: 34 mg/ml in ethanol
Store at - 20 ◦C.
Working concentration: 100 µg/ml.
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3.3.2. Production of competent bacteria
Competent bacteria are able to take up DNA. Either chemocompetent bacteria or electrocom-
petent bacteria were produced. The competency of the cells is indicated by the transformation
efficiency. The transformation efficiency was assessed by a test transformation and calculated as
follows:
transformation efficiency [cfu/µg] = number of colonies [cfu]amount of DNA [µg] · total volumeplated volume
Electrocompetent bacteria
The production of electrocompetent bacteria was carried out as described by Dower et al. (1988).
5 ml LB-medium were inoculated with a single colony of E.coli-cells and incubated over night at
37 ◦C and 200 rpm in a shaker. 500 ml LB-medium were inoculated with the over night culture
and incubated at 37 ◦C and 200 rpm in a shaker until an OD600 of 0.5 - 0.7 was reached. The
following steps were carried out at 4 ◦C. The bacterial cells were incubated for 15 minutes on
ice to cool down. Afterwards the bacteria were centrifuged for 20 minutes at 3000 g and 1 ◦C.
The supernatant was discarded and the pellet was resuspended in 5 ml of ice-cold water. 500
ml ice-cold water were added and the suspension was centrifuged for 20 minutes at 3000 g and
1 ◦C. The supernatant was discarded. The bacteria were washed in ice-cold water twice. After
the second wash, the bacterial cells were resuspended in the remaining supernatant and 40 ml
of ice-cold 10% glycerol were added. The suspension was centrifuged for 10 minutes at 3000 g
and 1 ◦C. The supernatant was discarded and the bacteria were resuspended in 1 volume of 10%
glycerol. 55 µl aliquots were snap frozen in liquid nitrogen and stored at - 80 ◦C.
The transformation efficiency of the bacterial cells was determined by a test-transformation. For
this purpose electrocompetent E.coli were transformed with a certain amount of DNA. To test the
efficiency, an aliquot of electrocompetent cells was transformed with 1 ng pUC19-DNA. Different
volumes (1, 10 and 100 µl) of the test-transformation were plated on LB-agar plates containing
ampicillin and incubated over night at 37 ◦C. The number of colonies on the plates was counted
and the transformation efficiency was calculated. Usually transformation efficiencies of about 109
cfu/µg were achieved for electrocompetent E.coli-BL21 (DE3) or E.coli-Rosettagami (DE3) pLysS.
Chemocompetent bacteria
Chemocompetent bacteria were produced based on the protocol of Mandel and Higa (1970). 50
ml LB-medium were inoculated with a single colony of E.coli-cells and grown over night at 37 ◦C
and 200 rpm in a shaker. 400 ml LB-medium were inoculated with an OD600 of 0.05. The bacterial
culture was incubated at 37 ◦C and 200 rpm in a shaker until an OD600 of 0.3 - 0.4 was reached.
The bacteria were aliquoted in prechilled 50-ml tubes and cooled down on ice for 10 minutes.
The cells were centrifuged for 15 minutes at 1600 g and 4 ◦C. The supernatant was discarded and
the pellet was resuspended in 10 ml ice-cold CaCl2 solution. The bacteria were centrifuged for 15
minutes at 1600 g and 4 ◦C. The supernatant was discarded and the pellet was again resuspended
in 10 ml ice-cold CaCl2 solution. The cells were kept on ice for 30 minutes. The bacteria were
centrifuged for 15 minutes at 1600 g and 4 ◦C. The supernatant was discarded and the pellet was
finally resuspended in 2 ml ice-cold CaCl2 solution. 100 µl aliquots were snap frozen in liquid
nitrogen and stored at - 80 ◦C.
The transformation efficiency of the chemocompetent bacteria were determined by a test-transformation.
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An aliquot of chemocompetent cells was transformed with 10 ng pUC19-DNA. Different volumes
(200 and 800 µl) of the test-transformation were plated on LB-agar plates containing ampicillin
and incubated over night at 37 ◦C. The number of colonies on the plates was counted and the
transformation efficiency was calculated. For chemocompetent E.coli-DH5α or E.coli-DH10Bac
transformation efficiencies of about 107 cfu/µg were achieved.
3.3.3. Transformation of bacteria
E.coli-cells were either transformed by electroporation or calcium transformation. The exposure
of bacterial cells to calcium ions enables them to take up DNA. Plasmid DNA is mixed with
chemocompetent cells and heat shocking the cells allows the DNA to enter. Transformation by
electroporation is achieved by briefly applying a high-voltage electrical field to the cells. Appar-
ently transient holes in the cell membrane are produced and the DNA can enter the cell. Electro-
poration can also be used to transform eukaryotic or plant cells.
Transformation of electrocompetent bacteria
One aliquot of electrocompetent cells was thawed on ice and mixed gently with 1 ng - 200 ng of
plasmid DNA. The DNA and cells were transferred to a prechilled electroporation cuvette. An
electric pulse (25 µF, 2.5 kV, 200 Ω, field strength: about 12,5 kV/cm) was applied. Usually a
time constant of 4.8 - 5.2 ms indicated that the procedure was successful. After transformation,
the bacteria were mixed with 1 ml SOC-medium immediately and incubated at 37 ◦C in a shaker
for 30 - 60 minutes. Different volumes of cells were either plated on LB-plates or the cells were
directly used to inoculate a liquid culture. The appropriate antibiotics were added to the medium
or plates to select for the desired transformants.
Transformation of chemocompetent bacteria
The chemocompetent cells were thawed rapidly and mixed gently with up to 500 ng of plasmid
DNA. The DNA and cells were cooled on ice for 15 min. The cells were heat shocked for 50
seconds at 42 ◦C. After transformation, the bacteria were chilled on ice for 2 minutes and mixed
with 1 ml SOC-medium. The bacteria were incubated at 37 ◦C in a shaker for 30 - 60 min. Different
volumes of cells were either plated on LB-plates or the cells were directly used to inoculate a
liquid culture. The appropriate antibiotics were added to the medium or plates to select for the
desired transformants.
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3.4. Methods: RNA
While working with RNA, special precautions have been taken to avoid the contamination with
RNases. Fresh gloves have been worn and the workspace has been cleaned with 100% ethanol.
The equipment like pipetmen and electrophoresis tanks have been cleaned before with 1% SDS,
rinsed with H2O followed by 100% ethanol and finally soaked in 3% H2O2 for 10 minutes and
cleaned with H2O. Bottles and flasks for preparing the solutions have been baked at 180 ◦C.
Tubes and pipet tips from unopened bags have been used and working was carried out without
speaking.
3.4.1. Isolation of RNA from Hydra magnipapillata
Total RNA of Hydra was isolated as described by Chomczynski and Sacchi (1987) with a mix-
ture of acid guanidinium thiocyanate-phenol-chloroform. About 50 - 100 polyps were washed
in Hydra Medium twice. The polyps were transferred to an Eppendorf tube and centrifuged at
top speed in a tabletop centrifuge for 1 minute. The Hydra Medium was removed and the polyps
were lysed completely in 500 µl of GTC-solution by pipetting them up and down several times on
ice. 50 µl of 2 M sodium acetate (pH 4.0) and 550 µl of phenol-chloroform-isoamyl alcohol (25:24:1)
were added. Mixing was achieved by vigorously shaking for 1 min by hand. The mixture was
kept on ice for 10 minutes and centrifuged at top speed in a tabletop centrifuge for 5 minutes to
separate the phases. The upper aqueous phase was transferred to a new Eppendorf tube. 250 µl
of 1.2 M sodium chloride, 0.8 M sodium citrate and isopropanol were added, respectively. The
mixture was incubated at room temperature for 15 minutes and the RNA was collected by cen-
trifugation at top speed in a tabletop centrifuge for 15 minutes. The RNA pellet was washed three
times with 250 µl of ice-cold 70% ethanol. Finally the RNA pellet was air-dried and solved in an
appropriate volume of H2O. To remove a possible contamination by genomic DNA, the RNA
was treated with RNase-free DNaseI. The total RNA was mixed with 1 µl DNaseI (10 U/µl) and
incubated for 20 minutes at 37 ◦C in 1 x Incubation Buffer. To remove the enzyme, the RNA was
extracted with phenol-chloroform-isoamyl alcohol (25:24:1). The concentration and purity of the
extracted RNA was determined by spectrophotometry and agarose gel electrophoresis (compare
3.5.3). The RNA was stored at - 80 ◦C.
Solutions for RNA extraction
GTC-solution: 4.2 M guanidinium thiocyanate (GTC)
25 mM sodium citrate (pH 7.0)
0.5% (w/v)N-lauroyl-sarcosine
5% (v/v)β-mercaptoethanol
Dissolve GTC in a small volume of H2O by heating.
Add 1 M sodium citrate solution 1:40 and 10% sarcosyl solution
1:20.
Add β-mercaptoethanol shortly before use.
The GTC-solution can be stored at 4 ◦C for about four weeks.
1 M sodium citrate: 1 M sodium citrate
Adjust the pH to 7.0.
Sterilize by autoclaving.
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10% N-lauroyl-sarcosine: Dissolve 10% N-laroyl-sarcosine in H2O.
Sterilize by autoclaving.
2 M sodium acetate: Dissolve 3 M sodium acetate in a small volume of H2O.
Adjust the pH to 4.0 by adding glacial acetic acid.
Sterilize by autoclaving.
2.5 M sodium chloride: Dissolve 2.5 M sodium chloride in H2O.
Sterilize by autoclaving.
3.4.2. Preparation of cDNA
cDNA was prepared for semiquantitative RT-PCR experiments and for 5’- and 3’-Race. 5’- and
3’-Race (rapid amplification of cDNA ends) PCR were performed to identify 5’- and 3’-ends of the
Hydra Polycomb Group genes. The cDNA for 5’ and 3’ RACE was a courtesy of Dr. Anne Kuhn
(Holstein lab).
Preparation of cDNA for 5’-Race
Hydra total RNA was reverse transcribed using the Invitrogen GeneRacer Kit according to the
manufacturer´s instruction. To obtain cDNA for 5’-Race, first of all the 5’ cap structure from in-
tact mRNA has to be removed and an RNA oligo has to be ligated to the 5’ end instead. 5 µg of
total RNA was mixed with 1 µl RNaseOut (40 U/µl) and 1 µl CIP (10 U/µl) in a total volume of
10 µl in 1 x CIP Buffer and incubated at 50 ◦C for 1 hour to remove the 5’ phosphates. The RNA
was extracted using phenol-chloroform-isoamyl alcohol (25:24:1) and precipitated by adding 2 µl
10 mg/ml mussel glycogen as a carrier, 10 µl 3 M sodium acetate (pH 5.2) and 220 µl 95% ethanol.
The RNA was incubated at - 20 ◦C over night and centrifuged at top speed in a tabletop cen-
trifuge for 20 minutes at room temperature. The RNA pellet was washed with 500 µl of ice-cold
70% ethanol. Finally the RNA pellet was air-dried and dissolved in 7 µl H2O. The RNA was de-
capped using the tobacco acid pyrophosphatase. The RNA was mixed with 1 µl 10 x TAP Buffer,
1 µl RNaseOUT (40 U/µl) and 1 µl TAP (0.5 U/µl) and incubated at 37 ◦C for 1 hour. Afterwards
the decapped RNA was phenol-chloroform extracted and precipitated again. Then the GeneR-
acer RNA Oligo (5’-CGACUGGAGCACGAGGACACUGACAUGGACUGAA GGAGUAGAAA-
3’) was ligated to the 5’ end of the RNA. The decapped RNA was mixed with 0.25 µg GeneRacer
RNA Oligo and incubated at 65 ◦C for 5 minutes. The reaction was chilled on ice and it was
mixed with 1 µl 10 mM ATP, 1 µl RNaseOut (40 U/µl) and 1 µl T4 RNA ligase (5 U/µl) in a total
volume of 10 µl in 1 x Ligase Buffer. The reaction was incubated for 1 hour at 37 ◦C. The RNA was
phenol-chloroform extracted and precipitated once more. The RNA was transcribed into cDNA
by reverse transcriptase. The RNA was mixed with 1 µl of 50 µM 5’ GeneRace primer and 1 µl
25 mM dNTP mix in a total volume of 12 µl. The mixture was incubated at 65 ◦C for 5 minutes
and chilled on ice for 1 minute. The cDNA was synthesized by adding 4 µl of 5 x RT buffer, 1 µl
Cloned AMV RT (15 U/µl), 2 µH2O and 1 µl RNaseOUT (40 U/µl). The reaction was incubated at
45 ◦C for 1 hour and terminated by inactivating the reverse transcriptase at 85 ◦C for 15 minutes.
The cDNA was stored at - 20 ◦C. 5’-Race cDNA was diluted 1:10 for RACE-PCR.
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Preparation of cDNA for 3’-Race
Hydra total RNA was reverse transcribed using the Invitrogen GeneRacer Kit according to the
manufacturer´s instruction. Since the provided GeneRacer 3’ primer was not useful for obtaining
correct 3’-ends of Hydra genes, the following primer was used instead:
QtdT 5’-CCAGTGAGCAGAGTGACGAGGACTCGAGCTCAAGC(T)18-3’. This primer was de-
scribed by Davis et al. (1995) for RACE-PCR in the flatworm Schistosoma mansoni. The 3’-Race
cDNA was transcribed in the same way as described for the 5’-Race cDNA. 5 µg of total RNA
was mixed with 1 µl of 50 µM QtdT primer and 1 µl 25 mM dNTP mix in a total volume of 12
µl. The mixture was incubated at 65 ◦C for 5 minutes to remove any RNA secondary structures
and chilled on ice for 1 minute. The cDNA was synthesized by adding 4 µl of 5 x RT buffer, 1 µl
Cloned AMV RT (15 U/µl), 2 µH2O and 1 µl RNaseOUT (40 U/µl). The reaction was incubated at
45 ◦C for 1 hour and terminated by inactivating the reverse transcriptase at 85 ◦C for 15 minutes.
Finally the cDNA was stored at - 20 ◦C. The cDNA was diluted 1:10 for RACE-PCR.
3.4.3. In situ hybridization
Whole mount in situ hybridization with Hydra was performed as described by Grens et al. (1996)
and Martinez et al. (1997).
Preparation of RNA probes for in situ hybridization
During in situ hybridization the transcripts of the gene of interest are detected using digoxygenin-
labeled, single stranded "antisense" RNA probes. Purified PCR products were used as template
for the in vitro run-off transcription of RNA probes. The "antisense" probe was obtained either
with SP6 or T7 RNA polymerase.
The template was obtained by amplifying the sequence of interest, which has been cloned into
pGEMT-vector - by PCR using M13 for and M13 rev primers. 1 ng of plasmid DNA were mixed
with 1 µl 10 mM dNTP, 1 µl of 5 pmol M13 for primer, 1 µl of 5 pmol M13 rev primer, 1 µl Phusion
DNA polymerase (2 U/µl) in a total volume of 50 µl in 1 x HF Buffer. The following PCR program
was used for amplification:
initial denaturation 98 ◦C 3 minutes
denaturation 95 ◦C 30 seconds
annealing 56 ◦C 30 seconds 30 cycles
elongation 72 ◦C 30 seconds
final elongation 72 ◦C 7 minutes
Note: For the amplification of the template for the riboprobe YY1 fl, a longer annealing time of 45 sec-
onds was used.
The PCR product was purified by Wizard SV Gel and PCR Clean-Up System from Promega ac-
cording to the manufacturer´s instruction. The concentration and purity of the DNA was deter-
mined by spectrophotometry and agarose gel electrophoresis. The template DNA was stored at
-20 ◦C.
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For the in vitro transcription of the RNA probe the DIG RNA Labeling Kit from Roche was used.
The reaction was performed as follows: 250 ng template DNA were mixed with 1 µl 10 x Tran-
scription Buffer, 1 µl 10 x DIG Labeling Mix, 0.5 µl RNaseH (40 U/µl) and 1 µl SP6 or T7 RNA
polymerase (20 U/µl) in a total volume of 10 µl. The reaction was incubated at 37◦C for 2 hours.
2 µl DNaseI (10 U/µl) were added and the mixture was incubated for additional 15 minutes at 37
◦C. The RNA probe was precipitated by adding 2 µl 200 mM EDTA (pH 8.0), 100.5 µl H2O, 135
µl 7.8 M ammonium acetate and 420 µl 100% ethanol. The probe was precipitated for 50 minutes
at room temperature and centrifuged at top speed in a tabletop centrifuge for 20 minutes at room
temperature. The pellet was washed with 250 µl of ice-cold 70% ethanol. Finally the pellet was
air-dried and dissolved in 40 µl 50% formamide. The labeled RNA probe was stored at - 80 ◦C.
The labeled probes were analyzed by agarose gel electrophoresis. Different volumes (1 µl, 2.5 µl
and 5 µl) of a 1:10 dilution of the labeled probe were loaded on a 1% agarose gel in formamide
loading dye (98% formamide, 10 mM EDTA (pH 8.0), 0.1% xylencyanol and 0.1% bromophenol
blue). Prior to loading, the RNA was incubated at 65 ◦C for 10 min. The amount of labeled probe
was estimated by comparison with a defined amount of control RNA which has been loaded onto
the gel as well. Finally the labeled RNA probe was diluted to 5 ng/µl in 100% hybridization mix
and stored at - 80 ◦C.
The following riboprobes have been generated:
riboprobe length gene
eed2 rp 1 742 bp N-terminal fragment of the Hydra Eed gene
eed2 rp 2 751 bp C-terminal fragment of the Hydra Eed gene
ez2 rp 1 743 bp N-terminal fragment of the Hydra EZ2 gene
ez2 rp 2 711 bp C-terminal fragment of the Hydra EZ2 gene
p55 rp 1 719 bp C-terminal fragment of the Hydra p55 gene
suz12 rp 1 713 bp N-terminal fragment of the Hydra SUZ12 gene
suz12 rp 2 767 bp C-terminal fragment of the Hydra SUZ12 gene
yy1 rp 1 759 bp C-terminal fragment of the Hydra YY1 gene
yy1 rp 2 478 bp N-terminal fragment of the Hydra YY1 gene
yy1 fl rp 1131 bp full length coding region of the Hydra YY1 gene
Whole mount in situ hybridization
For whole mount in situ hybridization about 300 Hydra polyps have been transferred to a 50 ml
tube. The polyps were washed with fresh Hydra Medium twice by aspirating the old medium
with a pasteur capillary pipette and adding fresh medium. To relax the animals, 20 ml 4% ure-
thane were added to 20 ml Hydra Medium. The animals were incubated in 2% urethane for
1 - 2 minutes. The urethane was removed completely and the polyps were washed once in 4%
formaldehyde. The formaldehyde was exchanged with 40 ml fresh 4% formaldehyde. The polyps
were fixed over night at 4 ◦C on a roller mixer.
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The fixative was removed from the animals and 40 ml 100% ethanol was added. Ethanol makes
the membranes permeable and the probes can enter the tissue easier. The polyps were incubated
for 5 minutes at room temperature on a roller mixer. This step was repeated four more times until
the polyps have lost their colour and turned white. To rehydrate the animals, subsequent washes
with 75%, 50% and 25% ethanol in 1 x PBST were performed. All steps were performed for 5 min-
utes at room temperature on a roller mixer. The animals were washed three times with 1 x PBST
for 5 minutes. 1 x proteinase K in 1 x PBST was added to the polyps for 10 minutes. The fixed tis-
sue is partially digested and gets permeabilized. The enzyme was removed completely from the
polyps and the proteinase K treatment was terminated by the addition of 1 x glycine in 1 x PBST.
The glycine solution was removed and the polyps were again washed in 1 x glycine in 1 x PBST
for 5 minutes. Afterwards, the polyps were twice washed with 1 x PBST for 5 minutes, followed
by two washes with 1 x TEA for minutes. To improve the signal to noise ratio, the animals were
incubated for 5 minutes with a 1:400 dilution of acetic anhydride in 1 x TEA followed by an in-
cubation for 5 minutes with a 1:200 dilution of acetic anhydride in 1 x TEA. The acetic anhydride
probably neutralizes NH2+ - groups which had been set free during the proteinase K treatment.
The animals are washed in 1 x PBST for 5 minutes twice before they are fixed a second time with
4% formaldehyde. This second fixation step was performed for 20 minutes at room temperature.
Once more the polyps were washed with 1 x PBST 5 times for 5 minutes. The animals were fixed
for 30 minutes at 80 ◦C in 1 x PBST. They were washed once with a solution of 50% hybridization
mix in 1 x PBST for 10 minutes before incubating the polyps in 100% hybridization mix for 10
minutes at room temperature. The animals were pre-hybridized in 100% hybridization mix for
about 2 hours at 55 ◦C. After this step, the fixed animals can be stored at - 20 ◦C until use.
For hybridization, 10 - 15 animals per riboprobe were transferred to an Eppendorf tube. Hy-
bridization with the riboprobes (0.2 ng/µl in 100% hybridization mix) was performed for 2.5
days at 55 ◦C.
The polyps were washed for minutes at 55 ◦C with decreasing concentrations (100%, 75%, 50%
and 25%) of hybridization mix in 2 x SSC to remove unbound probe. Finally, the animals were
incubated twice in 2 x SSC and 0.1% CHAPS for 30 minutes at 55 ◦C. The animals were washed
twice with MAB for 10 minutes at room temperature on a rocker before blocking for 1 hour with
MAB-B at room temperature. The animals were blocked for an additional 2 hours at room tem-
perature with 1 x Blocking Solution in MAB. For detection of the DIG-labeled riboprobes, an
anti-digoxigenin antibody conjugated to alkaline phosphatase (Fab fragment, Roche) was used.
The polyps were incubated with a 1:4000 dilution of the antibody in 1 x Blocking Solution at 4 ◦C
over night.
The animals were washed 8 times with MAB for 1 hour at room temperature on a rocker. Finally
they were incubated with MAB over night at room temperature on a rocker.
The polyps were washed twice for 5 minutes at room temperature with NTMT followed by NTMT
and Levamisol, respectively. The animals were transferred into a 24-well plate for staining. The
staining reaction was either performed with NBT/BCIP or BMPurple in NTMT. NBT/BCIP or
BMPurple serve as a substrate for the alkaline phosphatase; a purple indigo dye is formed and
the transcript of the gene of interest can such be detected. 250 µl of substrate were added to each
well. The polyps were stained for 30 minutes - 3 hours. The staining time is dependent on the
riboprobe used and the unspecific background which is forming in the animal.
The staining reaction was stopped by removing the substrate and adding NTMT. The stained
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polyps were incubated with 100% ethanol for 5 minutes until a colour change of the dye from
purple to blue occured. The ethanol was removed and the polyps were washed with decreasing
concentrations of ethanol (75%, 50% and 25%) for 5 min. Finally the animals were transferred into
1 x PBS.
The stained animals were mounted on microscope slides using 200 µl Mowiol per slide. After the
Mowiol has hardened, the staining was examined under a microscope.
Solutions for in situ hybridization
Urethane: 4% urethane (w/v) in H2O.
8% formaldehyde: 8% paraformaldehyde (w/v) in H2O.
Dissolve paraformaldehyde by heating to 60 ◦C for several hours
until the solution clearifies.
Adjust pH to 7.5 with 1 M sodium hydroxide.
Always use freshly prepared formaldehyde.
10 x PBS: 1.5 M NaCl
0.08 M Na2HPO4 phosphate
0.02 M NaH2PO4
Sterilize by autoclaving.
1 x PBST: Dilute 100 ml 10 x PBS in 900 ml H2O.
Add 1 ml Tween20.
1000 x proteinase K: 10 mg/ml proteinase K in H2O.
Aliquot and store at - 80 ◦C.
10 x glycine: 40 mg/ml glycine in H2O.
10 x TEA: 1 M triethanolamine in H2O.
Adjust pH to 7.8.
Hybridization mix: 50% formamide
5 x SSC
20 µg/ml yeast RNA
0.1% Tween20
0.1% Chaps
1 x Denhardt’s
100 µg/ml heparin
20 x SSC: 3 M NaCl
0.3 M sodium citrate
ad 900 ml H2O and adjust the pH to 7.0.
ad 1000 ml H2O
Sterilize by autoclaving.
Yeast RNA: 10 mg/ml yeast RNA in H2O.
Aliquot and store at - 20 ◦C.
1% Chaps: 1% Chaps (w/v) in H2O.
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50 x Denhardt’s: 1% polyvinylpyrrolidone
1% ficol
1% bovine serum albumin (BSA), fraction V
Sterilize by filtration.
Aliquot and store at - 20 ◦C.
Heparin: 10 mg/ml in H2O.
Aliquot and store at - 20 ◦C.
Maleic acid buffer (MAB): 100 mM maleic acid
150 mM NaCl
ad 900 ml H2O and adjust the pH to 7.5.
ad 1000 ml H2O
Sterilize by autoclaving.
MAB-B: 1% bovine serum albumine (fraction V)(w/v) in MAB.
10 x Blocking Solution: 10% Blocking Solution (Roche) (w/v) in MAB.
Aliquot and store at - 20 ◦C.
anti-digoxigenin antibody: anti-digoxigenin antibody, alkaline phosphatase conjugated (Fab
fragment, Roche) 1:4000 in 1 x Blocking Solution.
10 x sodium chloride: 1 M NaCl in H2O.
Sterilize by autoclaving.
10 x Tris-HCl (pH 9.5): 1 M Tris in H2O.
ad 900 ml H2O and adjust the pH to 9.5.
ad 1000 ml H2O
Sterilize by autoclaving.
10 x magnesium chloride: 0.5 M MgCl2 in H2O.
Sterilize by autoclaving.
NTMT: 100 mM sodium chloride
100 mM Tris-HCl (pH 9.5)
50 mM magnesium chloride
0.1% Tween20
Prepare shortly before use from stock solutions.
1 M levamisol: 1 M levamisol in H2O.
Store at 4 ◦C.
NBT/BCIP substrate: Add 50 µl NBT solution (Roche) and 37.5 µl BCIP (Roche) to 10
ml NTMT.
Prepare freshly before use.
BMPurple substrate: Use BMPurple substrate (Roche) undiluted.
Mowiol: Mix 6 g Mowiol with 6 g glycerol and dissolve for 1 hour at room
temperature with frequent agitation.
Add 6 ml H2O and stir for 1 hour at room temperature.
Add 12 ml 0.2 M Tris-HCl (pH 8.5) and incubate at 50 ◦C under
periodical stirring until the Mowiol has dissolved.
Centrifuge for 30 minutes at 2000 g to remove undissolved mate-
rial.
Aliquot the supernatant and store at - 20 ◦C.
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3.5. Methods: DNA
3.5.1. Purification of plasmid DNA
DNA has been amplified in bacteria as ’high copy’ (300 - >1000 copies per cell) or ’low copy’ (5 -
20 copies per cell) extrachromosomal plasmid DNA. The plasmid DNA was isolated by alkaline
lysis. The bacteria were lysed by the addition of sodium hydroxide. The cell membranes were dis-
solved and the proteins denatured. Neutralization led to precipitation of the denatured proteins
and bacterial chromosomal DNA. The plasmid DNA, which stays in solution, was isolated.
DNA minipreparation
For the purification of plasmid DNA in a small scale, the Wizard Plus SV Minipreps DNA Purifi-
cation System from Promega was used according to the manufacturer´s instruction. The system
is based on DNA preparation by alkaline lysis. For plasmid DNA purification 5 ml LB medium
with the appropriate antibiotics has been inoculated with a single colonie of E.coli-cells. The cul-
ture was incubated over night at 37 ◦C and 200 rpm in a shaker. The whole culture has been
used for plasmid DNA purification. The bacteria were spun down for 5 minutes at full speed
in a tabletop centrifuge. The bacterial pellet was resuspended in 250 µl Cell Resuspension Solu-
tion (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 100 µg RNaseA). 250 µl of Cell Lysis Solution (0.2
M NaOH, 1% SDS) and 10 µl of Alkaline Protease Solution were added. After incubation for
5 minutes at room temperature, cell lysis was stopped by the addition of 350 µl Neutralization
Solution (4.09 M guanidine hydrochloride, 0.759 M potassium acetate, 2.12 M glacial acetic acid).
The lysate was spun down for 10 minutes at top speed. The supernatant was decanted into a spin
column with a silica-impregnated porous membrane to bind DNA. After centrifugation for 1 min
at top speed, the bound DNA was washed with 750 µl of Wash Solution (60% ethanol, 60 mM
potassium acetate, 8.3 mM Tris-HCl pH 7.5, 0.04 mM EDTA). The step was repeated with 250 µl
of Wash Solution. After centrifuging for 2 minutes at top speed, the DNA was eluted with 250
µl - 250 µl H2O. The purified plasmid DNA was analyzed by spectrophotometry and agarose gel
electrophoresis.
3.5.2. Extraction and precipitation of DNA
Extraction of nucleic acids by phenol-chloroform
The phenol-chloroform extraction method is used to remove proteins from nucleic acids solu-
tions (Chomczynski and Sacchi, 1987). Proteins are denatured by phenol and accumulate in the
organic phase and at the interphase between the organic and the aqueous phase. Chloroform
helps to seperate the two phases and isoamyl alcohol prevents the formation of foam.
An equivalent volume of phenol-chloroform-isoamyl alcohol (25:24:1) was added to the DNA so-
lution. The solutions were vigourously mixed by shaking for 1 minute. The organic and the aque-
ous phase were seperated by centrifugation at top speed in a tabletop centrifuge for 5 minutes at
room temperature. The upper, aqueous phase was transferred to a new tube and an equal volume
of chloroform-isoamyl alcohol (24:1) was added. Again the solutions were mixed by shaking and
the phases were seperated by centrifugation. The aqueous phase contains the nucleic acids.
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Precipitation of DNA
Ethanol precipitation was used to purify and concentrate DNA from aqueous solutions. A mix-
ture of salt and ethanol forces the DNA to precipitate out of solution by decreasing its solubility
in water.
To an aqueous solution of DNA 1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of
100% ethanol were added. The DNA was centrifuged at top speed in a tabletop centrifuge for 20
minutes at room temperature. The pellet was washed with 70% ethanol. Finally the pellet was
air-dried and dissolved in an appropriate amount of H2O or TE-buffer.
3.5.3. Analysis of DNA
DNA was analyzed concerning both its quantity and quality. DNA quantity was determined by
spectrophotometry, the quality was determined by gel electrophoresis. The DNA sequence was
analyzed by automated sequencing.
Quantification of DNA
The concentration of DNA was determined by spectrophotometry using the Nanodrop spec-
trophotometer from Peqlab. 1 - 2 µl of DNA were used for analysis at an absorption of 260 nm. An
OD260 of 1.0 equals a DNA concentration of 50 µg DNA per ml. (For RNA, an OD260 of 1.0 equals
an RNA concentration of 40 µg RNA per ml.) Conclusions on the purity of the DNA were made
by examining the ratio of OD260 to OD280. A value between 1.8 and 2.0 represents a high-quality
DNA sample.
Analysis of DNA by gel electrophoresis: agarose gel electrophoresis (AGE)
The quality and size of DNA was analyzed by agarose gel electrophoresis. Plasmid DNA prepa-
rations and PCR reactions were analyzed on 1% agarose gels using 1 x TAE or 1 x TBE buffer. To
check the size of the DNA, additionally a DNA size marker has been loaded onto the gel. Elec-
trophoresis was carried out at 100 mV in the same buffer which was used for the preparation of
the gel. The DNA was visualised by staining for 5 minutes in an ethidium bromide solution and
detection at 254 nm using a transilluminator. The gels were documented using the INTAS gel
documentation system.
Solutions for gel electrophoresis
0.5 M EDTA: 186.12 g EDTA in 800 ml H2O.
Adjust pH to 8.0 with NaOH.
Adjust volume to 1 litre with H2O.
Sterilize by autoclaving.
50 x TAE: 242 g Tris base
100 ml 0.5 M EDTA (pH 8.0)
57.1 ml glacial acetic acid
Adjust volume to 1 litre with H2O.
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1 x TAE: 40 mM Tris acetate
1 mM EDTA (pH 8.0)
Dilute 20 ml of 50 x TAE solution with 980 ml H2O.
5 x TBE: 54 g Tris base
27.5 g boric acid
40 ml 0.5 M EDTA (pH 8.0)
Adjust volume to 1 litre with H2O.
1 x TBE: 44.5 mM Tris borate
2 mM EDTA (pH 8.0)
Dilute 200 ml of 5 x TBE solution with 800 ml H2O.
6 x DNA loading dye: 0.09% bromophenol blue (w/v)
0.09% xylencyanol (w/v)
60% glycerol (v/v)
60 mM EDTA (pH 8.0)
Ethidium bromide stock-solution: 10 mg/ml in H2O.
Working concentration: 100 ng/ml in H2O.
Analysis of DNA by gel electrophoresis: polyacrylamide gel electrophoresis
DNA molecules of short length were resolved by polyacrylamide gel electrophoresis rather than
agarose gel electrophoresis. The oligos used for band shift assays have been analyzed this way.
For gel electrophoresis 10 - 12% polyacrylamide gels in 1 x TBE buffer have been prepared be-
tween two glass plates. Electrophoresis and detection of the DNA have been performed like
agarose gel electrophoresis.
12% polyacrylamide gel:
H2O 10 ml
40% polyacrylamide (acrylamide - bisacrylamide 29:1) 6 ml
5 x TBE 4 ml
10% ammonium persulfate 200 µl
TEMED 10 µl
Analysis of DNA by restriction cleavage
The DNA clones were analyzed by restriction enzyme cleavage, followed by agarose gel elec-
trophoresis. To determine the correct insert size before sequencing, the plasmids were cut with
two restriction enzymes simultaneously. The insert size of pGEM-T plasmids has been always
analyzed by cleavage with ApaI and SacI, pET- and pFastBac1-clones have been analyzed by var-
ious enzymes. For analytical restriction enzyme cleavage, 300 ng of DNA have been incubated
with an appropriate amount of enzyme in the recommended 1 x buffer in a total volume of 10 µl.
After incubation for 1 hour at the appropriate temperature (usually 37 ◦C), 2 µl of 6 x DNA load-
ing dye were added. The DNA fragments were analyzed by agarose gel electrophoresis. Clones
of the correct insert size were further analyzed by sequencing.
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(The restriction enzyme activity required to cut a certain amount of DNA can be exactly de-
termined. A unit of restriction enzyme activity is the amount of restrition enzyme needed to
completely cut 1 µg of bacteriophage lambda DNA in 1 hour. To cut a DNA fragment of x bp to
completion, the following enzyme activity is required:
enzyme activity [units]= x bp (size of DNA fragment)48000 bp (size of lambda genome) · number of restriction sites in the lambda genomenumber of restriction sites in the DNA fragment )
DNA sequencing
DNA sequencing was carried out by the chain-termination method (Sanger et al., 1977). For the
chain-termination reaction ddNTPs, each labeled with a different fluorescent dye - were used.
The DNA sequence was detected by capillary electrophoresis. The DNA fragments of different
length are seperated in a capillary filled with a gel matrix. At the exit from the gel matrix, the
fluorescent dyes get excited by a laser and detected by a fluorescence detector. A data output is
produced by a software in form of a chromatogram. All sequencing reactions were performed
with the ABI PRISM 310 Genetic Analyzer from Applied Biosystems using the BigDye Termina-
tor v1.0 Cycle Sequencing Kit.
For the sequencing reaction 200 - 400 ng of template DNA were mixed with 1 µl primer (5
pmol/µl) and 2 µl Big Dye in a total volume of 10 µl. The termination reaction was carried
out in a thermal cycler (Gene Amp 2400, Perkin Elmer) using the following program:
initial denaturation 94 ◦C 5 minutes
denaturation 96 ◦C 10 seconds
annealing 58 ◦C 5 seconds 25 cycles
elongation 60 ◦C 4 minutes
The reaction was precipitated using 110 volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes
of 100% ethanol. The DNA was centrifuged at top speed in a tabletop centrifuge for 20 minutes
at room temperature. The pellet was washed with 250 µl of 70% ethanol. Finally the pellet was
air-dried and dissolved in 25 µl H2O. The DNA sample was automatically sequenced using the
ABI PRISM 310 Genetic Analyzer.
3.5.4. Amplification of DNA by polymerase chain reaction (PCR)
Polymerase chain reaction was routinely used to amplify DNA templates for cloning, sequencing
and for riboprobes. For all PCR reactions heat-stable Taq polymerases have been used: either the
proof-reading Phusion High Fidelity DNA polymerase or the EuroTaq DNA polymerase.
For PCR amplification 1 µl of DNA was mixed with 1 µl 10 mM dNTPs, 10 pmol forward primer,
10 pmol reverse primer and 0.6 U of Phusion DNA polymerase in 1 x HF-Buffer or 1.25 EuroTaq
polymerase in 1 x RB buffer containing 1.5 mM MgCl2. The total reaction volume was 50 µl. Am-
plification was performed using the following cycling conditions:
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initial denaturation 98 ◦C 3 minutes
denaturation 98 ◦C 30 seconds
annealing X ◦C 30 seconds x cycles
elongation 72 ◦C 1 minute / 1000 bp
final elongation 72 ◦C 7 minutes
Note: The annealing temperature depends on the melting temperature of the primers used.
All primers used for PCR amplification are listed in section 3.1.4 on page 40. The use of the
primers and their respective melting temperatures are indicated.
Amplification of core fragments of the Hydra PcG genes by PCR
The Hydra Polycomb Group and associated genes have been identified by in silico analysis of the
Hydra Genome Database followed by cloning of the genes. First, homologs of the Hydra Poly-
comb Group genes were identified by aligning protein sequences of Polycomb Group genes from
other species with the Hydra genome (tBLASTn). Sequences with the highest similarity and the
lowest E-value were double-checked by performing a BLASTp search with the most likely Hydra
protein sequences against the NCBI database. Only if the result of the BLASTp search showed
the correct protein, primers for the Hydra gene were designed. A fragment of the gene, which
matches the sequence identified by the tBLASTn search was amplified from Hydra cDNA. The
fragment does not correspond to the full length sequence of the gene, but to a part of the gene.
The gene fragment was termed ’core fragment’.
For PCR amplification 1 µl of a 1:10 dilution of Hydra 3’ RACE-cDNA was used. The core frag-
ments of the genes were amplified using the following cycling conditions:
initial denaturation 98 ◦C 3 minutes
denaturation 98 ◦C 30 seconds
annealing 65 ◦C 30 seconds 5 cycles
elongation 72 ◦C 30 seconds
denaturation 98 ◦C 30 seconds
annealing 55 ◦C - 60 ◦C 30 seconds 25 cycles
elongation 72 ◦C 30 seconds
final elongation 72 ◦C 7 minutes
Usually the obtained amount of DNA has not been enough for further analysis of the DNA and
for cloning. Therefore, the PCR reactions were reamplified with 1 µl of the initial PCR reaction.
The core fragments of the genes were reamplified using the following cycling conditions:
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initial denaturation 98 ◦C 3 minutes
denaturation 98 ◦C 30 seconds
annealing 55 ◦C - 60 ◦C 30 seconds 25 cycles
elongation 72 ◦C 30 seconds
final elongation 72 ◦C 7 minutes
Finally the PCR reactions have been purified, followed by cloning into pGEMT-vector and DNA
sequencing of the amplified gene. The following core fragments of Polycomb Group associated
genes have been amplified during this thesis:
gene length of the core fragment region of the gene
HyYY1 881 bp The core fragment starts at amino acid position 33 of the
full length gene and ends at amino acid 325.
HySCM 1703 bp The core fragment starts at amino acid position 180 of the
full length gene and ends at amino acid 747.
RACE (rapid amplification of cDNA)-PCR
5’RACE- and 3’RACE-PCR have been performed to identify the 5’ and 3’ ends of the Hydra Poly-
comb Group genes. After the amplification of the core fragments, the full length genes and the 5’
and 3’ untranslated regions were identified by RACE-PCR followed by nested PCR.
FIGURE 3.5 Schematic overview of the
amplification of a specific product by RACE-PCR
followed by nested PCR.
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For PCR amplification 1 µl of a 1:10 dilution of Hydra 3’ or 5’ RACE-cDNA was used for PCR. The
5’ and 3’ ends of the genes were amplified using the same cycling conditions as for the amplifica-
tion of the core fragments.
The PCR reactions have been used for reamplification of the DNA by nested PCR to reduce the
background of unspecific products. For nested PCR, 1 µl of the RACE-PCR reaction was used for
nested PCR. The nested PCR was carried out in the same way as the reamplification of the core
fragments. The PCR reactions have been purified, followed by cloning into pGEMT-vector and
DNA sequencing of the amplified fragment. The following 5’ and 3’ ends of Polycomb Group
associated genes have been amplified:
gene length of the fragment 5’ or 3’ end of the gene
HyYY1 185 bp The 5’ end includes the first 42 amino acids of the protein
coding region and spans the 5’ untranslated region of the
gene.
HyYY1 632 bp The 3’ end includes the last 55 amino acids of the protein
coding region and spans the 3’ untranslated region of the
gene and its 3’ end polyadenylation site.
HySCM 203 bp The 5’ end includes the first 186 amino acids of the protein
coding region and spans the 5’ untranslated region of the
gene.
HySCM 203 bp The 3’ end includes the last 33 amino acids of the protein
coding region and spans the 3’ untranslated region of the
gene and its 3’ end polyadenylation site.
Amplification of the full length Hydra PcG genes by PCR
After the amplification, cloning and sequencing of the core fragments, 5’ and 3’ ends of the Hydra
genes, the full length coding region was amplified by PCR.
For PCR amplification 1 µl of a 1:10 dilution of Hydra 3’ RACE-cDNA was used for PCR. The full
length coding region of the genes were amplified using the following cycling conditions:
initial denaturation 98 ◦C 3 minutes
denaturation 98 ◦C 30 seconds
annealing 60 ◦C 45 seconds 30 cycles
elongation 72 ◦C 30 seconds
final elongation 72 ◦C 7 minutes
The PCR reactions have been purified, followed by cloning into pGEMT-vector and DNA se-
quencing of the amplified full length gene. The following full length coding regions have been
amplified:
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gene length region
HyYY1 1131 bp The fragment corresponds to the full length protein coding re-
gion of the gene.
HySCM 2298 bp The fragment corresponds to the full length protein coding re-
gion of the gene.
PCR-mediated restriction site engineering
For cloning of the Hydra Polycomb Group and associated genes in other vectors than pGEMT,
new restriction sites have been attached to both ends of the genes by PCR-mediated restriction
site engineering. The desired restriction sites were incorporated into the primers used for PCR.
This method avoids blunt-end ligation of PCR products. The PCR product can be ligated into a
vector in the favoured direction, which is especially important for expression vectors. Appropri-
ate primer sites were added at the ends of gene specific primers. Since restriction endonucleases
often fail to cleave these sites if they are located directly at the end of the DNA molecule, addi-
tional bases have been added to the end of the restriction sites.
The PCR was carried out at the same conditions just like the PCR amplification of the full length
genes. Since the restriction sites do not anneal to the initial DNA template, the annealing tem-
perature was calculated but for the matching part of the primers. As a template for the PCR, the
pGEMT-vector containing the full length gene has been used. 1 ng DNA was mixed with 1 µl 10
mM dNTPs, 10 pmol of gene specific forward primer containg a new restriction site at its end,
10 pmol of gene specific reverse primer containing a new restriction site at its end and 0.6 U of
Phusion DNA polymerase in 1 x HF-Buffer.
This method was used for adding additional histidine tags to the N-terminus of the Hydra Poly-
comb Group genes, as well.
Colony-PCR
Colony-PCR was performed to check the outcome of a ligation reaction in a simple and fast way.
A DNA insert can be amplified from recombinant bacteria containing the desired DNA plasmid
with insert specific primers. After the bacteria have been transformed with a ligation reaction
and selected on agar plates containing antibiotics, single colonies have been used as template for
PCR. A single colony has been transferred into a reaction tube with the help of a sterile tooth pick.
After the tooth pick has been twisted in the reaction mixture, it has been transferred into 5 ml LB
medium containing antibiotics. The bacterial colony has been transferred into the following re-
action mixture: 1.5 mM MgCl2, 1 µl of 10 mM dNTPs, 10 pmol forward and reverse primer and
1.25 units of EuroTaq DNA polymerase in 1 x RB buffer in a total volume of 50 µl. The following
cycling conditions have been used: The PCR reaction was analyzed by agarose gel electrophore-
sis. In case a bacterial colony contained the desired DNA plasmid, the cells were cultured at
37 ◦C and 200 rpm over night and the plasmid DNA was isolated.
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initial denaturation 95 ◦C 5 minutes
denaturation 95 ◦C 30 seconds
annealing 55 ◦C 30 seconds 30 cycles
elongation 72 ◦C 30 seconds
final elongation 72 ◦C 7 minutes
Note: Usually these cycling conditions were used for colony-PCR. In case a longer DNA fragment had
to be amplified, both the annealing and elongation time were increased.
Purification of PCR-products
PCR products were purified using the Wizard SV Gel and PCR Clean-Up System from Promega
according to the manufacturer’s instructions. The PCR reaction was mixed with an equal volume
of Membrane Binding Solution (4.5 M guanidinium isothiocyanate, 0.5 M potassium acetate pH
5.0) and incubated for 1 minute in a minicolumn with a silica-impregnated porous membrane to
bind DNA. After centrifugation for 1 minute at top speed in a tabletop centrifuge, the membrane-
bound DNA was washed with 700 µl of Membrane Wash Solution (10 mM potassium acetate,
80% ethanol, 16.7 µM EDTA). The wash solution was spin down for 1 minute at top speed and
the membrane was washed for a second time with 500 µl of Membrane Wash Solution. After 5
minutes of centrifugation at top speed, the DNA was eluted with 30 - 50 µl H2O. The purified
plasmid DNA was analyzed by spectrophotometry and agarose gel electrophoresis.
3.5.5. Cloning
The Hydra Polycomb Group genes were cloned into diverse vectors for different purposes. The
Hydra YY1 gene has been cloned into pET-vectors for recombinant protein expression and into
the baculovirus expression vector pFastBac1 for the production of recombinant baculoviruses.
For cloning, new restriction sites have been attached to both ends of the gene by PCR (see page
73). The obtained fragments were cut with the respective enzymes and ligated into the target
vector.
Cloning into pGEM-T vector
The pGEM-T-vector was chosen for rapid cloning of PCR products. This vector exists as a linear
DNA molecule with thymidine overhangs at both 3’ termini. Adding compatible deoxyadeno-
sine overhangs to the PCR product allows the easy ligation into this vector. The pGEM-T-vector
contains SP6 and T7 RNA polymerase promoters flanking its multiple cloning site. DNA frag-
ments cloned into this vector have been used for the determination of the DNA sequence of the
Hydra Polycomb Group genes by sequencing. Furthermore the inserted DNA has been used as
a template for riboprobe production for in situ hybridization. Deoxyadenosine overhangs were
added to purified PCR products by A-tailing. Some DNA polymerases add a single deoxyadeno-
sine overhang in a template independent manner. However, the Polycomb Group genes have
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been amplified using the Phusion High Fidelity proof-reading DNA polymerase which does not
add a deoxyadenosine. Hence, the purified PCR product was A-tailed using the EuroTaq DNA
polymerase. 800 ng purified PCR product were mixed with 0.3 µl of 10 mM dNTPS, 1.5 mM
MgCl2 and 0.15 units of EuroTaq DNA polymerase in 1 x RB buffer in a total volume of 15 µl.
A-tailing was performed at 72 ◦C for 30 minutes in a thermal cycler. The A-tailed DNA molecule
was ligated into pGEM-T-vector.
Ligation
PCR products were ligated into an adequate target vector with the help of the T4 DNA Ligase.
During the ligation reaction, two ends of DNA molecules are covalently linked. The ligation re-
action was carried out using a three times molar excess of insert DNA compared to vector DNA.
The amount of insert DNA needed was calculated as follows:
amount of insert DNA [ng] = (amount of vector DNA [ng]·length of insert DNA [bp])(length of vector DNA [bp]) · 31
The appropriate amounts of vector DNA and insert DNA were mixed with 3 units of T4-DNA-
Ligase in 1 x Ligation buffer in a total volume of 10 µl. The ligation reaction was incubated over
night at 4 - 16 ◦C. 4 µl of the ligation reaction were directly transformed into chemocompetent
E.coli-DH5α. The cells were plated on LB agar plates containing the appropriate antibiotics. Cells
transformed with pGEM-T were plated on AXI-plates. Insertion of a DNA fragment into the mul-
tiple cloning site of the pGEM-T-vector interrupts the coding sequence of the lacZalpha gene and
disrupts the production of functional β-galactosidase, which leads to white coloured colonies on
AXI-plates. Positive colonies containing the correct plasmid DNA were verified by colony-PCR
or DNA isolation followed by restriction cleavage analysis.
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3.6. Methods: Proteins
3.6.1. Bacterial expression of recombinant HyYY1
The HyYY1 protein was recombinantly expressed for different purposes. The protein was ex-
pressed as antigen for antibody production and purification. Furthermore, the protein was used
for gel retardation assays. The prokaryotic vectors pET15b(+) and pET21(+) provide the basis
for recombinant protein expression in bacteria. The pET15b(+)-vector allows the expression of
an N-terminal 6His-fusion protein, whereas the pET21(+)-vector provides a C-terminal 6His-tag.
pET21(+) is a transcription vector, which lacks the ribosomal binding site and the ATG start codon
for efficient translation. For protein expression, the ribosomal binding site has been cloned into
the vector, together with the HyYY1 DNA. The HyYY1 DNA and a truncated version lacking the
C-terminal zinc finger domains have been cloned into both vectors. The proteins have been ex-
pressed as 6His-fusion proteins, which allows purification by metal ion affinity chromatography.
Electrocompetent Bl21DE3- and Rosettagami DE3 pLysS-cells have been transformed with the plas-
mid DNA, respectively. The transformed cells were used to inoculate a liquid preculture, which
was incubated in a shaker at 37 ◦C over night. 500 ml LB-medium containing 100 µg/ml ampi-
cillin were inoculated with the preculture at an OD600 of 0.05 (500 ml : (OD600 preculture / OD600
0.05) = x = volume needed to inoculate the expression culture). The expression culture was incu-
bated in a shaker at 37 ◦C until an OD600 of 0.5 - 0.7 was reached. Recombinant protein synthesis
was induced by the addition of IPTG at a final concentration of 1 mM. An induction with the
lactose-analog IPTG is possible since the pET-expression vectors contain an inducible lac operon.
The expression cultures have been incubated for 4 hours at either 37 ◦C (HyYY1-fusion) or at 25
◦C (HyYY1∆ZnF-fusion). The bacterial cells were centrifuged at 5000 g and 4 ◦C for 10 minutes.
The supernatant was discarded and the pellet was immediately used for protein purification or
stored at -20 ◦C until use.
1 ml samples of the expression culture have been taken after 0, 1, 2, 3 and 4 hours to analyze the
protein expression by SDS-PAGE. Equal amounts of cells were loaded onto the gel, to determine
the progression of protein expression. The OD600 of each sample was determined by spectropho-
tometry. The bacterial cells were spun down for 1 minute at top speed in a tabletop centrifuge.
The pellet was resuspended in (OD600 · 100) µl of 1 x PBS. An equal volume of 1 x protein sample
buffer was added. 8 µl of each sample were seperated by SDS-PAGE.
3.6.2. Purification of recombinant HyYY1
The recombinant fusion proteins have been purified by metal ion affinity chromatography either
under native or under denaturing conditions.
Protein purification under native conditions
The bacterial cell pellet was resuspended in 10 ml of a phosphate buffer (500 mM NaCl, 50 mM
NaH2PO4, pH 7.8). The cells were lysed by sonication using a Branson sonifier 200 equipped with
a microtip. Sonication was performed on ice for 3 times 60 seconds with 1 minute intervals on
ice using the following settings: power 5, duty cycle 40%. The lysate was centrifuged for 30 - 45
minutes at 10000 g and 4 ◦C in a Sorvall RC-5B centrifuge (SA 600 rotor). The cleared lysate was
transferred to a screw cap tube and mixed with 2 ml of a 50% Ni-NTA suspension, which has been
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equilibrated with phosphate buffer. (Note: The insoluble pellet was used for protein purification
under denaturing conditions.) The lysate was incubated with the agarose beads at 4 ◦C for 2
hours on a roller mixer to allow binding of the 6His-fusion protein to the beads. The suspension
was transferred to a disposable plastic column and incubated for 10 minutes at 4◦C until the bed
of agarose beads has settled. The flow through was discarded. The column was subsequently
washed with 20 ml of phosphate buffer containing increasing amounts of imidazole (0 mM, 20
mM, 50 mM, 100 mM). After the last wash step, the protein was incubated with 5 ml of phosphate
buffer containing 250 mM imidazole for 30 minutes. The protein was eluted and fractions of 0.5
ml were collected.
The protein fractions were seperated by SDS-PAGE to monitor the purity of the preparation. The
protein concentration was determined by spectrophotometry.
Protein purification under denaturing conditions using imidazole
The bacterial cell pellet was resuspended in 10 ml of lysis buffer containing guanidin (6 M guanidin-
HCl, 100 mM NaH2PO4, 10 mM imidazole, 1 mM β-mercaptoethanol, pH 8.0). The cells were
lysed for 30 minutes at room temperature on a roller mixer. The resultant lysate is very viscous
and the DNA was sheared by sonication using a Branson sonifier 200 equipped with a microtip.
Sonication was performed on ice for 3 times 10 seconds using the following settings: power 5,
duty cycle 40%. The lysate was centrifuged for 30 - 45 minutes at 10000 g and 4 ◦C in a Sorvall
RC-5B centrifuge (SA 600 rotor). Centrifugation was performed to remove bacterial remnants to
avoid clogging of the column. The supernatant was transferred to a screw cap tube and mixed
with 2 ml of a 50% Ni-NTA suspension, which has been equilibrated with lysis buffer. All further
purification steps were performed in the same way as for the purification under native conditions,
except that the lysis buffer was used as basis for the wash buffers and the elution buffer.
Protein purification under denaturing conditions using a stepwise decrease of the pH
The bacterial cell pellet was resuspended in 10 ml of lysis buffer pH 8.0 (6 M guanidin-HCl,
100 mM NaH2PO4, 10 mM Tris) and lysed over night at 4 ◦C on a roller mixer. The lysate was
centrifuged for 30 - 45 minutes at 10000 g and 4 ◦C in a Sorvall RC-5B centrifuge (SA 600 rotor).
The cleared lysate was transferred to a screw cap tube and mixed with 2 ml of a 50% Ni-NTA
suspension, which has been equilibrated with lysis buffer. The lysate was incubated with the
agarose beads at 4 ◦C for 2 hours on a roller mixer to allow binding of the 6His-fusion protein to
the metal beads. The suspension was transferred to a disposable plastic column and incubated
for 10 minutes at 4◦C until the bed of agarose beads has settled. The flow through was discarded.
The column was washed twice with 10 ml of lysis buffer pH 8.0. The washing steps were repeated
with lysis buffer pH 6.3. After the last wash step, the protein was eluted with 5 ml of lysis buffer
pH 5.9, followed by elution with 5 ml lysis buffer pH 4.5.
The protein fractions were seperated by SDS-PAGE to monitor the purity of the preparation. The
protein concentration was determined by spectrophotometry.
3.6.3. Buffer exchange of recombinant proteins
The buffer of the purified HyYY1 proteins were exchanged either by dialysis or by desalting using
a PD10 column. For immunization and gel retardation assays, the proteins were buffered in 1 x
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PBS.
Desalting using a PD10 column
To exchange the buffer of the purified HyYY1 proteins and to remove remaining salts like imida-
zole and/or guanidinium, a PD10 desalting column was used according to the manufacturer’s
instructions (GE Healthcare). The PD10 columns are packed with a Sephadex G-25 medium,
which allows the separation of high molecular weight substances (proteins) from low molecular
weight substances (salts) by chromatography.
The desalting column was equilibrated with 25 ml 1 x PBS, the flow-through was discarded. 2.5
ml of sample were added to the column and the flow-through was discarded. The protein was
eluted from the column with 3.5 ml of 1 x PBS. Fractions of 0.5 ml were collected and the protein
concentration of each fraction was determined by OD280 measurement and Bradford assay. The
first two fractions usually contain little protein and were discarded.
Dialysis
The buffers of the HyYY1 proteins, purified under denaturing conditions using a decreasing pH,
were exchanged by a stepwise dialysis procedure.
The proteins were transferred to a dialysis tubing (MWCO 5000) and dialyzed for 1 hour at 4
◦C against two changes of dialysis buffer pH 6.3 (1 M guanidin-HCl, 100 mM NaH2PO4, 10 mM
Tris). The pH was further increased by dialyzing the protein for 1 hour at 4 ◦C against two
changes of dialysis buffer pH 8.0 (0.1 M guanidin-HCl, 100 mM NaH2PO4, 10 mM Tris). Finally,
the protein was dialyzed for 1 hour at 4 ◦C against two changes of 1 x PBS. The protein solution
was transferred to a 1.5 ml reaction tube. The protein concentration was determined by OD280
measurement and Bradford assay. Furthermore, the protein was analyzed by SDS-PAGE. The
protein was used for gel retardation assay, immediatelly.
Preparing the membranes for dialysis:
To remove contaminants like heavy metals and sulfides, which may arise during the production
process, the dialysis tubings were rinsed before use. The dialysis tubings were heated in a carbon-
ate solution (10 mM EDTA, 10% sodium carbonate or bicarbonate) for 10 minutes at 60 - 70 ◦C.
The tubings were washed in H2O. They were again heated in the carbonate solution and washed
in H2O. Then, the tubings were heated to 70 ◦C in H2O, twice. The tubings were stored in 70%
ethanol at 4 ◦C.
3.6.4. Preparation of protein extracts from Hydra magnipapillata
Originally, the Hydra protein extracts were prepared for the establishment of an in vitro tran-
scription system in Hydra. The protein extracts were used for antibody characterization and to
determine the cellular compartment, in which the PcG proteins are located.
Preparation of Whole Cell Extracts (WCEs)
Hydra WCEs were prepared as described by Manley et al. (1980, 1983), yet on a smaller scale.
All steps were carried out at 4 ◦C and on ice. 5 ml of densly packed Hydra (∼5000 polyps) were
washed twice with Hydra Medium and twice with 1 x PBS. The animals were centrifuged for 5
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minutes at 2000 g in a Beckman GS-6KR centrifuge. The resultant Hydra pellet was resuspended
in four pellet volumes of 0.01 M Tris-HCl (pH 7.9 at 4 ◦C), 1 mM EDTA and 5 mM DTT. After 20
minutes, the cells were lysed in a Dounce homogenizer with 20 strokes using a B-type pestle. Four
pellet volumes of 0.05 M Tris-HCl (pH 7.9 at 4 ◦C), 0.01 M MgCl2, 2 mM DTT, 25% sucrose and
50% glycerol were added and the suspension was mixed gently. One pellet volume of saturated
(NH4)2SO4 was added in a dropwise fashion. Due to nuclear lysis, the suspension becomes more
and more viscous during the procedure. The lysate was stirred for 30 minutes. The extract was
centrifuged in a Beckman LB 55 ultracentrifuge at 45000 rpm in a SW 40Ti rotor for 3 hours.
The supernatant was decanted. Proteins and nucleic acids were precipitated by the addition of
solid (NH4)2SO4 (0.33 g/ml). After the (NH4)2SO4 has dissolved, 1 M NaOH (0.1 ml/10 g solid
(NH4)2SO4) was added and the suspension was stirred for 30 minutes. The suspension was
centrifuged at 15000 g for 20 min in a SA600 rotor in a Sorvall RC5C centrifuge. The precipitate
was resuspended with 5% of the volume of the supernatant with 0.025 M HEPES (pH 7.9), 0.1 M
KCl, 0.012 M MgCl2, 0.5 mM EDTA, 2 mM DTT and 17% glycerol. The suspension was dialyzed
against three changes of the resuspension buffer for 2 hours. The dialyzate was centrifuged at
10000 g for 20 minutes to remove insoluble material. The supernatant was aliquoted and stored
at -80 ◦C. The protein concentration was determined by Bradford assay and OD280 measurement.
The protein concentration varies from extraction to extraction and is ranging from ∼2 mg/ml to
∼8 mg/ml.
Preparation of Nuclear Extracts (NEs) and Cytoplasmatic Extracts (CEs)
Hydra nuclear and cytoplasmatic extracts were prepared as described by (Dignam et al., 1983a,b).
All steps were carried out at 4 ◦C and on ice. 5 - 15 ml of densly packed Hydra (∼5000 - 15000
polyps) were washed twice with Hydra Medium and twice with 1 x PBS. The animals were cen-
trifuged for 5 minutes at 2000 g in a Beckman GS-6KR centrifuge. The resultant Hydra pellet is
resuspended in three pellet volumes of buffer A (10 mM HEPES (pH 7.9 at 4◦ C), 1.5 mM MgCl2,
10 mM KCl, 0.25 mM DTT, 0.2 mM PMSF, 1 µM Pepstatin A, 2 x Roche complete EDTA-free). After
10 minutes, the cells were homogenized in a Dounce homogenizer with 20 strokes using a B-type
pestle. The homogenate was filtered using a gauze (Miracloth) of 22 - 25 µm mesh size. The sus-
pension was centrifuged at 3500 g for 15 min in a SA600 rotor in a Sorvall RC5C centrifuge. The
resulting supernatant was used for the preparation of cytoplasmatic extracts, the pellet was used
for the preparation of nuclear extracts. The supernatant was mixed with 0.1 volume of 10 x buffer
B (0.3 M HEPES (pH 7.9 at 4◦ C), 1.4 M KCl, 30 mM EDTA, 0.25 mM DTT, 0.2 mM PMSF, 1 µM
Pepstatin A, 2 x Roche complete EDTA-free) and centrifuged for 1 hour at 45000 rpm in a Beck-
man LB 55 ultracentrifuge in a SW 40Ti rotor. The supernatant is the cytoplasmatic extract. The
cytoplasmatic extract was dialyzed like the nuclear extract. The nuclear pellet was resuspended
in 1/2 pellet volume of low salt buffer (20 mM HEPES (pH 7.9 at 4◦ C), 25% glycerol(v/v), 0.02
M KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.25 mM DTT, 0.2 mM PMSF, 1 µM Pepstatin A, 2 x Roche
complete EDTA-free). 1/2 pellet volume of high salt buffer (20 mM HEPES (pH 7.9 at 4◦ C), 25%
glycerol (v/v), 1.6 M KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.25 mM DTT, 0.2 mM PMSF, 1 µM Pep-
statin A, 2 x Roche complete EDTA-free) was added in a dropwise fashion to prevent clumping.
The nuclei were extracted for 30 minutes with gentle stirring or mixing on a roller mixer. The sus-
pension was centrifuged at 10000 g for 30 minutes. The supernatant was dialyzed against three
changes of dialysis buffer (20 mM HEPES (pH 7.9 at 4◦ C), 20% glycerol (v/v), 0.1 M KCl, 0.2 mM
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EDTA, 0.25 mM DTT, 0.2 mM PMSF, 1 µM Pepstatin A, 10 µM Leupeptin, 10 µM Aprotinin, 1
mM Benzamidine). The dialyzate was centrifuged for 20 minutes at 10000 g to remove insoluble
material. The supernatant was aliquoted and stored at -80 ◦C. The concentration of the extracts is
determined by Bradford assay and OD280 measurement. The protein concentration varies from
extraction to extraction and is ranging from ∼2 mg/ml to ∼10 mg/ml.
3.6.5. Quantification of proteins
Bradford assay
The protein concentration of purified HyYY1 protein and Hydra protein extracts were determined
according to Bradford (1976). The Bradford assay is a colorimetric protein assay, which is based
on an absorbance shift of the dye Coommassie Brilliant Blue G-250 upon binding to protein. The
color of the dye changes from a brownish to a bluish color, the absorbance maximum shifts from
465 nm to 595 nm. Most of the buffer systems are compatible with the Bradford assay.
For each measurement, a complete calibration curve with BSA-standards ranging from 0 to 20
µg protein has been generated. The Bradford assay is almost linear over this range. The BSA-
standards for calibration were measured in triplicate. For the determination of the protein con-
centration, a total of 800 µl sample in H2O has been mixed with 200 µl of 5 x Bio-Rad Protein
Assay Dye Reagent Concentrate. After incubation for 5-30 minutes at room temperature, the
absorption at 595 nm has been determined using the BioRad SmartSpecPlus spectrophotometer.
The protein concentration of the samples was calculated with the help of the calibration curve.
OD280 measurement
The protein concentration of purified proteins and cell extracts was determined by measuring the
absorbance at 280 nm in a spectrophotometer versus a suitable control. An absorbance of 1.0 at
280 nm equates a protein concentration of 1 mg/ml. This method provides a rough approxima-
tion of the protein concentration.
3.6.6. SDS-PAGE
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is a technique, which
is used to separate proteins by size in a discontinuous gel system under denaturing conditions
(Laemmli, 1970). Due to binding of SDS, the proteins are charged identically in proportion to
their mass. The proteins are negatively charged and migrate to the anode during electrophoresis.
For protein separation, 10 - 14% resolving gels and 5% stacking gels have been cast between
two glass plates. After polymerization, the protein samples and a prestained molecular weight
marker (’PageRuler Prestained Protein Ladder’ from Fermentas or ’Prestained Protein Ladder,
Broad Range’ from NEB) have been loaded onto the gel. The molecular weight marker was used
to monitor the progress of the electrophoretic run and to calculate the molecular weights of the
samples. Gel electrophoresis was carried out at 20 mA/gel for 1.5 hours in 1 x SDS-running buffer.
Afterwards, the polyacrylamide gel was stained with Coomassie Brilliant Blue G-250, or the gel
was used for Western blotting.
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Gels for SDS-PAGE (amounts are calculated for two gels of ∼ 9 x 8 cm)
10 / 12 / 14% resolving gel:
H2O 9.8 / 8.8 / 7.8 ml
1.5 M Tris-HCl pH 8.8 5 ml
40% polyacrylamide (acrylamide - bisacrylamide 29:1) 5 / 6 / 7 ml
10% SDS 200 µl
10% APS 200 µl
TEMED 10 µl
5% stacking gel:
H2O 4.3 ml
1.5 M Tris-HCl pH 6.8 0.75 ml
40% polyacrylamide (acrylamide - bisacrylamide 29:1) 0.75 ml
10% SDS 60 µl
10% APS 60 µl
TEMED 6 µl
Sample preparation for SDS-PAGE
Protein samples for SDS-PAGE have been mixed with an equal volume of 2 x SDS-PAGE sample
buffer and boiled at 95 ◦C for 5 - 10 minutes shortly before loading onto the gel.
Protein samples in denaturing guanidinium buffer have been precipitated first to remove the salt:
225 µl of ice cold 100% ethanol have been added to 25 µl of protein sample. After vortexing for 10
seconds, the sample has been placed on -20 ◦C for 5 - 10 minutes. To precipitate the protein, the
sample has been centrifuged for 5 minutes in a tabletop centrifuge at top speed. The supernatant
was decanted and the pellet has been washed with 250 µl of 90% ethanol. After vortexing, the
sample has been centrifuged again and the supernatant has been decanted carefully. The pellet
has been resuspended in 25 µl of 1 x SDS-PAGE sample buffer and boiled for 5 - 10 minutes at 95
◦C prior to loading onto the gel.
Rapid Coomassie staining
The dye Coomassie Brilliant Blue binds unspecifically to proteins and can be used to stain pro-
teins (Wilson, 1983). For staining of proteins in polyacrylamide gels, the rapid Coomassie staining
described by Sasse and Gallagher (2009) has been used.
After SDS-PAGE, the polyacrylamide gel was soaked in fixation solution (25% isopropanol, 10%
acetic acid) and incubated for 30 minutes at room temperature. The gel was transferred to the
staining solution (10% acetic acid, 0.006% Coomassie Brilliant Blue G-250), and staining was per-
formed until distinct protein bands became clearly visible on the gel. The gel was documented
using the INTAS gel doc system.
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Solutions for SDS-PAGE and Coomassie staining
1.5 M Tris-HCl pH 8.8: Dissolve 181.71 g Tris base in 900 ml H2O.
Adjust pH to 8.8 with HCl.
Adjust volume to 1 litre with H2O.
Sterilize by autoclaving.
1.5 M Tris-HCl pH 6.8: Dissolve 181.71 g Tris base in 900 ml H2O.
Adjust pH to 6.8 with HCl.
Adjust volume to 1 litre with H2O.
Sterilize by autoclaving.
10% SDS: Dissolve 10 g SDS in 90 ml H2O.
Adjust volume to 0.1 litre with H2O.
Store at room temperature.
10% APS: Dissolve 0.1 g APS in 1 ml H2O.
Prepare freshly prior to use.
10 x SDS-PAGE running buffer: 10 g SDS
30.3 g Tris base
144.1 g glycine
Dissolve in 800 ml H2O.
Adjust volume to 1 litre with H2O.
2 x SDS-PAGE sample buffer: 10 ml 1.5 M Tris-HCl (pH 6.8)
12 ml 10% SDS
30 ml glycerol
15 ml β-mercaptoethanol
1.8 mg bromophenol blue
Adjust volume to 100 ml with H2O.
Aliquot and store at -20 ◦C.
Fixation solution: 25% isopropanol
10% acetic acid
Staining solution: 10% acetic acid
0.006 g Coomassie Brilliant Blue G-250
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3.7. Methods: Immunological techniques
3.7.1. Antibody production
Polyclonal antibodies against the Hydra PcG proteins were produced in New Zealand white
rabbits at the IBF (Interfakultäre Biomedizinische Forschungseinrichtung = Interdisciplinary Re-
search Facility for Biomedicine) at the university of Heidelberg. Handling of the animals and all
injections were performed by the local staff. The rabbits were injected with 100 µg of purified
recombinant HyYY1 protein in PBS. The immune response was enhanced by mixing the protein
antigen with Freund’s adjuvant complete for the initial immunization and Freund’s adjuvant in-
complete for boosting. A total volume of 300 µl was injected intradermally in the back of the
animal at several injection sites. Four weeks after the initial immunization, the rabbit has been
injected regularly (every two weeks) to boost the immunization. Boosting was performed in the
same way as the initial immunization. To monitor the progress of antibody production, samples
of blood have been taken at regular intervals from the marginal ear vein and the serum was sep-
arated from the whole blood. The sera have been used for immunoblotting to probe different
amounts of recombinantly expressed HyYY1 protein and Hydra protein lysates.
In total, three rabbits were injected with recombinantly expressed HyYY1 protein. Two animals
were injected with purified HyYY1∆ZnF, one animal was injected with the purified full length
HyYY1 protein. The antiserum obtained from the first rabbit injected with HyYY1∆ZnF was
affinity purified and used for all further studies.
Separation of serum from whole blood
The fresh blood samples were incubated at room temperature for 1 hour to clot. The clotted
blood was separated from the wall of the reaction tube with the help of a clean pipette. The
sample was incubated at 4◦C over night to allow the contraction of the clotted blood. The serum
was separated from the red blood cells and coagulation factors by centrifugation for 30 minutes
at 3000 rpm (Beckman GS-6KR; swing-out rotor). The serum (supernatant) was transferred to a
new reaction tube and centrifuged again for 30 minutes to remove residual red blood cells. The
serum was aliquoted and stored at -20◦C until use.
3.7.2. Antibody purification
The αHyYY1 antibody was affinity purified using an antigen column. This method allows the
purification of antigen-specific antibodies from a preparation of polyclonal antibodies. The pure
antigen is bound to a solid support and the antibodies in the preparation, which are specific for
the antigen will bind. Unspecific antibodies are removed by different washing steps.
Antigen coupling
Purified HyYY1∆ZnF was coupled to Affi-Gel 10 Gel according to the manufacturer’s instruc-
tions (BioRad). Affi-Gel 10 Gel consists of activated agarose beads containing a reactive ester
(N-hydroxysuccinimide). This ester is highly selective for primary amino groups (NH2), which
form a stable amide bond with the terminal carboxyl group (COOH) of the spacer.
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All following steps were performed at 4 ◦C in a cold room. 1 ml of Affi-Gel 10 Gel suspension
was loaded into a disposable plastic column. After the gel has settled, the column was washed
three times with 10 ml ice cold H2O. The coupling efficiency of the protein is dependent on its
isoelectric point (pI). Affi-Gel 10 is recommended for neutral to basic proteins with pIs ranging
from 6.5 to 11. However, HyYY1∆ZnF has a pI of 5.75. The coupling efficiency was enhanced by
manipulating the coupling conditions by altering the pH and the salt concentration. ∼ 1.5 mg of
purified protein were added to the column in a buffer containing 0.1 M MOPS pH 7.5 and 80 mM
CaCl2. The protein was incubated with the matrix for 4 hours at 4 ◦C. Uncoupled protein was
removed by several washing steps with the same buffers used for antibody purification. The gel
matrix was washed with 50 ml ice cold H2O, followed by 20 ml ice cold 10 mM Tris-HCl (pH 7.5),
20 ml 100 mM glycine (pH 2.5) and 20 ml ice cold 10 mM Tris-HCl (pH 8.8). The pH was checked
and the matrix was washed with 20 ml ice cold 100 mM triethylamine (pH 11.5). The pH was
neutralized with 20 ml ice cold 10 mM Tris-HCl (pH 7.5). The gel was stored in 10 mM Tris-HCl
(pH 7.5). For long-term storage, 0.2% sodium azide were added. To detect the coupling efficiency,
samples of the different fractions during the coupling procedure were seperated by SDS-PAGE.
Antibody affinity purification
The antibody was purified according to a protocol in "Antibodies: A Laboratory Manual" (Harlow
and Lane, 1988). 1 ml of the αHyYY1 final bleed was diluted 1 in 10 in 10 mM Tris-HCl (pH 7.5).
The antibody was passed through the column three times to ensure proper binding. The antigen-
column was washed with 20 ml 10 mM Tris-HCl (pH 7.5), followed by 20 ml of 0.5 M NaCl and
10 mM Tris-HCl (pH 7.5). Antibodies, which were bound by acid-sensitive interactions were
eluted with 10 ml 100 mM glycine (pH 2.5). 0.5 ml fractions of the eluate were collected in a
tube containing an equal volume of 1 M Tris-HCl (pH 8.0) to neutralize the pH. The column was
washed with 10 mM Tris-HCl (pH 8.8). The pH was checked and the antibodies, which were
bound by base-sensitive interactions, were eluted with 10 ml 100 mM triethylamine (pH 11.5). 0.5
ml fractions of the eluate were collected in a tube containing an equal volume of 1 M Tris-HCl (pH
8.0). The column was washed with 10 mM Tris-HCl (pH 7.5), until the pH was 7.5. The column
was stored at 4 ◦C. All eluate fractions were tested by Western blotting. The positive fractions
were combined and concentrated by ultrafiltration.
Antibody concentration
After affinity purification, the antibodies were heavily diluted (1:40) compared to the starting
serum. To concentrate the antibody solution, Vivaspin 15 columns (MWCO 10000) were used,
which allow the concentration of macromolecules by ultracentrifugation. The Vivaspin 15 column
was washed with 15 ml H2O by centrifugation for 10 - 15 minutes at 2000 g. The membrane
was blocked for 2 hours with 1 x PBS and 1% BSA. The blocking solution was discarded and
the column was washed 3 times with H2O by centrifugation at 2000 g. The combined antibody
fractions were added subsequently to the column and concentrated at 2000 g, until a volume of
∼1 m was reached. 40 ml antibody solution was concentrated to 0.8 ml. The antibody solution
was concentrated by a factor of 50.
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3.7.3. Immunoblotting
Immunoblot or Western blot is a technique used to detect proteins in a sample. Proteins are blot-
ted to a membrane and are probed with antibodies specific for the target protein (Burnette, 1981).
Proteins separated by SDS-PAGE were transferred to a PVDF-membrane using the semi-dry blot
technique. The PVDF-membrane was incubated in 100% methanol for 10 seconds, washing in
H2O for 5 minutes and equilibration in 1 x transfer buffer for at least 10 minutes. The protein
gel was placed on top of the membrane. The assembly was sandwiched between two layers of 5
Whatman papers each, which have been soaked in transfer buffer. The assembly was placed on
top of the anode of the blotting cell. The transfer was carried out at 15 V for 20 - 30 minutes. The
transfer was monitored by a prestained protein marker.
To prevent unspecific binding of antibodies, the membrane was blocked for 2 hours at room tem-
perature in blocking buffer. The membrane was incubated with the primary antibody in blocking
buffer for 1 hour at room temperature or at 4 ◦C over night. To wash away excess antibody, the
membrane was washed three times for 5 minutes with washing buffer at room temperature. Sub-
sequently, the membrane was incubated with the secondary antibody diluted in blocking buffer
for 0.5 - 1 hour at room temperature. The membrane was washed again three times for 5 minutes
at room temperature with washing buffer.
The signal was detected by chemiluminescence. The ECL solutions 1 and 2 were prepared and
mixed shortly before use, and the membrane was incubated for 1 - 5 minutes in the mixture. The
membrane was exposed to an x-ray film. Exposure times varied between 5 seconds and 5 min-
utes. The films were developed in a developer machine (Agfa Curix 60).
All antibodies used for immunoblotting are listed in table 3.19.
TABLE 3.19 Primary and secondary antibodies used for immunoblotting.
antibody species dilution purity
primary antibodies:
αPenta-His mouse IgG1 1:1000 affinity pure
αH3K27me3 rabbit (polyclonal) 1:10000 affinity pure
αHyYY1 rabbit (polyclonal) 1:1000 crude serum, affinity pure
αHyEZH2 rabbit (polyclonal) 1:500 - 1:1000 crude serum
αHyEED rabbit (polyclonal) 1:1000 crude serum
αHyp55 rabbit (polyclonal) 1:1000 crude serum
αHyPC rabbit (polyclonal) 1:1000 crude serum
αHyRING rabbit (polyclonal) 1:1000 crude serum
secondary antibody:
Goat-α-Mouse HRP goat IgG (H+L) 1:4000 HRP conjugate
Goat-α-Rabbit HRP goat IgG (H+L) 1:4000 HRP conjugate
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Solutions for Immunoblotting
10 x transfer buffer: 250 mM Tris-base
1.5 M glycine
10 x PBS: 80 g NaCl (1.37 M)
2 g KCl (27 mM)
2.4 g KH2PO4 (18 mM)
26.8 g Na2HPO4·7H2O (150 mM)
Adjust the pH to 7.4.
Sterilize by autoclaving.
Washing buffer: 0.2% Tween 20 in 1 x PBS
Blocking buffer: 2.5% milk powder in washing buffer
1 M Tris-HCl pH 8.5: Dissolve 121.14 g Tris base in 900 ml H2O.
Adjust pH to 8.5 with HCl.
Adjust volume to 1 litre with H2O.
Sterilize by autoclaving.
Luminol 250 mM Luminol in DMSO
(0.44 g / 10 ml)
Coumaric acid 90 mM coumaric acid in DMSO
(0.15 g / 10 ml)
ECL solution A: Mix 12 µl 30% H2O2 with
20 ml 100 mM Tris-HCl (pH 8.5).
Prepare freshly prior to use.
ECL solution B: Mix 88 µl coumaric acid and
200 µl luminol with
19.8 ml 100 mM Tris-HCl (pH 8.5).
Prepare freshly prior to use.
3.7.4. Immunohistochemistry
Immunofluorescence stainings with Hydra polyps were performed as described by Dunne et al.
(1985). The polyps were stained with antibodies against PcG proteins and H3K27me3.
10 - 12 Hydra polyps were transferred into a 1.5 ml reaction tube. The animals were relaxed in
2% urethane for 1 - 2 minutes. The polyps were fixed in either Lavdovsky’s fixative (ethanol :
formaldehyde : acetic acid : H2O (50 : 10 : 4 : 36)) or in 4% formaldehyde for 15 minutes at room
temperature. The fixative was removed and the polyps were washed 3 times 10 minutes in 1 x
PBS containing 0.1% Triton X-100 to permeabilize the membranes. For all tested antibodies, short
fixation times proofed best. Longer fixation times resulted in a loss of the signal.
The polyps were incubated with the primary antibody diluted in 1 x PBS and 1% BSA at 4 ◦C over
night. The primary antibody was removed and the polyps were washed 3 times for 10 minutes
with 1 x PBS. The polyps were incubated with the secondary antibody for 1 - 2 hours at room
temperature. To prevent unspecific binding, the secondary antibody had been preabsorped on
fixed Hydra polyps over night at 4 ◦C. To co-stain the nuclei, 0.5 ng/µl of DAPI was added to the
secondary antibody and incubated for additional 15 minutes.
The animals were washed 3 times for 10 minutes with 1 x PBS and mounted on microscope slides
3.7. METHODS: IMMUNOLOGICAL TECHNIQUES 87
using 200 µl Mowiol per slide. After the Mowiol has hardened, the staining was examined under
a fluorescence or confocal microscope. All antibodies used for immunostainings are listed in table
3.3.
TABLE 3.3 Primary and secondary antibodies used for staining Hydra.
antibody species dilution purity fixative
primary antibodies:
αH3K27me3 rabbit (polyclonal) 1:1000 affinity pure 4% formaldehyde
αHyYY1 rabbit (polyclonal) 1:200 crude serum,
affinity pure
Lavdovsky
αHyEZH2 rabbit (polyclonal) 1:200 crude serum Lavdovsky
αHyEED rabbit (polyclonal) 1:200 crude serum Lavdovsky
αHyp55 rabbit (polyclonal) 1:200 crude serum Lavdovsky
αHyPC rabbit (polyclonal) 1:200 crude serum Lavdovsky
αHyRING rabbit (polyclonal) 1:200 crude serum Lavdovsky
secondary antibody:
Alexa Fluor 488
donkey-α-rabbit
donkey 1:400 Alexa488-
conjugated
Lavdovsky,
4% formaldehyde
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3.8. Methods: Analysis of protein-DNA interactions
3.8.1. DNA binding site selection
The sequence specifity of the HyYY1 protein was determined by incubating the immobilized 6His-
fusion protein with a pool of random sequence oligonucleotides. Bound DNA was recovered
and amplified by PCR. The DNA was used for further rounds of binding and finally the HyYY1
consensus sequence was determined.
Oligonucleotides
To obtain a pool of double-stranded random sequence oligonucleotides for DNA binding site
selection, a single-stranded 85-mer oligonucleotide was annealed with a 20-mer complementary
primer and the Klenow fragment was used to fill in 3’ recessed ends. The following oligonu-
cleotide were used:
EMSA random: 5’-CGT GAT TGG CTA CGC ATC GT CAG CAG CAG CAG CAG (N)15 CAG CAG CAG
CAG CAG GTC ATA CTC ACT CAC GGA CT-3’
Klenow rev: 5’-AGT CCG TGA GTG AGT ATG AC-3’
5 µg of the random oligonucleotide pool were combined with an equal amount of the comple-
mentary primer and incubated at 95 ◦C for 10 minutes. The oligonucleotides were cooled down
slowly to 55 ◦C. The oligonucleotides were annealed at 55 ◦C for 30 minutes. To fill in the 3’
recessed ends, 2.5 µl of a 10 mM dNTP-mix and 1 µl of Klenow enzyme (5 U/µl) were added.
The reaction was incubated at 37 ◦C for 30 minutes. The DNA was precipitated with ethanol and
sodium acetate. The final DNA pellet was dissolved in 50 µl of H2O. DNA concentration was de-
termined by spectrophotometry and the DNA was analyzed by gel electrophoresis using a 12%
polyacrylamide gel.
DNA binding site selection
The binding site selection (panning) was performed both with immobilized 6His-HyYY1 fusion
protein and with immobilized 6His-HyYY1∆ZnF protein. The truncated protein served as a con-
trol for the binding site selection. The protein is lacking the C-terminal zinc fingers responsible
for DNA binding and should not be able to bind to any specific DNA sequence.
100 µl of the immobilized protein (∼2.5 - 5 µg of protein) were incubated with 100 ng of the
double-stranded random sequence oligonucleotide in 1 x binding buffer (10 mM HEPES-KOH
(pH 7.9), 100 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 0.025% NP40, 10% glycerine, 100 µg/ml
BSA, 2 mM spermidine, 0.5 mM DTT) and 1 µg of unspecific competitor (poly(dI-dC)) for 30
minutes at room temperature. The suspension was centrifuged in a tabletop centrifuge at 2000
rpm for 1 minute. The supernatant was discarded and the agarose beads were washed with 1
ml of 1 x binding buffer three times for 5 minutes. The suspension was centrifuged in a tabletop
centrifuge at 2000 rpm for 1 minute. After the last washing step, the beads were resuspended
in 50 µl of 1 x binding buffer and 150 µl of 0.1% SDS. The beads were incubated at 95 ◦C for
10 minutes. The DNA was extracted with phenol-chloroform-isoamylalcohol (25:24:1). 200 µl of
phenol-chloroform-isoamylalcohol were added. After vigorous mixing, the phases were sepa-
rated by centrifugation at top speed in a tabletop centrifuge for 5 minutes. The aqueous phase
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was transfered to a new reaction tube and again extracted with 200 µl of phenol-chloroform-
isoamylalcohol. The aqueous phase was precipitated with 1/10 volume of 3 M sodium acetate
and 2.5 volumes of 100% ethanol. 20 µg of glycogen were added as carrier. After centrifugation
in a tabletop centrifuge at top speed for 15 minutes, the supernatant was removed and the DNA
pellet was washed with 750 µl of 70% ethanol. Finally, the DNA pellet was dissolved in 20 µl of
H2O.
The DNA was amplified by PCR. 1 µl of the DNA solution were mixed with 1 µl 10 mM dNTP-
mix, 10 pmol forward primer (Klenow for), 10 pmol reverse primer (Klenow rev) and 0.5 µl (2.5
U) of EuroTaq DNA polymerase in 1 x RB-buffer containing 1.5 mM MgCl2 (total volume: 50 µl).
The DNA was amplified using the following cycling conditions:
initial denaturation 95 ◦C 5 minutes
denaturation 95 ◦C 15 seconds
annealing 55 ◦C 15 seconds 10 - 25 cycles
elongation 72 ◦C 15 seconds
final elongation 72 ◦C 7 minutes
The PCR products were analyzed by agarose gel electrophoresis on a 12% polyacrylamide gel.
The amplified DNA was analyzed after different numbers of cycles (10, 15, 20 and 25). The DNA
after cycle 10 - 15 was used for further rounds of binding site selection. A greater number of
cycles resulted in the production of multimers from the original 85-mer oligonucleotide. 2 µl of
the amplified DNA mixture were subjected to further rounds of selection, which were performed
in the same way as the initial round of selection.
After rounds 3 and 6, the DNA was purified using Promega’s ’Wizard SV Gel and PCR Clean-
Up System’. The concentration was determined by spectrophotometry and the amplified DNA
was ligated into pGEM-T vector at a vector : insert-ratio of ∼1 : 3. The ligation reaction was
incubated over night at 4 ◦C. Chemocompetent E.coli DH5α-cells were transformed with 2 µl
of the ligation reaction. Positive colonies were analyzed by colony-PCR. The DNA of positive
clones was isolated using Promega’s ’Wizard Plus SV Minipreps DNA Purification System’. The
purified DNA was used for sequencing. For a detailed description of ligation, transformation,
colony-PCR, DNA minipreparation and sequencing see section 3.5.
3.8.2. Gel retardation assay
Biotin-end-labeling of DNA
For labeling the target DNA sequence for gel retardation assays the terminal deoxynucleotidyl
transferase (TdT) was used. The polymerase catalyzes the addition of deoxynucleotides to the 3 ’
hydroxyl end of DNA. In this case biotinylated nucleotides were added to the DNA. For DNA la-
beling the ’Biotin 3’ End DNA Labeling Kit’ from Pierce was used according to the manufacturer’s
instructions. Two complementary single-stranded DNA oligonucleotides were both labeled and
annealed afterwards. 50-mer oligonucleotides containing the following target sequences were
used for gel retardation assays:
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HyYY1 round 6: GTAAAGTTTTCTTGA
(sequence obtained after round 6 of the binding site selection with the full length HyYY1 protein)
HyYY1 round 3: TTTTTGTTGAATGTC
(one of the sequences obtained after round 3 of the binding site selection with the full length HyYY1 protein)
control: CCTGCAGCACTGTGT
(one of the sequences obtained after round 6 of the binding site selection with the truncated HyYY1 protein)
YY1 consensus: GCCGCCATTTTGGGC
(known Pho/YY1 binding sequence from human or Drosophila)
(The entire sequences of the respective oligonucleotides are specified in section 3.1.4).
For the labeling reaction 5 pmol 3’-OH ends of the oligonucleotide were combined with 5 µl of 5
µM Biotin-11-UTP and 0.2 units/µl of TdT in 1 x TdT Reaction Buffer in a total volume of 50 µl.
The reaction was incubated at 37 ◦C for 30 minutes and terminated by the addition of 2.5 µl 0.2 M
EDTA. The DNA was extracted by chloroform-isoamyl alcohol (24:1). The complementary single-
stranded labeled DNA oligonucleotides were annealed before the application in a gel retardation
assay. Annealing was carried out by denaturing a mixture of equal amounts of complementary
single-stranded oligonucleotides at 90 ◦C for 1 minute. The mixture was allowed to cool down
slowly and incubated at the melting temperature of the oligonucleotides for 30 minutes followed
by cooling down slowly to room temperature. The double-stranded labeled oligonucleotide was
stored at - 20 ◦C.
The labeling efficiency was determined by comparing the labeled oligonucleotide with labeled
control oligo. 2 µl of samples and standards were spotted onto a positive charged nylon mem-
brane. After absorption into the membrane, the dot blot was cross-linked by a Stratalinker cross-
linking instrument using the auto cross-link function. Detection was carried out like for the gel
retardation assay (see next section). Figure 3.6 shows the labeling efficieny of the DNA oligonu-
cleotides used for gel retardation assays. All oligonucleotides could be labeled with a high effi-
ciency of 75 - 100% compared to a labeled control oligonucleotide.
FIGURE 3.6 Labeling efficiency. The names and the amounts of the spotted oligos are indicated. The
biotin-labeled control oligonucleotide is on the left side on each blot.
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Gel retardation assay
To study protein-DNA interactions by gel retardation technique, the ’LightShift Chemilumines-
cent EMSA Kit’ from Pierce was used according to the manufacturer’s instructions.
The binding reaction was performed in 1 x binding buffer (10 mM HEPES-KOH (pH 7.9), 100 mM
KCl, 2 mM MgCl2, 0.1 mM EDTA, 0.025% NP40, 10% glycerine, 100 µg/ml BSA, 2 mM spermi-
dine, 0.5 mM DTT) containing 20 µM zinc chloride and 1 µg of unspecific competitor (poly(dI-
dC)). The binding reactions were performed with 20 fmol of biotin-labeled oligonucleotide and
protein amounts ranging from 50 ng to 5 µg. The binding reactions were incubated at room tem-
perature for 30 minutes. 5 µl of 5 x loading buffer were added to each binding reaction and mixed
by gently pipetting up and down. 20 µl of each sample were loaded onto a prepared and pre-run
polyacrylamide gel. The gel was electrophoresed at 100 V in 0.5 x TBE buffer until the bromophe-
nol blue dye had migrated ∼ 3/4 of the distance of the gel.
The DNA was transferred to a positively charged nylon membrane. The membrane was soaked in
0.5 x TBE buffer for 10 minutes and the polyacrylamide gel was placed on top of the nylon mem-
brane. The assembly was sandwiched between two layers of 5 Whatman papers each, which have
been soaked in 0.5 x TBE buffer. The assembly was placed on top of the anode of the blotting cell.
The transfer was carried out at 380 mA for 45 minutes. The transferred DNA was cross-linked to
the nylon membrane using the auto-crosslink function of a Stratalinker cross-link instrument.
For detection, the membrane was blocked with 20 ml of 1 x blocking buffer for 15 minutes at room
temperature. The blocking buffer was discarded and replaced with 20 ml of conjugate/blocking
buffer (20 ml of 1 x blocking buffer containing 66.7 µl of Streptavidin-Horseradish Peroxidase
Conjugate). The membrane was incubated in the conjugate/blocking buffer for 15 minutes at
room temperature. The buffer was discarded and the membrane was rinsed in 20 ml of 1 x wash
buffer. The membrane was washed four times 5 minutes with 20 ml of 1 x wash solution, followed
by equilibration in 30 ml of substrate equilibration buffer for 5 minutes at room temperature. The
substrate equilibration buffer was removed completely and the membrane was incubated in the
freshly prepared substrate working solution for 5 minutes at room temperature. The substrate
working solution was prepared by adding an equal volume of luminol/enhancer solution to the
stable peroxide solution. The membrane was exposed to an x-ray film for 5 - 60 seconds and the
film was developed using an Agfa Curix 60 developer machine.
Preparation of a native polyacrylamide gel:
A native 6% polyacrylamide gel was prepared in 0.5 x TBE buffer. The gel was cast one day in
advance and stored at 4 ◦C. At the day of the experiment, the gel was pre-electrophoresed at 100
V in 0.5 x TBE buffer until the current did not change anymore. Before loading the samples, the
buffer was exchanged and the wells were flushed to remove residual polyacrylamide.
Recipe for 2 gels of 8 x 8 cm x 0.8 mm
H2O 6.1 ml
5 x TBE 2 ml
100% glycerol 0.25 ml
40% polyacrylamide (acrylamide - bisacrylamide 29:1) 1.5 ml
10% APS 100 µl
TEMED 5 µl
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3.9. Methods: Cell culture and Baculovirus production
3.9.1. Cultivation of Sf9 cells
The insect cell line Sf9 is a substrain from the Sf21 cell line. Sf21 is a continuous cell line that
has been developed from ovaries of a moth species: the Fall Armyworm Spodoptera frugiperda
(Vaughn et al., 1977). Both cell lines are often used for baculovirus production.
The Sf9 cells were kept in TC100 insect medium (Lonza), which has been supplemented with 10%
FBS and 1% Pen/Strep at 28 ◦C in an incubator. The cells were grown in an adherent culture in
a volume of 50 ml in a T-175 cm2 flask with a filter cap. When the cells reached a density of ∼2
· 106 cells/ml, the cells were subcultured. Normally, the cells were subcultured twice a week.
For subculturing, the cells were displaced from the flask’s surface by tapping the flask, until the
cells were detached. 10 ml of the cell suspension were transfered to 40 ml of pre-warmed fresh
medium in a new flask. The mixture of fresh medium and conditioned medium helps to maintain
the cells healthy.
Cell counting and determination of viability
To count the cells and to check the viability, 10 µl of the cell suspension were mixed with the
same volume of 0.4% trypan blue, which selectively stains dead cells. 10 µl of the suspension
were introduced into a Neubauer counting chamber and the number of live cells was determined
under a microscope. The cell number in four large squares of the counting grid was determined.
Each square has an area of 0.04 mm2 and a depth of 0.1 mm. The number of cells per milliliter
was calculated by multiplying the average number of cells by the chamber factor (104) and the
dilution factor:
cells/ml = total number of viable cells4 · 104 · 2
Freezing of Sf9 cells
For long-term storage, the cells were frozen in liquid nitrogen. For freezing the cells, the Sf9 cul-
ture was expanded and the cells were harvested in exponential growth. The cells were displaced
from the flask’s surface and the suspension was transfered 50 ml tubes. The number of cells and
the viability were determined. Only healthy cells were used for freezing and long-term storage.
The suspension was centrifuged at 500 g and 4 ◦C for 5 minutes. The cell pellet was resuspended
carefully in the desired volume of freezing medium (TC100 medium, 10% FBS, 1% Pen/Strep,
5% DMSO) to obtain cells at a density of ∼ 1 · 107 cells/ml. 1.5 ml of the cell suspension were
aliquoted into 2 ml cryovials. The cells were frozen at -80 ◦C at a freezing rate of 1 ◦C per minute.
After 24 hours, the cells were stored in liquid nitrogen, until use.
Thawing of the frozen cells was done rapidly at 37 ◦C in a water bath. The cell suspension was
transfered into a cell culture flask with pre-warmed medium and incubated at 28 ◦C.
3.9.2. Baculovirus production
Baculoviruses are a family of viruses with rod-shaped capsids found exclusively in arthropods.
They have a double-stranded, circular DNA genome with a length between 80 and 200 kilo-
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basepairs. The DNAs of the Autographa californica nuclear polyhedrosis virus (AcMNPV) and the
Bombyx mori nuclear polyhedrosis virus (BmNPV) are commonly used for expression vectors. The
baculovirus expression system is widely used to generate properly post-translationally modified
proteins in insect cells.
During this thesis, Invitrogen’s Bac-to-Bac Baculovirus Expression System was used for recom-
binant baculovirus production and protein expression of Hydra PcG proteins. The method was
developed by Ciccarone et al. (1997). This system provides a rapid method for the generation
of recombinant baculoviruses. It is based on a site-specific transposition of an AcMNPV-based
expression casette into a baculovirus shuttle vector called bacmid, which can be propagated in
E.coli. An overview of the baculovirus expression system is depicted in figure 3.7.
FIGURE 3.7 Diagram of the Bac-to-Bac Baculovirus Expression System. The figure was adapted from
Invitrogen’s Bac-to-Bac manual.
Production of recombinant bacmid DNA
For production of recombinant bacmid DNA, E.coli-DH10Bac-cells, which contain a baculovirus
shuttle vector (bacmid) and a helper plasmid were used. The vector sequence which is flanked
by mini-Tn7 sites allows the transposition into the mini-attTn7 attachment site on the bacmid.
Once the plasmid DNA is transformed into the DH10Bac-cells, the transposition occurs and a
recombinant bacmid is produced. The insertion into the mini-attTn7 site disrupts the expression
of the LacZα peptide and positive colonies can be selected using LB-agar plates containing X-Gal
and IPTG.
One aliquot of chemocompetent DH10Bac-cells was thawed on ice and transferred to a 15 ml
polypropylene round-bottom tube. The cells were mixed gently with 200 ng of pFastBac1-plasmid
DNA and incubated on ice for 30 minutes. The bacteria were heat shocked for 45 seconds at
42 ◦C and immediately chilled on ice for 2 minutes. 900 µl SOC-medium were added and the cells
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were incubated at 37 ◦C and 200 rpm for 4 - 6 hours to allow transposition between the bacmid
and the pFastBac1 vector. 10-fold serial dilutions of the cells were prepared and 100 µl of each
dilution were plated on LB-agar plates. The plates were incubated at 37 ◦C for 48 hours. Positive
white colonies were selected, restreaked on LB-plates and incubated at 37 ◦C for 48 hours. Only
clear white colonies were taken for further analysis and recombinant bacmid DNA isolation.
Large plasmid purification
To isolate recombinant bacmid DNA, which is greater than 135 kb in length, a method originally
developed for large plasmid DNA purification has been applied. The method was described in
Invitrogen’s manual of the Bac-to-Bac Baculovirus Expression System.
100 ml LB medium containing 50 µg/ml kanamycin, 7 µg/ml getamicin and 10 µg/ml tetracy-
cline was inoculated with the desired recombinant E.coli-DH10Bac. The culture was grown over
night at 37 ◦C and 200 rpm in a shaker. The cells were pelleted by centrifugation for 5 min at
5000 g. The supernatant was discarded and the cells were resuspended in 30 ml of Solution I.
The resuspension was gently mixed with 30 ml of Solution II. The mixture was incubated for 5
minutes at room temperature and 30 ml of 3 M potassium acetate (pH 5.5) were added. The sam-
ple was chilled on ice for 10 minutes and centrifuged for 30 minutes at 10000 g and 4 ◦C. The
supernatant was transferred to a new tube. In case the supernatant was still contaminated with a
white precipitate of bacterial genomic DNA and proteins, it was cleared additionally by a folded
filter. To precipitate the plasmid DNA, 80 ml of isopropanol were added and the mixture was
kept on ice for 15 minutes. The DNA was centrifuged for 45 minutes at 3000 g. The pellet was
washed with 10 ml 70% ethanol and air-dried. The DNA was dissolved in 500 µl TE-buffer (pH
8.0). The bacmid DNA was stored at 4 ◦C.
Solutions for large plasmid purification
Solution I: 15 mM Tris-HCl (pH 8.0)
10 mM EDTA
100 µg/ml RNase A
Sterilize by filtration and store at 4 ◦C.
Solution II: 0.2 N NaOH
1% SDS
Sterilize by filtration and store at room temperature.
3 M potassium acetate: 3 M potassium acetate
Adjust the pH to 5.5 with glacial acetic acid.
Sterilize by autoclaving.
TE-buffer: 10 mM Tris-HCl (pH 8.0)
1 mM EDTA (pH 8.0)
The recombinant bacmid DNA was analyzed by PCR using the M13 forward and M13 reverse
primers or gene specific primers. If transposition has occured, a PCR product of ∼2300 bp + size
of the insert can be detected on an agarose gel. If no transposition occured, a PCR product of 300
bp can be detected. For PCR amplification 100 ng isolated bacmid DNA were mixed with 1 µl
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10 mM dNTP-mix, 10 pmol forward primer, 10 pmol reverse primer and 2.5 U of EuroTaq DNA
polymerase in 1 x RB-buffer containing 1.5 mM MgCl2 (total volume: 50 µl). The insert DNA was
amplified using the following cycling conditions:
initial denaturation 98 ◦C 3 minutes
denaturation 98 ◦C 45 seconds
annealing 55 ◦C 45 seconds 35 cycles
elongation 72 ◦C 5 minutes
final elongation 72 ◦C 7 minutes
Figure 3.8 gives an example of the analysis of recombinant HyYY1-6His bacmid constructs by
PCR. For the following transfection of insect cells, one of the correct constructs was chosen.
FIGURE 3.8 1% agarose gels depicting the analysis of recombinant HyYY1-6His bacmid constructs.
The left gel shows the result of the PCR with M13 primers, the right gel shows the result with gene specific
primers. A PCR product of ∼3400 bp should be obtained with M13 primers, a PCR product of ∼1100 bp
should be visible with gene specific primers. All analyzed constructs showed a band of the correct size with
gene specific primers, but only clones # 2 and # 4 showed a band of the correct size with M13 primers.
Clone # 3 showed a faint band with M13 primers. For the transfection of insect cells, only such constructs
were used that showed a clear signal with both primer pairs.
Transfection of Sf9 cells
To produce recombinant baculoviruses, Sf9 cells were transfected with the recombinant bacmid
using a cationic lipid-based system. The cells were transfected in 6-well tissue culture plates.
For transfection, 9 · 105 cells were seeded per well in 2 ml of TC100 medium supplemented with
10% FBS and 1% Pen/Strep. The cells were allowed to attach to the surface at 28 ◦C for at least
1 hour. For transfection, 1 µg of recombinant bacmid DNA were diluted in 100 µl of unsup-
plemented TC100 medium. Furthermore, 6 µl of Cellfectin reagent were diluted in 100 µl of
unsupplemented TC100 medium. The diluted bacmid DNA and the lipids were combined and
incubated at room temperature for 30 - 60 minutes. Meanwhile, the medium was removed from
the cells and the cells were washed with 2 ml of unsupplemented TC100 medium. 0.8 ml of
unsupplemented medium were added to the DNA:lipid complexes. The medium was removed
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from the cells and the transfection mix was added. The cells were incubated with the transfection
mix at 28 ◦C for 5 hours. The DNA:lipid complexes were removed and 2 ml of supplemented
TC100 medium were added to the cells. The cells were incubated at 28 ◦C in a humidified incuba-
tor, until signs of baculovirus infection became clearly visible. Typically, detachment of the cells
from the surface and cell lysis became visible after 4 - 5 days post transfection.
Isolating P1 baculoviral stock
The P1 viral stock was isolated from the transfected cells showing signs of late stage infection.
Both the cells and the supernatant were transfered to a 2 ml reaction tube and centrifuged at top
speed in a tabletop centrifuge for 1 minute. The clarified supernatant was transfered to a fresh
tube and stored as P1 viral stock at 4 ◦C protected from light.
However, the P1 viral stock is a small-scale viral stock with a low titer. The titer of the P1 viral
stock was not determined. It can be assumed that the titer ranges from 1 · 106 - 1 · 107 pfu/ml.
For further experiments, the stock needs to be amplified.
Amplification of the baculoviral stock
To amplify the viral stock, Sf9 cells were infected at a multiplicity of infection (MOI) ranging from
0.05 - 0.1. Sf9 cells at a density of 2 · 106 cells/ml were seeded in a volume of 10 ml supplemented
TC100 medium in a T-75 cm2 flask. The cells have been allowed to attach to the surface at 28 ◦C
for at least 1 hour before the cells were infected with 0.4 ml of the P1 viral stock.
inoculum required (ml) = MOI (pfu/cell)·number of cellstiter of viral stock (pfu/ml) =
0.1·2·107
0.5·106 = 0.4 ml
After the cells signs of late stage infection, the cells and the supernatant were transfered to a
15 ml tube and centrifuged at 500 g and 4 ◦C for 5 minutes. The clarified supernatant resembles
the P2 viral stock. Again, the titer was not determined. Normally, the titer ranges from 1 · 107 - 1 ·
108 pfu/ml. The P2 viral stock was used to generate a high-titer P3 viral stock. The P3 viral stock
was produced in the same way as the P2 viral stock, except the scale was increased: Sf9 cells at
a density of 2 · 106 cells/ml in a volume of 50 ml were infected with 0.1 ml of the P2 viral stock
(MOI = 0.1). The titer of the P3 viral stock was determined. This stock was used for all further
experiments.
Determination of the baculoviral titer
The titer of the P3 viral stock was determined by a viral plaque assay.
Sf9 cells were harvested and a cell suspension at 5 · 105 cells/ml in supplemented TC100 insect
medium was prepared. 2 ml of the cell suspension were aliquoted into each well of two 6-well
tissue culture plates. The cells were allowed to settle for 1 hour at room temperature. Only plates
with attached cells and 50% confluence were used for the viral plaque assay. A logarithmic serial
dilution (10−1 - 10−7) of the P3 baculovirus stock was prepared in supplemented TC100 medium.
The medium of each well was removed and replaced with 1 ml of the appropriate virus dilution.
The partitioning of a 6-well plate is illustrated in figure 3.9. For each viral stock, two 6-well plates
were used: one sample plate and one duplicate. The cells were incubated with the virus for 1 hour
at room temperature. After 1 hour, the virus was removed from the cells completely and replaced
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with 2 ml of plaquing medium, which was prepared by combining 1.5 ml Neutral Red Solution (1
mg/ml in TC100 medium) with 10.5 ml supplemented TC100 medium and 12 ml 2% agarose in
unsupplemented TC100 medium. The plaquing medium has been kept at 40 ◦C in a water bath,
until use. The agarose was allowed to harden for 10 - 20 minutes at room temperature. The cells
were incubated at 28 ◦C in a humidified incubator for 7 - 10 days, until plaques became visible.
FIGURE 3.9 Typical appearance of a viral plaque assay 7 - 10 days post infection. The partitioning of
the 6-well plate is indicated.
The plaques were counted and the titer was calculated as follows:
titer (pfu/ml) = number of plaques · dilution factor · 1ml of inoculum/well
The titers of the baculoviral stocks used for further experiments are given in table 3.5:
TABLE 3.5 Titers of the P3 baculoviral stocks.
recombinant baculovirus titer (pfu/ml) produced by
HyYY1 not determined Sonja Matt
HyYY1-6His 1.7 · 107 Sonja Matt
HyEZH2 4 · 108 Volker Lauschke
HyEED 3 · 108 Volker Lauschke
HySUZ12 8.5 · 106 Volker Lauschke
Hyp55 3 · 108 Volker Lauschke
3.9.3. Expression of recombinant Hydra PcG proteins in insect cells
Recombinant Hydra PcG proteins were expressed in Sf9 cells using the baculovirus expression
system. The PcG proteins were expressed in insect cells to reconstitute the protein complexes and
to perform protein-protein interaction studies with the help of immunoprecipitation techniques.
To optimize the expression conditions, Sf9 cells were infected at varying MOIs (1, 2, 5, 10 and
20) and recombinant protein expression was assayed at different times after infection (24, 48,
72 and 96 hours). The optimization procedure was carried out in a 24-well format. For each
recombinant protein, 6 · 105 cells were seeded into each well of a 24-well plate in TC100 medium
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supplemented with 1% Pen/Strep. The cells were allowed to attach to the surface for at least one
hour at 28 ◦C. The medium was removed from the cells, and the cells were washed with fresh
medium once. The medium was replaced with 300 µl of fresh medium and the cells were infected
with the baculovirus stock in each well at the desired MOI. Figure 4.22 depicts the partitioning of
the 24-well plate. The infected cells were incubated at 28 ◦C in a humidified incubator and were
harvested at the appropriate time. For harvesting, the cells and the supernatant were transfered
to a 1.5 ml reaction tube and centrifuged at top speed in a tabletop centrifuge for 1 minute. The
supernatant was removed and the cell pellet was rinsed with 1 x PBS. The cells were lysed with
400 µl 1 x protein sample buffer and the samples were boiled for 5 - 10 minutes at 95 ◦C. Until
use, the samples were stored at -20 ◦C.
FIGURE 3.10 Partitioning of a 24-well plate for optimizing the protein expression conditions.
Samples of each protein expression condition were analyzed by immunoblotting. 20 µl of each
protein sample were seperated by SDS-PAGE. The proteins were transfered to a PVDF-membrane
and probed with a specific antibody to detect protein expression. For IP and Co-IP studies,
the cells were infected or co-infected with recombinant baculovirus. For the HyEZH2, HyEED,
HySUZ12 and Hyp55 baculoviruses a MOI of 5 was used for infection, for the HyYY1-6His bac-
ulovirus a MOI of 2 was used. The recombinant proteins were expressed for 48 hours. Table 3.6
gives an overview of the best conditions for recombinant protein expression. The conditions for
the HyEZH2, HyEED, HySUZ12 and Hyp55 baculoviruses were determined by Volker Lauschke
during his master thesis.
TABLE 3.6 Optimal conditions for infection and protein expression.
recombinant
baculovirus
titer (pfu/ml) MOI protein expression
HyYY1-6His 1.7 · 107 1 - 5 24 - 48 hours
HyEZH2 4 · 108 2 - 10 48 - 96 hours
HyEED 3 · 108 2 - 10 24 - 96 hours
HySUZ12 8.5 · 106 not determined not determined (no specific
antibody available)
Hyp55 3 · 108 2 - 10 24 - 96 hours
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3.10. Methods: Immunoprecipitation
Immunoprecipitation (IP) is a technique of isolating a protein antigen by binding to a specific
antibody coupled to a solid-phase matrix. The technique is not only used to precipitate individ-
ual proteins, but intact protein complexes. An antibody against a known member of a protein
complex is used to precipitate the entire complex. This method is called co-immunoprecipitation
(Co-IP) and is used to analyze protein-protein interactions and to identify unknown members of
protein complexes.
The immunoprecipitation technique is also used to locate DNA binding sites of a protein of inter-
est on the genome. DNA binding proteins can be cross-linked to the DNA they are binding to, and
a specific antibody against the DNA binding protein can be used to precipitate the DNA-protein
complex. This variant is called chromatin immunoprecipitation (ChIP).
3.10.1. IP and Co-IP
Immunoprecipitation was used to characterize the generated antibodies against the Hydra PcG
proteins and to check if they can be used for immunoprecipitation techniques like Co-IP and
ChIP. IP and Co-IP studies were performed with recombinantly expressed Hydra PcG proteins in
Sf9 insect cells and with endogenous Hydra proteins. For IP or Co-IP studies with recombinant
proteins,∼ 2 · 107 cells were infected or co-infected with the respective baculoviruses. The recom-
binant proteins were expressed using the conditions that have been previously tested. For studies
with endogenous Hydra proteins, ∼1 ml (' 1000 animals) of densly packed Hydra magnipapillata
105 polyps were used. IP and Co-IP studies were performed according to the protocols by Har-
low and Lane (1988) and Bonifacino et al. (2001). Figure 3.11 gives an overview of the different
steps during IP or Co-IP.
FIGURE 3.11 Flow chart depicting the different steps during IP or Co-IP.
100 3. MATERIALS AND METHODS
Preparation of antibody-conjugated beads
30 µl of 50% protein A-agarose bead slurry were combined with 0.5 ml ice-cold 1 x PBS (137 mM
NaCl, 2.7 mM KCl, 1.8 mM KH2PO4 15 mM Na2HPO4 (pH to 7.4)) and the respective amount of
antibody in a 1.5 ml reaction tube. 1 µg of affinity purified antibody (e.g. α-HyYY1, αPenta-His)
or 5 µl of polyclonal antiserum have been used. It has to be kept in mind that antibodies from
mouse bind to protein A with a lower affinity compared to antibodies from rabbit. The used
αPenta-His antibody is an IgG1 from mouse, all other antibodies used for immunoprecipitation
are from rabbit.
The suspension was mixed thoroughly and incubated over night at 4 ◦C in a rotator. The suspen-
sion was centrifuged in a tabletop centrifuge at top speed and 4 ◦C for 2 seconds. The supernatant
containing the unbound antibody was removed. The beads were resuspended in 1 ml of nonde-
naturing lysis buffer (300 mM NaCl, 50 mM Tris-HCl (pH 7.4), 5 mM EDTA, 0.1% (w/v) Triton
X-100, 0.02 mM sodium azide) and incubated on a rotator at 4 ◦C for 5 minutes. The suspension
was centrifuged in a tabletop centrifuge at top speed and 4 ◦C for 2 seconds. The washing step
was repeated two more times. The antibody-bound beads were stored at 4 ◦C until use.
Coupling antibodies to protein A-agarose beads
If the same antibody (or an antibody from the same species) was used for immunoprecipitation
and detection, the IP antibody was cross-linked to protein A-agarose beads to avoid the contam-
ination of the eluate with antibody. The heavy and the light chain of the antibody would be
detected by the antibody used for immunoblotting and the antigen band may be masked.
50 µl of 50% protein A-agarose bead slurry were combined with 1 ml ice-cold 1 x PBS (137 mM
NaCl, 2.7 mM KCl, 1.8 mM KH2PO4 15 mM Na2HPO4 (pH to 7.4)) and the respective amount of
antibody in a 1.5 ml reaction tube. 2 µg of affinity purified antibody (e.g. α-HyYY1) or 10 µl of
polyclonal antiserum have been used. The suspension was mixed thoroughly and incubated for
1 hour at room temperature in a rotator. Unbound antibodies were removed by centrifugation
in a tabletop centrifuge at top speed for 5 seconds. The beads were washed twice with 1 ml of
0.2 M sodium borate (pH 9.0) for 5 minutes on a rotator, followed by centrifugation in a tabletop
centrifuge at top speed for 5 seconds. The antibodies were cross-linked to the protein A-agarose
beads using dimethylpimelimidate (DMP). The beads were resuspended in 0.5 ml of sodium bo-
rate (pH 9.0) and 20 mM DMP. The DMP was added shortly before use as solid substance. The
suspension was incubated for 30 minutes at room temperature on a rotator. The coupling reaction
was stopped by washing the beads once in 0.2 M ethanolamine (pH 8.0), followed by incubation
of the beads for 2 hours at room temperature on a rotator in 0.2 M ethanolamine. The suspension
was centrifuged in a tabletop centrifuge at top speed for 5 seconds and the supernatant was re-
moved. The beads were washed three times in 100 mM glycine (pH 3.0) for 5 minutes to remove
any antibodies bound by noncovalent binding to the protein A-agarose. Finally, the suspension
was centrifuged in a tabletop centrifuge at top speed for 5 seconds and the antibody coupled
beads were resuspended in 1 x PBS with 0.01% merthiolate. The beads were stored at 4 ◦C until
use.
The coupling procedure was monitored. Samples before and after cross-linking of the antibody
were taken. The samples were eluted by boiling for 5 minutes at 95 ◦C and separated by SDS-
PAGE. If the coupling procedure was successful, no antibody band should be visible on the SDS-
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gel in the fraction after elution/boiling. In figure 3.12 the coupling procedure of α-HyYY1 was
monitored.
FIGURE 3.12 12% SDS-gel visualizing the subsequent steps during cross-linking of the α-HyYY1
antibody to protein A-agarose beads. Different amounts of the beads were taken as sample to monitor the
cross-linking procedure. Samples were taken before cross-linking with DMP, after cross-linking and after
the final wash step with glycine. The beads were resuspended in an equal volume of 2 x protein sample
buffer and boiled at 95 ◦C for 5 minutes prior to separation by SDS-PAGE. Whereas the band of the antibody
heavy chain is clearly visible in the eluate before cross-linking, no band is visible after cross-linking and the
final wash step.
Immunoprecipitation
The insect cells or Hydra polyps were harvested by centrifugation at 500 g and 4 ◦C for 5 minutes.
The supernatant was aspirated and the cells or Hydra polyps were washed in ice-cold 1 x PBS (137
mM NaCl, 2.7 mM KCl, 1.8 mM KH2PO4 15 mM Na2HPO4 (pH to 7.4)) twice. The cells or Hydra
polyps were resuspended in 1 ml of ice-cold RIPA buffer (150 mM NaCl, 50 mM Tris-HCl (pH 8.1),
1% NP-40, 0.5% DOC, 0.1% SDS 1 mM PMSF and 1 x Roche complete protease inhibitor EDTA-
free) per 0.5 - 2 · 107 cells or per ∼ 1000 Hydra polyps (∼ 105cells per polyp). The suspension was
incubated on ice for 15 - 30 min and transfered to a 1.5 ml reaction tube. The lysate was cleared
by centrifugation in a tabletop centrifuge at top speed and 4 ◦C for 15 minutes. The supernatant
was transfered to a fresh tube with 30 µl of 50 % protein A-agarose slurry for preclearing. The
mixture was incubated on a rotator for 30 minutes at 4 ◦C. The protein A-sepharose was removed
by centrifugation in a tabletop centrifuge at 4 ◦C for 5 minutes. The cleared lysate was transfrered
to a fresh tube.
To immunoprecipitate, the entire lysate was transfered to a tube containing 10 µl of 10% BSA and
µl specific antibody bound to protein A-agarose. The mixture was incubated for 2 hours at 4 ◦C
on a rotator. Unbound proteins were removed by centrifugation in a tabletop centrifuge at top
speed and 4 ◦C for 5 seconds. The supernatant containing unbound proteins was aspirated and
the beads were washed with 1 ml of ice-cold wash buffer (300 mM NaCl, 50 mM Tris-HCl (pH
7.4), 5 mM EDTA, 0.1% (w/v) Triton X-100) for 5 minutes on a rotator. The protein A-agarose
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beads were spun down in a tabletop centrifuge at top speed and 4 ◦C for 5 seconds. The super-
natant was removed. This washing step was repeated four more times. The last washing step was
performed with 1 ml of ice-cold 1 x PBS instead of wash buffer. The protein A-agarose pellet was
resuspended in an equal volume of 2 x protein sample buffer and used for Western blot analysis.
Samples of the different steps during immunoprecipitation were analyzed by Western blotting.
Table 3.7 gives an overview of the conditions used for immunoprecipitation and co-immunoprecipitation.
TABLE 3.7 Conditions used for immunoprecipitation and detection.
immuno-
precipitation
technique
system antibody used
for IP
antibody used
for detection
IP Sf9 cells expressing
6His-HyYY1 fusion protein
α-HyYY1 αPenta-His
IP Sf9 cells expressing
6His-HyYY1 fusion protein
αPenta-His α-HyYY1
IP Sf9 cells expressing
HyYY1 protein
α-HyYY1
(cross-linked to
protein A-agarose)
α-HyYY1
Co-IP Sf9 cells expressing
6His-HyYY1 fusion protein and
HyEZH2, HyEED, HySUZ12, Hyp55
αPenta-His α-HyEZH2,
α-HyEED,
α-Hyp55
IP Hydra α-HyYY1
(cross-linked to
protein A-agarose)
α-HyYY1
Co-IP Hydra α-HyYY1
(cross-linked to
protein A-agarose)
α-HyEZH2,
α-HyEED,
α-Hyp55
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3.10.2. ChIP
To identify DNA binding sites and target genes of HyYY1, chromatin immunoprecipitation (ChIP)
followed by sequencing was performed (ChIP-Seq). Formaldehyde cross-linking and chromatin
immunoprecipitation were adapted from a protocol optimized for Drosophila embryos (Cavalli
et al., 1999). Figure 3.13 gives an overview of the ChIP/ChIP-Seq procedure.
FIGURE 3.13 Flow chart depicting the different steps of ChIP-Seq.
Formaldehyde cross-linking of chromatin from Hydra polyps
∼1 ml densly packed Hydra polyps were taken as starting material. The polyps were homoge-
nized in a Dounce homogenizer with 20 strokes in 5 ml of buffer A1 and 1.8% formaldehyde (290
µl of 37% solution) at room temperature. Crosslinking was performed for 15 minutes at room
temperature on a roller mixer. Crosslinking was stopped by the addition of glycine solution to
225 mM (540 µl of 2.5 M glycine solution for 6 ml of cross-linked material). The mixture was incu-
bated for 5 minutes at room temperature and transfered to ice. The homogenate was centrifuged
at 4000 g and 4 ◦C for 5 minutes. The supernatant was discarded and the pellet was resuspended
in 3 ml of buffer A1. The washing step was repeated three more times. The pellet was washed in
3 ml of lysis buffer without SDS and centrifuged at 4000 g and 4 ◦C for 5 minutes. The pellet was
resuspended in lysis buffer with SDS to 0.1% and N-lauroylsarcosine to 0.5 %. The suspension
was incubated for 10 minutes at 4 ◦C on a rotator. The chromatin was sheared by sonication. The
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suspension was sonicated for 8 times 30 seconds with 1 minute intervals on ice using a Branson
sonifier 250 equipped with a microtip. The following settings for sonication were tested: power
2, duty cycle 20% or power 3, duty cycle 30%. After sonication, the suspension was rotated for
10 minutes followed by centrifugation for 5 minutes at top speed in a tabletop centrifuge. The
supernatant was transfered to a new tube. The pellet was resuspended in 0.5 ml of lysis buffer
and rotated for 10 minutes. The suspension was again centrifuged for 5 minutes. The super-
natant was combined with the supernatant from the previous centrifugation step. The combined
supernatants were centrifuged 2 times for 10 minutes at top speed. The resultant supernatant is
the chromatin extract. At this step, the extract may be stored at -80 ◦C until use. The chromatin
extract was washed 4 times with 1 ml of lysis buffer using a Vivaspin 50 column (MWCO 50000).
The final volume of the chromatin extract was 1 ml. The chromatin extract was pre-incubated
with 100 µl of PAS suspension for 2 hours at 4 ◦C. The sepharose was removed and the cross-
linked chromatin was aliquoted (200 µl aliquots) and stored at -80 ◦C.
Preparation of protein A-sepharose (PAS) slurry:
100 mg of protein A-sepharose CL-4B (GE Healthcare, 17-0780-01) were resuspended in 1 ml of
lysis buffer. The sepharose was washed three times with 1 ml of lysis buffer. The washing was
completed within 1 hour. The suspension was centrifuged in a tabletop centrifuge at 2000 rpm
for 1 minute. The supernatant was discarded and the PAS was blocked for 2 hours with blocking
buffer. Again, the sepharose was washed three times with 1 ml of lysis buffer. The washing steps
were completed within 1 hour. The suspension was centrifuged in a tabletop centrifuge at 2000
rpm for 1 minute. The supernatant was discarded and the PAS beads were finally resuspended
in 1 ml of lysis buffer. The PAS slurry was aliquoted and stored at 4 ◦C.
Preparation of the Vivaspin 50 column:
The Vivaspin columns were washed with 2 ml of H2O by centrifugation at 3000 rpm in a Beckman
GS-6KR centrifuge with a swinging-bucket rotor, until the water has passed the column. The
column was incubated with 2 ml of blocking buffer for 2 hours at room temperature. The blocking
buffer was decanted and the column was washed four times with H2O.
Purification of cross-linked Hydra chromatin
To analyze the amount of DNA and the size, the chromatin had to be reverse cross-linked first.
To reverse cross-link the chromatin, proteinase K up to 100 µg/ml (0.5 µl) and SDS to a final
concentration of 1% (5 µl) were added to 100 µl of chromatin extract. The mixture was reverse
cross-linked for 6 hours at 60 ◦C, followed by 20 minutes at 70 ◦C. DNase-free RNase was added
to a final concentration of 50 µg/ml (1 µl) and the mixture was incubated for an additional 2 hours
at 37 ◦C. The DNA was extracted by phenol-chloroform. An equal amount of phenol-chloroform-
isoamylalcohol (25:24:1) was addded to the chromatin extract. After vigorous mixing, the phases
were separated by centrifugation at top speed in a tabletop centrifuge for 5 minutes. The up-
per aqueous phase was transfered into a new tube and again extracted with phenol-chloroform-
isoamylalcohol. The DNA was precipitated with 1/10 volume of 3 M sodium acetate (pH 5.2)
and 2.5 volumes of 100% ethanol. The DNA was precipitated for 30 minutes at -20 ◦C, followed
by centrifugation at top speed in a tabletop centrifuge for 15 minutes. The resultant pellet was
washed with 70% ethanol and again centrifuged at top speed for 5 minutes. The supernatant was
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discarded and the DNA pellet was air dried. The pellet was resuspended in 12 µl of H2O. The
amount of DNA was determined by spectrophotometry using the Nanodrop spectrophotometer,
the size of the chromatin fragments was determined by agarose gel electrophoresis using a 1.5 %
TAE-agarose gel. Ideally, the chromatin should have a size ranging from 200 to 500 bp.
Chromatin immunoprecipitation
The prepared Hydra chromatin was immunoprecipitated by adding the desired antibody to 200
µl of the chromatin extract. Additionally, a control without antibody and a control using the α-
HyYY1 preimmuneserum were prepared. After incubation on a rotator for 4 hours at 4 ◦C, 50 µl
of PAS suspension were added to each reaction. The suspension was incubated over night at 4 ◦C
on a rotator. Table 4.8 gives an overview of the antibodies used for ChIP.
TABLE 3.8 Antibodies used for ChIP.
antibody specifications amount used for
precipitation
α-H3K27me3 rabbit; affinity pure (1 mg/ml) 5 µl
α-HyYY1 rabbit; affinity pure (1 mg/ml) 10 µl
α-HyEZH2 rabbit; polyclonal antiserum 20 µl
α-HyPC rabbit; polyclonal antiserum 20 µl
control α-HyYY1 preimmuneserum 20 µl
Purification of immunoprecipitated Hydra chromatin
The PAS suspension was washed four times with lysis buffer, followed by two wash steps with
TE-buffer. Each wash step was performed with 1 ml of the respective buffer for 5 minutes on a
rotator at 4 ◦C. After each wash step, the PAS suspension was centrifuged in a tabletop centrifuge
for 1 minute at 2000 rpm and 4 ◦C and the supernatant was discarded. After the final wash step,
the beads were mixed with 100 µl of elution buffer 1. The suspension was incubated at 65 ◦C for
10 minutes, followed by centrifugation in a tabletop centrifuge for 1 minute at 2000 rpm and 4
◦C. The supernatant was transfered to a new reaction tube. The beads were mixed with 150 µl of
elution buffer 2. The suspension was centrifuged again and the supernatant was combined with
the first supernatant. The combined supernatants are the chromatin precipitate.
The precipitate was reverse cross-linked for 6 hours at 65 ◦C. 250 µl of proteinase K solution
were added and the mixture was incubated for 2 - 3 hours at 50 ◦C. 55 µl of 4 M LiCl and 500
µl of phenol-chloroform-isoamylalcohol were added. After vigorous mixing, the phases were
separated by centrifugation at top speed in a tabletop centrifuge for 5 minutes. The aqueous
phase was transfered to a new reaction tube and precipitated with 1 ml of 100% ethanol. After
centrifugation in a tabletop centrifuge at top speed for 15 minutes, the supernatant was removed
and the DNA pellet was washed with 750 µl of 70% ethanol. After centrifugation for 5 minutes,
the precipitate was air dried and dissolved in 25 µl of H2O.
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Ligation of a phosphorylated linker DNA
At this stage, the DNA consists of fragments with various 5’- and 3’-ends, which result from the
random shearing of the chromatin by sonication. For PCR amplification, the fragments were end-
repaired and a short linker DNA with primer binding sites was ligated.
For the generation of blunt ends, 3 µl of T4 DNA ligase buffer and 1 µl (10 U) of polynucleotide
kinase (PNK) were added to the DNA solution. The reaction was incubated at 37 ◦C for 30 min-
utes. The PNK was inactivated at 68 ◦C for 20 minutes. After the solution has cooled down to
37 ◦C, 1 µl of a 2 mM dNTP-mix and 1 µl (5 U) of Klenow fragment were added. The reaction
was incubated at 37 ◦C for 30 minutes. The enzyme was inactivated for 10 minutes at 70 ◦C. The
solution was cooled down slowly to 4 ◦C.
1 µl of 10 mM ATP, 1 µl of 1 µM linker DNA and 4 U of T4 DNA ligase were added to 9 µl of the
end-repaired DNA. The ligation reaction was incubated at 4 ◦C over night.
Preparation of the linker DNA:
The linker DNA consists of a double-stranded oligonucleotide with a phosphorylated 5’-end. The
following two oligonucleotides were annealed:
24-mer: 5’-AGA AGC TTG AAT TCG AGC AGT CAG-5’ phosphorylated
20-mer: 5’-CTG CTC GAA TTC AAG CTT CT-3’
20 µl of 100 µM 24-mer oligo and 100 µM 20-mer oligo were mixed in 160 µl of TE-buffer. The
mixture was incubated at 70 ◦C for 5 minutes and cooled down to 55 ◦C. The oligo solution was
incubated for 5 minutes at 55 ◦C and cooled down slowly to 25 ◦C. The oligos were incubated at
this temperature for 2 hours. After cooling down slowly to 4 ◦C, the linker DNA was stored at
-20 ◦C until use.
Amplification of the immunoprecipitated DNA by PCR and ligation into pGEM-T
vector
The ligation reaction was directly used for PCR amplification. For PCR amplification 12 µl of the
ligation reaction were mixed with 2 µl 10 mM dNTP-mix, 2 µl of 1 µM 20-mer oligo and 0.5 µl (2.5
U) of EuroTaq DNA polymerase in 1 x RB-buffer containing 1.5 mM MgCl2 (total volume: 80 µl).
The DNA fragments were amplified using the following cycling conditions:
initial denaturation 94 ◦C 2 minutes
denaturation 94 ◦C 1 minute
annealing 55 ◦C 1 minute 35 cycles
elongation 72 ◦C 3 minutes
final elongation 72 ◦C 7 minutes
The PCR products were purified using Promega’s ’Wizard SV Gel and PCR Clean-Up System’.
The amount of DNA was determined by spectrophotometry using the Nanodrop spectropho-
tometer, the size of the PCR products was determined by agarose gel electrophoresis using a 1.5
% TAE-agarose gel.
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The precipitated and amplified DNA was ligated into pGEM-T vector at a vector : insert-ratio of
∼1 : 3. The ligation reaction was incubated over night at 4 ◦C. Chemocompetent E.coli DH5α-cells
were transformed with 4 µl of the ligation reaction. Positive colonies were analyzed by colony-
PCR. The DNA of positive clones was isolated using Promega’s ’Wizard Plus SV Minipreps DNA
Purification System’. The purified DNA was used for sequencing.
For a detailed description of PCR product purification, ligation, transformation, colony-PCR,
DNA minipreparation and sequencing see section 3.5.
Solutions for chromatin immunoprecipitation
37% formaldehyde: Dissolve 11.1 g paraformaldehyde in H2O at 80 ◦C.
Add 40 µl 10 M KOH.
Adjust volume to 30 ml with H2O.
Freeze 1 ml aliquots at -80 ◦C.
2.5 M glycine: 9.4 g glycine
Adjust volume to 50 ml with H2O.
10% N-lauroylsarcosine: 5 g N-lauroylsarcosine
Adjust volume to 50 ml with H2O.
Sterilize by autoclaving.
1 M sodium butyrat: Dissolve 1 M sodium butyrate in H2O.
Store at 4 ◦C until use.
10% sodium deoxycholate: 5 g sodium deoxycholate
Adjust volume to 50 ml with H2O.
Mix until completely dissolved.
Store protected from light.
3 M KCl: 11.18 g potassium chloride
Adjust volume to 50 ml with H2O.
Sterilize by autoclaving.
2.5 M NaCl 7.31 g sodium chloride
Adjust volume to 50 ml with H2O.
Sterilize by autoclaving.
1 M MgCl2: 10.17 g magnesium chloride hexahydrate
Adjust volume to 50 ml with H2O.
Sterilize by autoclaving.
1 M HEPES (pH 7.6): 119.1 g HEPES
Adjust volume to 450 ml with H2O.
Adjust pH to 7.6 with 1 M KOH.
Adjust volume to 500 ml with H2O.
Sterilize by autoclaving.
10% Triton X-100: Mix 5 ml 100% Triton X-100 in 45 ml of H2O.
0.5 M EDTA: 18.61 g disodium EDTA
Adjust volume to 90 ml with H2O.
Adjust pH to 8.0 with 1 M NaOH.
Adjust volume to 100 ml with H2O.
Sterilize by autoclaving.
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0.5 M EGTA: 19.02 g EGTA
Adjust volume to 90 ml with H2O.
Adjust pH to 8.0 with 1 M NaOH.
Adjust volume to 100 ml with H2O.
Sterilize by autoclaving.
25 x Roche complete EDTA-free: Dissolve 1 tablet in 2 ml of H2O.
Store at -20 ◦C until use.
Buffer A1: 60 mM KCl, 15 mM NaCl, 4 mM MgCl2, 15 mM HEPES (pH
7.6), 0.5% Triton X-100, 0.5 mM DTT, 10 mM sodium butyrate,
1 x Roche complete EDTA-free
Prepare freshly prior to use.
Lysis buffer: 140 mM NaCl, 15 mM HEPES (pH 7.6), 1 mM EDTA, 0.5 mM
EGTA, 1% Triton X-100, 0.5 mM DTT, 0.1% sodium deoxycholate,
0.05% SDS, 10 mM sodium butyrate, 1 x Roche complete EDTA-
free
Prepare freshly prior to use.
TE-buffer: 10 mM Tris-HCl (pH 8.0), 1 mM EDTA
Sterilize by autoclaving.
Elution buffer I: 50 mM Tris (pH 8.0), 10 mM EDTA, 1% SDS
Elution buffer II: 10 mM Tris (pH 8.0), 1 mM EDTA, 0.67% SDS
Blocking buffer: 1 mg/ml BSA, 1 mg/ml yeast tRNA
glycogen: 20 mg/ml in H2O
Aliquot and store at -20 ◦C.
proteinase K: 20 mg/ml in H2O
Aliquot and store at -20 ◦C.
RNaseA: Dissolve 5 mg RNaseA in 0.91 ml 0.001 M sodium
acetate (pH 5.2).
Inactivate DNases for 15 minutes at 99 ◦C.
Cool slowly down to room temperature.
Add 90 µl 1 M Tris-HCl (pH 7.4).
Store aliquots at -20 ◦C.
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4. Results and discussion
4.1. Identification of PcG-encoding genes in Hydra
PcG genes have been first identified in context of regulating homeotic gene expression
in Drosophila. Subsequently, PcG proteins have been found in mammals and in plants.
Recent data suggest that PcG proteins act in the regulation and maintenance of gene ex-
pression patterns involved in the majority of developmental and proliferation processes.
PcG proteins are not only linked to homeotic gene silencing, but also to stem cell main-
tenance or silencing processes based on non-coding RNAs. To investigate the situation
in a non-bilaterian animal, the PcG proteins in the cnidarian Hydra have been analyzed.
During this study, the main focus was on identifying the genes coding for the DNA bind-
ing proteins which are important for recruiting the PcG complexes to their target genes.
Candidate genes were: Pleiohomeotic (Pho/YY1), Zeste (Z), Pipsqueak (Psq) and GAGA-
factor/Trithorax-like (Gaf/Trl). However, it has to be kept in mind, that Zeste, Psq and
Gaf/Trl are only found in Drosophila. No homolog genes could be identified in verte-
brates.
To identify the PcG proteins in Hydra, an approach based on genome database screens
has been followed. Known PcG proteins from other species like fly, fish, frog, mouse
or human were compared with the Hydra genome and the best hit sequences with the
highest E-values were taken for further analysis. To identify the Hydra PcG genes, the
intron-exon boundaries have been identified and the DNA sequences of ’core fragments’
of the Hydra genes could be assembled. These core fragments were cloned from Hydra
cDNA. The full length coding regions and the 5’- and 3’-ends of the genes were obtained
by RACE-PCR.
4.1.1. Screening the Hydra genome for PcG genes
To identify genes that are homologous to vertebrate and fly PcG genes, the Hydra genome
was browsed on the Hydra genome database Metazome (http://hydrazome.metazome.net/).
Known protein sequences from different species have been retrieved from the NCBI
protein database (http://www.ncbi.nlm.nih.gov/protein) and used to scan the Hydra
genome with the help of a tBLASTn search using default parameters. The selected pro-
tein sequences were compared to the translated nucleotide database of the Hydra genome.
Table 4.1 provides an overview of the protein sequences used in the search of PcG asso-
110 4. RESULTS AND DISCUSSION
ciated genes and DNA binding factors.
TABLE 4.1 Protein sequences from different species which have been used for the search of Hydra
YY1, SCM and PcG associated DNA binding factors are indicated. The identification numbers of the NCBI or
GenBank reference sequences are given. The sequences have been retrieved from the NCBI protein database.
For Trl, Psq and Zeste only the known Drosophila proteins could be used.
Protein
Drosophila
melanogaster
danio rerio Xenopus laevis mus musculus homo sapiens
YY1
pleiohomeotic YY1 YY1 YY1 YY1
GenBank NCBI Ref Seq NCBI Ref Seq NCBI Ref Seq NCBI Ref Seq
AAC39123.1 NP_997782.1 NP_001087404.1 NP_033563.2 NP_003394.1
520 aa 357 aa 370 aa 414 aa 414 aa
Trl/Gaf
trithorax-like - - - -
NCBI Ref Seq
NP_001034015.1
567 aa
Psq
pipsqueak - - - -
GenBank
CAA62475.1
660 aa
Z
zeste - - - -
GenBank
AAF45783.1
575 aa
Grh
grainyhead Grhl2 Grhl1 Grhl1 GRHL1
GenBank NCBI Ref Seq NCBI Ref Seq NCBI Ref Seq NCBI Ref Seq
AAM68470.2 NP_001076541.1 NP_00108907.1 NP_001154878.1 NP_937825.2
784 aa 554 aa 609 aa 618 aa 618 aa
Dsp1
dorsal switch protein 1 Hmgb2 Hmgb2 Hmgb2 HMGB2
NCBI Ref Seq GenBank NCBI Ref Seq NCBI Ref Seq GenBank
NP_727960.1 AAI65150.1 NP_001079387.1 NP_032278.1 AAI00020.1
385 aa 388 aa 211 aa 210 aa 209 aa
Scm
sex combs on midleg - Scmh1 Scmh1 SCMH1
GenBank NCBI Ref Seq GenBank NCBI Ref Seq
AAF54419.2 NP_00108740.8 BAA90554 NP_001026864
877 aa 602 aa 664 aa 660 aa
Sfmbt
Scm-related gene
containing four mbt do-
mains
- - Sfmbt1 SFMBT1
GenBank NCBI Ref Seq NCBI Ref Seq
AAF53249.2 NP_062333.1 NP_057413.2
1220 aa 863 aa 866 aa
Hits in the Hydra genome could be found for almost all proteins, except for Zeste. How-
ever, hits with the highest significances and lowest E-values could be found for YY1,
SFMBT, SCM and DSP1. All other proteins produced E-values higher than e−05. For ex-
ample, figure 4.1 shows the graphical presentation of the result of the tBLASTn search
for YY1 and SCM, when comparing the respective Drosophila proteins with the Hydra
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genome. For YY1 the best hit with the highest E-value could be found in Contig 38857 on
the minus strand for all proteins subjected to the search. The Drosophila protein produced
the best hit. For SCM, the most promising hits could be found in Contig 37649. These hits
were not ranked the most significant hits by E-value, but the aligned sequences spanned
a larger region of SCM than the best hit sequences. After the identification of the Contigs,
the expressed regions/coding regions (exons) of the genes were identified.
The genomic region of the candidate gene was analyzed for open reading frames and for
intron/exon boundaries. A ’core fragment’ of the coding region of the candidate gene
was assembled and the DNA sequence was translated into the protein sequence. The
identified Hydra protein sequences, were reverse checked by a NCBI BLASTp search and
cloned from Hydra cDNA. In table 4.1 a summary of the genome database screen and the
reciprocal BLASTp search is given.
FIGURE 4.1 Screenshot of the result of a tBLASTn search when browsing the Hydra genome for YY1
and SCM. The top part of the figure shows the result when using the Drosophila Pho protein sequence as a
source for the search. In the bottom part of the figure, the genome was searched for Drosophila Scm. The
graphical outputs on the left side of the figure show the range and distribution of HSPs (high scoring pairs)
of query and target sequence. The texts on the right sides show a part of the summary of target sequences
producing significant alignments.
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Of all proteins searched for, the putative Hydra YY1 homolog gave the best result in the
BLASTp analysis. The Hydra protein ’core fragment’ was identified as the transcription
factor Pho/YY1 in Drosophila, Danio rerio, Xenopus laevis, mouse and human with satisfac-
tory E-values. In Drosophila, Pho has been shown to form a third Polycomb repressive
complex together with Phol and dSfmbt, which is called Pleiohomeotic Repressive Com-
plex (PhoRC) (Klymenko et al., 2006). A putative homolog of the second member of this
complex, dSfmbt, could be found in Contig 39254 in the Hydra genome. The sequence
of the putative HySFMBT gene is distributed over two successive gene models accord-
ing to the Hydra genome browser (http://hydrazome.metazome.net.): Hma2.231754 and
Hma2.231755. The gene models are hypothetical protein coding genes within the Hydra
genome. Over 30000 gene models have been predicted by homology and ab initio based
gene modeling during the Hydra genome project (Chapman et al., 2010). dSfmbt contains
four MBT domains and displays a specific histone binding activity (Usui et al., 2000; Wu
et al., 2007). The protein has been shown to directly interact with a second PcG protein
containing MBT domains: Scm (Grimm et al., 2009). A candidate sequence for Scm could
be found in Contig 37649. Scm has been shown to be a PcG protein and to be associated
to the PRC1 complex (Peterson et al., 1997; Shao et al., 1999; Saurin et al., 2001). Loss
of Scm in fly embryos leads to HOX gene misexpression and severe defects with phe-
notypes typical for the loss of PcG proteins. The reciprocal BLASTp search aligned the
Hydra protein fragment with another MBT domain-containing protein called l(3)mbt.
Among the candidate genes of the PcG associated DNA binding proteins, only candi-
dates for grainyhead and Dsp1 could be identified in the Hydra genome with satisfactory
E-values. The putative Hydra Trl/Gaf protein turned out to be the Drosophila kelch or
kelch-like protein during reciprocal BLASTp search. The kelch protein belongs to a mem-
ber of a protein superfamily with kelch repeats required to maintain actin organization.
It shares a BTB/POZ (broad domain, tramtrack, bric a brac) domain with Trl/Gaf. Trl is
been classified as PcG and TrxG protein, likewise (Farkas et al., 1994; Mishra et al., 2001).
A homolog of the Drosophila Zeste protein could not be identified in the Hydra genome.
Like Trl/Gaf, Zeste is associated with both PcG and TrxG mediated gene regulation (Mul-
holland et al., 2003).
A similar sequence to the helix-turn-helix (HTH) motif of Pipsqueak could be found in
the Hydra genome with an unconvincing E-value of 0.003. However, reciprocal BLASTp
search aligned the Hydra sequence with pipsqueak from mosquito (Culex quinquefascia-
tus) and with Psq isoform B of Drosophila with good E-values. The pipsqueak protein
has been co-purified from a PRC1 related complex termed CHRASCH (chromatin asso-
ciated silencing complex for homeotics) (Huang et al., 2002; Huang and Chang, 2004).
CHRASCH has been purified from Drosophila tissue culture cells and consists of Pc, Ph,
Rpd3 and Psq. Psq has been shown to bind the same consensus sequence as Trl/Gaf. A
vertebrate homolog is missing.
A candidate sequence for grainyhead could be identified in the Hydra genome and ver-
ified by reciprocal BLASTp. The BLASTp search aligned the Hydra protein fragment as
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grainy head/grhl1. Grainyhead has been shown to interact with dRing/Sce of the PRC1
complex and the YY1 transcription factor (Tuckfield et al., 2002; Blastyák et al., 2006).
Grainyhead is not essential for the recruitment of PcG proteins to PRE sites in Drosophila,
but it can assist the binding. In contrast to Trl/Gaf, Psq and Zeste, homologs of grainy-
head exist in other species.
For the last possible DNA binding protein Dsp1, a candidate sequence could be identi-
fied in the Hydra genome. Déjardin et al. (2005) showed that the binding of Dsp1 to PRE
sites is important for Polycomb recruitment in Drosophila. Sequence motifs for the DNA
binding proteins Dsp1, GAF and Pho were sufficient for efficient PcG recruitment to a
PRE site. The BLASTp search identified the protein as HMGB3. However, the homolog
of Dsp1 would be HMGB2. Both proteins share a so-called HMG (high mobility group)
box. HMG box proteins are non-histone components in chromatin with DNA binding
activity (for a review see (Stros, 2010)).
4.1.2. Cloning the Hydra PcG genes
Of all putative Hydra PcG and PcG associated genes, HyYY1 and HySCM were further an-
alyzed during this thesis. The candidate genes were cloned from complementary DNA
(cDNA) which was synthesized from Hydra total RNA by reverse transcription. In fig-
ure 4.2 isolated total RNA which has been separated by agarose gel electrophoresis is
depicted. The 28S rRNA of Hydra has a size of about 2400 bp, the 18S rRNA is of about
1300 bp in size. The cellular mRNA, which is less abundant and has no specific size,
could only be detected as a smear. RACE (rapid amplification of cDNA ends) cDNA was
synthesized from total RNA. The resulting pool of cDNAs is flanked by defined oligonu-
cleotides and can be used for the amplification of both terminal ends of the genes. The
Hydra cDNA used for RACE PCR was a courtesy of Dr. Anne Kuhn (Holstein lab). It was
used to amplify HyYY1 and HySCM. For details see materials and methods sections 3.4.2
and 3.5.4.
FIGURE 4.2 Isolated total RNA from Hydra magnipapillata 105.
The total RNA was seperated on a 1 % agarose gel and visualized
by ethidium bromide staining. Both the 28S and 18S rRNA bands
are visible. The size is indicated by a molecular weight marker (left
side).
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HyYY1
For HyYY1 a core fragment of 880 bp in size was amplified from the Hydra cDNA and for
the 3’-end a fragment of∼ 500 bp in size was obtained. However, the amplified fragment
containing the 5’-end was not homogeneous. Several fragments have been amplified by
RACE and nested PCR. For the 5’-end DNA fragments ranging from 200 bp to 500 bp
in size were obtained (see figure 4.3 A). Nevertheless, the DNA fragments were cloned
into pGEM-T vector. The insert sizes were determined by restriction analysis with ApaI
and SacI restriction endonucleases. The endonucleases cut the plasmids adjacent to both
ends of the insert and were used to verify the correct insert size (see figure 4.3 B). The
nucleotide composition was determined by sequencing. For the HyYY1 5’-end fragments,
only the sequence of the smaller fragment was found in the Hydra genome. The larger
fragment could not be identified. Two 3’-end fragments were identified. The smaller
fragment is 139 nucleotides shorter and differs in its polyadenylation site.
A full length cDNA sequence of 1546 bp could be assembled for HyYY1. The full length
sequence contains a 5’ UTR of 37 bp, an open reading frame of 1083 bp coding for 361
amino acids and a 3’ UTR of 85 bp and a polyadenylation signal. The coding region of
HyYY1 was amplified from cDNA with specific primers and cloned into pGEM-T vector.
The pGEM-T-HyYY1-vector forms the basis for all further studies with the HyYY1 gene.
An overview of the amplification and cloning of HyYY1 is given in figure 4.3 C.
FIGURE 4.3 Amplification and cloning of HyYY1 from cDNA. The obtained cDNA fragments were
seperated by agarose gel electrophoresis. A 1% agarose gel depicting the gene fragments of HyYY1 amplified
from Hydra cDNA. The size of the fragments was estimated by comparison with a DNA molecular weight
marker. Sizes of the marker bands are indicated on the left side of each gel. B 1% agarose gels showing the
result of the restriction analysis after cloning the HyYY1 gene fragments into pGEM-T vector. C Schematic
overview of the cloned HyYY1 cDNA fragments after amplification.
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An overview of the genomic organisation and the nucleotide and amino acid sequences
of HyYY1 is given in figure 4.4. On genomic level, HyYY1 is organized in 6 exons and
spans a genomic region of ∼10.5 kilobases.
FIGURE 4.4 Overview of the HyYY1 genomic organisation. Features are indicated: On the level
of the genomic DNA, the number and length of the exons are indicated, on the mRNA level, the untrans-
lated regions and the coding region are indicated. The conserved protein domains are displayed on the
protein level. The HyYY1 DNA and protein sequence are shown. The DNA sequence includes the coding
region of the gene (upper case letters) and the untranslated regions (lower case letters). The coding region
is highlighted in gray.
4.1. IDENTIFICATION OF PCG-ENCODING GENES IN Hydra 117
HySCM
The HySCM gene was cloned in the same way as HyYY1. The full length cDNA sequence
of HySCM was obtained by means of PCR with specific primers against a conserved re-
gion of the candidate gene, followed by 5’- and 3’-RACE PCR. A core fragment of ∼1700
bp, a fragment containing the 3’-end of ∼200 bp and fragments of varying sizes contain-
ing the 5’-end were amplified from cDNA. Sequencing identified a ∼850 bp fragment as
the correct fragment containing the 5’-end. All other sequenced 5’-end clones could not
be found in the Hydra genome, at all.
A full length cDNA sequence of 2636 bp could be assembled for HySCM. The full length
sequence contains a 5’ UTR of 85 bp, an open reading frame of 2496 bp coding for 832
amino acids and a 3’ UTR of 85 bp including a polyadenylation signal. The cloning and
amplification process of HySCM is depicted in figure 4.5.
FIGURE 4.5 Amplification and cloning of HySCM from cDNA. The obtained cDNA fragments
were seperated by agarose gel electrophoresis. A 1% agarose gel depicting the gene fragments of HySCM
amplified from Hydra cDNA. B 1% agarose gel showing the result of the restriction analysis with ApaI and
SacI restriction endonucleases after cloning the gene fragments into pGEM-T vector. C Schematic overview
of the cloned HySCM cDNA fragments after amplification.
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An overview of the genomic organisation and both the nucleotide and amino acid se-
quences of HySCM is given in figure 4.6. HySCM is organized in 18 exons and spans a
genomic region of > 60 kb.
FIGURE 4.6 Overview of the HySCM genomic organisation. Features are indicated. The number
and length of the exons, the untranslated regions, the coding region and the conserved protein domains
are indicated on the different levels of organisation. The HySCM DNA and protein sequence are shown.
The DNA sequence includes the coding region of the gene (upper case letters) and the untranslated regions
(lower case letters). The coding region is highlighted in gray.
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4.1.3. Conserved domains of the Hydra PcG proteins
During this study, the Hydra PcG genes HyYY1 and HySCM have been identified in the
genome and amplified from cDNA. Alltogether, the full length clones of 10 Hydra PcG
genes are available: HyPC, HyPH, HyPSC, HyRING and HySCM from the Hydra PRC1
complex, HyEZH2, HyEED, HySUZ12 and Hyp55 from the PRC2 complex and HyYY1
from the PhoRC complex. Figure 4.7 gives an overview of all Hydra PcG genes, which
have been amplified from cDNA. The full length translated regions of each gene were
amplified by PCR using specific primers and seperated by agarose gel electrophoresis.
The complete sequence information for the Hydra PcG genes can be found in appendix
A. The Hydra PcG genes were analyzed further by in silico based methods. The translated
protein sequences were analyzed as to their domain composition and compared with
PcG proteins from other species.
FIGURE 4.7 Overview of the Hydra PcG genes. The 1% agarose gel shows the translated region of
each of the Hydra PcG genes, which have been amplified from cDNA by PCR. The names of the genes and
the correct sizes of the coding regions are indicated.
The domain composition of the Hydra PcG proteins has been analyzed in silico by com-
paring the protein sequences with the SMART (Simple Modular Architecture Research
Tool) database (Schultz et al., 1998; Letunic et al., 2009). An overview of the domain
architecture of Hydra PcG protein homologs is depicted in figure 4.8. The Hydra PcG pro-
teins are composed of the same functional domains as the human or Drosophila proteins,
except HySCM, which has a HMG box at its N-terminus instead of a C2H2-type zinc fin-
ger. However, the similarity of the proteins can be mainly found within these domains;
the other regions are not conserved. Protein sequence alignments of all identified Hydra
PcG proteins with homolog proteins of other species like human, mouse, frog, fish or
Drosophila can be found in appendix A section 3.
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PRC1 conserved domains
The functional domains of Hydra PRC1 include the CHROMO domain of HyPC, the
RING fingers of HyRING and HyPSC and a SAM domain of HyPH. A comparison of
the domain architecture of Hydra, Drosophila and human PRC1 proteins is given in fig-
ure 4.9. The CHROMO (CHRomatin Organization MOdifier) domain was first identified
in the heterochromatin-associated protein 1 (HP1) and in Pc (Paro and Hogness, 1991;
Singh et al., 1991). The domain is necessary for chromatin binding; point mutations
in the chromo domain of Pc disrupt chromatin binding (Messmer et al., 1992). Jacobs
et al. (2001) could show that the chromo domain binds to methylated lysines on histone
tails. Whereas HP1 has been shown to bind methylated H3K9, Fischle et al. (2003) and
Min et al. (2003) could show that Pc preferentially binds trimethylated H3K27. Pc is the
’reader’ of the epigenetic mark set by the PRC2 complex. The RING zinc fingers of dRing
and Psc have been shown to possess H2AK119 E3 ubiquitin ligase activity (Wang et al.,
2004c; Cao et al., 2005). The SAM domain which can be found in Polyhomeotic and Sex
combs on midleg is a putative protein interaction module. Ph and Scm have been shown
to interact with each other via their SAM domains in vitro (Peterson et al., 1997, 2004).
Additionally, the PRC1 associated protein Scm has two MBT (Malignant Brain Tumor)
domains, which could bind to various monomethylated lysines on histones H3 and H4
(H3K4mer, H3K9me, H3K27me, H3K36me and H4K20me) (Grimm et al., 2007; Santiveri
et al., 2008).
FIGURE 4.9 Domain architecture of Hydra, Drosophila and human PRC1 proteins. The underlying
protein sequences of the human and Drosophila proteins were retrieved from the NCBI database.
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PRC2 conserved domains
The functional domains of the PRC2 proteins include the SANT and SET domain of
HyEZH2, a zinc finger and VEFS box of HySUZ12 and stretches of WD40 repeats in both
HyEED and Hyp55. A comparison of the domain architecture of the Hydra PRC2 proteins
with homologs from Drosophila and human is depicted in figure 4.10.
FIGURE 4.10 Domain architecture of Hydra, Drosophila and human PRC2 proteins. The underlying
protein sequences of the human and Drosophila proteins were retrieved from the NCBI database.
The SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain is responsible for the histone
lysine methyl transferase activity of Enhancer of zeste. E(z) has been shown to methy-
late both H3K9 and H3K27. Mutations in the SET domain disrupt its HKMTase activity
(Czermin et al., 2002; Müller et al., 2002). The SANT (SWI3, ADA2, N-CoR and TFIIIB”
DNA-binding) domain is similar to the DNA binding domain of c-Myb related proteins
(for a review see: Boyer et al. (2004); de la Cruz et al. (2005)). The domain is involved
in the recruitment of histone-modifying enzymes to histone tails and in the regulation of
their enzymatic activity (Boyer et al., 2002). The exact function of the E(z) SANT domain
is yet to be shown. The Supressor of zeste contains a VEFS (VRN2-EMF2-FIS2-Su(z)12)
box composed of acidic clusters, which is associated with a zinc finger domain about
100 residues towards the N-terminus. The domain is exclusively found in Su(z)12 and
the related plant PcG proteins VRN2, EMF2, FIS2 (Birve et al., 2001). In Drosophila, ho-
mozygous mutants expressing a truncated protein lacking the VEFS box show extensive
misexpression of HOX genes. p55 and Esc/EED have several WD40 repeats. Proteins
containing these repeats have diverse biological functions and are important for the as-
sembly of multi-protein complexes (Li and Roberts, 2001). So far, the role of the WD40
domains in the assembly of the PRC2 complex is not known in detail. More recent studies
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showed that both p55 and EED have an import function in histone recognition. p55 has
been shown to bind to histone H4 via the β-propeller structure of its WD40 repeats (Song
et al., 2010). EED has been shown to bind different trimethyllysine histone peptides on
histone H3 and histone H1 via the β-propeller architecture of its WD40 repeats (Xu et al.,
2010). Moreover, it could be shown that EED differentially regulates the histone methyl-
transferase activity of the PRC2 complex: binding of EED to H3K27me3 stimulates the
HKMTase activity, whereas binding to H1K26me3 inhibits the methylation of H3K27.
PhoRC conserved domains
The conserved protein domains of the third PcG repressive complex, PhoRC, include zinc
fingers, MBT and SAM domains. The DNA binding protein Pho/YY1 has four C2H2-
type zinc fingers at its C-terminus, which can bind to DNA in a sequence specific manner.
Additionally, Pho/YY1 has a short domain of 26 amino acids called REPO (REcruitment
of POlycomb) domain. This domain has been shown to be necessary and sufficient for
PcG recruitment in Drosophila (Wilkinson et al., 2006). The Hydra homolog also possesses
this domain. A Hydra homolog of dSfmbt has been identified in silico, but has not been
cloned, yet. Like the PRC1 associated protein Scm, dSfmbt contains MBT domains. In
contrast to Scm, dSfmbt has four MBT domains and binds to both monomethylated and
dimethylated lysine residues on histones H3 and H4 (Grimm et al., 2009). Several human
homologs exist. A comparison of the domain architecture of the putative Hydra PhoRC
proteins with homologs from Drosophila and human is depicted in figure 4.11.
FIGURE 4.11 Domain architecture of Hydra, Drosophila and human PhoRC proteins. The underlying
protein sequences of the human and Drosophila proteins were retrieved from the NCBI database.
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4.1.4. SUMMARY
A complete set of PcG-encoding genes could be identified in Hydra
The results of the present thesis and previous studies of this lab show that the freshwater
polyp Hydra magnipapillata 105 has a complete set of PcG proteins. By comparing the
sequences of the Hydra PcG proteins with known protein sequences from vertebrates, it
could be shown that the key domains are conserved between species. However, the sur-
rounding sequences are less similar. These findings are in accordance with a study from
Whitcomb et al. (2007) who could show that the PcG proteins of organisms from plant to
human differ significantly from each other outside of key domains. In the course of this
study, homologs of the DNA binding protein YY1 and the PRC1 associated gene SCM
have been successfully identified in the Hydra genome and cloned from cDNA.
By in silico analysis of the Hydra genome only two of the PcG associated DNA binding
proteins known from Drosophila could be found in Hydra: homologs of the Drosophila
Pho and Dsp1. All other PcG associated DNA binding factors known from Drosophila
are absent from Hydra. Neither Trl/Gaf nor Psq nor Zeste could be identified. Although
a possible homolog of Dsp1 has been identified in the Hydra genome, it has not been
cloned so far. Only one study could link the protein to PcG-mediated gene regulation:
In Drosophila, Dsp1 has been shown to assist Pho in recruiting the PcG complexes to
their target genes (Déjardin et al., 2005). PcG protein binding to the Fab7 and Engrailed
Polycomb response element was lost by abolishing the binding of Dsp1. Hence the iden-
tification and cloning of Pho/YY1 was preferential.
The human homolog of the HyYY1 protein is a transcription factor that has been ini-
tially identified as a repressor of the P5 promoter of the adeno-associated virus (AAV)
serotype 2 (Shi et al., 1991). Interestingly, its function could be altered from a repressor to
a trans-activator by the viral protein E1A. Because of this dual function, the protein has
been termed Yin Yang 1 (YY1). Around the same time, Hariharan et al. (1991) identified
the protein as the transcription factor δ, which activates transcription of some murine
ribosomal proteins. Furthermore, YY1 could be linked to transcription initiation (Seto
et al., 1991). YY1 has been shown to interact with a number of transcriptional regulators,
including Sp1, TFIIB, TAFII55, TBP, p300 and CBP (Seto et al., 1993; Usheva and Shenk,
1994; Austen et al., 1997). Usheva and Shenk could show that YY1 can direct basal tran-
scription together with TFIIB and polymerase II. YY1 is involved in the regulation of
promoters like c-myc, c-fos, Surf-2, IFN-γ, p53 or IL-4 (Riggs et al., 1993; Gualberto et al.,
1992; Gaston and Fried, 1994; Ye et al., 1994; Furlong et al., 1996; Guo et al., 2001). It has
also been found as a critical regulator of histone genes (Guo et al., 1995; Eliassen et al.,
1998).
Satijn et al. (2001) provided the first evidence for an interaction of YY1 with PcG pro-
teins. In Xenopus they could show that YY1 interacts with EED, a subunit of PRC2. No
interaction between YY1 and PRC1 could be discovered in this study. In Drosophila S2
cells however, Mohd-Sarip et al. (2002) could demonstrate that YY1 can interact with
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Pc and Ph, which belong to PRC1. A region within the protein that is important for
the recruitment of Polycomb to DNA could be identified. Wilkinson et al. (2006) could
narrow the region and identify a short conserved motif that is sufficient for PcG recruit-
ment and transcriptional repression. The motif was termed REPO domain (REcruitment
of POlycomb). Atchison et al. (2003) could show that the vertebrate YY1 can substitute
for Drosophila Pho in transcriptional repression. The Hydra homolog of Pho/YY1 both
exhibits the four conserved zinc fingers, which are important for DNA binding and the
REPO domain, which is essential for PcG binding, as well. However, no N-terminal his-
tidine stretches, transactivation or repression domain could be found in HyYY1, when
comparing it to the human or mouse homolog (Hariharan et al., 1991; Lee et al., 1994,
1995). In figure 4.12, schematic diagrams of the human YY1 protein and HyYY1 are de-
picted.
FIGURE 4.12 Schematic representation of the human and Hydra YY1 protein. The diagram of
the human protein has been adapted from (He and Casaccia-Bonnefil, 2008). The transcriptional activation
and repression domains and the DNA binding domain are indicated. Acidic, acidic clusters; His, histidine-
rich domain; GK, glycine-lysine-rich domain; REPO, recruitment of Polycomb domain. The proteins and
complexes that have been demonstrated to interact with the human YY1 protein are shown below each
region of interaction.
In Drosophila, Pho can be found in a dINO80 complex or in an assembly together with
dSfmbt called PhoRC (Klymenko et al., 2006). A possible homolog of dSfmbt could be
found in the Hydra genome in silico, but has not been cloned from cDNA so far. In con-
trast, the closely related PcG protein Scm has been successfully cloned. Surprisingly the
Hydra homolog of Scm has no N-terminal zinc finger domain like its human counterpart,
but a HMG-box instead. As well as zinc fingers, HMG-boxes have been found in a wide
variety of DNA binding proteins. Originally, the domain has been found in chromatin-
associated proteins (for a review see Stros et al. (2007)).
In the past, Scm mutants have been shown to cause strong derepression of homeotic
genes in Drosophila (Bornemann et al., 1996). Scm was classified as PcG gene and has
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been co-purified with PRC1 in substoichiometric amounts (Saurin et al., 2001). It can in-
teract with the PRC1 subunit Ph via its SAM domain. A PRC1 complex containing SCM
could be assembled in vitro (Peterson et al., 2004). SCM contains two MBT domains and
is related to L(3)MBT (three MBT domains) and SFMBT (four MBT domains). In two
recent studies the importance of SCM and SFMBT in recruiting the PcG complexes to
their targets begins to reveal. In Drosophila Wang et al. (2010) could show that Scm asso-
ciates with a Polycomb response element upstream of Ultrabithorax which is also bound
by PRC1, PRC2 and PhoRC. By knocking down Scm the binding of PRC1 and PRC2 to
Polycomb response elements is affected. It is hypothesized that Scm may interact with a
still unknown DNA binding factor and function in a complex like Pho and dSfmbt in the
PhoRC complex. Grimm et al. (2009) could show that Scm and dSfmbt physically inter-
act with each other. Furthermore by ChIP analysis it could be detected that both proteins
co-occupy Polycomb response elements of target genes in Drosophila. It is suggested that
the combined action of Scm and dSfmbt is important for PcG silencing. Results of this
study and findings of previous studies of could show that both Scm and dSfmbt can
bind to the same set of mono- and dimethylated histone lysine residues via their MBT
domains. Both proteins have been found to bind to methylated H3K4, H3K9, H3K27,
H3K36 and H4K20, respectively. However dSfmbt seems to bind the modified residues
with a higher affinity. It is hypothesized that the heterodimerization of the proteins, each
bound to a different histone - are important for chromatin compaction and maintenance
of PcG repression of target genes. In this respect further work is required to clone the
Hydra homolog of SFMBT. In future investigations, HySFMBT and HySCM might be in-
teresting for the identification of PcG target genes in Hydra.
Polycomb Group proteins during animal evolution
The PcG proteins form large complexes which post-translationally modify histone tails.
They act in transcriptional repression of target genes by altering higher order chromatin
structure. The PcG protein complexes are evolutionary conserved. Components of the
PRC2 complex can be found from plants to animals. However, the complex is absent
from unicellular yeast. Components of the PRC1 complex are less conserved and absent
from both yeast and plants. In the yeast Schizosaccharomyces pombe only one homolog of
a protein from the PRC2 complex has been identified so far: Mis16, which has a strong
similarity to the human RBBP4 and RBBP6 (Hayashi et al., 2004). In plants, a homolog to
the PRC2 complex could be identified (for a review see Hennig and Derkacheva (2009)).
An overview of the phylogenetic distribution of the PcG members is shown in figure 4.13.
The figure was constructed on the basis of a phylogenetic study of Schuettengruber et al.
(2007) and on the basis of genome data.
The phylogenetic tree shows that PcG-encoding genes can be already found in the single-
celled choanoflagellate Monosiga brevicollis. This finding is supported by a recent study
of Shaver et al. (2010) who could identify homologs of PcG proteins in quite a few uni-
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cellular organisms. In the demosponge Amphimedon queenslandica all components of the
PRC2 complex and some members of PRC1 can be found. In the placozoan Trichoplax
adherens and the cnidarians Nematostella vectensis and Hydra magnipapillata the set of PcG-
encoding genes is completed. However, some of the genes seem to have been lost during
evolution in the nematode Caenorhabditis elegans. In vertebrates like mouse or human,
some of the PcG-encoding genes have been duplicated repeatedly during evolution and
multiple homologs exist, especially genes encoding the PRC1 proteins.
FIGURE 4.13 Phylogenetic distribution of the Polycomb Repressive Complexes PRC1 and PRC2. The
phylogenetic relationships are depicted on the left hand side and are according to the studies of Srivastava
et al. (2010). On the right hand side, the presence or absence of the Polycomb Group proteins in the respective
eukaryotic organism is indicated. The presence of the proteins is indicated by +, the absence by -. The data
are either retrieved from literature or from the respective genome database. The asterisked references are
reviews on the topic. The in silico data are retrieved from the following genome databases by performing a
BLASTP or TBLASTN search with the respective human or Hydra protein:
1 Branchiostoma: http://genome.jgi-psf.org/Brafl1/Brafl1.home.html; cited in Putnam et al. (2008)
2 Schistosoma: http://www.genedb.org/Homepage/Smansoni; cited in Berriman et al. (2009)
3 Nematostella: http://genome.jgi-psf.org/Nemve1/Nemve1.home.html; cited in Putnam et al. (2007)
4 Trichoplax: http://genome.jgi-psf.org/Triad1/Triad1.home.html; cited in Srivastava et al. (2008)
5 Amphimedon: http://spongezome.metazome.net/amphimedon; cited in Srivastava et al. (2010)
6 Monosiga: http://genome.jgi-psf.org/Monbr1/Monbr1.home.html; cited in King et al. (2008)
The retrieved Polycomb Group proteins are hypothetical protein models with a high similarity to the query
sequence and the best E value.
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4.2. Expression patterns of PcG and associated genes in Hydra
RNA in situ hybridizations (ISH) were performed to detect the transcript expression pat-
tern of the PcG genes. The emphasis during this thesis was placed on HyYY1 and the
PRC2 complex. In situ hybridizations were performed using whole polyps of the Hy-
dra magnipapillata 105 strain. The transcripts were hybridized with digoxigenin-labeled
RNA probes for 2.5 days at 55 ◦C. The antisense RNA-probes for in situ hybridization
were produced by SP6-RNA polymerase from a DNA template. The sense control RNA-
probes were reverse transcribed with T7-RNA polymerase. The concentration of the
digoxigenin-labeled probes was analyzed by agarose gel electrophoresis since the la-
bel interferes with spectrophotometric concentration determination. An overview of the
used riboprobes is given in table 4.3 and figure 4.14. The best conditions and probe con-
centrations have been determined beforehand. For HyEZH2, HyEED and HySUZ12 two
RNA-probes of about 700 - 800 bp in size have been used simultaneously. For Hyp55 one
probe of about 700 bp has been used, for HyYY1 either one probe corresponding to the
full length translated region of the gene or two probes of about 700 and 400 bp have been
used, respectively. All probes have been used at a concentration of 0.2 ng/µl.
TABLE 4.3 The riboprobes used for in situ hybridization are listed above. The nucleotide lengths and
the estimated concentrations of the ’antisense’ riboprobes and ’sense’ controls are given.
riboprobe length gene concentration: ’antisense’ ’sense’ control
ezh2 rp 1 743 bp HyEZH2 N-terminus 400 ng/µl 400 ng/µl
ezh2 rp 2 711 bp HyEZH2 C-terminus 200 ng/µl 150 ng/µl
eed2 rp 1 742 bp HyEED N-terminus 400 ng/µl 400 ng/µl
eed2 rp 2 751 bp HyEED C-terminus 400 ng/µl 150 ng/µl
suz12 rp 1 713 bp HySUZ12 N-terminus 200 ng/µl 200 ng/µl
suz12 rp 2 767 bp HySUZ12 C-terminus 200 ng/µl 150 ng/µl
p55 rp 1 719 bp Hyp55 C-terminus 400 ng/µl 200 ng/µl
yy1 rp 1 759 bp HyYY1 C-terminus 400 ng/µl 200 ng/µl
yy1 rp 2 478 bp HyYY1 N-terminus 1000 ng/µl 250 ng/µl
yy1 rp fl 1131 bp HyYY1 coding region 200 ng/µl 100 ng/µl
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FIGURE 4.14 Riboprobes for the Hydra PRC2 complex and YY1. Different amounts of RNA-probes
have been analyzed on a 1 % agarose gel in 1 x TBE buffer. The concentration of the digoxigenin-labeled
probes was estimated in comparison to a control RNA with known concentration. Some of the RNA-probes
(ezh2 rp 1 ’sense’, ezh2 rp 2 ’sense’, suz12 rp 1 ’sense’ and suz12 rp 2 ’antisense’) show a double-band on the
gel, probably due to RNA secondary structures.
4.2.1. Localization of the PcG transcripts in adult Hydra polyps
The expression patterns of the PRC2 genes in Hydra magnipapillata 105 adult polyps are
restricted to the body column of Hydra. The foot and head region including tentacles
and hypostome showed no expression of the PRC2 genes (figure 4.15). Staining could
be observed in the interstitial cell lineage. Interstitial cells and clusters of nematoblasts
are visible in the respective close-up views. Single cells can be clearly distinguished in
polyps stained with freshly prepared NBT-BCIP substrate (figure 4.15 A, B, C and D).
In samples stained with BMPurple substrate no single cells could be distinguished (fig-
ure 4.15 A’, B’, C’ and D’). The stained region for both substrates remained the same,
however with NBT/BCIP the pattern was clearer and the stained cells could be detected
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FIGURE 4.15 In situ hybridization of whole-mount Hydra magnipapillata 105 polyps with anti-sense
RNA probes directed against the mRNA species of the Hydra PRC2 genes. In A and A’ the expression of
HyEZH2 is shown, B and B’ shows the expression of HyEED, C and C’ shows the expression of HySUZ12
and D and D’ the expression of Hyp55. An overview of the expression patterns in whole polyps is shown
on the left side of the respective picture (scale bar: 500 µm), a close-up view is given on the right side (scale
bar: 50 µm).
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more easily. The enhanced BMPurple substrate, which is also based on NBT/BCIP, led to
a more diffuse staining pattern. The cell types could not be distinguished anymore. For
the genes of the PRC2 complex, the NBT/BCIP solution has been utilised for all further
expression analyses by in situ hybridization.
The result for HyEED is consistent with the results obtained for Hydra vulgaris AEP by
Genikhovich et al. (2006). Compared to the other genes of the complex, the strongest
expression/staining was observed when hybridizing with Hyp55.
The expression of HyYY1 is limited to the region of the body column and the tentacle
base. No expression could be detected in the head or foot region. No specific cell types
could be distinguished in a close-up view, which indicates that HyYY1 is ubiquitously
expressed (figure 4.16; top). The expression is not limited to the interstitial cell lineage;
HyYY1 can also be localised in epithelial cells. During the budding process, an increase
in the expression level can be detected in the developing bud. A stronger signal could
be detected in the endodermal layer of the developing bud and in emerging tentacles
(figure 4.16; bottom; red arrows). For these in situ hybridizations two riboprobes (yy1
rb1 and yy1 rb2) have been used simultaneously. Staining has been performed using the
BMPurple substrate. Using NBT/BCIP substrate resulted in a very faint staining which
could not be satisfactorily documented.
FIGURE 4.16 In situ hybridization of whole-mount Hydra magnipapillata 105 polyps with anti-sense
RNA probes directed against the mRNA species of HyYY1. Top: RNA expression pattern of HyYY1. An
overview of the expression pattern in a whole polyps is shown on the left side of the picture (scale bar:
500 µm), a close-up view is given on the right side (scale bar: 50 µm). Bottom: Expression pattern of
HyYY1 during the budding process. Red arrows indicate an increasing signal in the endodermal layer of the
developing bud and the emerging tentacles.
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4.2.2. PcG gene expression in Hydra lacking interstitial cells
To further examine the transcript expression of the PRC2 genes in Hydra, polyps lack-
ing interstitial cells have been used for in situ hybridization. In 1976 Bode et al. could
show that treatment of Hydra vulgaris with hydroxyurea leads to a selective depletion
of interstitial cells and the generation of so-called ’epithelial animals’. After three days
of treatment with 10 mM hydroxyurea, the number of interstitial cells has been reduced
significantly. By inhibiting the enzyme ribonucleotide reductase, hydroxyurea either kills
the cells during S-phase or prevents the transition from G1 to S-phase (Sinclair, 1965).
According to this study, Hydra magnipapillata 105 polyps have been treated with 10 mM
hydroxyurea for four days to deplete the interstitial cells. Animals which have been
treated in this way have been used for in situ hybridization with probes against the PRC2
genes and HyYY1. In case the expression pattern is restricted to interstitial cells, the ex-
pression level should be decreased - if not completely vanished.
In figure 4.17 the expression pattern of the Hydra PRC2 genes and HyYY1 is shown in I
cell-depleted polyps and control animals. After drug-induced depletion of the intersti-
tial cells, the transcript expression of the Hydra PRC2 genes is dramatically decreased.
By comparing the respective control with the interstitial cell-depleted animals, an ob-
vious difference between the transcript expression level can be detected. For HyEZH2
and HyEED, no expression can be detected in hydroxyurea treated polyps at all (figure
4.17 A’, B’). For HySUZ12 only a spot-like staining can be observed which corresponds
to an unspecific accumulation of dye (figure 4.17 C’). After treatment with hydroxyurea,
expression of Hyp55 can still be found in some huge single cells throughout the body col-
umn (figure 4.17 D’), which resemble egg-restricted stem cells discovered by Littlefield
(1991) in Hydra oligactis. Treatment of polyps of this species with hydroxyurea elimi-
nated all ’little’ interstitial stem cells undergoing somatic differentiation, nematoblasts
and neurons. In contrast to these little I cells, the ’big’ interstitial cells committed to the
gamete lineages showed to be hydroxyurea-resistant. The germ line interstitial stem cells
are cycling more slowly than the little interstitial cells. Hence the expression of Hyp55 is
not only present in interstitial cells of the of the somatic lineage but also in the big inter-
stitial cells of the germ line. Even in non-sexual animals a subset of germ line cells can
be found. In contrast to the other genes of the Hydra PRC2 complex (HyEZH2, HyEED
andHySUZ12), Hyp55 is consequently expressed in the entire interstitial cell lineage. The
other genes are not expressed in the egg-restricted cells.
HyYY1 expression can be detected in the body column and in the tentacle base of the con-
trol animal ((figure 4.17 E)). An increased signal can be found in the youngest developing
bud. The signal is decreased in hydroxyurea treated ’epithelial animals’ (figure 4.17 E’).
Transcript expression can still be found at epidermal cells of the tentacle base and in the
budding region. Nevertheless, the expression level throughout the body column is obvi-
ously decreased. These findings are in concordance with the previous results. Whereas
the genes of the PRC2 complex are restricted to the I cell lineage, HyYY1 shows a weaker
but broader expression.
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FIGURE 4.17 In situ hybridization of whole-mount Hydra magnipapillata 105 with anti-sense RNA
probes directed against the mRNA species of the Hydra PRC2 genes and HyYY1. The transcript expression
is shown for interstitial cell-depleted polyps and control animals. The respective genes are indicated. An
overview of the expression patterns in whole polyps is shown on the left side of the respective picture (scale
bar: 500 µm) and a close-up view is given on the right side of each picture (scale bar: 50 µm). In A, B,
C, D and E the expression of the genes in control animals is shown. The hydroxyurea-treated, interstitial
cell-depleted polyps are shown in A’, B’, C’, D’ and E’.
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4.2.3. PcG gene expression in Hydra during regeneration
The freshwater polyp Hydra has an enormous regeneration capacity. To test whether any
of the Hydra PRC2 genes or HyYY1 play a role in the process of regeneration, in situ
hybridizations with animals undergoing regeneration have been performed.
For in situ hybridization, animals decapitated directly beneath the tentacle zone (80%
body length) have been used. The animals have been allowed to regenerate a new head
for different time periods (1.5 - 48 hours). Provided that the genes of the Hydra PRC2
complex and HyYY1 are important for regeneration, an upregulation of the transcript
expression should be visible at the regenerating tip at some time point after decapitation.
Figure 4.18 shows the expression pattern of Hyp55 and HyYY1 during head regeneration.
Hyp55 serves as an example for the genes of the Hydra PRC2 complex in this context.
The expression patterns for HyEZH2, HyEED and HySUZ12 are comparable (data not
shown). The expression of Hyp55 is limited to the body column. At no time during the
head regeneration process a signal can be detected in the apical tip. The expression of
HyYY1 is upregulated in the apical tip during regeneration. When the tentacles begin to
emerge, the signal shifts into the base of the tentacles.
FIGURE 4.18 Top: In situ hybridization of regenerating Hydra magnipapillata 105 polyps with anti-
sense RNA probes directed against the mRNA species of Hyp55 and HyYY1. The area of the regenerating
apical tip is shown. The different time points after decapitation are indicated.
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It has been shown that Hydra can regenerate missing body parts in a rather short period
of time. Among the best studied regeneration processes is Hydra head regeneration. Hy-
dra polyps are able to regenerate a new head structure in 48 - 72 hours. It could be shown
that tissue movement of both epithelial layers is responsible for the formation of the new
head. No cell proliferation seems to be involved (Cummings and Bode, 1984). The results
of the in situ hybridization suggest that the genes of the PRC2 complex are not involved
in the process of head regeneration. The genes are exclusively expressed in interstitial
cells; no upregulation or shift of expression to epithelial cells could be detected. The
apical tip of the regenerating animal shows no expression of the PRC2 genes (HyEZH2,
HyEED, HySUZ12 and Hyp55). In contrast, the expression of HyYY1 is upregulated in
the regenerating tip soon after decapitation. After two days of regeneration, new tenta-
cles begin to form and the expression shifts from the apical tip towards the base of the
tentacle zone. As could already be seen during the budding process, HyYY1 is probably
involved in tentacle formation.
4.2.4. PcG gene expression in Hydra during gametogenesis
To gain inside into the expression of PcG genes in Hydra during gametogenesis, sexual
polyps of the Hydra vulgaris AEP strain have been used for in situ hybridization. This
strain seasonally produces eggs and sperms. Provided that the genomes of both Hydra
magnipapillata 105 and Hydra vulgaris AEP are almost identical in their nucleotide com-
position, the same RNA-probes have been used. At least one of the PRC2 genes of Hydra
magnipapillata 105 could be compared with its homolog in Hydra vulgaris AEP. The Hydra
vulgaris AEP nucleotide sequence of HyEED is available (GenBank AY347258) and the
HyEED genes of both species show a nucleotide sequence identity of 96%.
The results of the in situ hybridization are depicted in figure 4.19. During the process of
gametogenesis, the Hydra PRC2 genes and HyYY1 are expressed in the bases of the testes
of male polyps. The expression is probably restricted to spermatogonia and spermato-
cytes; no signal could be localized at the region of mature sperms. Hyp55 and HyYY1 are
also visible in the egg patch of female polyps. The transcript expression is very intense
within the gonads. Due to the lack of animal material, only few stages in female game-
togenesis have been probed so far. Up to now, no stages of embryogenesis have been
probed.
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FIGURE 4.19 In situ hybridization of sexual Hydra vulgaris AEP polyps with anti-sense RNA probes
directed against the mRNA species of the Hydra PRC2 genes and HyYY1. The respective genes are indicated.
The transcript expression is shown for both male (♂) and female (♀) polyps with clearly visible gonads. The
female gonad is visible as a clustered egg patch (x), the male testes are visible as papilla-like protrusions
(*). In the right upper corner, a schematic cross-section of the male testis is depicted. An overview of the
expression patterns in whole polyps is shown on the left side of the respective picture (scale bar: 500 µm).
In case the expression pattern of the genes is found in the gonads, a close-up view is given on the right side.
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4.2.5. SUMMARY
The expression of the Hydra PRC2 genes is restricted to the interstitial cell lineage
The freshwater polyp Hydra has three coexistent stem cell lines: namely two epithelial
stem cell lines and the interstitial stem cells. However, genes of the PRC2 complex in
Hydra are exclusively expressed in the interstitial cell lineage. No expression could be
detected in the epithelial cell lineages. The expression is limited to interstitial stem cells,
nematoblasts and germ cells. No expression can be detected in endodermal gland cells or
in nerve cells, which accumulate in the tentacle and foot region. This raises the questions:
Why are the PRC2 genes of Hydra restricted to the interstitial cell lineage?
In higher animals, epigenetic regulation by Polycomb Group proteins has been shown to
be important for the maintenance of stem cell activity and for lineage commitment. In
2006 Boyer et al. and Lee et al. have shown that embryonic stem cells lacking PRC2 genes
lose their ability to maintain their undifferentiated state. They lose their ’stemness’. Bern-
stein et al. (2006) and Mikkelsen et al. (2007) could show that the H3K27me3 histone mark
set by the PcG proteins is coexistent with another histone mark: H3K4me3. H3K4me3 is
set by the Trithorax Group proteins and is associated with active transcription. This ’bi-
valent’ chromatin state in embryonic stem cells has been proposed to maintain PcG target
genes in a poised state. Upon differentiation, the bivalent poised state shifts to an active
(H3K4me3) or inactive state (H3K27me3). Target genes are expressed in a lineage-specific
way. The model is depicted in figure 4.20.
FIGURE 4.20 The repressive H3K27me3 histone mark coincides with the active H3K4me3 histone
mark. The bivalent chromatin state is released upon differentiation.
In Hydra, the PcG genes are expressed in a cell lineage-specific way. They maintain the
characteristics of the interstitial cell lineage in contrast to the epithelial cells. Only the
terminally differentiated cells of the I cell lineage like neurons, nematocytes and gland
cells show no PcG gene expression anymore. Which genes are expressed/repressed in
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an I cell lineage-specific way is still unclear and has yet to be determined. Whether the
PcG proteins are the only important regulators in the discrimination of the cell lineages is
questionable. An interplay between PcG complexes and other regulators like chromatin-
remodeling complexes is likely.
FIGURE 4.21 Overview of the stem cell system of Hydra.
Figure 4.21 depicts the stem cell system of Hydra. The epithelial stem cells of Hydra are
oligopotent stem cells, which give rise to terminally differentiated cells of the head and
foot region. In contrast to stem cells of higher animals, Hydra’s epithelial stem cells do
not solely act as stem cells but also take over physiological functions which are usually
accomplished by differentiated cells. In this respect the epithelial cells are no ’true’ stem
cells. This properties of the epithelial stem cells in Hydra may reflect the evolutionary
state (Bode, 2003). At early stages of metazoan evolution the stem cells possibly had a
dual function. On the one hand they act as stem cells and on the other hand they still have
a physiological function. In contrast, the interstitial stem cells of Hydra can be compared
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to stem cells of higher animals. They act as ’true’ stem cells. They are multipotent and
give rise to different classes of differentiation products (gland cells, neurons, nematocytes
and gametes).
Hyp55 is additionally expressed in the egg restricted cell lineage
It is interesting to note that Hyp55 is also expressed in the egg restricted cell lineage.
In situ hybridization with hydroxyurea treated animals of the Hydra magnipapillata 105
strain and sexual animals from the Hydra vulgaris AEP strain showed that Hyp55 is addi-
tionally expressed in the egg restricted stem cell lineage and in oocytes. In contrast, all
other genes of the PRC2 complex are absent from the egg restricted cell lineage. A possi-
ble explanation for this result might be that p55 is not only a member of the PRC2 com-
plex. p55 which is also known as Caf-1 (Chromatin assembly factor 1) or Nurf-55 (Nu-
cleosome remodeling factor 55) can also be found in a chromatin-remodeling complex of
the ISWI family: NURF. Chromatin-remodeling complexes alter the nucleosome struc-
ture in an ATP-dependent manner. There exist four main families: the SWI/SNF family,
the ISWI family, the CHD and the INO80 family. Some of the chromatin-remodeling
complexes belong to the Trithorax Group complexes which oppose the Polycomb Group
complexes. The complexes are both associated with transcriptional activation and repres-
sion. The expansion of some gene families of the subunits during evolution allows the
combinatorial assembly and formation of several hundred complexes. It seems that each
complex functions in a different context. Depending on the composition of its subunits,
each complex has only one distinct function (Ho and Crabtree, 2010).
The NURF complex is composed of the following subunits: the ATPase Iswi, Nurf-38,
Nurf-55 (p55) and Nurf-301 in Drosophila and the ATPase SNF2L, RbBP4 or RbBP7 (p55)
and BPTF in humans, respectively. The complex was first isolated from Drosophila em-
bryos as a nucleosome remodeling factor which acts in concert with the transcription
factor GAGA to alter chromatin structure (Tsukiyama and Wu, 1995). Martínez-Balbás
et al. (1998) isolated Nurf-55 as a component of this complex. Some years later the human
ortholog of the NURF complex has been purified and possibly plays a role in neuronal
development by the regulation of Engrailed (Barak et al., 2003). The complex has been
associated with the H3K4me3 methylation mark which can be recognized via the PHD
finger of BPTF (Li et al., 2006; Wysocka et al., 2006). In Drosophila it has been shown that
the NURF complex is involved in oogenesis. Deuring et al. (2000) could show that loss
of maternal Iswi blocks oogenesis. Therefor the expression of Hyp55 in the egg restricted
cell lineagein Hydra is likely. It can therefore be assumed that Hyp55 does not function as
a member of the PRC2 complex in egg restricted cells but as a member of the chromatin-
remodeling complex NURF. Possible homologs of the other members of NURF, like the
ATPase subunit SNF2L and BPTF - could be identified in the Hydra genome in silico.
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4.3. Antibody production and purification
PcG and associated proteins in Hydra have been identified, and the mRNA expression
pattern of the Hydra PRC2 genes and HyYY1 has been analyzed by means of in situ hy-
bridization. To further characterize the Hydra PcG proteins, antibodies against the re-
spective proteins have been produced. Antibodies against the Hydra proteins open up
new possibilities in studying the intracellular protein localization and protein interac-
tions. Methods like immunoprecipitation, co-immunoprecipitation and chromatin im-
munoprecipitation could be applied.
Antibodies against the core components of the Hydra PRC1 and PRC2 complexes have
been produced by Christoph Herbel, Anne Kuhn and Volker Lauschke (Holstein lab).
In the course of this study, an antibody against the DNA binding protein HyYY1 has
been produced. Polyclonal antibodies against the full length protein and against the first
144 amino acids of HyYY1 have been produced. The truncated protein is lacking the
C-terminal zinc finger region and was used as antigen to avoid cross-reactivity of the an-
tibody with other zinc finger proteins. When performing a tBLASTn search against the
Hydra genome, similar sequences could only be found in the HyYY1 zinc finger region,
but not for the N-terminal region.
4.3.1. Protein antigen expression
All immunizations and boosts have been performed with bacterially expressed protein
antigens. Both the full length coding region and the truncated version of the HyYY1
protein have been cloned into the pET15b(+)-vector and overexpressed in bacteria. The
proteins have been expressed as His-tagged fusion proteins and purified by metal ion
affinity chromatography (for details see materials and methods section 3.6). To deter-
mine the best conditions for protein expression, the proteins were expressed in different
bacterial strains at different temperatures and protein expression was examined at var-
ious times after induction with IPTG. The time course of protein expression has been
monitored by SDS-PAGE. The results are depicted in figure 4.22.
The full length HyYY1 protein was expressed in two different bacterial strains: BL21DE3
and Rosettagami (DE3) pLysS. The Rosettagami-strain allows disulfide bond formation
and the enhanced expression of eukaryotic proteins that contain rare codons. HyYY1
is expressed sufficiently in both bacterial strains at a temperature of 37◦C (figure 4.22
A). The protein migrates at ∼60 kDa in a 12% SDS-gel. This differs from the theoret-
ical molecular weight of the protein, which is calculated to be 43 kDa. However, it is
known from recombinantly expressed human YY1 protein that the experimentally ob-
served molecular weight differs from the calculated molecular weight (Shi et al., 1997).
The solubility of the recombinant protein varies. Whereas most of the protein can be
found within the soluble fraction for BL21DE3, most of the protein is aggregated in Roset-
tagami (DE3) pLysS.
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FIGURE 4.22 SDS-gels showing the expression of HyYY1 and of HyYY1∆ZnF. A depicts a time course
of HyYY1 protein expression in two different bacterial strains (BL21DE3 and Rosettagami (DE3) pLysS) at
37◦C. B depicts a time course of HyYY1∆ZnF protein expression at different temperatures (25◦C and 37◦C)
in BL21DE3. To compare the amount of expressed protein, an equal number of bacterial cells has been loaded
onto the gels for each time point. To test whether the proteins are soluble, samples of the different fractions
after sonication have been loaded onto the gels (whole lysate, soluble/supernatant, insoluble/pellet). Red
arrow marks the recombinant fusion proteins.
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The HyYY1∆ZnF protein was expressed in the bacterial strain BL21DE3 at different tem-
peratures (figure 4.22 B). The solubility of the protein is greatly enhanced at 25◦C com-
pared to 37◦C. Like the full length protein, the truncated protein migrates at a higher
molecular weight during SDS-PAGE. The protein migrates at ∼35 kDa instead of the cal-
culated 18,8 kDa.
In addition, immunoblots were performed to confirm that the protein bands on the SDS-
gels are indeed the HyYY1 fusion proteins and no artefacts. A time course of recombinant
protein expression was performed and monitored by immunoblotting. As a negative
control, protein expression was induced from the empty pET15b(+) vector and a time
course was performed as well. The samples were probed with a specific antibody rec-
ognizing the 6His-tag of the fusion proteins (α-pentaHis antibody). Figure 4.23 shows
the results of the immunoblots. The immunoblots confirm the identity of the fusion pro-
teins and are in accordance with the SDS-gels. For the full length protein a specific band
at ∼60 kDa is visible and several bands smaller than ∼60 kDa, which probably corre-
spond to degradation products or not fully translated proteins (figure 4.23 A). For the
HyYY1∆ZnF protein a band of ∼35 kDa is visible (figure 4.23 B). For both proteins, a
baseline expression can already be detected in BL21DE3 cells that have not been induced
with IPTG. No proteins can be detected in the negative control samples.
FIGURE 4.23 Immunoblots showing the expression of HyYY1 and of HyYY1∆ZnF. A depicts a time
course of HyYY1 protein expression in BL21DE3 at 37◦C. B depicts a time course of HyYY1∆ZnF protein
expression at 25◦C in BL21DE3. To compare the amount of expressed protein, an equal number of bacterial
cells has been loaded onto the gels for each time point. Red arrow marks the recombinant fusion proteins.
For immunization both HyYY1 and of HyYY1∆ZnF were purified. After protein expres-
sion, the bacterial cells were lysed by sonication. The soluble fraction was separated
from the insoluble fraction by centrifugation. The full length protein was purified as na-
tive protein from the soluble fraction by metal ion affinity chromatography and eluted
from the matrix using increasing amounts of the histidine analog imidazole. An adequate
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FIGURE 4.24 Purification of HyYY1 and HyYY1∆ZnF monitored by SDS-PAGE. A depicts the
purification of HyYY1 under native conditions from the soluble fraction. Samples from the different steps
during protein purification have been loaded onto the gel. B depicts the purification of HyYY1∆ZnF under
native and denaturing conditions. Samples from the different steps during protein purification have been
loaded onto the gel. Red arrow marks the recombinant fusion proteins.
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amount of purified protein could be obtained for the immunization procedure. (figure
4.24 A). The truncated protein was purified both from the soluble and the insoluble frac-
tion by metal ion affinity chromatography using increasing amounts of imidazole. A
sufficiently purified protein was obtained with both purification methods (figure 4.24
B). Under denaturing conditions the HyYY1∆ZnF protein seems to bind to the Ni-NTA
beads with a lower affinity and is already eluted during the wash steps with low imi-
dazole concentrations. By comparison, most of the native protein is not eluted from the
beads until an imidazole concentration of 250 mM is reached. The amount of purified
protein varies. A greater amount of the recombinant protein could be purified from the
insoluble fraction under denaturing conditions.
4.3.2. Antibody production and characterization
Both the purified full length HyYY1 protein and HyYY1∆ZnF have been used as antigens
for the production of polyclonal antibodies in rabbits. 100 µg of protein in Freund’s
adjuvant have been used for the initial immunization and each boost. Figure 4.25 shows
the route of injections.
FIGURE 4.25 Antibody production. Route of injections.
During this study, two rabbits have been immunized with HyYY1∆ZnF and one rabbit
has been immunized with the full length protein. Table 4.4 gives an overview of the
produced α-HyYY1 antibodies. The antigen preparation used for the injections and the
number of injections including the primary immunization are listed.
TABLE 4.4 Antigens used for immunization.
antibody antigen rabbit number of injections
α-HyYY1 HyYY1∆ZnF (pET15b(+)); native # 1 4
α-HyYY1 2 HyYY1∆ZnF (pET15b(+)); denatured # 2 3
α-HyYY1 3 HyYY1 (pET15b(+)); native # 3 5
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To monitor the progress of antibody production, samples of blood have been taken at
regular intervals and analyzed by immunoblots. The blood samples have been used to
probe different amounts of recombinantly expressed HyYY1 protein and Hydra protein
lysates. In figure 4.26 the analysis of the α-HyYY1 preimmune serum and the first test
serum taken four weeks after the initial immunization of rabbit # 1 is depicted exemplar-
ily. It is well known that rabbits may contain cross-reactive antibodies in their preim-
mune serum, making it necessary to test the serum for reactivity as well. The sera were
used to probe increasing amounts of the antigen. Whereas the recombinant protein is not
detected by the preimmune serum (figure 4.26 A), the protein is detected when probed
with the first test bleed (figure 4.26 B). Both the preimmune serum and the first α-HyYY1
test serum cross-react with proteins from bacterial lysate.
FIGURE 4.26 Immunoblot. Different amounts of recombinant HyYY1∆ZnF protein and bacterial
lysate were probed with the α-HyYY1 preimmune serum (A) and with the first α-HyYY1 test bleed after the
initial immunization (B).
Since all generated antibodies specifically recognize recombinant HyYY1 protein, they
were used to localize the endogenous protein. Therefore, all sera were tested on Hydra
extracts. The sera were tested on nuclear extracts, cytoplasmatic extracts, whole cell ex-
tracts and Hydra polyps lysed in protein sample buffer. Simultaneously, the respective
preimmune sera were tested on the Hydra extracts. The immunoblots in figure 4.27 give
an overview of the analysis of the produced α-HyYY1 sera in comparison to the respec-
tive preimmune sera. The results for the α-HyYY1 antibody produced in rabbit # 1, # 2
and # 3 are depicted.
The α-HyYY1 final serum produced in rabbit # 1 recognizes multiple bands in Hydra ex-
tracts. The most prominent bands in the nuclear, cytoplasmatic and whole cell extract
migrate between ∼25 and 35 kDa and at ∼40 kDa. Additionally, a faint band can be
detected at ∼70 kDa in the nuclear extract. When probing lysed Hydra polyps, proteins
between ∼25 and 35 kDa, at ∼40, 55 and 70 kDa can be detected. The distribution of the
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detected bands varies from the Hydra extracts to the freshly prepared Hydra lysate. The
FIGURE 4.27 Immunoblots. Hydra extracts were probed with different α-HyYY1 preimmune and test
sera. The respective sera are indicated. All sera were diluted 1:1000 for immunoblotting.
NE = nuclear extract (100 µg); CE = cytoplasmatic extract (100 µg); WCE = whole cell extract (100 µg); Hydra
= 10 whole polyps lysed in protein sample buffer.
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higher molecular weight bands at 55 and 70 kDa are not detected in the extracts. The
full length protein may be subjected to degradation in the cause of the extraction proce-
dure (for details see materials and methods section 3.6.4). Unfortunately, the preimmune
serum cross-reacts with several proteins in the Hydra extracts. The preimmune serum
detects bands at ∼40, 55 and 100 kDa. This background has to be considered for all fur-
ther applications of the antibody. When comparing the final serum with the preimmune
serum, the bands detected at ∼40 kDa (red asterisk) with the final serum are probably
not specific and do not correspond to the HyYY1 protein.
As for the first α-HyYY1 antibody, the preimmune serum of the antibody produced in
rabbit # 2 also cross-reacts with some Hydra proteins. The preimmune serum detects
various bands between 35 and 70 kDa. Because of the increasing background, the im-
munization of rabbit # 2 was stopped after the second boost. The final serum recognizes
bands migrating between 15 and 35 kDa and a high molecular weight band migrating be-
tween 100 and 130 kDa. These bands are not detected with the preimmune serum. Bands
that are recognized by the preimmune serum are marked (red asterisk). The serum was
not used for further experiments.
For the α-HyYY1 antibody produced in rabbit # 3, an immunoblot with the second test
serum retrieved two weeks after the first boost is depicted. A specific band between 25
and 35 kDa is recognized in all Hydra extracts. In lysed Hydra polyps two specific bands
at 35 and 55 kDa can be detected. The preimmune serum detects no specific bands in
freshly prepared Hydra lysate. However, there is a high background (smear) when prob-
ing Hydra extracts. Rabbit # 3 was boosted further with the full length HyYY1 protein.
The serum produced in rabbit # 3 is promising. However, the α-HyYY1 3 antibody could
not be characterized further in the scope of this studies because of time constrictions.
All tested sera detect multiple bands in different Hydra extracts and produce a high back-
ground. No definite statement on the intracellular localization of HyYY1 can be made.
For all further experiments, the α-HyYY1 antibody produced in rabbit # 1 has been used.
The antibody recognizes specific bands between 25 and 35 kDa and at 55 and 70 kDa in
immunoblots with Hydra extracts. From the overexpression of the HyYY1 protein in bac-
teria, a protein of∼60 kDa is expected for the full length protein. The band detected at 55
kDa in immunoblotting probably corresponds to the full length protein. The other bands
may correspond to post-translationally modified protein (25-35 kDa and 70 kDa). The
human YY1 protein is known to be post-translationally modified by phosphorylation,
acetylation and caspase-dependent cleavage (He and Casaccia-Bonnefil, 2008).
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4.3.3. Antibody purification
Since the crude serum produces a high background and recognizes multiple probably
unspecific bands when probing Hydra extracts, the α-HyYY1-antibody was affinity puri-
fied using an antigen column. The antigen was recombinantly expressed and covalently
coupled to a solid support (AffiGel 10). Coupling was monitored by SDS-PAGE and the
prepared matrix was used for the affinity purification of the α-HyYY1 antibody (for de-
tails see materials and methods section 3.7.2).
For the purification of the antibody, two different antigen preperations were used. The
antigen was either expressed in the pET15b(+)-vector or in the pET21(+)-vector. The
antigen expressed in the pET21(+)-vector has no additional vector sequence at its N-
terminus. Since several of the Hydra PcG proteins were expressed in the pET15b(+)-
vector with the same N-terminal vector sequence (MGSSHHHHHHSSGLVPRGSHML),
affinity purification of the antibody against an antigen expressed in a different vector can
prevent cross-reactivity of the antibody with other recombinantly expressed Hydra PcG
proteins.
Theα-HyYY1-antibody was purified either against the antigen expressed in the pET15b(+)-
vector or in the pET21(+)-vector. The final serum was passed through the antigen column
and unspecific antibodies were washed away. Cycles of low pH and high pH were used
for elution. Antibodies bound by acid-sensitive interactions were eluted at pH 2.5, anti-
bodies bound by base-sensitive interactions were eluted at pH 11.5. For each elution cy-
cle, 20 fractions of 0.5 ml were collected and the pH was neutralized. The activity of the
antibody in the different fractions was tested by immunoblotting. Each fraction was used
to probe 20 ng of the antigen HyYY1∆ZnF. For this purpose, the antigen was transfered
to a PVDF membrane. The membrane was cut in stripes, and each stripe was used for
testing one of the antibody fractions. For detection, the stripes were put together again.
Exemplarily, the immunoblots for the purification of the α-HyYY1 antibody against the
antigen expressed in the pET15b(+)-vector are depicted in figure 4.28.
FIGURE 4.28 Survey of the antibody affinity purification by immunoblotting. Each elution fraction
was diluted 1:1000 and used to probe 20 ng of the antigen. The number of the fractions (1 - 20) of the elution
cycles at low pH and high pH are indicated. In addition, the crude serum (final bleed) and the ’flow through’
have been tested.
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The antibody is active in all fractions eluted from the antigen column at both low pH
(figure 4.28 A) and high pH (figure 4.28 B). The activity is comparable with the the crude
serum (final bleed). Additionally, the ’flow through’-fraction after binding of the anti-
body to the column has been tested. This fraction still shows antibody activity, which
indicates that not all of the specific antibody could bind to the antigen column.
Positive fractions were combined and the purified antibody was concentrated. Table 4.5
gives an overview of the antibody concentrations after purification.
TABLE 4.5 Affinity purified α-HyYY1 antibodies.
antibody antigen used for affinity purification concentration
α-HyYY1 HyYY1∆ZnF (pET15b(+)) 0.78 mg/ml
α-HyYY1 HyYY1∆ZnF (pET21(+)) 0.98 mg/ml
Additionally, the purified antibodies were analyzed by SDS-PAGE in comparison to the
crude serum (figure 4.29 A). Whereas the serum albumin band at 70 kDa is the predomi-
nant band in the unpurified serum, the strongest band in the affinity purified sera corre-
sponds to the antibody heavy chain at 55 kDa. However, a small band at 70 kDa is still
visible in the samples of the affinity purified antibodies.
FIGURE 4.29 Analysis of the affinity purified α-HyYY1 antibodies on a 12% SDS-PAGE gel. The anti-
body preparation and the respective molecular weights are indicated. Purified antibody # 1 = serum purified
against HyYY1∆ZnF expressed in pET15b(+); purified antibody # 2 = serum purified against HyYY1∆ZnF
expressed in pET21(+).
The affinity purified sera were used to probe Hydra extracts. Immunoblots with the puri-
fied antibodies are depicted in figure 4.30. Figure 4.30 A shows an immunoblot with the
unpurified serum, figures 4.30 B and C show immunoblots with the affinity purified sera.
Both preparations of the affinity purified antibodies still recognize multiple bands in Hy-
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dra extracts. No obvious difference can be detected in the distribution of the bands when
probing the extracts with the purified sera in comparison to the unpurified final serum.
The specificity of the antibody did not increase after purification. There are still several
bands visible, which migrate between 25 and 35 kDa, two bands migrating at ∼40 kDa
and two higher molecular weight bands migrating between 50 and 70 kDa when probing
whole Hydra animals. The higher molecular weight bands are not detected in the nuclear,
cytoplasmatic and whole cell extracts. Whether all bands visible correspond to HyYY1 or
whether the antibody cross-reacts with other Hydra proteins could not be determined.
FIGURE 4.30 Analysis of the affinity purified α-HyYY1 antibodies by immunoblotting. Hydra extracts
were probed with the unpurified final serum (A), the serum purified against HyYY1∆ZnF expressed in
pET15b(+) (B) and the serum purified against HyYY1∆ZnF expressed in pET21(+) (C). All sera were diluted
1:1000. NE = nuclear extract (100 µg); CE = cytoplasmatic extract (100 µg); WCE = whole cell extract (100
µg); Hydra = 10 whole polyps lysed in protein sample buffer.
4.3.4. Localization of Hydra PcG proteins by immunostaining
The HyYY1 protein was localized in Hydra by indirect immunofluorescence. Whole Hy-
dra polyps were stained with the α-HyYY1 final serum. The polyps were fixed with Lav-
dovsky fixative, a mixture of ethanol, formaldehyde and acetic acid. A short fixation time
of 15 minutes proved best for the α-HyYY1 antibody. Staining with the primary antibody
was performed over night at 4◦C, followed by the incubation with a fluorescent labeled
secondary antibody (for details see materials and methods section 3.7.4). Nuclei were
co-stained with DAPI. The staining pattern was detected by fluorescence microscopy.
In immunostainings with the α-HyYY1 final serum, mainly the ectodermal epithelial cells
are stained (figure 4.31). Staining can be observed in the membranes of epithelial cells
and in the nuclei. In figure 4.31 E and E’, some nuclei of ectodermal cells are marked
in the α-HyYY1 staining and the corresponding DAPI staining. Only the big nuclei of
ectodermal epithelial cells are stained, the smaller nuclei interstitial cell nests are devoid
of the antibody signal. In contrast to the HyYY1 in situ hybridization, the whole polyp is
4.3. ANTIBODY PRODUCTION AND PURIFICATION 151
stained. Whereas the in situ hybridization showed no HyYY1 expression in the foot and
the head region, the staining signal for the antibody can also be localized in these regions.
As a control for the the α-HyYY1 staining, polyps were stained with the HyYY1 preim-
mune serum and the secondary antibody. Neither with the preimmune serum nor with
the secondary antibody alone, a specific signal could be observed.
FIGURE 4.31 Immunostaining. Whole Hydra polyps were co-stained with α-HyYY1 (green) and DAPI
(blue). The head region of a polyp with hypostome (*) and tentacle base (x) is depicted in A, a close-up of the
hypostome region is shown in B. In C and D a region of the body column of Hydra is depicted. Some nuclei
of ectodermal cells are marked by a white arrowhead in the α-HyYY1 staining (E) and the corresponding
DAPI staining (E’).
Scale bars: 50 µm.
Immunostainings were also performed with the purifiedα-HyYY1 serum. The immunoflu-
orescent staining was detected by means of confocal microscopy (Nikon A1 confocal laser
microscope system). The result is depicted in figure 4.32. At the top left side, an overview
of the HyYY1 staining pattern in a developing bud is depicted. The figure at the top right
side gives an overview of the body regions of Hydra and serves for orientation. In figures
4.32 A - E representative immunofluorescence images of different sections of the Hydra
polyp are shown at higher magnification. The staining pattern of the purified antibody
does not differ from the pattern obtained with the crude final serum. Mainly the nuclei
and the membranes of ectodermal epithelial cells are stained. In figure 4.32 A the nuclei
are clearly visible, in 4.32 C a net-like structure corresponding to the membranes of the
epithelial cells can be observerd. Additionally, some cells of the interstitial lineage are
stained (figure 4.32 D, asterisks).
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FIGURE 4.32 Immunostaining. Whole Hydra polyps were co-stained with α-HyYY1 (green) and DAPI
(blue). The two columns in the right show merged images and merged images overlaid with transmitted
light images. Scale bars: 50 µm.
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Since antibodies against proteins of the Hydra PRC2 complex are available, indirect im-
munofluorescence stainings were performed with theα-HyEZH2, α-HyEED andα-Hyp55
antibodies. An antibody against HySUZ12 is not available. As for the α-HyYY1 antibody,
fixation with Lavdovsky for 15 minutes proofed best. The polyps were stained with
the respective primary antibody over night and incubated with the fluorescent labeled
secondary antibody. The nuclei were co-stained with DAPI. The staining pattern was
detected by fluorescence microscopy using a confocal microscope. In addition to the ap-
plication in immunostainings, the antibodies were used for immunoblotting to test their
specificity.
The result for the α-HyEZH2 antibody is depicted in figure 4.33. The antibody was used
to probe Hydra lysate to test the specificity of the α-HyEZH2 serum (figure 4.33 A). The
antibody detects a double-band at ∼80 kDa and to a lesser extent several bands of lower
molecular weights. The calculated molecular weight of HyEZH2 is 83.6 kDa and it can be
concluded that the band at ∼80 kDa corresponds to HyEZH2. It is likely that the serum
cross-reacts with other Hydra proteins. This fact has to be taken into account for all fur-
ther applications. A characteristic result of the immunostaining is depicted in figure
4.33 B. As for the α-HyYY1 antibody, the α-HyEZH2 antibody mainly stains the nuclei
of ectodermal epithelial cells, which can be clearly localized by co-staining with DAPI
(figure 4.33 B). Furthermore, precipitates that are intensely stained can be observed all
over the sample. These precipitates look different from the surrounding staining pattern
and are probably artifacts. Staining can be observed in the entire polyp. The staining
pattern obtained with the α-HyEZH2 antibody is contradictory to the expression pattern
for HyEZH2 obtained by in situ hybridization. Whereas the HyEZH2 mRNA is localized
in interstitial cells (compare section 4.2.1), the HyEZH2 protein could not be detected in
the interstitial lineage.
FIGURE 4.33 A Immunoblot. Hydra lysate was probed withα-HyEZH2 final bleed. B Immunostaining.
Whole Hydra polyps were co-stained with α-HyEZH2 (green) and DAPI (blue). A section of the Hydra body
column is depicted. The two pictures in the right show a merged image and a merged image overlaid with
the transmitted light image. Scale bar: 50 µm.
Figure 4.34 A shows an immunoblot and figure 4.34 B shows a characteristic immunos-
taining result with the α-HyEED antibody. For the immunoblot, Hydra lysate was probed
with the α-HyEED antibody. The antibody recognizes one distinct band at ∼70 kDa,
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which migrates at a higher molecular weight than expected for the HyEED protein. The
calculated molecular weight of HyEED is 47.9 kDa. A typical result for the immunos-
taining is depicted in figure 4.34 B. The antibody mainly stains the nuclei of ectodermal
epithelial cells and cell membranes (figure 4.34 B). The whole polyp is stained, including
head and foot region. As for HyEZH2, the staining pattern is contrary to the result of the
in situ hybridization. The HyEED mRNA is localized in interstitial cells (compare section
4.2.1), whereas the HyEED protein is only detected in ectodermal epithelial cells.
FIGURE 4.34 A Immunoblot. Hydra lysate was probed with α-HyEED final bleed. B Immunostaining.
Whole Hydra polyps were co-stained with α-HyEED (green) and DAPI (blue). A section of the Hydra body
column is depicted. The two pictures in the right show a merged image and a merged image overlaid with
the transmitted light image. Scale bar: 50 µm.
The result for the α-Hyp55 antibody is depicted in figure 4.35. In immunoblotting, the
α-Hyp55 serum detects a band at ∼55 kDa in Hydra lysate (4.35 A), which probably cor-
responds to the Hyp55 protein. The calculated molecular weight of Hyp55 is 49.1 kDa.
Figure 4.35 B shows a typical result for the immunostaining of Hydra with the α-Hyp55
antibody. Staining can be observed in the nuclei of ectodermal epithelial cells and in
nuclei of nematoblasts, which belong to the I cell lineage. However, the intensity of the
staining is stronger in the nuclei of the nematoblasts (4.35 B, asterisk). Nuclei all over the
polyp are stained with the α-Hyp55 antibody. Compared to the Hyp55 mRNA, which is
solely localized in the interstitial cell lineage (see section 4.2.1), the Hyp55 antibody can
be additionally localized in ectodermal epithelial cells.
FIGURE 4.35 A Immunoblot. Hydra lysate was probed with α-Hyp55 final bleed. B Immunostaining.
Whole Hydra polyps were co-stained with α-Hyp55 (green) and DAPI (blue). A section of the Hydra body
column is depicted. The two pictures in the right show a merged image and a merged image overlaid with
the transmitted light image. Scale bar: 50 µm.
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4.3.5. Localization of the H3K27me3 epigenetic mark
The PRC2 complex catalyzes the trimethylation of histone H3 at lysine 27. To get an idea
of the existence and the cellular localization of the epigenetic mark in Hydra, immunos-
tainings and Western blots were performed with an antibody against H3K27me3.
Histone proteins are highly conserved and a putative Hydra histone H3 could be found
in the genome (see appendix B.2). The N-terminal tail is 100% identical to the human
histone, including the site of H3K27 trimethylation (figure 4.36 C). An antibody against
human H3K27me3 was used to stain whole Hydra polyps and to probe Hydra lysate. For
immunostaining, polyps were co-stained with DAPI and an antibody specifically recog-
nizing H3K27me3. The antibody against the epigenetic mark set by the PRC2 complex
is exclusively localized to the nuclei of the interstitial cell lineage (figure 4.36 A). With
the help of Western blot analysis, it could be shown that the used antibody is specific for
trimethylated H3K27. The antibody could not detect unmethylated H3K27 when prob-
ing unmodified recombinant histone octamers (figure 4.36 B). In Hydra lysates, a clear
signal could be detected.
FIGURE 4.36 A Immunostaining. Whole Hydra polyps were co-stained with α-H3K27me3 (green)
and DAPI (magenta). A section of the Hydra body column is depicted. The two pictures in the right show
a merged image and a transmitted light image. B Immunoblot. Hydra lysate and recombinant histone
octamers were probed with α-H3K27me3. In lane 3 the recombinant octamer is separated by SDS-PAGE. The
same amount of protein has been used for the immunoblotting. C Alignment of the amino acid sequences
of the N-terminal tail of human histone H3 and a putative Hydra histone H3.
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4.3.6. SUMMARY
The intracellular localization of HyYY1
Immunostainings suggest that the HyYY1 protein is mainly localized in ectodermal ep-
ithelial cells. Furthermore, the stainings show that the generated α-HyYY1 antibody is
not only localized in the cell nucleus, but a clear signal can also be detected in cell mem-
branes. The same result was obtained by Western blot analysis. When probing isolated
cellular fractions of Hydra, a signal could be detected in all subcellular fractions (nuclear,
cytoplasmatic and whole cell fractions).
For mammalian YY1, a clear nuclear localization has been demonstrated by performing
immunostainings (Rylski et al., 2008). However, another study could show that the sub-
cellular localization of YY1 changes in the course of the cell cycle (Palko et al., 2004). YY1
has been shown to interact with several cell cycle regulators including Rb, p53 and c-Myc.
Whereas YY1 is primarily localized in the cytoplasm in late mitosis, it undergoes a switch
in localization at the G1/S boundary of the cell cycle. During S-phase, YY1 is localized
in the nucleus. Rizkallah and Hurt (2009) could show that the switch in localization is
dependent on the phosphorylation status of YY1. Phosphorylation of YY1 abolishes its
DNA binding and the protein is localized in the cytoplasm.
The result for HyYY1 is not consistent with the literature. The protein could be local-
ized in the cell nucleus and mainly in cell membranes. No study could localize the YY1
protein to be associated with the cell membrane. Since the generated α-HyYY1 antibody
recognizes quite a number of polypeptides in Hydra during Western blot analysis, it is
most likely that the antibodies cross-react with Hydra proteins during immunostainings
as well. Therefore, the generated α-HyYY1 antibody is not useful for the intracellular
localization of the endogenous HyYY1 protein. The question whether the HyYY1 protein
is localized in the nucleus or in the cell membrane could not be solved. Nevertheless, the
antibody is suitable for the detection of the recombinant HyYY1 protein.
The intracellular localization of the Hydra PRC2 proteins
There is a discrepancy between the gene expression pattern of the PRC2 genes obtained
by in situ hybridizations and the localization of the proteins by means of immunostainings.
Whereas the results of in situ hybridizations suggest that the PRC2 genes are expressed in
a lineage-specific way in cells of the interstitial lineage, the results of the antibody stain-
ings suggest that the PRC2 proteins are additionally expressed in ectodermal epithelial
cells. Surprisingly, the PRC2 antibodies could not only be localized to nuclear regions,
but also to cytoplasmic regions and cell membranes.
However, in several studies with mammalian cells, the Polycomb Group proteins could
be clearly localized to the cell nucleus. Whereas the proteins of the PRC2 complex are
distributed throughout the whole nucleus, proteins of the PRC1 complex are localized to
pericentromeric heterochromatin and form distinct compartments in the nucleus called
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PcG bodies (Saurin et al., 1998; Sewalt et al., 1998). These PcG bodies even remain stably
associated throughout mitosis, allowing the inheritance of the PcG complex through suc-
cessive cell divisions. Ren et al. (2008) could show that the PcG bodies get more dispersed
during embryonic stem cell differentiation, which is explained by the existence of differ-
ent PcG target genes in differentiating cells. Hernández-Muñoz et al. (2005) could show
that the recruitment of the PRC1 protein BMI1 is dependent on proteins of the PRC2
complex. By knocking down EED or EZH2, BMI1 could not be recruited to the PcG
bodies. In a more recent study, it was suggested that the PcG bodies allow the spatial
organization of Polycomb target genes in the cell nucleus and stabilize the maintenance
of epigenetic gene silencing (Bantignies et al., 2011). Even PcG target genes that are sepa-
rated by large genomic distances can come in close proximity in the PcG bodies and can
be co-repressed. That study shows that the PcG bodies co-localize with Antennapedia and
the bithorax complex gene Abd-B in Drosophila.
The results obtained with the help of antibody stainings contradict the immunostain-
ings with the α-H3K27me3 antibody and the results obtained by in situ hybridizations.
Both the RNA expression pattern of the Hydra PRC2 genes and the H3K27me3 epige-
netic mark are clearly localized in the interstitial cell lineage. In contrast, all available
antibodies against proteins of the Hydra PRC2 complex can additionally be localized to
cells of the ectodermal epithelial lineage. Neither the RNA expression pattern nor the
H3K27me3 modification do correlate with the protein expression profiles of the Hydra
PRC2 proteins. In addition, the literature clearly localizes the PcG proteins to the cell
nucleus. However, the only antibody, which is clearly found in the cell nucleus is α-
Hyp55. Therefore, it is questionable whether the generated antibodies are useful for the
intracellular localization of the Hydra PRC2 proteins by immunostainings.
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4.4. The PcG protein HyYY1 can interact with DNA
YY1 is a GLI-Krüppel related protein and has four C2H2-zinc fingers at its C-terminus.
This C-terminal region is highly conserved among species and has a high similarity with
the Drosophila PcG gene Pleiohomeotic (Pho), which has been shown to recruit the PcG
complexes to their target genes in a sequence-specific manner (Brown et al., 1998; Mohd-
Sarip et al., 2002).
Zinc finger proteins have been shown to interact with DNA following some chemical and
stereochemical rules for the interaction between amino acid residues and nucleotides.
With regard to these rules, the YY1-DNA interaction could be predicted (Suzuki et al.,
1994): three of the four zinc fingers participate in the protein-DNA interaction. To iden-
tify a DNA consensus sequence for YY1, binding site selections with purified protein and
random DNA oligonucleotides have been performed (Hyde-DeRuyscher et al., 1995; Yant
et al., 1995). A core consensus sequence of four nucleotides could be identified: CCAT.
In a study of do Kim and Kim (2009), this sequence could be expanded to a longer bind-
ing motif: GCCGCCATTTTG. Figure 4.37 provides a co-crystal structure and a schematic
representation of the YY1-DNA interction. The co-crystal structure of YY1 bound to the
AAV P5 initiator element, which has been resolved by Houbaviy et al. (1996) - is in ac-
cordance with the previous findings and predictions on YY1’s DNA binding activity.
FIGURE 4.37 Structure of YY1 bound to DNA. A presents the co-crystal structure of YY1 bound to
the AAV P5 initiator element. The DNA is shown as a wireframe (gray), the YY1 zinc fingers are shown as a
ribbon representation. Zinc fingers 1 - 4 are colored in yellow, orange, dark orange and red, respectively. The
zinc ions are depicted as blue spheres. A top view of the model is depicted on the left, a lateral view on the
right. The 2.5 Å structural model was retrieved from the Protein Data Bank entry 1UBD (www.pdb.org/).
The picture was generated using a molecular graphics visualisation tool based on RasMol (by Roger Sayle).
B represents a schematic model of the YY1-DNA interaction based on the crystal structure. The DNA strand
is depicted and the protein-DNA contacts are colored dependent on their zinc finger of origin. Residues,
which are responsible for the interaction are indicated. The model has been simplified; interactions with the
DNA backbone are not shown. The co-crystal structure and the schematic model were taken from Houbaviy
et al. (1996).
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YY1 is a sequence-specific DNA binding protein that has been found in a vast number
of different contexts. The consensus sequence of the Drosophila and human protein is
known. In this study, the DNA binding activity of the Hydra homolog has been exam-
ined. Since the four zinc fingers of HyYY1 are highly similar to their counterparts in other
species (see figure 4.46 on page 169), it is probable that HyYY1 binds to the same consen-
sus sequence. To provide evidence for this assumption, a DNA binding site selection
followed by gel retardation assays has been performed with the Hydra protein.
4.4.1. DNA binding site selection
The DNA binding site selection for HyYY1 was carried out in the same way as described
for the human YY1 protein in the study by Hyde-DeRuyscher et al. (1995). In this study, a
recombinantly expressed GST-YY1 fusion protein bound to glutathione-Sepharose beads
was incubated with a double-stranded DNA containing a central random sequence. Af-
ter the removal of unbound DNA, the protein-bound DNA has been eluted and amplified
by PCR. The selected DNA was again incubated with the protein. After several rounds of
selection, the sequences of the protein-bound DNA have been determined. In contrast to
the mentioned approach, a His-YY1 fusion protein bound to agarose beads has been used
for the binding site selection in this study. In figure 4.38 an overview of the procedure is
depicted.
FIGURE 4.38 Schematic overview of the binding site selection procedure.
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Oligonucleotide generation and protein immobilization
For the DNA binding site selection, a DNA of 85 nucleotides containing a random core
sequence of 15 nucleotides and primer binding sites at both ends has been used. Accord-
ing to previous studies on YY1-DNA interactions, the zinc fingers contact a binding motif
of 9 - 12 base pairs (Suzuki et al., 1994; Hyde-DeRuyscher et al., 1995; Yant et al., 1995;
Houbaviy et al., 1996). Therefore, a random core of 15 nucleotides should be sufficient for
the selection of the HyYY1 consensus sequence. To generate a double-stranded oligonu-
cleotide, the single-stranded DNA has been annealed with a short complementary DNA
primer; the Klenow fragment was used to fill in recessed 3’ ends. The double-stranded
DNA oligonucleotide was analyzed by gel electrophoresis (figure 4.39).
FIGURE 4.39 Left: Analysis of the Klenow reaction on a 12% polyacrylamide gel. The generated
double-stranded (ds) oligonucleotide migrates slower in the gel than the single-stranded (ss) DNA. Right:
The 5’ –> 3’ polymerase activity of the Klenow fragment has been used to fill in the 3’ recessed ends of the
single-stranded oligonucleotide.
The generated oligonucleotides were incubated with recombinant HyYY1 protein immo-
bilized on agarose beads. The His-YY1 fusion protein was recombinantly expressed in
bacteria and purified using metal ion affinity chromatography. The purified protein was
not eluted from the nickel-NTA beads. Instead it was left bound to the beads. The purity
and amount of the bound protein was analyzed by SDS-PAGE prior to the binding site
selection. The HyYY1∆ZnF protein was used as a background control for the binding
site selection. The truncated protein should not have the ability to specifically bind to
DNA, since the zinc fingers are responsible for its DNA binding activity. As shown in
figure 4.40, both the full length recombinant protein and the truncated version could be
sufficiently expressed and purified. 5 µl of the agarose-protein suspension were loaded
onto the SDS-gel to estimate the amount of the bound protein in comparison to different
amounts of BSA. The binding capacity of the Ni-NTA beads is up to 50 mg His-tagged
protein per ml resin according to the manufacturer (Qiagen). The binding capacity varies
and is strongly dependent on the characteristics of the fusion protein (for example amino
acid composition, molecular weight, expression level). Whereas about 50 ng of the full
length HyYY1 fusion protein were bound to 1 µl of the Ni-NTA beads (figure 4.40 A),
the truncated protein could be expressed more effectively and several microgram of the
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protein were bound to 1 µl of the beads. The high protein amount resulted in a smear on
the gel (figure 4.40 B).
FIGURE 4.40 Protein immobilization on Ni-NTA beads. The SDS-gel on the left presents the
protein purification procedure of the recombinant HyYY1 fusion protein. The SDS-gel on the right shows
the purification of the truncated control protein. 5 µl of each fraction have been applied to the gel. The
respective protein fraction bound to the agarose beads is left to the protein size standard. The full length
protein has a size of about 60 kDa, the truncated protein has a size of about 35 kDa. Decreasing amounts of
BSA serve as a standard for estimating the concentration of the immobilized proteins. The red arrowheads
indicate the positions of the recombinant proteins.
Selection and analysis of HyYY1 binding sites
For the first round of selection, 100 ng of the pool of random double-stranded oligonu-
cleotides were incubated with an excess amount of immobilized protein (2.5 - 5 µg). Un-
bound DNA was removed and protein-bound DNA was retrieved and amplified by PCR.
The amplified product was used for the next round of capture and amplification. A to-
tal of six rounds has been performed. After the third and the sixth round of selection,
the amplified DNA was purified and ligated into pGEM-T vector. Competent bacterial
cells were transformed with the ligation reaction. Positive clones were selected and the
inserted DNA fragments have been sequenced to obtain the HyYY1 consensus sequence.
The captured DNA from the HyYY1∆ZnF background control was amplified as well and
the sequences have been determined.
The polyacrylamide gel in figure 4.41 shows the amplified DNA after each round of selec-
tion. The DNA captured by the truncated HyYY1∆ZnF protein migrates at the expected
85 bp on a 12% polyacrylamide gel after each round of selection. However, the DNA cap-
tured by the full length protein changed in size. In the course of the binding site selection
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two fragments of different sizes were amplified. The DNA amplified after round 4 of
the selection procedure migrates at 85 bp and an additional band of a lower molecular
weight appears on the gel. The lower band became more abundant during the following
rounds of selection.
FIGURE 4.41 The amplified DNA after each round of selection was seperated by gel electrophoresis.
Left: DNA amplified during the binding site selection with the full length HyYY1 protein. The red asterisk
indicates the position of the lower molecular weight oligonucleotide. Right: DNA amplified during the
binding site selection with the truncated HyYY1∆ZnF protein.
The tables on the following pages show the result of the binding site selection. The first
table shows the sequences of oligonucleotides captured after rounds 3 and 6 of the se-
lection procedure with the full length HyYY1 protein (table 4.6), in the second table the
sequences obtained with the truncated HyYY1∆ZnF protein are depicted (table 4.7). The
full length sequence of the captured oligonucleotides is shown. Random regions are in-
dicated by underlined letters. There is an enrichment of the following sequence after
round 6 of the selection procedure with the full length protein: GTAAAGTTTTCTTGA.
21 out of 21 sequenced clones contained the same conserved core sequence. No other
sequence was otained during the binding site selection with the full length HyYY1 pro-
tein. After round 3, no specific sequence was enriched. The captured oligonucleotide
after round 6 is lacking 15 nucleotides in the constant region compared to the original
oligonucleotide. This is in accordance with the observation during gel electrophoresis:
The captured oligonucleotide shifts to a lower molecular weight in the course of the se-
lection procedure. The sequences obtained with the truncated HyYY1∆ZnF protein are
completely random. As expected, no specific sequence was captured by the background
control.
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TABLE 4.6 Sequences of oligonucleotides captured by HyYY1. Upper case letters indicate the
constant regions, the random regions of the oligonucleotide are highlighted. In the first half of the table the
sequences captured after round 3 of the binding site selection are listed, in the second half of the table the
enriched sequences after round 6 of the selection procedure are listed.
HyYY1: Consensus sequences after 3 rounds of selection
# sequence orientation
CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG NNNNNNNNNNNNNNN CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT
1 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TATCTATACATCGGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
2 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATCTTGTATATTTAT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
3 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATTGATCTTTAATTT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
4 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATTTAAAGAGTGTGG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
5 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TGGCGGGGAAACGCG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
6 ...GATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATAGAAATTTTGGTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
7 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TATCCTTGGGAGTTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
8 ......TGGCTACGCATCGTCAGCAGCAGCAGCAG GTCTAAATTTGAGGG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
9 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TATCTATACATCGGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
10 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AGTTTTTTGTTGAAT CAG.....GCAGCAGGTCATACTCACTCACGGACT -
11 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATTTCAGCTCTACAG CAGCAGCA.CAGCAGGTCATACTCACTCACGGACT -
12 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG CCGTCTATATGGATT CAGCAGCAG.AGCAGGTCATACTCACTCACGGACT -
13 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AGTTTTTTGTTGAAT .....CAGCAGCTAGGTCATACTCACTCACGGACT -
14 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GCGTCGACTCATTCA CAGCAGCAGCAGCAGGTCANACTCACTCACGGACT -
15 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATTGGAAGGATATTT CAGCAG.......AGGTCATACTCACTCACGGACT -
16 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TTGGCGAAGTTAAT. CAGCA.CAGCAGCAGGTCATACTCACTCACGGACT -
17 ....................CAGCAGCAGCAGCAG GGTTGTATGATATTA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
18 ..TGATTGGCTACGCATCGTCAGCAGCAGCAG... CTACATGTTTTTGTT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
19 CGTGATTGGCT.CGCATCGTCAGCAGCAGCAGCAG CCGTGTCTATGTCAT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
20 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATATGCTAAGTATAA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
21 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TTGGACTGGCATATC ...CAGCAGCAGCAGGTCATACTCACTCACGGACT -
HyYY1: Consensus sequences after 6 rounds of selection
# sequence orientation
CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG NNNNNNNNNNNNNNN CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT
1 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
2 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
3 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
4 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
5 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
6 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
7 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
8 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
9 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
10 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
11 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
12 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
13 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCGGGTCATACTCACTCACGGACT -
14 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
15 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
16 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
17 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
18 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
19 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAG...GTCATACTCACTCACGGACT -
20 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
21 CGTGATTGGCTACGCATCGT............... GTAAAGTTTTCTTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
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TABLE 4.7 Sequences of oligonucleotides captured by HyYY1∆ZnF (background control). Upper case
letters indicate the constant regions, the random regions of the oligonucleotide are highlighted. In the first
half of the table the sequences captured after round 3 of the binding site selection are listed, in the second
half of the table the sequences obtained after round 6 of the selection procedure are listed.
HyYY1∆ZnF: Consensus sequences after 3 rounds of selection
# sequence orientation
CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG NNNNNNNNNNNNNNN CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT
1 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AGCTGTGTCCTTTAT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
2 ....ATTGGCTACGCATCGTCAGCAGCAGCAGCAG TAGACGGTGGACACT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
3 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GTGGTGGTTTAGTCC CAGCAGCAGCAG.AGGTCATACTCACTCACGGACT -
4 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GTCGTCTGGTGCATA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
5 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GAGCTTGGATGAATT CAGAAGCAGCAGCAGGTCATACTCACTCACGGACT +
6 ...GATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATTACAAGTGGAGCG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
7 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GTACTCTTCACTTCT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
8 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AAAGATATTTCTTGC CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
9 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG CCGTAAGCATGAATA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
10 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TAGTTAGCGTAGTAG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
11 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATATTATCCACCGGG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
12 ....ATTGGCTACGCATCGTCAGCAGCAGCAGCAG TAGACGGTGGACACT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
13 CGTGATTGGCTACGCATCGTCAGCAGCAGAAG... CCGTGGGTCGCCTGA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
14 CGTGATTGGCTACGCATCGTCGGCAGCAGCAGCAG TCATCCGTCTGCGTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
15 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AAAGATATTTCTTGC CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
16 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TTGGAACTCATAGCT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
17 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GGACAGGCGGATGTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
18 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AGGGATTCGGGGGTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
19 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG AGGGGGGGGTTCCAC CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
20 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATCAGTTGATGGGCG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
21 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG CTTGGTGCCCTTCAT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
22 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GGCCCCGGTGGTGTA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
HyYY1∆ZnF: Consensus sequences after 6 rounds of selection
# sequence orientation
CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG NNNNNNNNNNNNNNN CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT
1 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ACGTGGAGTATTAAT CAGCAGCAGCAACAGGTCATACTCACTCACGGACT +
2 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GTGTGAAGCTTATGT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
3 CGTGATTGGCTACGCATCGTCAGTAGCAGCAGCAG TAGACGTTGTCGTCG CAGTAGCAGCAGCAGGTCATACTCACTCACGGACT -
4 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GGTCGCGCAAGGTTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
5 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ACGTGGAGTATTAAT CAGCAGCAGCAACAGGTCATACTCACTCACGGACT +
6 ...GATTGGCTACGCATCGTCAGCAGCAGCAGCAG AATTTCTACGGAGTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
7 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GGCGGCGTGTCACTC CAGCAGCAGCAGCAGGTCATACTCACTCACGGA-T -
8 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG CCTGCAGCACTGTGT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
9 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TAAATTCTAGAAGTC CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
10 ...GATTGGCTACGCATCGTCAGCAGCAGCAGCAG GGTCTTGTTTTGTAG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
11 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TAAGAGGATGGTGCT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
12 CGTGATTGGCTACGCATCGTCAGCAGCAGCAACAG TTCGTCGTGCGACTT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
13 .GTGATTGGCTACGCATCGTCAGCAGCAGCAG... CGGTTGAGTTTAAAG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
14 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GAAGATAGTCGAGAT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
15 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TGATTTTCTGTCTAA CAGCAGCAGCAACAGGTCATACTCACTCACGGACT -
16 CGTGATTGGCTACGCATCGTCAGCAG.AGCAGCAG ATTTGGTTTACTATA CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
17 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG ATCACGTTTTTCCCG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
18 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TTTGATTTCAATTGC CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
19 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG GAAGATAGTCGAGAT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
20 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TACCTAATAGTTAAC CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT +
21 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TACCCGTTTCCATTG CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
22 CGTGATTGGCTACGCATCGTCAGCAGCAGCAGCAG TAAGAGGATGGTGCT CAGCAGCAGCAGCAGGTCATACTCACTCACGGACT -
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4.4.2. Gel retardation assays
To determine whether HyYY1 can, indeed, bind to the selected site (GTAAAGTTTTCTTGA),
a gel retardation assays have been performed. The gel retardation assay or electromobil-
ity shift assay (EMSA) is one possibility to analyze interactions between proteins and nu-
cleic acids. Complexes of DNA and protein migrate more slowly compared to unbound,
free DNA when subjected to gel electrophoresis. The protein-bound DNA is retarded /
shifted in the gel. For gel retardation assays with the HyYY1 protein a double stranded
DNA oligonucleotide was used. The target DNA was end-labeled with biotin at its 3’
termini. After the binding of the protein to the target DNA, the complex was resolved
by non-denaturing gel electrophoresis using a TBE-polyacrylamide gel. The shift was
detected by chemiluminescence using horseradish peroxidase coupled streptavidin.
The recombinant HyYY1 and HyYY1∆ZnF proteins for the gel retardation assays were
expressed as 6His-fusion proteins and purified by metal ion affinity chromatography.
The proteins were purified under the same conditions. In contrast to the proteins used
for the binding site selection, the proteins were purified under denaturing conditions us-
ing a guanidin buffer. The proteins were eluted from the agarose beads using a buffer
with a low pH. The buffer was exchanged to a neutral buffer and the proteins were re-
natured by a stepwise dialysis procedure (for details see materials and methods section
3.7.2). Finally the soluble proteins were buffered in 1 x PBS. The conditions for purifica-
tion and the subsequent renaturing of the protein by dialysis were described for a human
His-YY1 fusion protein by Shi et al. (1991).
The SDS-gel in figure 4.42 shows the purified proteins. With this purification method the
protein yield was higher compared to the protein purification under native conditions.
Protein amounts of 5 - 10 mg could be obtained compared to 1 - 2 mg.
FIGURE 4.42 Purification of HyYY1 and HyYY1∆ZnF
monitored by SDS-PAGE. The proteins were purified under
denaturing conditions and eluted using a stepwise decrease
of the pH. The respective eluate fractions at pH 4.5 and the
protein after dialysis against 1 x PBS are depicted.
Gel retardation assay with HyYY1 protein and oligonucleotides containing putative
HyYY1 consensus sequences
To determine the ability of HyYY1 to interact with DNA in a sequence-specific manner,
a gel retardation assay with the purified recombinant protein and 50 bp oligonucleotides
containing putative HyYY1 consensus sequences was performed. 5 µg of recombinant
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protein were incubated with 0.6 ng (= 20 fmol) of oligonucleotides containing the follow-
ing 15 bp core sequences:
HyYY1 round 6: GTAAAGTTTTCTTGA
HyYY1 round 3: TTTTTGTTGAATGTC
control: CCTGCAGCACTGTGT
YY1 consensus: GCCGCCATTTTGGGC
The consensus sequence of the ’YY1 consensus’ oligonucleotide matches the known Pho/
YY1 binding site, which has been identified by Hyde-DeRuyscher et al. (1995) and used
for several YY1-DNA interaction studies. The ’HyYY1 round 3’ oligonucleotide contains
one of the sequences, which was obtained after round 3 of the binding site selection,
the ’HyYY1 round 6’ oligonucleotide contains the core sequence, which was captured
by HyYY1 after round 6 of the binding site selection. The core sequence of the ’con-
trol’ oligonuleotide matches one of the sequences that was obtained after round 6 of the
binding site selection with the truncated HyYY1 protein. This oligonucleotide serves as a
negative control. The DNA was seperated by gel electrophoresis on a 6% native polyacry-
lamide gel and the bands were visualized by chemiluminescence. The result is depicted
in figure 4.43.
FIGURE 4.43 Gel retardation assay with recombinant HyYY1 protein. 0.6 of a biotin-labeled 50
bp oligonucleotide were incubated with 5 µg of HyYY1 protein and seperated by gel electrophoresis on a
6% polyacrylamide gel. Oligonucleotides containing the core sequences obtained after rounds 3 and 6 of
the HyYY1 binding site selection and an oligonucleotide containing the known Pho/YY1 binding site were
used for the binding reaction. The bands were detected by HRP-conjugated streptavidin and visualized by
chemiluminescence. A control with free oligonucleotide is shown in the first lane.
The gel retardation assay revealed that the HyYY1 protein can indeed interact with DNA.
The protein efficiently forms a complex with the oligonucleotide containing the known
Pho/YY1 consensus sequence. A shift of the DNA is clearly visible (figure 4.43 lane 2).
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However, the recombinant protein could not bind to the oligonucleotide containing the
putative HyYY1 consensus sequence, which was obtained in the course of the binding site
selection. No shift was visible (figure 4.43 lane 4). No DNA-protein complex was formed
with the ’HyYY1 round 3’ oligonucleotide and the control DNA (figure 4.43 lane 6 and
8). The HyYY1 protein could only interact with the oligonucleotide containing the known
Pho/YY1 consensus sequence: GCCATNTT. The other oligonucleotides were level with
the free oligonucleotide on the gel (figure 4.43 band 1). The protein-DNA interaction of
HyYY1 is sequence-specific.
Gel retardation assay with increasing amounts of HyYY1 and HyYY1∆ZnF protein
Since the truncated HyYY1∆ZnF protein could bind to the random core oligonucleotide
during the binding site selection quite well, it was determined whether the protein can in-
teract with DNA in an unspecific manner. A gel retardation assay with different amounts
of either HyYY1 or HyYY1∆ZnF protein was performed. The recombinant proteins were
incubated with 20 fmol of the biotin labeled DNA oligonucleotide containing the known
Pho/YY1 consensus sequence. Figure 4.44 shows that only the full length protein con-
taining the four C2H2-type zinc fingers can bind to DNA. The protein lacking the zinc
finger region could not form a protein-DNA complex and shift the DNA in the gel (figure
4.44 lanes 7 - 10). The outcome of the experiment is not surprising since several studies
showed that the DNA binding activity of YY1 is dependent on its zinc fingers.
The binding reaction was performed with increasing amounts of recombinant protein
ranging from 0.5 - 5 µg. A protein amount of 2.5 µg could shift the DNA completely
(figure 4.44 lane 3). This is equivalent to a∼4 fold molar excess of protein. Lower protein
amounts (0.5 - 1 µg) led to an incomplete shift of the oligonucleotide. Both free oligonu-
cleotide and complexed DNA are visible on the gel (figure 4.44 lane 4 and 5).
FIGURE 4.44 Gel retardation assay with recombinant HyYY1 and HyYY1∆ZnF. 0.6 ng of the biotin-
labeled oligonucleotide containing the known Pho/YY1 binding site were incubated with different amounts
of HyYY1 protein ranging from 0.5 - 5 µg and seperated by gel electrophoresis on a 6% polyacrylamide gel.
The bands were detected by HRP-conjugated streptavidin and visualized by chemiluminescence.
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4.4.3. SUMMARY
The DNA binding motif of the Hydra YY1 homolog corresponds to the motif of the
human YY1 and the Drosophila Pho
With the help of the gel retardation assays it could be shown that the HyYY1 protein can
indeed interact with DNA like its human or Drosophila homolog. HyYY1 binds to double-
stranded DNA in a sequence-specific manner and its consensus motif corresponds to the
known Pho/YY1 consensus sequence. The DNA binding activitiy of HyYY1 exclusively
depends on its C-terminal zinc finger domains. A truncated protein without these do-
mains could not form a complex with DNA during gel retardation compared to the full
length HyYY1 protein.
Obviously, HyYY1 binds to the known Pho/YY1 consensus motif. The sequence enriched
during the binding site selection was not bound by HyYY1 in the course of the gel retar-
dation assays. The captured sequence (GTAAAGTTTTCTTGA) differs from the known
consensus sequence of human YY1 or Drosophila Pho. The known consensus sequence is:
GCCATNTT (Hyde-DeRuyscher et al., 1995; do Kim and Kim, 2009). Sequence logos of
the captured sequence and the mammalian consensus are depicted in figure 4.45.
FIGURE 4.45 Sequence logos. The sequence captured by HyYY1 in the course of the bind-
ing site selection is depicted on the left and was generated with the help of the sequence logos program
(http://weblogo.berkeley.edu/) The consensus sequence of the human YY1 is depicted on the right. The
logo was taken from (do Kim and Kim, 2009).
It is very unlikely that the Hydra YY1 protein binds to a different consensus, since the
amino acid sequence of the HyYY1 zinc fingers is 94% identical to the human protein se-
quence and 92% identical to the zinc fingers of Pho. Especially, the amino acid residues,
which are responsible for the DNA contact are identical (Houbaviy et al., 1996; Kim et al.,
2007). A sequence alignment of the zinc finger domains of HyYY1 and YY1 proteins from
other species is depicted in figure 4.46. The amino acid residues, which are known to
contact the target DNA are highlighted.
Neither the residues that directly contact the bases, nor the residues that contact the
DNA backbone are exchanged in the Hydra protein. However, there are several amino
acid substitutions in residues that are not known to contact the DNA. When compared
to the human YY1 protein, there are four substitutions in the first zinc finger domain
(Ala→Ser209, Lys→Ser213, Thr→Leu216, Met→Leu218), there is one substitution in the
second zinc finger (Val→Thr296) and there are two amino acid substitutions in the forth
zinc finger domain (Gly→Ser360, Lys→Cys364). Maybe these residues alter the structure
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FIGURE 4.46 Sequence alignment of the YY1 zinc finger domains. A The zinc finger domains
of HyYY1 are compared to the zinc fingers of YY1 proteins from different species. The HyYY1 amino acid
sequence is framed in red. The zinc finger domains are indicated and highlighted in yellow, green, blue
and red. The cysteine and histidine residues of the C2H2-type zinc fingers are highlighted in gray, residues
known to contact the bases of the target DNA are highlighted and indicated on the last row (black letters).
Residues that contact the DNA backbone are indicated on the last row (red letters). B Overview of the Hydra
YY1 zinc fingers. The color code is the same as for the alignment. Non-conserved residues in comparison to
the human YY1 protein are highlighted in black.
of the affected zinc fingers and decrease the binding affinity of the Hydra protein to the
DNA.
Kim et al. (2007) could show that YY1 has been duplicated by retroposition events in
the course of time in Drosophila and mammals. In fly, Phol (Pleiohomeotic like) has been
duplicated from Pho and in mammals YY2 and REX1 (Reduced Expression 1) have been
duplicated from YY1. The duplicated proteins all show amino acid substitutions in their
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zinc finger regions and have been shown to bind DNA with a lower affinity. But even
REX1, which shows some of the amino acid exchanges of HyYY1, has a consensus motif
with a conserved core sequence: CCAT. This sequence can be found in the YY1 motif and
in the consensus motifs of all duplicated proteins.
The results of the HyYY1 binding site selection are not in accordance with the gel
retardation assays
There is a discrepancy between the results of the HyYY1 binding site selection and the
gel retardation assays. The question arises: Why is the captured sequence not shifted by
HyYY1 during the gel retardation assay? One possibility would be that the known con-
sensus sequence is not found in the pool of random oligonucleotides used for the binding
site selection at all, another possibility would be that the enriched consensus sequence is
a PCR artifact.
The first possibility is very unlikely - in case the four nucleobases get equally incorpo-
rated in the oligonucleotide during the synthesis. 1.07 · 109 (= 415) different molecules
varying in their random core sequences would exist. At the beginning of the binding site
selection, 100 ng of the pool of random oligonucleotides has been used for the first round
of selection. 100 ng correspond to 1.96 · 1012 molecules (n = m/M = 100 · 10−9 g / 30730
g/mol = 3.25 · 10−12 mol; N = NA · n = 6.022 · 1023 mol−1 · 3.25 · 10−12 mol = 1.96 · 1012
molecules). Since the number of molecules is about 2000 times higher than the number of
possible different molecules, each molecule should exist in the pool of oligonucleotides
in an adequate amount.
Probably, the enriched sequence is a PCR artifact. The sequence captured by the full
length HyYY1 protein decreases in size in the course of the binding site selection. The
smaller oligonucleotide may be a PCR artifact, which competes with the original 85 bp
oligonucleotide during amplification. The truncated oligonucleotide gets enriched and
adulterates the result. However, the sequence never gets enriched by the control protein.
This contradicts the notion that the enrichment of the truncated sequence is just an arti-
fact during PCR amplification. Maybe the HyYY1-DNA interaction is specific but weak
and the protein-DNA complex is not stable during electrophoresis.
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4.5. Protein-protein interactions and targeting
In Drosophila, the PcG proteins are recruited to their target genes via the interaction of the
Pleiohomeotic repressive complex (PhoRC) with so-called Polycomb response elements
(PREs). Pho is a member of the PhoRC complex and serves as a molecular linker between
the PcG repressive complexes and their target genes (Klymenko et al., 2006). A direct in-
teraction between Pho and proteins of the Drosophila PRC1 and PRC2 complexes could
be demonstrated (Mohd-Sarip et al., 2002; Poux et al., 2001b).
The existence of a vertebrate PhoRC complex and its role in recruiting the PcG complexes
to their target genes is still to be shown. However, there is growing evidence for a role
of YY1 in PcG target gene recruitment and the interaction of YY1 with proteins of the
PRC1 and PRC2 complexes in vertebrates. Satijn et al. (2001) could identify YY1 in a
complex together with EED and EZH, and they could demonstrate that an interaction
between YY1 and EED is important for Xenopus neural induction. Caretti et al. (2004)
could demonstrate the interaction of YY1 with EZH2 during muscle differentiation in
mouse embryos and Kobrossy et al. (2006) could show that YY1 interacts with the PRC1
protein Mel18 (Psc) during neural differentiation in mouse.
During this study, it could already be shown that HyYY1 interacts with DNA in a sequence-
specific manner, which is a prerequisite for the role of HyYY1 as a molecular adapter. The
interaction between HyYY1 and other Hydra PcG proteins is examined with the help of
co-immunoprecipitation studies. In figure 4.47 a possible model of YY1 as a molecular
adapter linking the PRC1 and PRC2 complexes to DNA is depicted.
FIGURE 4.47 YY1 as a molecular adapter linking the PcG complexes to DNA.
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4.5.1. Interactions between HyYY1 and the Hydra PRC2 complex
The interaction between HyYY1 and the Hydra PRC2 proteins was examined with the
help of immunoprecipitation techniques. Co-immunoprecipitations were performed both
with recombinant proteins expressed in insect cells and with endogenous Hydra proteins.
The recombinant system has the advantage that some of the Hydra PcG proteins can be
expressed as tagged fusion proteins, which allows the use of antibodies raised in dif-
ferent species for precipitation and detection, since all generated antibodies against the
Hydra PcG proteins were produced in rabbit. Using antibodies of the same species can re-
sult in the cross-reactions of the detection antibody with the heavy and light chain of the
precipitation antibody. Non-covalently bound antibodies will elute from the solid sup-
port together with the precipitated proteins and appear on Western blot gels. Mainly the
cross-reaction with the antibody’s heavy chain may cause a problem. The heavy chain is
detected at ∼55 kDa during Western blotting, which is in the range of some of the PcG
proteins (HyEED: ∼70 kDa , Hyp55: ∼55 kDa and HyYY1: ∼60 kDa on SDS-gels). The
proteins of interest may be masked by the heavy chain. To avoid this cross-reactivity
in the endogenous system using Hydra extracts, the precipitating antibody was immobi-
lized on protein A-agarose beads by cross-linking the antibody to the solid support.
For immunoprecipitation studies with recombinant proteins, HyYY1 and the Hydra PRC2
proteins were expressed in Sf9 insect cells. Compared with a bacterial expression system,
the insect cells are a higher eukaryotic system, which allows post-translational modifica-
tions and the correct folding of the recombinant proteins. It has already been demon-
strated that functional PcG complexes can be reconstituted in Sf9 insect cells - both for
the Drosophila PRC1 complex (Francis et al., 2001) and for the Hydra PRC2 complex
(Lauschke, 2009).
HyYY1 protein expression in insect cells
In a first step, HyYY1 had to be expressed in Sf9 insect cells and the conditions for recom-
binant protein expression had to be optimized.
The HyYY1 protein was expressed using the baculovirus expression system. For this pur-
pose, the full length coding sequence of HyYY1 was cloned into the baculovirus expres-
sion vector pFastBac1 and a recombinant bacmid was produced. Sf9 insect cells were
transfected with the bacmid to produce recombinant HyYY1-6His-baculoviruses. The
baculovirus stock was amplified to obtain a high titer P3 viral stock, which was used for
all further experiments. The conditions for HyYY1-6His protein expression were opti-
mized by infecting insect cells with increasing MOIs. The amplification procedure from
the generation of the low titer P1 viral stock to the high titer P3 viral stock is depicted in
figure 4.48 A. In figure 4.48 B and C the optimization procedure is shown. Recombinant
protein expression was monitored by immunoblotting.
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FIGURE 4.48 Recombinant HyYY1-6His protein expression in Sf9 insect cells detected by immunoblot-
ting using the α-HyYY1-antibody. The red asterisks marks the height of the recombinant HyYY1-6His pro-
tein. A Amplification of the recombinant HyYY1-6His baculovirus. Uninfected Sf9 cells served as a control.
B, C Optimization of the infection and protein expression conditions. Sf9 cells were infected with the P3
viral stock using MOIs ranging from 1 to 20.
The HyYY1 protein could be successfully expressed in Sf9 cells. Infecting Sf9 cells with a
MOI ranging from 1 - 5 for 24 - 48 hours were the best conditions for HyYY1-6His protein
expression. Infection of the insect cells with higher MOIs (10 - 20) resulted in a decreased
protein expression. Longer expression periods (> 48 hours) resulted in an increase of
protein degradation.
Immunoprecipitation of HyYY1
Different antibodies were tested for the immunoprecipitation of the HyYY1-6His fusion
protein from Sf9 cells. Both the generated α-HyYY1-antibody (rabbit, polyclonal) and
the commercially available α-pentaHis-antibody (mouse, monoclonal) were tested for
the application in immunoprecipitation studies. For each approach, 2 · 107 Sf9 cells were
infected with the generated P3 stock of the recombinant HyYY1-6His baculovirus using
a MOI of 2. The recombinant protein was expressed for 48 hours. The cells were lysed
and immunoprecipitated with the respective antibodies bound to immobilized protein
A-agarose beads. The precipitated protein was eluted by boiling the beads in protein
sample buffer and detected by Western blotting. Figure 4.49 shows the result of the im-
munoprecipitations.
The HyYY1-6His fusion protein can be successfully precipitated with both the α-HyYY1-
antibody and the α-pentaHis-antibody (figure 4.49 A, B). When precipitating with α-
HyYY1, the α-pentaHis-antibody was used for detection and vice-versa. Since the an-
tibodies were raised in different species, no cross-reactivity of the antibodies interfered
with the detection of the fusion protein.
Figure 4.49 C shows the result of the immunoprecipitation of the HyYY1-6His fusion
protein using the α-HyYY1-antibody for both precipitation and Western blotting. The
precipitating antibody was cross-linked to the immobilized protein A-agarose beads to
circumvent or minimize the cross-reactivity during detection. Cross-linking was per-
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FIGURE 4.49 HyYY1-immmunoprecipitations using antibodies either against the His-tag of the
6His-HyYY1 fusion protein (α-pentaHis-antibody; mouse) or against HyYY1 (α-HyYY1-antibody; rabbit).
Western blots of the immunoprecipitations were probed with the same antibodies. The red asterisks marks
the height of the recombinant HyYY1-6His protein.
A Antibody used for IP: α-pentaHis; antibody used for WB: α-HyYY1.
B Antibody used for IP: α-HyYY1; antibody used for WB: α-pentaHis.
C Antibody used for IP: α-HyYY1; antibody used for WB: α-HyYY1.
formed with the bi-functional coupling reagent dimethyl pimelimidate (DMP). The suc-
cessful cross-linking of the antibody could be detected by the absence of the antibody
light chain in the elution fraction. One would expect to see the heavy and light chains of
the antibody in the elution fraction if the cross-linking failed. In the case of the immuno-
precipitation of the HyYY1-6His fusion protein, no definite conclusion could be drawn
for the heavy chain since both migrate on the same height on the gel.
Immunoprecipitation studies are strongly dependent on the abundance of the antigen
and the affinity of the precipitating antibody to its antigen. This initial experiment demon-
strates that the HyYY1 protein is expressed in Sf9 cells in an adequate amount for im-
munoprecipitation and that the generated α-HyYY1-antibody is useful for precipitation.
Co-immunoprecipitation of recombinant HyYY1 and Hydra PRC2 proteins: first
results
To study possible protein-protein interactions between HyYY1 and the Hydra PRC2 pro-
teins, a co-immunoprecipitation of the proteins was performed. An antibody against
HyYY1 was used to target a putative HyYY1-PRC2 multiprotein complex and pull the
entire complex out of solution. During his master thesis, Volker Lauschke could already
demonstrate an interaction between HyEED and HyEZH2 with this technique.
For the co-immunoprecipitation of HyYY1 with the Hydra PRC2 proteins, Sf9 insect cells
were co-infected with the respective baculoviruses. The cells were co-infected with the
following viruses: HyYY1-6His, HyEZH2, HyEED, HySUZ12 and Hyp55. For all viruses,
except for HySUZ12, a MOI of 1 was used for infection. For HySUZ12 a MOI of 2
was used. The proteins were expressed for 48 hours. The cells were lysed and the
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cleared lysate was used for immunoprecipitation. For precipitation, an antibody against
HyYY1 (α-pentaHis) was used, for detection antibodies against HyEZH2, HyEED and
Hyp55 were used. In figure 4.50 the result of the co-immunoprecipitations of HyYY1 and
HyEZH2 is depicted.
FIGURE 4.50 Co-immmunoprecipitations using an antibody against the HyYY1-6His fusion protein
(α-pentaHis-antibody; mouse). Western blots of the immunoprecipitations were probed with an antibody
against HyEZH2 (α-HyEZH2-antibody; rabbit). A Co-immunoprecipitation using Sf9 cells co-expressing
HyYY1 and HyEZH2. B Co-immunoprecipitation using Sf9 cells co-expressing HyYY1, HyEZH2, HyEED,
HySUZ12 and Hyp55.
The co-immunoprecipitation of HyYY1 and the Hydra PRC2 proteins indicate that HyYY1
physically interacts with the HyEZH2 protein. A weak band of the correct size (∼80
kDa) for HyEZH2 is visible in the elution fraction. The HyEZH2 protein could be co-
immunoprecipitated with HyYY1 from infected Sf9 cells either expressing HyYY1 and
HyEZH2 (figure 4.50 A) or expressing HyYY1, HyEZH2, HyEED, HySUZ12 and Hyp55
(figure 4.50 B). These co-immunoprecipitations give a first evidence for the interaction of
HyYY1 with one of the proteins of the Hydra PRC2 complex. However, the obtained band
is weak and at the blot in figure 4.50 B shows a strong background masking a part of the
band.
The presented co-immunoprecipitations should be seen as a preliminary experiment,
which has to be repeated to assure the interaction between HyYY1 and the Hydra PRC2
proteins. Two other antibodies were used for the detection of HyEED and Hyp55. An
antibody against HySUZ12 was not available. However, no interaction between HyYY1
and HyEED or Hyp55 could be detected, so far. Furthermore, the interaction between
HyYY1 and proteins of the Hydra PRC1 complex has yet to be demonstrated.
For future experiments, could be useful to perform the co-immunoprecipitation using
varying conditions. The precipitation was performed with cells lysed under denaturing
conditions using ionic detergents like SDS and sodium deoxycholate, which may con-
tribute to the denaturing of multiprotein complexes and protein-antibody complexes.
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Instead, a milder, non-denaturing buffer, which allows efficient cell lysis and keeps the
protein complexes intact, could be applied for future experiments, since immunoprecip-
itations rely on the formation of a stable antigen-antibody complex.
Co-immunoprecipitation of endogenous Hydra PcG proteins: first results
Co-immunoprecipitation using endogenous Hydra proteins were performed in the same
way as co-immunoprecipitations with recombinant proteins expressed in Sf9 cells. about
1000 Hydra polyps (∼108 cells) were used for each immunoprecipitation approach. The
precipitating antibodies were cross-linked to the protein A-agarose beads. Immunopre-
cipitations of endogenous Hydra proteins were performed with the following precipitat-
ing antibodies: α-HyYY1, α-HyEED and α-Hyp55. The suitability of these antibodies for
immunoprecipitation has been tested before. During this study, the α-HyYY1-antibody
has been successfully tested, the α-HyEED and α-Hyp55 antibodies have been tested by
Volker Lauschke during his master thesis. However, the antibodies were used for the
precipitation of recombinantly overexpressed proteins in insect cells, no immunoprecipi-
tations of endogenous Hydra proteins were performed, yet. Figure 4.51 shows exemplary
results of the co-immunoprecipitation of endogenous Hydra proteins. The result for the
co-immunoprecipitation of HyYY1 and HyEED is depicted in figure 4.51 A, the result of
the co-immunoprecipitation of HyEED and Hyp55 in figure 4.51 B.
FIGURE 4.51 Immunoprecipitation of endogenous Hydra proteins. A Co-immmunoprecipitations
using an antibody against HyYY1. Western blots of the immunoprecipitations were probed with an antibody
against HyEED. B Immunoprecipitation using an antibody against HyEED. Western blots of the immuno-
precipitations were probed with an antibody against Hyp55.
No protein-protein interactions could be detected for the endogenous Hydra PcG pro-
teins. Neither for HyYY1 and HyEED, nor for HyEED and Hyp55. In the elution fractions,
no bands at the expected size of the probed Hydra PcG proteins are visible. Instead, clear
bands at 55 kDa and 25 kDa are visible. These bands correspond to the heavy and light
chains of the precipitating antibodies. This indicates that the cross-linking of the precip-
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itating antibody to the matrix was not successful. The antibody is still eluted from the
beads and interferes with the detection of the target proteins. In addition, higher molec-
ular weight bands greater than 100 kDa are visible (red asterisks) - no matter, which com-
bination of the antibodies was used for precipitation and detection. The bands even ap-
peared in the control reaction, when precipitating was performed with protein A-agarose
beads only. It seems that some of the endogenous Hydra proteins bind to the protein A-
agarose matrix, even though a pre-clearing step with protein A-agarose beads was per-
formed. Protein bands at the expected sizes for HyEED and Hyp55 can be detected in the
’preclearing’, ’input’ and ’unbound’ fraction (blue asterisks). For HyEED a band at ∼70
kDa is visible, for Hyp55 a band at ∼55 kDa can be detected.
The results for both co-immunoprecipitations are negative. Either the target proteins are
masked in the elution fraction, or the abundance of the proteins is too low and they could
not be precipitated at all.
For further immunoprecipitations using Hydra lysates, the different steps of the proce-
dure need to be otimized. Optimization could include the use of a different cell lysis
buffer, more thorough washing steps and milder elution conditions. The RIPA buffer
used for cell lysis may denature the multiprotein complexes and interfere with the for-
mation of a stable protein-antibody complex. Furthermore, the elution by boiling the
beads in SDS is a rather harsh method and the proteins could be eluted at a low pH us-
ing a glycine buffer, instead. Due to the lack of material and time constrictions, no further
experimental conditions could be tested during this study.
4.5.2. Identification of PcG target genes in Hydra by ChIP-Seq
In 2006 the first genome-wide analyses of PcG binding patterns by ChIP-on-chip have
been reported in Drosophila (Nègre et al., 2006; Schwartz et al., 2006; Tolhuis et al., 2006).
In the same year, first ChIP-on-chip analyses have been carried out in murine and human
embryonic stem cells and human embryonic fibroblasts, respectively (Boyer et al., 2006;
Bracken et al., 2006; Lee et al., 2006). An alternative to the ChIP-on-chip technology is
ChIP-Seq. Since no microarray for ChIP-on-chip is available for the Hydra genome, the
ChIP-Seq method has been chosen to identify PcG target genes in Hydra.
Small-scale ChIP-Seq: initial settings
During this study, an initial small-scale ChIP-Seq experiment was performed with the
generated antibodies against the Hydra PcG proteins and a commercially available α-
H3K27me3 antibody. The α-H3K27me3 antibody is directed against the epigenetic mark
set by the PRC2 complex: trimethylation of lysine 27 in histone H3. A putative Hydra
histone H3 can be found in the genome, and the amino acid sequence of the N-terminal
histone tail is 100% identical to the human histone. See appendix B for more details on
Hydra histones.
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For ChIP-Seq, ∼5000 Hydra polyps were used as starting material. The protein-DNA
complexes were cross-linked with paraformaldehyde and chromatin was sheared by son-
ication. Different sonication settings were tested to obtain DNA fragment sizes ranging
from 200 - 500 basepairs, which are optimal for chromatin immunoprecipitation. Figure
4.52 depicts the Hydra chromatin preparations. Chromatin preparation 2 was used for
precipitation. Most of the chromatin fragments are ranging from ∼300 - 1000 basepairs.
The size of the obtained chromatin fragments is still very big. Nevertheless, the prepared
chromatin was immunoprecipitated with the following antibodies: α-HyEZH2, α-HyPC,
α-HyYY1 and the commercially available α-H3K27me3 antibody. The DNA was puri-
fied from the precipitated chromatin and amplified. The obtained DNA was cloned into
pGEM-T vector, isolated and further analyzed by sequencing. For details see materials
and methods section 3.10.2. Table 4.8 gives an overview of the sequenced clones.
FIGURE 4.52 Sheared Hydra chromatin. Chromatin was sheared with the help of a Branson Sonifier
250 sonicator. Different settings were used for shearing. Chromatin 1: power 2, duty cycle 20%; Chromatin
2: power 3, duty cycle 30%. For analysis, 1 µg of DNA was loaded per lane on a 1% agarose gel.
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This initial experiment shows that the generated antibodies against the Hydra PcG pro-
teins are suitable for chromatin immunoprecipitation experiments. Sequencing of the
precipitated DNA revealed that indeed Hydra chromatin was precipitated. Hydra chro-
matin could be precipitated with the α-HyPC and α-HyEZH2 antibodies. In addition,
chromatin could be precipitated with the commercial α-H3K27me3 antibody. Most of the
precipitated sequences are found within repetitive elements in the Hydra genome. Un-
fortunatelly, none of the precipitated sequences with the α-HyYY1 antibody can be found
in the genome. With this small-scale ChIP-Seq experiment no PcG target genes could be
identified in Hydra, yet. However, the outcome of the initial experiment is promising.
For a high throughput ChIP-Seq experiment, the DNA fragments derived from ChIP are
sequenced by next-generation methods. Protein-DNA interaction sites can be profiled
by massively parallel sequencing. The resulting sequences are mapped to the reference
genome and peaks at specific genomic regions are obtained with the most abundant se-
quenced fragments.
There are several steps, which have to be improved for high-throughput ChIP-Seq exper-
iments. First of all, the shearing of the chromatin has to be improved. For ChIP-Seq, the
size of the chromatin is important. Ideally, the fragments should have a length of about
200 bp for a good resolution. The sheared Hydra chromatin used for precipitation was
most abundant at 600 - 700 bp. This is too large and the sonication settings need to be
optimized. Second, an appropriate background control has to be included. For example,
a mock IP without any antibody or an IP with an unspecific antibody can be performed
as a background control.
However, only a sensitive antibody will enrich specific sequences compared to the back-
ground control. Whether the generated antibodies against the Hydra PcG proteins are
sensitive enough, could not be determined.
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4.5.3. SUMMARY
YY1 and the targeting of Polycomb Repressive Complexes
The Hydra homolog of the DNA binding protein YY1 was of special interest during this
thesis. The Drosophila homolog Pho is the only DNA binding protein that is found in a
PcG complex. Pho is a member of the third major Polycomb repressive complex PhoRC,
which recruits the other Polycomb repressive complexes to their target genes via the
interaction with a so-called Polycomb response element (PRE). In Drosophila, PcG target
genes could be mapped to the genome by the identification of PRE sites. However, the
existence of the PhoRC complex and PRE sites in species other than Drosophila is still
unclear. There is emerging evidence that PcG proteins can be recruited to their target
genes in a PRE-independent manner by long non-coding RNAs.
Preliminary results of co-immunoprecipitation studies at least suggest a direct interaction
between the HyYY1 protein and a protein of the Hydra PRC2 complex. However, unlike
the genes of the Hydra PRC2 complex, the expression of HyYY1 is not limited to the
interstitial cell lineage. The gene has been found to be mainly expressed in ectodermal
epithelial cells. Like Hyp55, HyYY1 is additionally expressed in cells of the future oocyte.
The broader expression of HyYY1 can be explained by the more general function of YY1.
YY1 does not solely act as a PcG protein. Whether HyYY1 really acts as a molecular
adapter in linking the Polycomb repressive complexes to their target DNA in Hydra has
yet to be shown. For the future, it is planned to identify PcG target genes in Hydra by an
approach based on ChIP-Seq. ChIP-Seq experiments are made possible, since antibodies
against some of the Hydra PcG proteins are available now. During this thesis only an
initial small-scale ChIP-Seq experiment with some of the generated antibodies could be
performed. This initial experiment should be seen as ’proof of principle’. More work
needs to be accomplished and large-scale ChIP-Seq experiments need to be performed to
identify the Hydra PcG target genes.
ChIP-based identification of Polycomb Group target genes
In 2006 the first genome-wide analyses of PcG binding patterns by ChIP-on-chip have
been reported in Drosophila (Nègre et al., 2006; Schwartz et al., 2006; Tolhuis et al., 2006).
In the same year, first ChIP-on-chip analyses have been carried out in murine and human
embryonic stem cells and human embryonic fibroblasts, respectively (Boyer et al., 2006;
Bracken et al., 2006; Lee et al., 2006). Binding patterns for components of the PRC1 and
PRC2 complexes and the H3K27me3 mark have been analyzed. A strong coincidence for
the binding patterns could be observed. Among the bound genes are many genes impor-
tant for differentiation and development (see figure 4.53).
Components of all major signaling pathways that are regulated by PcG-mediated silenc-
ing mechanisms in higher animals have been found in Hydra. Homologs of almost all
vertebrate genes involved in developmental processes and pattern formation could be
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found in the freshwater polyp, including genes of the wnt-, TGFβ, RTK-, hedgehog- and
notch/delta-signalling pathway (Hobmayer et al., 2000, 2001; Miller and Steele, 2000;
Käsbauer et al., 2007; Münder et al., 2010; Kaloulis, 2000). In contrast, most of the HOX
genes are absent or secondarily lost (Garcia-Fernàndez, 2005; Steele et al., 2010).
Drosophila target
gene
Human target gene
armadillo β-catenin
ventral veins lacking POU3F1/Oct6
eyes absent EYA2
pannier GATA4
disco BNC1
cousin of atonal ATOH1
ladybird early LBX1
pdp1 HLF
caudal CDX2
Rx RAX
B-H1 BARHL1, BARHL2
H15 TBX20
vestigial VGLL1, VGLL2
dachshund Dachshund homolog
1
engrailed EN1, EN2
even skipped Even-skipped home-
obox1
eyes absent Eyes absent
giant Hepatic leukemia fac-
tor
gooseberry Paired box gene 3
hairy HES1, HES2
knirps Estrogen receptor 1
tailless NR2E1
wingless WNT1
homothorax MEIS2
Ubx HOXA7, HOXB7
abd-A HOXB-D8
abd-B HOXA-D9
FIGURE 4.53 Polycomb Group target genes detected in human embryonic fibroblast. Left: Polycomb
Group target genes are conserved in Drosophila and humans. Confirmed or predictet Drosophila target genes
are in accordance with the identified human targets. Right: PcG target genes which are involved in major
signaling pathways are depicted. The figure has been adapted from Bracken et al. (2006).
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A.1. Information on Hydra PcG genes
TABLE A.1 Information on Hydra PcG genes. The position of the genes in the Hydra genome is
indicated by the Contig in which the sequence can be found and the genomic span. The number of exons
is given. Gene models which resemble parts of the sequences are indicated. The genomic information was
retrieved from the Hydra genome browser: http://hydrazome.metazome.net/cgi-bin/gbrowse/hydra/.
Gene Contig number Genomic span Exons Coding
region
Comments
Polycomb Repressive Complex 1 (PRC1)
HyPC 29278 (- strand)
34962 (- strand)
10507 - 9850
34963 - 29278
1 - 2
3 - 6
675 nt The sequence is distributed over 2 Con-
tigs. Parts can also be found in the fol-
lowing gene models: Hma2.202781 and
Hma2.210328.
HyPH 39256 (+ strand) 101145 - 110657 1 - 6 972 nt The sequence can also be found in the fol-
lowing gene models: Hma2.2231779 and
Hma1.135095.
HyPSC 38639 (+ strand) 88289 - 94536 1 - 10 762 nt Part of the sequence can also be found in
the following gene model: Hma1.128026.
HyRING 35899 (- strand) 62102 - 39091 1 - 4 975 nt Parts of the sequence can also be
found in the following gene models:
Hma2.212836, Hma2.212837, Hma1.13039
and Hma1.102404.
HySCM 37649 (+ strand) 71904 - 119561 1 - 18 2496 nt Parts of the sequence can also be
found in the following gene mod-
els: Hma2.219746, Hma2.219747,
Hma1.111023, Hma1.111024 and
Hma1.131847.
Polycomb Repressive Complex 2 (PRC2)
HyEZH2 38429 (- strand)
18810 (- strand)
83750 - 525
576 - 481
1 - 7, 9 - 22
8
2172 nt The sequence is distributed over 2
Contigs. Contig 38429 seems to be mis-
arranged. The spatial order of the exons
is: 1 - 7, 9 - 11, followed by 18 - 22 and
12 - 17 at the end. Parts of the sequence
can also be found in the following gene
models: Hma1.108906, Hma1.132922,
Hma2.224311, Hma2.224312 and
Hma1.112227.
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Gene Contig number Genomic span Exons Coding
region
Comments
HyEED 38295 (- strand) 73097 - 34821 1 - 17 1260 nt Parts of the sequence can also be found in
the following gene models: Hma1.123942
and Hma2.223416.
HySUZ12 37069 (+ strand)
37069 (- strand)
38304 (+ strand)
74040 - 76899
101530 - 79197
7582 - 11070
1 - 2
3 - 9
11 - 14
1914 nt The sequence is distributed over 2 Con-
tigs. Contig 37069 seems to be misar-
ranged. The spatial order of the exons
is the following: Contig 37069 starts with
exons 3 - 9 on the - strand, which are fol-
lowed by exons 1 - 2 on the + strand. Ex-
ons 11 - 14 can be found in Contig 38304.
’Exon 10’ could not be found in any
Contig. Parts of the sequence can also
be found in the following gene models:
Hma1.10833, Hma1.121070, Hma2.217024
and Hma2.223484.
Hyp55 39183 (+ strand)
38803 (- strand)
290158 - 290218
191502 - 162173
1
3 - 14
1302 nt The sequence is distributed over 2 Con-
tigs. Parts of the sequence can also
be found in the following gene mod-
els: Hma1.133695, Hma1.120922 and
Hma2.227018.
Pleiohomeotic Repressive Complex (PhoRC)
HyYY1 38857 (- strand)
24938 (- strand)
65227 - 35086
2875 - 2072
1, 5 - 6
2 - 4
1083 nt The sequence is distributed over 2 Con-
tigs. Parts of the sequence can also
be found in the following gene mod-
els: Hma2.227444, Hma2.200971 and
Hma1.128713
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A.2. Information on Hydra PcG proteins
TABLE A.2 Information on Hydra PcG proteins. The amino acid sequence lengths are
given. The respective calculated molecular weights (MW) and isoelectric points (pI) of the pro-
teins are indicated. Conserved domains found in the Hydra proteins are indicated. Information
on the molecular weights and isoelectric points have been calculated using the ProtParam tool:
http://www.expasy.ch/tools/protparam.html. Information on conserved protein domains was obtained
from SMART (Simple Modular Architecture Research Tool): http://smart.embl-heidelberg.de/.
Protein Length MW pI Domains
Polycomb Repressive Complex 1 (PRC1)
HyPC 225 aa 25.1 kDa 5.76 CHROMO domain
HyPH 324 aa 36.5 kDa 6.89 SAM domain
HyPSC 254 aa 30.1 kDa 7.87 RING zinc finger
HyRING 325 aa 37.2 kDa 6.47 RING zinc finger
HySCM 832 aa 94.0 kDa 7.66 HMG box, MBT domains and SAM domain
Polycomb Repressive Complex 2 (PRC2)
HyEZH2 724 aa 83.7 kDa 7.94 SANT and SET domain
HyEED 420 aa 47.9 kDa 6.24 WD 40 repeats
HySUZ12 638 aa 74.1 kDa 8.43 zinc finger domain and VEFS box
Hyp55 434 aa 49.1 kDa 4.99 WD 40 repeats
Pleiohomeotic Repressive Complex (PhoRC)
HyYY1 361 aa 40.5 kDa 5.54 REPO domain and C2H2-type zinc fingers
A.3. Sequence information on Hydra PcG genes 
 
HyPC     
 
From gene to protein: 
The HyPC gene is composed of 6 exons and spans a genomic region of > 20 kb. The respective 
exon and intron lengths are indicated. Undetermined lengths are indicated by a question mark. 
Based on a ~ 1 kb mRNA, a protein of 225 aa is translated. 
 
 
 
 
Sequence information: 
Nucleotide  and  derived  amino  acid  sequence  of HyPC  from Hydra magnipapillata  105.    The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the  polyadenylation  site  is  indicated  by  underlined  nucleotides.  The  trans‐spliced  leader 
sequence  is  marked  by  a  dashed  line.  The  translation  initiation  start  and  stop  codons  are 
highlighted in red. The coding sequence and the derived amino acid sequence are indicated by 
capital  letters.  The  protein  domains  are  indicated.  The  CHROMO  domain  is  highlighted  in 
yellow. 
 
 
  Exon 1                          3’ UTR 
    1  acggaaaaaa acacatactg aaacttttta gtccctgtgt aataagtttt 
   51  acattctgct gtccccctca aatacaatta tcttaaATGC CTAAGGACAC 
                                                M   P  K  D 
                                    CHROMO domain 
  101  TGGTCCTGGA GTTTTTGCTG CTGAAAAAAT ATTGAAAAAG AGATATAAAA 
       T  G  P  G   V  F  A   A  E  K   I  L  K  K   R  Y  K 
        Exon 2                                                    Exon 3  
  151  AG|GGGCGAGC TGAGTATTTA ATAAAATGGC AAGGTTATTC AGCT|AAGTAT 
        K    G  R   A  E  Y  L   I  K  W   Q  G  Y   S  A     K  Y 
  201  AACACATGGG AACCAGCTGC AAACATACTT GATGAAAGAT TACTTCAATG 
         N  T  W   E  P  A   A  N  I  L   D  E  R   L  L  Q 
                  Exon 4  
  251  TTACAAAAGT TT|ACAATCAG CTTCAAGAGG GAGAAAAAGA AAAAAAGGAT 
       C  Y  K  S     L  Q  S   A  S  R   G  R  K  R   K  K  G 
                                              Exon 5  
  301  CAATAAGCAA GTCAACAAAA AAATCGAAAC ATGATGAG|TC TTTTGAAGTG 
        S  I  S   K  S  T  K   K  S  K   H  D  E   S  F  E  V 
  351  AATGATTCAA CAGCAGAAGA TAGTGTAACG CAAGATGAAG ATGAAATTGT 
         N  D  S   T  A  E   D  S  V  T   Q  D  E   D  E  I 
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  401  TTCAGTTGGA TCAGTAGAAG ATTCCATTCA ATCATCCATT CAGGATGATT 
       V  S  V  G   S  V  E   D  S  I   Q  S  S  I   Q  D  D 
  451  TGACCAATGA ACAAAATGAG ACAGCAACAC TTAGTGACAG TTCTAATAAG 
        L  T  N   E  Q  N  E   T  A  T   L  S  D   S  S  N  K 
                                          Exon 6  
  501  AATGGAAAAA AACTTGGTAA AGATTTAAAA TTGG|GTAACG GAGATAACGA 
         N  G  K   K  L  G   K  D  L  K   L    G  N   G  D  N 
  551  TACGTCTGAC ACTATGATTC ATCATAATAC ACAAAAGATG TCTTCTACTG 
       D  T  S  D   T  M  I   H  H  N   T  Q  K  M   S  S  T 
  601  TTCGTTTAAC AGAAAAAACT TTTAGCAAAA CTGAAACAGA AGAAGTAGAA 
        V  R  L   T  E  K  T   F  S  K   T  E  T   E  E  V  E 
  651  TGCATATGTT GGAAAAAACC GCTGATTGAT CAAGTCACAA TCACTGACGT 
         C  I  C   W  K  K   P  L  I  D   Q  V  T   I  T  D 
  701  CACACTAAAT GGATTAACAG CAACTTTCAC AGAAGCTTCA ACAGACCAAG 
       V  T  L  N   G  L  T   A  T  F   T  E  A  S   T  D  Q 
                                5‘ UTR 
  751  GTTTTTTTGC ATGAaatatt attacaaaga aatctcataa gtaattcagg 
        G  F  F   A  *   
  801  gatcatgttc agctatttat tattattatt ttgctgtttt ggatgtctag 
  851  ttggctttaa atacgcattt tatagttgag ttccttattt gttattaatt 
  901  atgagtaatc taccaattcc aacgaataat gatagataac ccaacgatgt 
  951  aatattacga tgttgtgtat atattatagt atctattagc gtgtgtaata 
 1001  tattttctgt attgtttgcg ttatgtgtaa tatgaaataa accaagatca 
            polyA site 
 1051  aaacaaaaaa aaaaaaaaaa aaaa 
 
 
Protein alignment: 
Comparison of HyPC with PC protein sequences from other species reveals a conservation on 
the  amino  acid  level  of  only  13%.  Areas  of  high  matches  are  highlighted  in  grey.  The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
                                            ------C H R O M O  d o m a i n------ 
hydra PC          1 -----MPKDTGPG-----------VFAAEKILKKRYKKGRAEYLIKWQGYSAKYNTWEPA 
zebrafish CBX2    1 -----MEGLSAVGEQ---------VFDAECILNKRTRKGKLEYLVKWRGWSSKHNSWEPQ 
mouse Cbx2        1 -----MEELSSVGEQ---------VFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPE 
human CBX2        1 -----MEELSSVGEQ---------VFAAECILSKRLRKGKLEYLVKWRGWSSKHNSWEPE 
xenopus CBX2      1 -----MEELSAVGEQ---------VFAAECILSKRLRKGTAEYLVKWRGWSSKHNSWEPE 
drosophila Pc     1 MTGRGKGSKGKLGRDNATDDPVDLVYAAEKIIQKRVKKGVVEYRVKWKGWNQRYNTWEPE 
                    C H R O M O d o m a i n 
hydra PC         45 ANILDERLLQCY------KSLQSASRGRK-----RKKGSISKSTKKSKHDE--------S 
zebrafish CBX2   47 ENLLDPRLLVAFNKREQEKELLISKKGKRPRGRPRK--IMETIPVVSK----SSSSSSSS 
mouse Cbx2       47 ENILDPRLLLAFQKKEHEKEVQNRKRGKRPRGRPRKHTVTSSCSRRSKLKEPDAPSKSKS 
human CBX2       47 ENILDPRLLLAFQKKEHEKEVQNRKRGKRPRGRPRKLTAMSSCSRRSKLKEPDAPSKSKS 
xenopus CBX2     47 ENILDPRLLVAFQKREQEKELRNRKRGKRPRGRPRKNV------------ETDIPLKAKS 
drosophila Pc    61 VNILDRRLIDIYEQT------------NKSSGTPSKR------GIKKKEKEPD------- 
 
hydra PC         86 FEVNDSTAEDSVTQDEDE------------------------------IVSVGSVEDSI- 
zebrafish CBX2  101 SSSGSSSSSSSSSSSTDDDDEDDHNMTPKPI-PRPREHLPVPQKKAQIVVAKPGPP---- 
mouse Cbx2      107 SSSSSSSTSSSSSSDEEE---DDSDLDSK-RGPRGRETHPVPQKKAQILVAKPELKDPIR 
human CBX2      107 SSSSSSSTSSSSSSD-EE---DDSDLDAK-RGPRGRETHPVPQKKAQILVAKPELKDPIR 
xenopus CBX2     95 SSSSSSSSSSSSSSSSSSSSSDDSDAETQQRNPRPRDSHPVPQKKAPAVLARTELKEPVR 
drosophila Pc    96 ---------PEPESEEDEYTFTENDVDTH-QATTSSATHDKESKKE---------KKHHH 
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hydra PC            ------------------------------------------------------------ 
zebrafish CBX2  156 KKRGRKALPPELKAIRQVKGTRKILKPISRDSDLRGIKKPLMPASFTYTGL--------- 
mouse Cbx2      163 KKRGRKPLPPEQKAARRPVSLAKVLKTTRKDLGTSAAKLP-PPLSAPVAGLAALKAHTKE 
human CBX2      162 KKRGRKPLPPEQKATRRPVSLAKVLKTARKDLGAPASKLP-PPLSAPVAGLAALKAHAKE 
xenopus CBX2    155 KKRGRKPLPPEQKLPRR----AKGAKPGPK---GSMNKLQ-P--GHNIQGFQALKTHSKD 
drosophila Pc   137 HHHHHHHIKSERNSGRRSES--------------------------PLTHHHHHHHH--- 
 
hydra PC        115 ------------------------------------------QSSI---QDDLTNEQNET 
zebrafish CBX2  207 ------NRTSGREPMAMHNRGSFTHKSSLSSLGRSIGSVSSPPT-----LNRSPQTKSAS 
mouse Cbx2      222 AC-------GGPSTMATPENLASLMKGMAGSPSRGG---I-WQSSIVHYMNRMSQSQVQA 
human CBX2      221 AC-------GGPSAMATPENLASLMKGMASSPGRGG---ISWQSSIVHYMNRMTQSQAQA 
xenopus CBX2    205 MHASSNNRPGGLSA----ELLSSIAKNSPTQPNGSSPRSLSWQSSIVHYMNRINQNSSQP 
drosophila Pc   168 ------------------ESKRQRIDHSSSS-----------NSSFTH--NSFVPEPDSN 
 
hydra PC        130 AT-----LSDSSNKNGKKLGKDLKL----------------------------------- 
zebrafish CBX2  256 DFKLSVSDMNS--------GLDPKTPTCKSPGVAALNLHSSNGQTCPQLSPTVPKDQTLL 
mouse Cbx2      271 ASRLALKA-QATNKCG--LGLDLKVRTQKGGELGG----SPAGGKVPKAPGGGAAEQQRG 
human CBX2      271 ASRLALKA-QATNKCG--LGLDLKVRTQK-GELGM----SPPGSKIPKAPSGGAVEQKVG 
xenopus CBX2    261 GRKPASSTFNAKRSC-----LDAKSLFKPRSEAEI----SPA---MPKT-------SKLH 
drosophila Pc   197 SSSSEDQPLIGTKRKAEVL--------KESGKIGVTIKTSPDGPTIKP------------ 
 
hydra PC            ------------------------------------------------------------ 
zebrafish CBX2  308 QR-----SASLPKSPSSSFSSLKTPS---SLQALNLQSVNKTVQGNGTDLKTSPHSGRKS 
mouse Cbx2      324 N-----HS--------GSPGAQLAPTQELSLQVLDLQSVKNGVPGVGL---LARHAPA-K 
human CBX2      323 NTGGPPHTHGASRVPAGCPGPQPAPTQELSLQVLDLQSVKNGMPGVGL---LARHATATK 
xenopus CBX2    302 ENEEQTHSHTVQPAPTVAAGSNENPSQN-----APVQTKTQGM----------------R 
drosophila Pc   237 -----------------QPTQQVTPSQQQPFQ---------------------------- 
 
hydra PC        150 --------------GNGD------------NDTSDTMIHHNTQKMSSTVRLTEK------ 
zebrafish CBX2  360 SGFNTSSAPNTPSKFQTSQQALKSPQKLKADDL-AERLGKKSQARTEKILPTEGRD---- 
mouse Cbx2      367 AIPATNPATG---KGPGSGPTGANMTNAPTDNNKGEKLTCKATALP---APSVKRDTVKS 
human CBX2      380 GVPATNPAPG---KGTGSGLIGASGATMPTDTSKSEKLASRAVAPP---TPASKRDCVKG 
xenopus CBX2    341 AVVVTSPTSQNTQKSNGSHAVGV------ATSCKGDKIGKKTGVVT---EP--------- 
drosophila Pc   252 ------------------------------DQQQAEKIASEAAT----QLKSEQQ----- 
 
hydra PC        178 ---------------------TFSKTETEEVECIC------------------------- 
zebrafish CBX2  415 -SQPA-QDR-PSSKDPSKQSKTLSELSTGEEGSSSDTDHDS-SFPRDSHDL-----SISV 
mouse Cbx2      421 VAASGGQEG-HTAPGEGRKPPALSELSTGEENSSSDSDPDSTSLPSAAQNL-----SVAI 
human CBX2      434 SATPSGQES-RTAPGEARKAATLPEMSAGEESSSSDSDPDSASPPSTGQNP-----SVSV 
xenopus CBX2    383 TAHPATERA-Q--PTEGQRDVA--DLSTGDD-SSLDSDHDS-SLSSQ---------DMAV 
drosophila Pc   273 -ATPLATEAINTTPAESG--------AEEEEVANEEGNQQAPQVPSENNNIPKPCNNLAI 
 
hydra PC        192 ------------------WK--KPLIDQ-VTITDVTLNGLTATFTEASTDQGFFA----- 
zebrafish CBX2  466 QAGQD-------------WRPTRSLIEH-VFVTDVTANLVTVTVKESPTSVGFFSIRNY- 
mouse Cbx2      475 QTSQD-------------WKPTRSLIEH-VFVTDVTANLITVTVKESPTSVGFFNLRHY- 
human CBX2      488 QTSQD-------------WKPTRSLIEH-VFVTDVTANLITVTVKESPTSVGFFNLRHY- 
xenopus CBX2    427 QASQD-------------WKPARSLLEH-VFVTDVTANLITVTVKESPTSVGFFNMRHF- 
drosophila Pc   324 NQKQPLTPLSPRALPPRFWLPAKCNISNRVVITDVTVNLETVTIRECKTERGFFRERDMK 
 
hydra PC            ------- 
zebrafish CBX2      ------- 
mouse Cbx2          ------- 
human CBX2          ------- 
xenopus CBX2        ------- 
drosophila Pc   384 GDSSPVA 
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HyPH    
 
From gene to protein: 
The HyPH gene  is composed of 6 exons and spans a genomic region of ~ 9 kb. The respective 
exon  and  intron  lengths  are  indicated.  Based  on  a  ~  1.8  kb  mRNA,  a  protein  of  324  aa  is 
translated. 
 
 
 
 
Sequence information: 
Nucleotide  and  derived  amino  acid  sequence  of HyPH  from Hydra magnipapillata  105.    The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the  polyadenylation  site  is  indicated  by  underlined  nucleotides.  The  trans‐spliced  leader 
sequence  is  marked  by  a  dashed  line.  The  translation  initiation  start  and  stop  codons  are 
highlighted in red. The coding sequence and the derived amino acid sequence are indicated by 
capital letters. The protein domains are indicated. The SAM domain is highlighted in light blue. 
 
 
  Exon 1  
    1  acggaaaaaa acacatactg aaacttttta gtccctgtgt aataagcttc 
   51  tataagttta aattATGGCT GTTTCATTGG TGCAAAAAAG TAATTGGACT 
                        M  A   V  S  L   V  Q  K   S  N  W  T 
  101  AATATTACAG ATACTTATAG TTCTGCTGAT AATTGTATAA AATCGAAATC 
         N  I  T   D  T  Y   S  S  A  D   N  C  I   K  S  K 
  151  AGATCTTTTT TGTAATAAGC ATGATGAATC GAAAGTTACT TTGTTGATAC 
       S  D  L  F   C  N  K   H  D  E   S  K  V  T   L  L  I 
                                                        Exon 2  
  201  ATGTTATTGA TGGTTGGATA ATTGAAGAAA GCAATCAACC ATTTAAG|GAT 
        H  V  I   D  G  W  I   I  E  E   S  N  Q   P  F  K    D 
  251  TCAAATATTG ATGAAAATAT AAATGGGGGT GTTAAGTCAT TAGCAGAGAA 
         S  N  I   D  E  N   I  N  G  G   V  K  S   L  A  E 
  301  TGGTAAATGT AGTGATGATT TTGTAGAAGT TCAGGAAAAA GAAATTAACA 
       N  G  K  C   S  D  D   F  V  E   V  Q  E  K   E  I  N 
        Exon 3   
  351  CTG|TTCAACC TAATCTTGAG GATAAAGATG AGCTTATGTC ACTCTTACCA 
        T    V  Q   P  N  L  E   D  K  D   E  L  M   S  L  L  P 
  401  ACAAAATGCA AATATTGTGG AGCTGAGCTA CCAGAGAGAC GGGCTATGTG 
         T  K  C   K  Y  C   G  A  E  L   P  E  R   R  A  M 
  451  GGGAAAACGT TTTTGTAGTG TATCATGTGG TAAAAGGTAC AGTGTAAAGT 
       W  G  K  R   F  C  S   V  S  C   G  K  R  Y   S  V  K 
A. MOLECULE INFORMATION ON Hydra PCG GENES 209
  501  GTTCAAAAAA AGCTAGGAAA GCTCTTCAAA GTATGTCTAC TTTAAAGAAT 
        C  S  K   K  A  R  K   A  L  Q   S  M  S   T  L  K  N 
  551  GATAAAAAGG TAAACTATAA GGAAAGTAAA TCCGAAAGAA CTAGGAAATC 
         D  K  K   V  N  Y   K  E  S  K   S  E  R   T  R  K 
         Exon 4  
  601  TGAG|AATTTG AATCTTTCAA GTAGAGAAGC TTCACCGGAT AGCACAAAGA 
       S  E    N  L   N  L  S   S  R  E   A  S  P  D   S  T  K 
                            Exon 5  
  651  AAAATTTGTT AAAATACCAA G|ATTCTGAAT CCACATTATG CTTTCCTCCA 
        K  N  L   L  K  Y  Q     D  S  E   S  T  L   C  F  P  P 
  701  CGAGATCCTT TGGGTTTTGG TCTTGATGTT TTTGATTTTG AAGATGAACT 
         R  D  P   L  G  F   G  L  D  V   F  D  F   E  D  E 
  751  TTATGATGGC ATTGAGCCTA TCCAAAATTA CTCATTTTTA CCATTAGTAA 
       L  Y  D  G   I  E  P   I  Q  N   Y  S  F  L   P  L  V 
                                          Exon 6  
  801  CATGGTCTGT TAACCAAGTT TCGGACTATA TAAG|CACGAT TCCCGGATGC 
        T  W  S   V  N  Q  V   S  D  Y   I    S  T   I  P  G  C 
SAM domain 
  851  GCTCAATACG TGCCAGTTTT TGAAGCTGAA GAGATTGACG GTCAGGCATT 
         A  Q  Y   V  P  V   F  E  A  E   E  I  D   G  Q  A 
  901  ATTGTTATTA AAGGTAGAAC ATATGGTTCA CGGTATGAAT ATCAAGGTTG 
       L  L  L  L   K  V  E   H  M  V   H  G  M  N   I  K  V 
  951  GACCTGCTAT TAAAATTGCT GCCACTATAC GTTCAATCAA GTTAAAGTAT 
        G  P  A   I  K  I  A   A  T  I   R  S  I   K  L  K  Y 
 1001  GGAATTAAAA CTAGATCGAA GTATTTAAGT TCACCATAGt tttaagatcg 
         G  I  K   T  R  S   K  Y  L  S   S  P  *    
 1051  ccatagcttt gcgcaaactc taatgcttca gttttaatca acaacggtgt 
 1101  ctttcatgat atataggagg aacaagattc aaatatcttt gttttgattg 
 1151  aaaacttctt ggctgctatt ggattgttca tagaatattg attttaatgg 
 1201  aagtttagat attaaatttc ataaaattcg aaaatacatg tagtgaatag 
 1251  acaacagaaa gtgcaacaga gtatgttaaa atgcgtaatg cgctagtgaa 
 1301  tatttttcga gtttattatt cattgttgca aataaaaggt tcactaaatt 
 1351  tgacttgctt ctgaatttat ggttaaagtc taaaaactgc tacaagagca 
 1401  tttttttttt tacttgcaac caaattgagc gatgttgacc agttaaccat 
 1451  taagattctt ttaatccact gacattttga actacaaatg taatttctta 
 1501  ttttgtagtt tgagttagta ttaactagcc ttagtgaaaa aatcctgaaa 
 1551  gatattatat aaaaatctct aaggactgtt ttatatgata ttggaacaag 
 1601  ttatgtttag aataaatgca ataggacgtg gcatatatgg ttaactatac 
 1651  gttgattcct agaggagttt tatacaatct tgctcaaaag tattatagtt 
 1701  taatgtattt ttattttgaa attttaacaa atatttaaaa tgtacagtta 
 1751  gcaattaaat gtaataagta tttatatata tgaatgttat aagaaaatta 
 1801  aaataaaaaa aaaaaaaa 
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Protein alignment: 
Comparison of HyPH with PH protein sequences from other species reveals a conservation on 
the  amino  acid  level  of  only  16%.  Areas  of  high  matches  are  highlighted  in  grey.  The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p   1 MDRRALKFMQKRADTESDTTTPVSTTASQGISASAILAGGTLPLKDNSNIREKPLHHNYN 
mouse Phc2        1 ----------------------------DTGSQNGHPEGGSHPPQRRFQHTSAVILQ--- 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2        1 ----------------------------------MCLRGGCSP------RAPAAAPQ--- 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p  61 HNNNNSSQHSHSHQQQQQQQVGGKQLERPLKCLETLAQKAGITFDEKYDVASPPHPGIAQ 
mouse Phc2       30 --------------------------------------------------VQPASPVTPQ 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2       18 --------------------------------------------------PRPPPALPPR 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH          1 -----------MAVSLVQKSNWTN------------------------------------ 
drosophila Ph-p 121 QQATSGTGPATGSGSVTPTSHRHGTPPTGRRQTHTPSTPNRPSAPSTPNTNCNSIARHTS 
mouse Phc2       40 QCAPDDWKEVVPAEKSVPVXR------PGPSPHQQAIIPAIP-----GG----------- 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2       28 PRAP------------VPASR------PG----RPLLTPARPCGRMRRG----------- 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p 181 LTLEKAQNPGQQVAATTTVPLQISPEQLQQFYASNPYAIQVKQEFPTHTTSGSGTELKHA 
mouse Phc2       78 -------LPGPK---SPNIQQCPAH------------------------ETGQG--IVHA 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2       55 -------SPGPRLGGSRGERRRPAGRDPARVGPGQGLRRPARPGPAAWTETGQG--IVHA 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH         14 ITD-------------TYSSADNCIKSKS------------------------------- 
drosophila Ph-p 241 TNIMEVQQQLQLQQQLSEANGGGAASAGAGGAASPANSQQSQQQQHSTAISTMSPMQLAA 
mouse Phc2      102 LTDLS-------SPGMTSGNGNSA--SSIAGTA--------------------------- 
xenopus PHC2      1 ---------------MTSGNGSSPVPTAATGNR--------------------------- 
human PHC2      106 LTDLS-------IPGMTSGNGNSA--SSIAGTA--------------------------- 
zebrafish PHC2    1 ---------------MTSGSGNNA--PTVTGSA--------------------------- 
 
hydra PH         30 --------------------------------DLFCNKHDESKVT--------------- 
drosophila Ph-p 301 ATGGVGGDWTQGRTVQLMQPSTSFLYPQMIVSGNLLHPGGLGQQPIQVITAGKPFQGNGP 
mouse Phc2      126 --------------------------PQ----------NGENKPP-QAIVK--------P 
xenopus PHC2     19 --------------------------TQ----------NGENKPP-QAVVK--------P 
human PHC2      130 --------------------------PQ----------NGENKPP-QAIVK--------P 
zebrafish PHC2   17 --------------------------PQ----------NGESKPPPQAVVK--------P 
 
hydra PH         43 -LLIHVIDGW-------------------------------------------------- 
drosophila Ph-p 361 QMLTTTTQNAKQMIGGQAGFAGGNYATCIPTNHNQSPQTVLFSPMNVISPQQQQNLLQSM 
mouse Phc2      141 QILTHVIE----------GF---------------------------------------- 
xenopus PHC2     34 QILTHFIE----------GF---------------------------------------- 
human PHC2      145 QILTHVIE----------GF---------------------------------------- 
zebrafish PHC2   33 QILTHVIE----------GF---------------------------------------- 
 
hydra PH         52 -------------------------------------------------IIEESN----- 
drosophila Ph-p 421 AAAAQQQQLTQQQQQFNQQQQQQLTQQQQQLTAALAKVGVDAQGKLAQKVVQKVTTTSSA 
mouse Phc2      151 -------------------------------------------------VIQE------- 
xenopus PHC2     44 -------------------------------------------------VIQE------- 
human PHC2      155 -------------------------------------------------VIQE------- 
zebrafish PHC2   43 -------------------------------------------------VIQE------- 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p 481 VQAATGPGSTGSTQTQQVQQVQQQQQQTTQTTQQCVQVSQSTLPVGVGGQSVQTAQLLNA 
mouse Phc2          ------------------------------------------------------------ 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2          ------------------------------------------------------------ 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH         58 ------------------QPFKDSNIDENIN---------------GGVKS--------- 
drosophila Ph-p 541 GQAQQMQIPWFLQNAAGLQPFGPNQIILRNQPDGTQGMFIQQQPATQTLQTQQNQIIQCN 
mouse Phc2      155 ----------------GAEPF-P---------VGRSSLLV------GNLKKKYAQ----- 
xenopus PHC2     48 ----------------GAQPF-PSHRSRAVLEVGHSSLLT------G-AQEKYQQ----- 
human PHC2      159 ----------------GAD-----------VSRWDARLLV------GNLKKKYAQ----- 
zebrafish PHC2   47 ----------------GAEPF-P---------VERPSLLI------ENLKQKQHH----- 
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hydra PH         76 ---------------LAENGKCSDDFV-------EVQEKEINTVQPNLEDKDELMSLLP- 
drosophila Ph-p 601 VTQTPTKARTQLDALAPKQQQQQQQVGTTNQTQQQQLAVATAQLQQQQQQLTAAALQRPG 
mouse Phc2      178 -------------GFLPEKPPQQDH---TTTTDSEMEE---PYLQESKEE---------G 
xenopus PHC2     79 -------------SLLAEKVPQQDNNTTTTTTDSEMEETLVPGFPESKGD---------G 
human PHC2      181 -------------GFLPEKLPQQDH---TTTTDSEMEE---PYLQESKEE---------G 
zebrafish PHC2   70 -------------AY----SDLQKH-----NADSEMEDLS---LQELNNQ---------P 
 
hydra PH        113 ---------------------------------------------TKCKYCGA------- 
drosophila Ph-p 661 APVMPHNGTQVRPASSVSTQTAQNQSLLKAKMRNKQQPVRPALATLKTEI-GQVAGQNKV 
mouse Phc2      210 TPL-----------------------------------------KLKCELCGRVDFAYKF 
xenopus PHC2    117 DPP-----------------------------------------KLKCELCGRVDFEYKF 
human PHC2      213 APL-----------------------------------------KLKCELCGRVDFAYKF 
zebrafish PHC2   96 EPV-----------------------------------------RT-CEFCGNVDFAFNF 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p 720 VGHLTTVQQQQQATNLQQVVNAAGNKMVVMSTTGTPITLQNGQTLHAATAAGVDKQQQQL 
mouse Phc2          ------------------------------------------------------------ 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2          ------------------------------------------------------------ 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p 780 QLFQKQQILQQQQMLQQQIAAIQMQQQQAAVQAQQQQQQQVSQQQQVNAQQQQAVAQQQQ 
mouse Phc2          ------------------------------------------------------------ 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2          ------------------------------------------------------------ 
zebrafish PHC2      ------------------------------------------------------------ 
 
hydra PH        121 --ELPERRAMWGKRFCSVSCG--------------------------------------- 
drosophila Ph-p 840 AVAQAQQQQREQQQQVAQAQAQHQQALANATQQILQVAPNQFITSHQQQQQQQLHNQLIQ 
mouse Phc2      229 ---------KRSKRFCSMACA--------------------------------------- 
xenopus PHC2    136 ---------KRSKRFCSMACA--------------------------------------- 
human PHC2      232 ---------KRSKRFCSMACA--------------------------------------- 
zebrafish PHC2  114 ---------KRSKRFCSTVCA--------------------------------------- 
 
hydra PH        140 ---------------------------KRYSVK---------CSKKA---------RKAL 
drosophila Ph-p 900 QQLQQQAQAQVQAQVQAQAQQQQQQREQQQNIIQQIVVQQSGATSQQTSQQQQHHQSGQL 
mouse Phc2      241 ---------------------------KRYNV---------GCT-KRVGLF--HSDRSKL 
xenopus PHC2    148 ---------------------------KRYNV---------GCT-KRVGLF--HPDRSKL 
human PHC2      244 ---------------------------KRYNV---------GCT-KRVGLF--HSDRSKL 
zebrafish PHC2  126 ---------------------------KRYNV---------GCT-KRMGLFPGKSSPEDT 
 
hydra PH        155 QS---------------------------------------------------------- 
drosophila Ph-p 960 QLSSVPFSVSSSTTPAGIATSSALQAALSASGAIFQTAKPGTCSSSSPTSSVVTITNQSS 
mouse Phc2      262 Q-------------KAGTTTHNRRRA--------------------------------SK 
xenopus PHC2    169 Q-------------KPTVAKHARRRS--------------------------------RK 
human PHC2      265 Q-------------KAGAATHNRRRP--------------------------------AK 
zebrafish PHC2  149 K-------------KPKASDESPKNC--------------------------------S- 
 
hydra PH        157 --MSTLKNDKKVNY---------------------------------------------- 
drosophila Ph-p1020 TPLVTSSTVASIQQAQTQSAQVHQHQQLISATIAGGTQQQPQGPPSLTPTTNPILAMTSM 
mouse Phc2      277 ASLPTLTKDTKKQPS--------------------------------------------- 
xenopus PHC2    184 TPLQTVGADPKKQQA--------------------------------------------- 
human PHC2      280 PVCHHLPRIPRSSQQ--------------------------------------------- 
zebrafish PHC2  163 --TETRKRNPSIQTT--------------------------------------------- 
 
hydra PH            ------------------------------------------------------------ 
drosophila Ph-p1080 MNATVGHLSTAPPVTVSVTSTAVTSSPGQLVLLSTASSGGGGSIPATPTKETPSKGPTAT 
mouse Phc2      292 ----------------------------------------GTV-------------PLSV 
xenopus PHC2    199 ----------------------------------------APVTPMNP-------GPIPS 
human PHC2      295 ----------------------------------------A-LCPFR------------- 
zebrafish PHC2  176 ----------------------------------------TGASLFSP-------HP--- 
 
hydra PH        169 ----------------------------KESKSERTRK---------SENLN-------- 
drosophila Ph-p1140 LVPIGSPKTPVSGKDTCTTPKSSTPATVSASVEASSSTGEALSNGDASDRSSTPSKGATT 
mouse Phc2      299 TAAL----------------------QLAHSQEDSSR---------CSDNSS-------- 
xenopus PHC2    212 PSAL----------------------KLSNSQEDSSR---------CSDNSS-------- 
human PHC2      301 LLLL----------------------CVTHSQEDSSR---------CSDNSS-------- 
zebrafish PHC2  186 ----------------------------SHHGE-SSQ---------CSDMSS-------- 
 
hydra PH        184 ----------------------------------------------------------LS 
drosophila Ph-p1200 PTSKQSNAAVQPPSSTTPNSVSGKEEPKLATCGSLTSATSTSTTTTITNGIGVARTTAST 
mouse Phc2      320 -----------------------YEEP-------------------------------LS 
xenopus PHC2    233 -----------------------YEEP-------------------------------LS 
human PHC2      322 -----------------------YEEP-------------------------------LS 
zebrafish PHC2  200 -----------------------YEEP-------------------------------IS 
 
hydra PH        186 SREASPDSTKKNLLKY----------------------------------------QDSE 
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drosophila Ph-p1260 AVSTASTTTTSSGTFITSCTSTTTTTTSSISNGSKDLPKAMIKPNVLTHVIDGFIIQEAN 
mouse Phc2      326 PISASSSTSRR---------------------------------------------RQGQ 
xenopus PHC2    239 PMSASSSLSRA---------------------------------------------RQ-E 
human PHC2      328 PISASSSTSAG---------------------------------------------DKAS 
zebrafish PHC2  206 PLS-NSSFGAP---------------------------------------------IEHE 
 
hydra PH        206 STLCFPP---RDPLGFGL------------------------------------------ 
drosophila Ph-p1320 EPFPVTRQRYADKDVSDEPPKKKATMQEDIKLSGIASAPGSDMVACEQCGKMEHKAKLKR 
mouse Phc2      341 RDLDLPDMHMRD-------------------LVGV-------------GH---------- 
xenopus PHC2    253 HNVEPPNLHSRD-------------------PIAM-------------SQ---------- 
human PHC2      343 GTWSSP--------------------------TCI-------------CG---------- 
zebrafish PHC2  220 ESFD----HSRE-------------------LTPL-------------LT---------- 
 
hydra PH        221 --------------------------------------------DVFDFEDELYDGIEPI 
drosophila Ph-p1380 KRYCSPGCSRQAKNGIGGVGSGETNGLGTGGIVGVDAMALVDRLDEAMAEEKMQTEATPK 
mouse Phc2      359 --------------------------------------------H-FLPSEP-------- 
xenopus PHC2    271 --------------------------------------------D-FLPSDP-------- 
human PHC2      354 --------------------------------------------T-WWAWDT-------- 
zebrafish PHC2  234 --------------------------------------------QHFLASDP-------- 
 
hydra PH        237 QNYSFLPL---------------------------------------------------- 
drosophila Ph-p1440 LSESFPILGASTEVPPMSLPVQAAISAPSPLAMPLGSPLSVALPTLAPLSVVTSGAAPKS 
mouse Phc2          ------------------------------------------------------------ 
xenopus PHC2        ------------------------------------------------------------ 
human PHC2          ------------------------------------------------------------ 
zebrafish PHC2      ------------------------------------------------------------ 
                         ----------------S A M  d o m a i n--------------------- 
hydra PH        245 -----VTW------SVNQVSDYISTIPGCAQYVPVFEAEEIDGQALLLLKVEHMVHGMNI 
drosophila Ph-p1500 SEVNGTDRPPISSWSVDDVSNFIRELPGCQDYVDDFIQQEIDGQALLLLKEKHLVNAMGM 
mouse Phc2      366 -----TKW------NVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLMSAMNI 
xenopus PHC2    278 -----TKW------NVEDVYDFVRSLPGCQEISEEFRAQEIDGQALLLLKEDHLMSAMNI 
human PHC2      361 -----TSCQVSHQVNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLMSVMNI 
zebrafish PHC2  242 -----TKW------KVEDVYEFICSLPGCHEIAEEFRSQEIDGQALMLLKEDHLMSTMNI 
                    S A M  d o m a i n 
hydra PH        294 KVGPAIKIAATIRSIKLKYGIKTRSKYLSSP 
drosophila Ph-p1560 KLGPALKIVAKVESIKEVPPPGEAKDPGAQ- 
mouse Phc2      415 KLGPALKIYARISMLKDS------------- 
xenopus PHC2    327 KLGPALKLYARISMLKDS------------- 
human PHC2      416 KLGPALKIYARISMLKDS------------- 
zebrafish PHC2  291 KLGPALKIFARISMLKDS------------- 
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HyPSC 
 
From gene to protein: 
The HyPSC gene is composed of 10 exons and spans a genomic region of ~ 6 kb. The respective 
exon  and  intron  lengths  are  indicated.  Based  on  a  ~  1  kb  mRNA,  a  protein  of  254  aa  is 
translated. 
 
 
 
 
Sequence information: 
Nucleotide  and derived  amino  acid  sequence  of HyPSC  from Hydra magnipapillata  105.   The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the  polyadenylation  site  is  indicated  by  underlined  nucleotides.  The  trans‐spliced  leader 
sequence  is  marked  by  a  dashed  line.  The  translation  initiation  start  and  stop  codons  are 
highlighted in red. The coding sequence and the derived amino acid sequence are indicated by 
capital letters. The protein domains are indicated. The RING finger is highlighted in light red. 
 
 
 Exon 1  
   1  ggacactgac atggactgaa ggagtagaaa acggaaaaaa acacatactg 
  51  aaacttttta gtccctgtgt aataagtaaa gctataaata tatttgtaaa 
                                             Exon 2  
 101  ctattaccaa aaatATGGAA GAAAAGAACT CACATAAG|GT TTCCATCAAG 
                       M  E   E  K  N   S  H  K     V  S  I  K 
 151  TTACGAGATC TGAATCCTTA TTTGGTTTGT ATGCTTTGTG CTGGATATTT 
        L  R  D   L  N  P   Y  L  V  C   M  L  C   A  G  Y 
            RING finger                      Exon 3  
 201  TGTAGATGCC ACAACTATTA TAGAATGCTT GCATACAT|TT TGCAAAAGTT 
      F  V  D  A   T  T  I   I  E  C   L  H  T    F   C  K  S 
 251  GCATAGTTCG ACATCTTCAA TCCAGTAAAC GATGTCCTAC TTGTAATATT 
       C  I  V   R  H  L  Q   S  S  K   R  C  P   T  C  N  I 
                                          Exon 4  
 301  CAAATTCACG AGACTGAACC CATGTCTAAA CTTAT|GCTTG ACCGAACCAT 
        Q  I  H   E  T  E   P  M  S  K   L    M   L   D  R  T 
                                                Exon 5  
 351  GCAAGATATC ATTCAAAAGT TGATACCATG GGTTTTTATT G|ATGAAAGTC 
      M  Q  D  I   I  Q  K   L  I  P   W  V  F  I     D  E  S 
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                                                        Exon 6  
 401  GTCGTGCACA AGACTTTGGA TGTAAATTAA ACAAGCAAGT TGTGACAG|AT 
       R  R  A   Q  D  F  G   C  K  L   N  K  Q   V  V  T    D 
 451  ATACCTAAAA ATGATTTTCA AAAACTTGAG TTGGTAGAAC TAAAGAATAG 
        I  P  K   N  D  F   Q  K  L  E   L  V  E   L  K  N 
                                                     Exon 7  
 501  TTATTTAAGC GATGAACAGA TCAATTTGTG TTTATGTTTG GAAAG|ACGTC 
      S  Y  L  S   D  E  Q   I  N  L   C  L  C  L   E    R  R 
                                   Exon 8  
 551  CGGATTTTTT CGCTCAAATG AAATTGGAG|G AAATCGAACA TAAATACGTG 
       P  D  F   F  A  Q  M   K  L  E     E  I  E   H  K  Y  V 
 601  CGCTGTTCAT TCCGATCGCA TATACACCAT ATTCGCCATT TATTGAGTAA 
        R  C  S   F  R  S   H  I  H  H   I  R  H   L  L  S 
                                      Exon 9  
 651  ACTATACGAC ATTTCTCTCA AAGACTACAA G|ATTCAAATC TCGTGTGATG 
      K  L  Y  D   I  S  L   K  D  Y   K    I  Q  I   S  C  D 
 701  GAAAAATATT ATCTGATTTA AATAATCTGA AATTGATATA TTTTGTACAT 
       G  K  I   L  S  D  L   N  N  L   K  L  I   Y  F  V  H 
                 Exon 10  
 751  TGGAAATGCA AG|TCTCAACC AATGGTCTTA ACTTATACTA TAGAAGAAAA 
        W  K  C   K    S  Q   P  M  V  L   T  Y  T   I  E  E 
 801  AGAAGAAAAC ATCGTCGCTA ATATTGTAGA AAGATTGCTT CAATACGTCA 
      K  E  E  N   I  V  A   N  I  V   E  R  L  L   Q  Y  V 
 851  TATGTAATAG ATTCGAAATA GTTTGTTAAa gataaagtta taactgtttt 
       I  C  N   R  F  E  I   V  C  *    
 901  tactggcaaa aaaaaaaaa 
 
 
Protein alignment: 
Comparison of HyPSC with PSC protein sequences from other species reveals a conservation on 
the amino acid  level of 21%. Areas of high matches are highlighted  in grey. The BLOSUM62 
matrix was used for the multi‐way protein sequence alignment. 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc    1 MMTPESKAIQPAAATTKQTAEATATTTMAHTQQKSQLSTLAKTTTTTATNKAAKSVVSNA 
 
hydra PSC         1 -----------------------------------------MEEKNSHKVS-IK------ 
human BMI1        1 ----------------------------------------------MHRTTRIK------ 
mouse Bmi1        1 ----------------------------------------------MHRTTRIK------ 
xenopus BMI1      1 ----------------------------------------------MHRTTRIK------ 
zebrafish BMI1    1 ----------------------------------------------MHRTTRIK------ 
drosophila Psc   61 NSSGNNSSKKLALSQSQKTTTTTTPPTTTTTTTAAAAAEATTNADKMQKQQQLKQQLFAA 
 
hydra PSc           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc  121 CSIKVKSENTLATTANAALAAATTTTTTATPALATGKAAKTILENGIKKESTPPAVESVE 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc  181 ASSSSSSSSSSSSSSSSSWPTTRRATSEDASSNGGASADEEKSEEDPTAAVAASSTATTT 
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                                          ---------R I N G  f i n g e r--------- 
hydra PSC        13 -------------LRDLNPYLVCMLCAGYFVDATTIIECLHTFCKSCIVRHLQSSKRCPT 
human BMI1        9 -------------ITELNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLETSKYCPI 
mouse Bmi1        9 -------------ITELNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLETSKYCPI 
xenopus BMI1      9 -------------ITELNPHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLETSKYCPI 
zebrafish BMI1    9 -------------ITELNPHLMCVLCGGYFIDATTIIECLHSFCKMCIVRYLETSKYCPI 
drosophila Psc  241 SDLATTSRPRPVLLTAVNPHIICHLCQGYLINATTIVECLHSFCHSCLINHLRKERFCPR 
                    - 
hydra PSC        60 CNIQIHETEPMSKLMLDRTMQDIIQKLIPWVFIDESRRAQDF-----------GCKLNKQ 
human BMI1       56 CDVQVHKTRPLLNIRSDKTLQDIVYKLVPGLFKNEMKRRRDFYAAHPSADAANGSNEDRG 
mouse Bmi1       56 CDVQVHKTRPLLNIRSDKTLQDIVYKLVPGLFKNEMKRRRDFYAAHPSADAANGSNEDRG 
xenopus BMI1     56 CDVQVHKTRPLLNIRADKTLQDIVYKLVPGLFKGEMKRRRDFYAAHPSADVANGSNEDRG 
zebrafish BMI1   56 CDVQVHKTKPLLNIRSDKTLQDIVYKLVPGLFKNEMKRRRDFYAEHPSVDAANGSNEDRG 
drosophila Psc  301 CEMVINNAKP--NIKSDTTLQAIVYKLVPGLYERELMRKRAFYKDRPE-EAALATPEQRG 
 
hydra PSC       109 VVTDIPKNDFQKLELVELKNSYLSDEQINLCLCLERRPDFFAQMKLEEIEHKYVRCSFRS 
human BMI1      116 EVADEDKRIITDDEIISLSIEFFDQNRLDRK--VNKDKE---KSKEEVNDKRYLRCPAAM 
mouse Bmi1      116 EVADEEKRIITDDEIISLSIEFFDQSRLDRK--VN--KE---KPKEEVNDKRYLRCPAAM 
xenopus BMI1    116 EVADEDKRIITDDEIISLSIEFFDQNKADRKGSKDKDKE---KSKDETNDKRYLRCPAAL 
zebrafish BMI1  116 EVADEDKRIITDDEIISLSIEFFDH----RAQQQGCTEE---RQKEEVNNKRYLQCPAAM 
drosophila Psc  358 D--DTEHLIFSPSDDMSLSLEYAELGEL------KTDSE---PELVDTLRPRYLQCPAMC 
 
hydra PSC       169 HIHHIRHLLSKLYDISLKDYKIQISCDGK--ILSDLNNLKLIYFVHWKCKSQPMVLTYTI 
human BMI1      171 TVMHLRKFLRSKMDIP-NTFQIDVMYEEEP--LKDYYTLMDIAYIYTWRRNGPLPLKYRV 
mouse Bmi1      169 TVMHLRKFLRSKMDIP-NTFQIDVMYEEEP--LKDYYTLMDIAYIYTWRRNGPLPLKYRV 
xenopus BMI1    173 TIMHLRKFLRSKMDIP-SNFQIDVMYEEEA--LKDYYTLMDIAYIYTWRRNGPLPLKYRV 
zebrafish BMI1  169 TVMHLRKFLRSKMDIP-PTYQIEVMYEDEP--LKDYYTLMDIAYIYTWRRNGPLPLKYRV 
drosophila Psc  407 RVSHLKKFVYDKFEIDAQRFSIDIMYKVKTIVLLDYYTLMDIAYIYTWKRDAPMRFYYRV 
 
hydra PSC       227 EEKEENIVANIVERLLQYVICNRFEIVC-------------------------------- 
human BMI1      228 --------RPTCKRM-----------------------------------------KISH 
mouse Bmi1      226 --------RPTCKRM-----------------------------------------KMSH 
xenopus BMI1    230 --------RPTCKRV-----------------------------------------KINP 
zebrafish BMI1  226 --------RPSCKKM-----------------------------------------KITH 
drosophila Psc  467 YESPQPLVKPAPRRVLPLKLEKQERENQEQQLAVEVASSKVEPVSLPEDQKAEASIKVEE 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1      239 Q----------------------------------------------------------- 
mouse Bmi1      237 Q----------------------------------------------------------- 
xenopus BMI1    241 H----------------------------------------------------------- 
zebrafish BMI1  237 P----------------------------------------------------------- 
drosophila Psc  527 QESTREIVKEVIKDVAATPPTETLKLVINRNMLDKREKSHSPQMSSKSSSKSSPCTPVSS 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1      240 -----------------------------------------------RDG---------- 
mouse Bmi1      238 -----------------------------------------------RDG---------- 
xenopus BMI1    242 -----------------------------------------------TDR---------- 
zebrafish BMI1  238 -----------------------------------------------QEG---------- 
drosophila Psc  587 PSEPNIKLKIDLSKQNSVTIIDMSDPERREIVKPLKPEKESRSKKKDKDGSPKSSSSSSS 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc  647 SSSGERKRKSPSPLTVPPLTIRTERIMSPSGVSTLSPRVTSGAFSEDPKSEFLKSFALKP 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1      243 -----------LTN-A-------------------------------------------- 
mouse Bmi1      241 -----------LTN-A-------------------------------------------- 
xenopus BMI1    245 -----------INHTS-------------------------------------------- 
zebrafish BMI1  241 -----------LNN-A-------------------------------------------- 
drosophila Psc  707 IKVKVESPERTLNNRAITPPSPSVQQSASPKSKGNNLDDSILMKPPSCMPPKSIASSKRK 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc  767 SKEPVKAVSKKQKLSPPLPTVDFKIRLPVTNGNSSGTASPKIEKPLMPPPAKPPMLAPRK 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc  827 LQPSAQFAPPPSPIHHHAGVQMSAPGNRTPIAKRYQPILPKASRPNPFANIPNDVNRLLK 
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hydra PSC           ------------------------------------------------------------ 
human BMI1      247 -----------GELESDS------------GSDKANSPA-----------------GGIP 
mouse Bmi1      245 -----------GELESDS------------GSDKANSPA-----------------GGVP 
xenopus BMI1    250 -----------GDMESDS------------GSDKAGSLG-----------------VVIP 
zebrafish BMI1  245 -----------NRSESDS------------ASDKACSPA------------------GVP 
drosophila Psc  887 DAGTEIKSIGGGSVENNSNAAQKPHLYGPKGESKMGPPALPATTPSQGNKNVGKQAGNLP 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1      267 --------------------STSSC------------LPSPSTPVQSPH----------P 
mouse Bmi1      265 --------------------STSSC------------LPSPSTPVQSPH----------P 
xenopus BMI1    270 --------------------STSSC------------IPSP--PVQSPH----------P 
zebrafish BMI1  264 --------------------STSSP------------LPSPSTLVQPSQ----------P 
drosophila Psc  947 MSAPPNKGNSSNNYLNLALFNSSKCKGKEAPPGCRTPMYTPNSPIYSPSSPQYVPSYNIP 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1      285 QFPHISSTMNGTSNSPSGNHQSS------------------FANRPRKSSVN-------- 
mouse Bmi1      283 QFPHISSTMNGTSNSPSANHQSS------------------FASRPRKSSLN-------- 
xenopus BMI1    286 HFPHISSTINGTSSS-SSSHQNP------------------FTNRARKISLN-------- 
zebrafish BMI1  282 HFTHISSPINGTTMT-SPNRQFN------------------FS-KVRKSALN-------- 
drosophila Psc 1007 TMPTYKYTPKPTPNSGSGNGGSGSYLQNMLGGGNGGSLGGLFPSPPTKSDQNTNPAQGGG 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1      319 -GSSATSSG--------------------------------------------------- 
mouse Bmi1      317 -GSSATSSG--------------------------------------------------- 
xenopus BMI1    319 -GVSAISSG--------------------------------------------------- 
zebrafish BMI1  314 -GSS-TSSG--------------------------------------------------- 
drosophila Psc 1067 GSSSATQSGGNNGIVNNNIYMPNEDAPEKQQVKVKSLLNSCNINIPSSLSITISRDNGDS 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1127 SSPNNGQHPKHKSPVNNYIEIVKLPDQPQDQVQAAKEAQKRQSPPAAVPGHLAAKLPPPP 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1187 PSKAIPSPQHLVSRMTPPQLPKVATPPPPSSPRVITPPKTSPPANAAKVTPLKPVLTPTQ 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1247 VDKKTPSPEKRTAAQMGSHSPTASENKSPKGGPAGVANSTGGAQNGDPAAKKFRPILPRQ 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1307 NGMPELAPKLPTLAPFVGFNPLQNPAAGKKVPPSKKSPNAGAAAHQSGQQKLVNGGQSQP 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1367 AQQKTSPPAQKNQQQVKKVSKNPTPPPPSLPAVGKMMPHPVMHSQNAPLSIASSASAAAV 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1427 ASGQLDLSNFLKENLRRVHAAQAAQAAQVAAAANQSNMMYNLAQMGHMTPAMYNYQQAYF 
 
hydra PSC           ------------------------------------------------------------ 
human BMI1          ------------------------------------------------------------ 
mouse Bmi1          ------------------------------------------------------------ 
xenopus BMI1        ------------------------------------------------------------ 
zebrafish BMI1      ------------------------------------------------------------ 
drosophila Psc 1487 REQLSRMQRVGNEVFNDYLQKLKTAAATGGGGPVEGELKPMLPTVTLPSPGATPPAASPK 
 
hydra PSC           ------------------------------------------------------- 
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human BMI1          ------------------------------------------------------- 
mouse Bmi1          ------------------------------------------------------- 
xenopus BMI1        ------------------------------------------------------- 
zebrafish BMI1      ------------------------------------------------------- 
drosophila Psc 1547 TSPLPAGKLTAAATAPQTKGNSSSGAANARQQTAATGNNGATVPAASLPPATKSK 
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HyRING   
 
From gene to protein: 
The HyRING gene is composed of 5 exons and spans a genomic region of > 20 kb. The respective 
exon  and  intron  lengths  are  indicated.  Based  on  a  ~  1.2  kb  mRNA,  a  protein  of  325  aa  is 
translated. 
 
 
 
 
Sequence information: 
Nucleotide and derived amino acid sequence of HyRING  from Hydra magnipapillata 105.   The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the  polyadenylation  site  is  indicated  by  underlined  nucleotides.  The  trans‐spliced  leader 
sequence  is  marked  by  a  dashed  line.  The  translation  initiation  start  and  stop  codons  are 
highlighted in red. The coding sequence and the derived amino acid sequence are indicated by 
capital letters. The protein domains are indicated. The RING finger is highlighted in light red. 
 
 
  Exon 1  
    1  acggaaaaaa acacatactg aaacttttta gtccctgtgt aataagctgt 
   51  ttaaaataac gatgcaaaat ttttcgcata taattcagta ccatataatc 
                    Exon 2  
  101  agttgcatat aatc|agtttc gaagctagct aacccaaaat ttgtgtctgc 
  151  ataaaaaata tttgtgatat gtaaatgtag tctatgATGT CACAGTCTGC 
                                                M   S  Q  S 
  201  ACAAGGTCTT CAACAACCAA AATCTTGGGA ACTGAGTTTG TATGAGCTTC 
       A  Q  G  L   Q  Q  P   K  S  W   E  L  S  L   Y  E  L 
  251  ATCGAACACC ACAAGAAGTT ATTACAGATG ATACAGAAAT TGCTATATCA 
        H  R  T   P  Q  E  V   I  T  D   D  T  E   I  A  I  S 
  301  CCGAGATCTC TTCATAGCGA ACTTATGTGT CCAATTTGTT TAGATATGTT 
         P  R  S   L  H  S   E  L  M  C   P  I  C   L  D  M 
RING finger 
  351  AACTAATACT ATGACAACAA AGGAATGCTT ACATAGGTTT TGTCATGATT 
       L  T  N  T   M  T  T   K  E  C   L  H  R  F   C  H  D 
  401  GTATAATAAC CGCTTTAAGA GCTGGGAACA AAGAGTGTCC TACATGTAGA 
        C  I  I   T  A  L  R   A  G  N   K  E  C   P  T  C  R 
  451  AAAAAGTTAA TATCAAAAAG ATCACTGAGA CCCGATCCTA ACTTTGATTC 
         K  K  L   I  S  K   R  S  L  R   P  D  P   N  F  D 
A. MOLECULE INFORMATION ON Hydra PCG GENES 219
                   Exon 3  
  501  TCTAATTGCA AAG|ATATATC CTAATCGAGA CGAGTATGAA GCTCATCAAG 
       S  L  I  A   K    I  Y   P  N  R   D  E  Y  E   A  H  Q 
  551  AACAGGCACT TGAAAAGTTA CATCAACATA CCAATCAGCA AGCACTGACC 
        E  Q  A   L  E  K  L   H  Q  H   T  N  Q   Q  A  L  T 
                                                  Exon 4  
  601  AACAGTATAG AAGAAGGTCT TCGTATTCAA GCTAGAAACA G|ACTGAACCG 
         N  S  I   E  E  G   L  R  I  Q   A  R  N     R  L  N 
  651  AATGCTTAAA CAACAGCGCA AGCAAGCAGA ACATGCTCTA GTTGATCATT 
       R  M  L  K   Q  Q  R   K  Q  A   E  H  A  L   V  D  H 
                                                   Exon 5  
  701  CAGCGACTGT TAAAGAGGAA GATAGCCCAG TAATTTCACA AG|ATTCTGGT 
        S  A  T   V  K  E  E   D  S  P   V  I  S   Q    D  S  G 
  751  GAAATGTCGA CAGAAAATAA CGATTCAGCA GTTATGACTG GAAAACATAA 
         E  M  S   T  E  N   N  D  S  A   V  M  T   G  K  H 
  801  AGTTTCGAAG AGAAAACACA AAGATTCTAC TGGTTCTCTT ACCGATAATT 
       K  V  S  K   R  K  H   K  D  S   T  G  S  L   T  D  N 
  851  CAAACTTTTT AAATAATGAA GTAAACGAGG TAGAAGTGCT GTTTCACCCT 
        S  N  F   L  N  N  E   V  N  E   V  E  V   L  F  H  P 
  901  CATCCTGCTT GTGATATTCT TAAACACTTT AAATCGCGAT ATTTAAAAAC 
         H  P  A   C  D  I   L  K  H  F   K  S  R   Y  L  K 
  951  TACGGGAATT GCAACTGTTG CTCATTTGTG TCAATTTTTA GTTACAAGAA 
       T  T  G  I   A  T  V   A  H  L   C  Q  F  L   V  T  R 
 1001  TTTCTCTAGA AGAAATAACT CCGTGTATCG ACTTTGAAGT GTTGGTACGT 
        I  S  L   E  E  I  T   P  C  I   D  F  E   V  L  V  R 
 1051  ACGGTCGGGG AATATCAGAA ACTTGAAAAA CATTTAACTC TTGCAGAAAT 
         T  V  G   E  Y  Q   K  L  E  K   H  L  T   L  A  E 
 1101  TAAACAGCTT TATTCAAAAG ATTCGACACC ACTTGAACTT TTTTTTTCAA 
       I  K  Q  L   Y  S  K   D  S  T   P  L  E  L   F  F  S 
 1151  GTGAAAATCG GTAAtttgtt taaaaactaa atagtttaaa caaaaaaaaa 
        S  E  N   R  *  
 1201  aaaaaaaaaa aaaaaaaa 
  
 
Protein alignment: 
Comparison of HyRING with RING protein  sequences  from other  species  reveals  significant 
conservation on the amino acid level (44%). Areas of high matches are highlighted in grey. The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
                                                                      ---------- 
hydra RING        1 MSQSAQ--GLQQ-PKSWELSLYELHRTPQEVITDDTEIAISPRSLHSELMCPICLDMLTN 
drosophila Sce    1 -----MTSLDPAPNKTWELSLYELQRKPQEVITDSTEIAVSPRSLHSELMCPICLDMLKK 
mouse Rnf2        1 MSQAVQTNGTQPLSKTWELSLYELQRTPQEAITDGLEIVVSPRSLHSELMCPICLDMLKN 
human RNF2        1 MSQAVQTNGTQPLSKTWELSLYELQRTPQEAITDGLEIVVSPRSLHSELMCPICLDMLKN 
xenopus RNF2      1 MAQAVQTNGAQPLSKTWELSLYELQRTPQEAITDGLEIVVSPRSLHSELMCPICLDMLKN 
zebrafish RNF2    1 MTQTVQTNGVQPLSKTWELSLYELQRTPQEAITDGLEIAVSPRSLHSELMCPICLDMLKN 
                    ----R I N G  f i n g e r------ 
hydra RING       58 TMTTKECLHRFCHDCIITALRAGNKECPTCRKKLISKRSLRPDPNFDSLIAKIYPNRDEY 
drosophila Sce   56 TMTTKECLHRFCSDCIVTALRSGNKECPTCRKKLVSKRSLRADPNFDLLISKIYPSREEY 
mouse Rnf2       61 TMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIYPSRDEY 
human RNF2       61 TMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIYPSRDEY 
xenopus RNF2     61 TMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIYPSRDEY 
zebrafish RNF2   61 TMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIYPSRDEY 
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hydra RING      118 EAHQEQALEKLHQHTNQQALTNSIEEGLRIQARNRLNRMLKQQRKQAEHA---------- 
drosophila Sce  116 EAIQEKVMAKFNQTQSQQALVNSINEGIKLQSQNRPQRFRTKGGGGGGGGGGNGNGAANV 
mouse Rnf2      121 EAHQERVLARINKHNNQQALSHSIEEGLKIQAMNRLQRGKKQQIENGSGAEDNGD----- 
human RNF2      121 EAHQERVLARINKHNNQQALSHSIEEGLKIQAMNRLQRGKKQQIENGSGAEDNGD----- 
xenopus RNF2    121 EAHQERVLARINKHNNQQALSHSIEEGLKIQALNRLPRGKKQQVENGSGAEDNAD----- 
zebrafish RNF2  121 EAHQERVLARISKHNNQQALSHSIEEGLKIQAMNRLQRGKKHQIENGSGAEDNGD----- 
 
hydra RING      168 ------------------------LVDHSATVKEEDSPVISQDSGEMSTENNDSAVMTGK 
drosophila Sce  176 AAPPAPGAPTAVGRNASNQMHVHDTASNDSNSNTNSIDRENRDPGHSGTSAASAITSASN 
mouse Rnf2      176 -------------------------SSHCSNASTHS----NQEAG------------PSN 
human RNF2      176 -------------------------SSHCSNASTHS----NQEAG------------PSN 
xenopus RNF2    176 -------------------------SSHCSNASVHS----NQEAG------------PSN 
zebrafish RNF2  176 -------------------------SSHCSNASVHS----NQEAG------------PSI 
 
hydra RING      204 HKVSKRKHKDSTGSLT-------DNSN--------------------------------- 
drosophila Sce  236 ---AAPSSSANSGASTSATRMQVDDASNPPSVRSTPSPVPSNSSSSKPKRAMSVLTSERS 
mouse Rnf2      195 ---KRTKTSDDSG-------LELDNNNAAVAI----DPVMDGAS---------------- 
human RNF2      195 ---KRTKTSDDSG-------LELDNNNAAMAI----DPVMDGAS---------------- 
xenopus RNF2    195 ---KRTKTSDDSG-------LELDTNNETASM----DSVLDGAS---------------- 
zebrafish RNF2  195 ---KRTKTSDDSG-------LDMDNATENGGG----DIALDGVS---------------- 
 
hydra RING      224 --------------------------FLNNEVNEVEVLFHPHP--------ACDILKHFK 
drosophila Sce  293 EESESDSQMDCRTEGDSNIDTEGEGNGELGINDEIELVFKPHPTEMSADNQLIRALKENC 
mouse Rnf2      225 ---------------------------------EIELVFRPHPTLMEKDDSA-------Q 
human RNF2      225 ---------------------------------EIELVFRPHPTLMEKDDSA-------Q 
xenopus RNF2    225 ---------------------------------EIELVFRPHPTLMEKDDSA-------Q 
zebrafish RNF2  225 ---------------------------------EIELVFRPHPTLMEKEDAA-------Q 
 
hydra RING      250 SRYLKTTGIATVAHLCQFLVTRISLEEITPCID-------------FEVLVRTV-GEYQK 
drosophila Sce  353 VRYIKTTANATVDHLSKYLAMRLTLDLGADLPE-------ACRVLNFCIYVAPQPQQLVI 
mouse Rnf2      245 TRYIKTSGNATVDHLSKYLAVRLALEELRSKGESNQMNLDTASEKQYTIYIATASGQFTV 
human RNF2      245 TRYIKTSGNATVDHLSKYLAVRLALEELRSKGESNQMNLDTASEKQYTIYIATASGQFTV 
xenopus RNF2    245 TRYIKTSGNATVDHLSKYLAVRLALEEFRSKGENNEMSLSAASEKQYTIYIATANGQFTV 
zebrafish RNF2  245 TRYIKTSGNATVDHLSKYLAVRLALEEMRKNGEASPINVEAASEKQYTIYIPTASNQFTV 
 
hydra RING      296 LEKHLTLAEIKQLYSKDSTPLELFFSSENR-- 
drosophila Sce  406 LNGNQTLHQVNDKFWKVNKPMEMYYSWKKT-- 
mouse Rnf2      305 LNGSFSLELVSEKYWKVNKPMELYYAPTKEHK 
human RNF2      305 LNGSFSLELVSEKYWKVNKPMELYYAPTKEHK 
xenopus RNF2    305 LNGSFSLELVSEKYWKVNKPMELYYAPTKEHK 
zebrafish RNF2  305 LNGSFSLELVSEKYWKVNKPMELYFAPTKEHK 
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HySCM  
 
From gene to protein: 
The  HySCM  gene  is  composed  of  18  exons  and  spans  a  genomic  region  of  >  60  kb.  The 
respective exon and intron lengths are indicated. Based on a ~ 2.6 kb mRNA, a protein of 832 aa 
is translated. 
 
 
 
 
Sequence information: 
Nucleotide and derived amino  acid  sequence of HySCM  from Hydra magnipapillata  105.   The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the polyadenylation site is indicated by underlined nucleotides. The translation initiation start 
and  stop  codons  are  highlighted  in  red.  The  coding  sequence  and  the  derived  amino  acid 
sequence are  indicated by capital  letters. The protein domains are  indicated. The HMG‐box  is 
highlighted  in  brown,  the MBT domains  are  highlighted  in  light  blue  and  yellow,  the  SAM 
domain is highlighted in green.  
Note: In the sequenced clones there is probably a nucleotide‐deletion in the 5´UTR after position 
261. One adenine  is missing  (framed A). This  leads  to a shorter coding sequence  for HySCM! 
The  coding  region  of  the  sequenced  clones  starts  at  position  287  (highlighted  in  light  red), 
whereas the correct coding region according to the Contig starts at position 86 (highlighted in 
red). The correct sequence according to the Contig is given below.  
 
 
  Exon 1                                                 Exon 2  
    1  aaccaaaaaa aaaatttaat ctatctattt tcttgagaa|a gacttgttag 
   51  gtacactagt aaatgttgct caaaatgatt gttctATGGA AATGATTAAC 
                                               M   E  M  I  N 
  101  GCAAACACAA TTAATTTAAT AAAAAGTGAA CTTTCTTCTC CTCCTTTAAA 
         A  N  T   I  N  L   I  K  S  E   L  S  S   P  P  L 
                                           Exon 3  
  151  AAGAAAAAAA TCTTTTATTG AAGATTCGAA CCAAG|ATGCA ACAGATTCAG 
       K  R  K  K   S  F  I   E  D  S   N  Q    D  A   T  D  S 
                                    Exon 4  
  201  AGCAGGTTTC TGAACACAAC ACATCTCGG|A CTAATAATGG TCATTTTGAG 
        E  Q  V   S  E  H  N   T  S  R     T  N  N   G  H  F  E 
  251  ATGACAAATT TACCAAAGAA GCCTTTGACC CCATATATGA GCTACAGAAA 
         M  T  N   L  P  K   K  P  L  T   P  Y  M   S  Y  R 
                                Exon 5    
  301  TATGGTTTTC CAAGACATTA AACAC|AAACA CCCAGGTTGT TCACCATATG 
       N  M  V  F   Q  D  I   K  H    K   H  P  G  C   S  P  Y 
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HMG box 
  351  ACTTGGCTTG CGTCATAAGT GCAAAATGGA GTTTGTTAAG TGATGTAGAA 
        D  L  A   C  V  I  S   A  K  W   S  L  L   S  D  V  E 
           Exon 6  
  401  AGAAAG|GTAT GGGAAGTAAA GTATGAAAAA GAAATGAAAA GTTATGAAAA 
         R  K    V   W  E  V   K  Y  E  K   E  M  K   S  Y  E 
  451  AAAGTTGAGA TTGTATCACC AAAAAGCTCT TAAACGGAAA ACTAATGAAG 
       K  K  L  R   L  Y  H   Q  K  A   L  K  R  K   T  N  E 
                            Exon 7  
  501  ATAAAAGTTT TTCACCAATA G|GTGATGAAG TCCATGAACT AAACAAATTT 
        D  K  S   F  S  P  I     G  D  E   V  H  E   L  N  K  F 
  551  GACACATTGG ATTATTGCTC AGGTTGTAAA AAACTTAAAG AGCTTCAAGG 
         D  T  L   D  Y  C   S  G  C  K   K  L  K   E  L  Q 
  601  GTTTTCAGCA GAAATTAATG GCAGACAGGT ATATAGAGGG GATCTTTGTT 
       G  F  S  A   E  I  N   G  R  Q   V  Y  R  G   D  L  C 
  651  CTAAAGCATG TTTTTTAGAA GCTTCGAAGC AGTTAAAATG CGTAGATGGA 
        S  K  A   C  F  L  E   A  S  K   Q  L  K   C  V  D  G 
                                                Exon 8  
  701  AGTACTTATA TCAAACATAG TAACAGCGAT CCAGTGTCAG|TTAATTTATC 
         S  T  Y   I  K  H   S  N  S  D   P  V  S    V  N  L 
  751  ACCATTTAAT TGGGCAGAAT ACTTATCTGA AACAAATTCT GAACCTGCTG 
       S  P  F  N   W  A  E   Y  L  S   E  T  N  S   E  P  A 
                          Exon 9  
  801  ATTGGATGTA CTGCAGACAG|GCTTCTTATC CCCCATCAAA TGCGTTTTCA 
        D  W  M   Y  C  R  Q    A  S  Y   P  P  S   N  A  F  S 
MBT domain 
  851  GTTGGGATGA AACTTGAAGC ACGAAGACAC GATCAAATAA AAGATTCCAA 
         V  G  M   K  L  E   A  R  R  H   D  Q  I   K  D  S 
  901  TCAAATTATT TTTAGTCTTG CTACAGTAGC TTTTATGATT GGTCCTAGGT 
       N  Q  I  I   F  S  L   A  T  V   A  F  M  I   G  P  R 
  951  TGCTTCTTCA CTTTGATGGC TCTTCTTCAA AGTATGATAT ATGGACACTA 
        L  L  L   H  F  D  G   S  S  S   K  Y  D   I  W  T  L 
 1001  TGTGATTCAT GGGATATACA TCCTGTTGGT TGGACTGATC GTGGCTCTTT 
         C  D  S   W  D  I   H  P  V  G   W  T  D   R  G  S 
                     Exon 10  
 1051  GCTTCCACCA ACAGG|CTATA GGCATGACCC AAAAAACTAC ATGCAATTTT 
       L  L  P  P   T    G  Y   R  H  D   P  K  N  Y   M  Q  F 
 1101  ATTCTTTAAA GATCCAGAAA GCAGAACTTG CAACTGCAAG ATGCTTCAAA 
        Y  S  L   K  I  Q  K   A  E  L   A  T  A   R  C  F  K 
         Exon 11  
 1151  AAAG|TACCTT CAATGCCACC TAAAAATTGT TTTGAGGTTG GAATGAAGTT 
         K    V  P   S  M  P   P  K  N  C   F  E  V   G  M  K 
MBT domain 
 1201  AGAGGCAGTA GATAAACAGA ATCCAAGTGT AATAGGTGTG GCCTCTGTTG 
       L  E  A  V   D  K  Q   N  P  S   V  I  G  V   A  S  V 
 1251  TTAGAGTTCA AGACGAATTA GTGTATATAG AGTTTGATGG TTACCCTGGT 
        V  R  V   Q  D  E  L   V  Y  I   E  F  D   G  Y  P  G 
 1301  TTAGGATATT CCTCTCATTA TGGAGATCGT GATTTTTTTC CAGTTGGCTG 
         L  G  Y   S  S  H   Y  G  D  R   D  F  F   P  V  G 
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                                            Exon 12  
 1351  GTGCGCTCAT GCAAAGCATC CACTACGAAT TCCAGG|TGAT GCAAAAAATA 
       W  C  A  H   A  K  H   P  L  R   I  P    G  D   A  K  N 
               Exon 13  
 1401  CTTTATCAAA|TATTGGATCT TCTTGTTCTA GTTCCAGATA CTCCCCTAAC 
        T  L  S    N  I  G  S   S  C  S   S  S  R   Y  S  P  N 
 1451  TCTTCTTCAA AACTTTCTAT GCATGAAATC GCTATGCATG CAGAAAAAAC 
         S  S  S   K  L  S   M  H  E  I   A  M  H   A  E  K 
                                         Exon 14  
 1501  TACTCCAATG AAGCCTAAAA CACTAAATCA AGC|GGAAGTT TGTATCAATA 
       T  T  P  M   K  P  K   T  L  N   Q    A  E  V   C  I  N 
 1551  TAGAATGTGT TTGTGGCCCT TACATTGATG TAGAAAAACT TAGAAAACTG 
        I  E  C   V  C  G  P   Y  I  D   V  E  K   L  R  K  L 
 1601  ACTCCAATTC GCAAAGGAGA AATCATACAT GTTCTTAAAG GAGTTTTAGA 
         T  P  I   R  K  G   E  I  I  H   V  L  K   G  V  L 
 1651  AGACATCATT GCTTGTGCAA TATCACCAAA AACTGTTATA GGGTTTCTGA 
       E  D  I  I   A  C  A   I  S  P   K  T  V  I   G  F  L 
            Exon 15  
 1701  AGCCTGG|TAG AGGAAATTGT GTAATCACTA CTGTTTGTGA AGGCACAACA 
        K  P    G   R  G  N  C   V  I  T   T  V  C   E  G  T  T 
 1751  TTTCAATGCT GTCTTACTGT TATTGATCAT GTTTCATCAT TATGGGATAT 
         F  Q  C   C  L  T   V  I  D  H   V  S  S   L  W  D 
 1801  TCTTAAACAG TTTGCAGACA ATTTAAGGTC TTGTCCTAAC TTATTTTCAA 
       I  L  K  Q   F  A  D   N  L  R   S  C  P  N   L  F  S 
 1851  CTGAAATGTA TGCTTCTTGT CCACGTTGTT TAAACAAACC TTCCACTGCC 
        T  E  M   Y  A  S  C   P  R  C   L  N  K   P  S  T  A 
 1901  ATCTCCATAC CATTGATTTA TCAGAGGTTA ACATCAAACC CTGGTTCTTA 
         I  S  I   P  L  I   Y  Q  R  L   T  S  N   P  G  S 
                                     Exon 16  
 1951  TCTGGCTTCT TCTTTTCAAT ATCCTAAAAG|CTCTAGGTTT ATTGAATTTG 
       Y  L  A  S   S  F  Q   Y  P  K    S  S  R  F   I  E  F 
 2001  AAGATGGTGA CATTCATTCA GTTATGGATT TGGAAAAAAA TGAACCATTA 
        E  D  G   D  I  H  S   V  M  D   L  E  K   N  E  P  L 
 2051  AGTTTGAACC AGATAAAGTG TAATCAAGAC TCTCGGAATC CGGATAAAAA 
         S  L  N   Q  I  K   C  N  Q  D   S  R  N   P  D  K 
 2101  TACTAAAAAA CATGTAACTT GGCCGGCAAT ATCTCAGGCT GAAGTATTTA 
       N  T  K  K   H  V  T   W  P  A   I  S  Q  A   E  V  F 
 2151  ATTATCAACC AGTTTATGCA GATACAGCAT CTCAAACAGA ATCCTTTTGT 
        N  Y  Q   P  V  Y  A   D  T  A   S  Q  T   E  S  F  C 
 2201  TTCACTTGTA ATTCTCTTAG TCATAAATGT AGTCTCACAG ACAAAAATAG 
         F  T  C   N  S  L   S  H  K  C   S  L  T   D  K  N 
 2251  GTTAAAAGAT GGTGGTGTTG AAATTGAAAG TGCAGAAATA TTGAGTAATA 
       R  L  K  D   G  G  V   E  I  E   S  A  E  I   L  S  N 
           Exon 17        
 2301  TCCAAG|CTGC TGGTATCGAT ATTATGAATC GCCCTAGCAT GTGGAATGTG 
        I  Q    A   A  G  I  D   I  M  N   R  P  S   M  W  N  V 
 2351  GATGATGTTG TTCTTTTTTT AAAGAAAACT TGCATTAAAG AATTTTCTCA 
         D  D  V   V  L  F   L  K  K  T   C  I  K   E  F  S 
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                      Exon 18  
 2401  AGTATTTAAA GACCAT|GAAA TTGATGGTAA AGCCCTACTT CTTTTGCAAA 
       Q  V  F  K   D  H    E   I  D  G   K  A  L  L   L  L  Q 
SAM domain 
 2451  ATGAGCATAT TCTTCATCAT ATGGGTTTTA AACTCGGACC AGCCGTCAAA 
        N  E  H   I  L  H  H   M  G  F   K  L  G   P  A  V  K 
 2501  CTTCTGGATT TGATTGAAGA TTTGAAGGTT GCGGAACGTT CTTTTTCAAA 
         L  L  D   L  I  E   D  L  K  V   A  E  R   S  F  S 
 2551  AACGAAAGAG TTTATTGATA CTTTGACTCC ATAGgtgaat aagaaatcat 
       K  T  K  E   F  I  D   T  L  T   P  *   
 2601  ttttaaataa cagcaagcta atatatatga atataataaa gtaataaata 
 2651  aaaaaaaaaa aaaaaa 
 
 
Protein alignment: 
Comparison of HySCM with SCM protein sequences from other species reveals a conservation 
on the amino acid level of 20%. Areas of high matches are highlighted in grey. The BLOSUM62 
matrix was used for the multi‐way protein sequence alignment. 
 
                                                                               - 
hydra SCM         1 -MEMINANTINLIKSELSSPPLKRKKSFIEDSNQDATDSEQVSEHNTSRTNNGHFEMTNL 
drosophila Sce    1 MSGGRDSSTSSGSNSAAPGASTNATSSASASASSTSTSASPGSTTSPASTQRQRGRPAKR 
human SCMH1       1 -----------------------------------------------------------M 
mouse SCMH1       1 -----------------------------------------------------------M 
xenopus SCMH1     1 -----------------------------------------------------------M 
                    -----------------------H M G  b o x------------------------- 
hydra SCM        60 PKKPLTPYMSYRNMVFQDIKHKHPGCSPYDLACVISAKWSLLS--DVERKVWEVKYEKEM 
drosophila Sce   61 ATCTWCGEGKLPLQYVLPTQTGKKEFCSETCIAEFRKAYSKGACTQCDNVIRDGAPNKEF 
human SCMH1       2 LVC-----------------------------------YSVLAC----EILWD------L 
mouse SCMH1       2 LVC-----------------------------------YSVLAC----ESLWD------L 
xenopus SCMH1     2 RKP-----------------------------------GHLKAT----D--WKDGRRHGR 
                    ------------ 
hydra SCM       118 KSYEKKLRLYHQKALKRKTNEDKSFSPIGDEVHELNKFDTLDYCSGCKKLKELQGFSAEI 
drosophila Sce  121 -C---SIMCMNKHQKKNCSTRHSGGSASG------------------------------- 
human SCMH1      17 PC---SIM----------------GSPLG------------------------------- 
mouse SCMH1      17 PC---SIM----------------GSPLG------------------------------- 
xenopus SCMH1    21 PS---DTH----------------ANQ-G------------------------------- 
                                                                  -------------- 
hydra SCM       178 NGRQVYRGDLCSKACFLEASKQLKCVDGSTYIKHSNSDPVSVNLSPFNWAEYLSETNSEP 
drosophila Sce  146 -----------------KGLAESERKLLASGAPAPTGPFQYESFHVFDWDAYLEETGSEA 
human SCMH1      27 -----------------H----------------------------FTWDKYLKETCSVP 
mouse SCMH1      27 -----------------H----------------------------FTWDKYLKETCSVP 
xenopus SCMH1    30 -----------------H----------------------------FSWEKYLKETGSQP 
                    -----------------------M B T  d o m a i n------------------- 
hydra SCM       238 ADWMYCRQASY-PPSNAFSVGMKLEARRHDQIKDSNQIIFSLATVAFMIGPRLLLHFDGS 
drosophila Sce  189 AP-AKCFKQAQNPPNNDFKIGMKLEAL-----DPRNVTSTCIATVVGVLGSRLRLRLDGS 
human SCMH1      42 AP-VHCFKQSYTPPSNEFKISMKLEAQ-----DPRNTTSTCIATVVGLTGARLRLRLDGS 
mouse SCMH1      42 AP-VHCFKQSYTPPSNEFKISMKLEAQ-----DPRNTTSTCIATVVGLTGARLRLRLDGS 
xenopus SCMH1    45 AP-PHCFRQSCSPPSNDYKIGMKLEAQ-----DPRNTTSTCIASVVGLTGARLRLRLDGS 
                    -------M B T  d o m a i n------       -   M B T domain-----  
hydra SCM       297 SSKYDIWTLCDSWDIHPVGWTDR--GSLLPPTGYRHDPKNYMQFYSLKIQKAELATARCF 
drosophila Sce  243 DSQNDFWRLVDSTEIHAIGHCEKNGGMLQPPLGFRMNASSWPGYLCKILNNAMVAPEEIF 
human SCMH1      96 DNKNDFWRLVDSAEIQPIGNCEKNGGMLQPPLGFRLNASSWPMFLLKTLNGAEMAPIRIF 
mouse SCMH1      96 DNKNDFWRLVDSSEIQPIGNCEKNGGMLQPPLGFRLNASSWPMFLLKTLNGAEMAPIKIF 
xenopus SCMH1    99 DNKNDFWRLVDSSEIQPIGTCEKSGGMLQPPLGFRLNASSWPMFLLKTLNGAEMAPAKVF 
                    -----------------------M B T  d o m a i n------------------- 
hydra SCM       355 KKVPSMPPKNCFEVGMKLEAVDKQNPSVIGVASVVRVQDELVYIEFDGYPG-LGYSSHYG 
drosophila Sce  303 QPEPPEPEENLFKVGQKLEAVDKKNPQLICCATVDAIKDDQIHVTFDGWRGAFDYWCNYR 
human SCMH1     156 HKEPPSPSHNFFKMGMKLEAVDRKNPHFICPATIGEVRGSEVLVTFDGWRGAFDYWCRFD 
mouse SCMH1     156 HKEPPSPSHNFFKMGMKLEAVDRKNPHFICPATIGEVRGAEVLVTFDGWRGAFDYWCRFD 
xenopus SCMH1   159 HKEPPSPPQNYFEIGMKLEAVDRKNPHFICPATIGELRGSEILVTFDGWRGAFDYWCRYD 
                    -M B T  d o m a i n- 
hydra SCM       414 DRDFFPVGWCAHAKHPLRIPGDAKNTLSNIGSSCSSSRYSPNSSSKLSMH---------- 
drosophila Sce  363 SRDIFPAGWCARSCHPMQPPGHKSRMDSSSSKQRCPRPRYTVVAESEAMVPASPATAHFH 
human SCMH1     216 SRDIFPVGWCSLTGDNLQPPGTKVVIPKN------PYPASDVNTEKPSIHSSTKTVLEHQ 
mouse SCMH1     216 SRDIFPVGWCSLTGDNLQPPGTKVVIPKN------PSPSSDVSTEKPSIH-STKTVLEHQ 
xenopus SCMH1   219 SRDIFPVGWCSLTGDNLQPPGTKVAIPKS------PLPAAGIAT---SMMRGPKNLLPVV 
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hydra SCM       464 ---------------------------EIAMHAEKTTPM--------------------- 
drosophila Sce  423 PNCKGGPFINNSKLPCMVTGPTYQTLAKLCLQEVLAASTDTQQLSKLLFALEGDVHIVTA 
human SCMH1     270 PGQRG-------RKPGKKRGRT----PKTLISHPISAP------SKTAEPLK-------- 
mouse SCMH1     269 PGQRG-------RKPGKKRGRT----PKILIPHPTSTP------SKSAEPLK-------- 
xenopus SCMH1   270 PGRRR-------RKPGRKKGQL----PKALVHQLSSQP------SKLCEPFR-------- 
 
hydra SCM       476 -----------------KPKTL--------------------------------NQAEVC 
drosophila Sce  483 AGKNFTVKI-PSPMRMKDDESLAQFIETLCTTCRACANLISLVHETEECKKCANSRKRQL 
human SCMH1     305 ----FPKKRGPKPGSKRKPRTLLNPPPASPTTSTPEPDTSTVPQDAATIPSSAMQAPTVC 
mouse SCMH1     304 ----FPKKRGPKPGSKRKPRTLLSPPPTSPTTSTPEPDTSTVPQDAATVPSSAMQAPTVC 
xenopus SCMH1   305 ----FPKKRGPKPGSKRKPRLLLNQIPTSPTNSTPEPDTSTVPQDAATIPCAAMQAPTVC 
 
hydra SCM       487 I--NIECVCGPYIDVEKLRKLT----PIRKGEIIHVLKGVLEDIIAC------------A 
drosophila Sce  542 TQSATPPSSPVLADKRNRQSNSATTSPSEKII---KQELAVKSPVESKSKTSTNNGKEPA 
human SCMH1     361 IYLNKNGSTGPHLDKKKVQQLPDHFGPARASV---VLQQAVQACIDC------------A 
mouse SCMH1     360 IYLNKSGSTGPHLDKKKIQQLPDHFGPARASV---VLQQAVQACIDC------------A 
xenopus SCMH1   361 IYLNKNGDSGPHLDRKKVQHLPDHFGPARASV---VLQQAVQACIDC------------A 
 
hydra SCM       529 ISPKTVIGFLKPGRGNCVITTVCEGTTFQCCLTV-----IDHVSSLWDILKQFADNLRSC 
drosophila Sce  599 SQQNSNHSLNNNNNSASKSSNKVVIKSEPNGANAQT-SSTTQALRKVRFQHHANTNTNS- 
human SCMH1     406 YHQKTVFSFLKQGHGGEVIS--AVFDREQHTLNLPAVNSITYVLRFLEKLCH---NLRS- 
mouse SCMH1     405 YHQKTVFSFLKQGHGGEVIS--AVFDREQHTLNLPAVNSITYVLRFLEKLCH---NLRS- 
xenopus SCMH1   406 YHQKTVFSFLKQGHGGEIIS--AVFEREQHTLNLPAVNSIGYVLRFLEKLCR---NLRS- 
 
hydra SCM       584 PNLFSTEMYASCPRCLNKPSTAISIPLIYQRLTSNPGSYLASSFQYPKSSRFIEFEDGDI 
drosophila Sce  657 SATNGNQDTSQT--------THVSTSHCSSSSTSSSTSLAGGSANTSTIGKYLAPLVAEV 
human SCMH1     460 DNLFGNQPFTQTHLSL----TAIEYSHSHDRYLPGETFVLGNSLARS-LEPHSDSMDSAS 
mouse SCMH1     459 DNLFGNQPFTQTHLSL----TATEYNHNHDRYLPGETFVLGNSLARS-LETHSDLMDSAL 
xenopus SCMH1   460 ENLFGNQPFTQNSSLQ----TG---SCDNDRYL-AERSNCDGSL-------HGPGRGSKR 
 
hydra SCM       644 HSVMDLEKNEPLSLNQIKCNQDSRNPD-----------KNTKKHVTWPAISQAEVFNYQP 
drosophila Sce  709 H---------PEQANVKPSNSYYKSP--TTLSSSASLPTSVSTPFTGCQSASSTALAAGG 
human SCMH1     515 N---------P--TNLVSTSQR-----HRPLLSSCGLPPST--------ASAVRRLCSRG 
mouse SCMH1     514 K---------P--ANLVSTSQNLRTPGYRPLLPSCGLPLST--------VSAVRRLCSKG 
xenopus SCMH1   505 Y---------P--SE--------TPPYNAPLCPK--LPKND--------CHA-----SEG 
                                                                              -- 
hydra SCM       693 VYADTASQTESFCF-TCNSLSHKCSLTDKNRLKDGGVEIESAEILSNIQAAGIDIMNRPS 
drosophila Sce  758 VTAAKAATAPAGAAATAGASPSYTAITSPVSTPTSALANSHLRSQ-------------PI 
human SCMH1     551 VLKGSNERRDMESFWKLNRSP--------------GS-DRYLESRDASRLSGRD----PS 
mouse SCMH1     555 VLKGKKERRDVESFWKLNHSP--------------GS-DRHLESRDPPRLSGRD----PS 
xenopus SCMH1   531 -----------ETFMLDAGLP--------------GSLEQHLGTVDSP------------ 
                    ----------------------S A M  d o m a i n-------------------- 
hydra SCM       752 MWNVDDVVLFLKKTC--IKEFSQVFKDHEIDGKALLLLQNEHILHHMGFKLGPAVKLLDL 
drosophila Sce  805 DWTIEEVIQYIESNDNSLAVHGDLFRKHEIDGKALLLLNSEMMMKYMGLKLGPALKICNL 
human SCMH1     592 SWTVEDVMQFVREADPQLGPHADLFRKHEIDGKALLLLRSDMMMKYMGLKLGPALKLSYH 
mouse SCMH1     596 SWTVEDVMQFVREADPQLGSHADLFRKHEIDGKALLLLRSDMMMKYMGLKLGPALKLSFH 
xenopus SCMH1   554 --TSPNTSRVSRE-----------YRSPS--------YRS--VHKPSNISQGTVRRLSSG 
                    ------- 
hydra SCM       810 IEDLKVAERSFSKTKEFIDTLTP------------------------------ 
drosophila Sce  865 VNKVNGRRNNLAL---------------------------------------- 
human SCMH1     652 IDRLKQ------------------------------GKF-------------- 
mouse SCMH1     656 IDRLKQVFWKRETILWSREGLSREV--WPISEDTALGHFFSGMDKVFGSLSKR 
xenopus SCMH1   591 V---------------------REVPKWPAGTT-------------------- 
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HyEZH2      
 
From gene to protein: 
The  HyEZH2  gene  is  composed  of  22  exons  and  spans  a  genomic  region  of  >  83  kb.  The 
respective  exon  and  intron  lengths  are  indicated.  Undetermined  lengths  are  indicated  by  a 
question mark. Based on a ~ 2.4 kb mRNA, a protein of 724 aa is translated. 
 
 
 
 
Sequence information: 
Nucleotide and derived amino acid sequence of HyEZH2  from Hydra magnipapillata 105.   The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the polyadenylation site is indicated by underlined nucleotides. The translation initiation start 
and  stop  codons  are  highlighted  in  red.  The  coding  sequence  and  the  derived  amino  acid 
sequence are indicated by capital letters. The protein domains are indicated. The SANT domain 
is highlighted in light red and the SET domain in light blue.  
 
 
    Exon 1                 5‘ UTR 
    1  aaaatatcct gtgtatagtt gtgagctaag aacATGCAAG AAGATATTGA 
                                             M  Q   E  D  I 
   51  AGCTAAAGAG AGACATTTAG ATCCTGCTTA CTTAGAAAAG ATTAATCATT 
       E  A  K  E   R  H  L   D  P  A   Y  L  E  K   I  N  H 
  101  TTAAAAAAGT TATTCAGTTG GAATATGTTC GTATTTGTAG GAAGAGAAAA 
        F  K  K   V  I  Q  L   E  Y  V   R  I  C   R  K  R  K 
                               Exon 2 
  151  CAAAATAAAA CTGAAGAAGC AAAG|TCTATT TACAAAAGCA GCCGAGAAGA 
         Q  N  K   T  E  E   A  K     S  I   Y  K  S   S  R  E 
  201  GTTGTTAAAT GTATTGAAAA AACGTCAGCA AATTTTAAAA GAGAAAAAGA 
       E  L  L  N   V  L  K   K  R  Q   Q  I  L  K   E  K  K 
  251  GAGAGCCATT GACCACTATT CCTATTGCTA TTGTAACAGA GGCTTCAACA 
        R  E  P   L  T  T  I   P  I  A   I  V  T   E  A  S  T 
              Exon 3  
  301  AGAAAG|GCTC AAGTTCAAAG TGGTTTTAAC TATTTATCTC AAAATGTTAC 
         R  K     A   Q  V  Q   S  G  F  N   Y  L  S   Q  N  V 
  351  ACTACAAACA ATTTACTCAC CTCCAGCATT GCCGACTATG ATCTCATGGG 
       T  L  Q  T   I  Y  S   P  P  A   L  P  T  M   I  S  W 
                                     Exon 4  
  401  CTCCTCTACA ACAAAATTTT ATT|GTTGATG ATGAAACAGT TTTGCATAAT 
        A  P  L   Q  Q  N  F   I     V  D   D  E  T   V  L  H  N      
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  451  ATTCCTTACA TGGGAGAAGA TGTTATTGAC CAAGATGGGC AGTTTATTGA 
         I  P  Y   M  G  E   D  V  I  D   Q  D  G   Q  F  I 
   
  501  AGAGCTTATT AAAAACTATG ATGGCAAAGT TCACACTTCT TCAAGTTTAG 
       E  E  L  I   K  N  Y   D  G  K   V  H  T  S   S  S  L   
     Exon 5  
  551  |ATAGTATTAT GGATGATGAA CTTTTTTTGG AATTAATAAA AGCTGGGATT 
          D  S  I   M  D  D  E   L  F  L   E  L  I   K  A  G  I 
  601  GTTTACCAAG ATGAATATAG GAGCTCTGAG AATTATAAAG AACAGTTTTC 
         V  Y  Q   D  E  Y   R  S  S  E   N  Y  K   E  Q  F      
          Exon 6  
  651  AGACG|AATCT TTAACTAAAA AATTATCAAA CGATTTAAAA TTTCAAACTA 
       S  D     E  S   L  T  K   K  L  S   N  D  L  K   F  Q  T 
  701  ATGATCCTAG CGAGTTACTT TTTGACACAA TAGCACATTA TTTCTCAGAG 
        N  D  P   S  E  L  L   F  D  T   I  A  H   Y  F  S  E 
                                            Exon 7  
  751  CAAGGTGTGA CTGCAAAAGA AGTAAAACAG AGGCAT|ATGC TATTAAAAGA 
         Q  G  V   T  A  K   E  V  K  Q   R  H     M   L  L  K 
                                                         Exon 8  
  801  AAAAGAAAGC AGTCAGCCGC CTGCTGAATG TACTCCAAAT ATTGATGG|CC 
       E  K  E  S   S  Q  P   P  A  E   C  T  P  N   I  D     G 
  851  CAGATGTAAT AACAACGAAC AGGGAGAGAA CCATGCACTC TTACCATACA 
        P  D  V   I  T  T  N   R  E  R   T  M  H   S  Y  H  T 
  901  TTGTTTTGTC GTAGATGTTA CAAGTATGAT TGCTTTCTTC ATGCTGTACG 
         L  F  C   R  R  C   Y  K  Y  D   C  F  L   H  A  V 
  951  CCCTGGTCCA GTTAAAGTGC AAAGAAAGCA GTTAATGGAT ATACAAAATA 
       R  P  G  P   V  K  V   Q  R  K   Q  L  M  D   I  Q  N 
                                           ‘Exon 9’  
 1001  TTGAGCCTTG TGGAGAAAAC TGCTATATGC ATTTG|GAAAG GTCTTTAACA 
        I  E  P   C  G  E  N   C  Y  M   H  L     E   R  S  L  T  
 1051  ATTCAAGATA CAAAAGATTT ACCAAAAAGT TTACCAGAAA CAGATCGAAA 
          I  Q  D   T  K  D   L  P  K  S   L  P  E   T  D  R 
 1101  TGAAGACTCA AAAATGAAGA AATTTAAGAG GAAAAAAAGT TTTAATAAAG 
        N  E  D  S   K  M  K   K  F  K   R  K  K  S   F  N  K 
                                 Exon 10  
 1151  CAGAAACATC AGTAGAAGTT TTAGCG|CCTG TTAAATCAAC ATACTTAATT 
        A  E  T   S  V  E   V  L  A     P   V  K  S   T  Y  L  I 
 1201  GAAGATACAA ATGATGAACC ATGGACATCA TCTGATTTAT CAATGTTTCG 
         E  D  T   N  D  E   P  W  T  S   S  D  L   S  M  F 
SANT domain 
 1251  TGTGCTTATC AAGAATTTTC CAAATAATTA CTGCACAATA GCCCAACTAT 
       R  V  L  I   K  N  F   P  N  N   Y  C  T  I   A  Q  L 
                                 Exon 11  
 1301  TGAATTACTC CCATACATGT AAACAG|ATAT ATCGTCATGC TATGTTAGAA 
        L  N  Y   S  H  T  C   K  Q     I   Y  R  H   A  M  L  E 
 1351  CCTCGTGATG AAAATCCTTC CAATGATGTT ATGACTCCTC CAACAAAAAA 
         P  R  D   E  N  P   S  N  D  V   M  T  P   P  T  K                        
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                        Exon 12  
 1401  GAAGAAACAA ACTGTCAG|AT CTTGGGCCAA TCATTGCAAA AAAGTACAAA 
       K  K  K  Q   T  V     R   S  W  A   N  H  C  K   K  V  Q     
              Exon 13  
 1451  TGAAAAAAG|A AAATTCAGCT TCTATGCTAA TTGGTTATTA CCCATGTGAA 
        M  K  K      E  N  S  A   S  M  L   I  G  Y   Y  P  C  E 
 
 1501  CATCCTGGGC AGCCATGCAA TGCATCTTGT CCTTGTATAT TTAACCATAA 
         H  P  G   Q  P  C   N  A  S  C   P  C  I   F  N  H 
                               Exon 14                                     
 1551  TTTTTGCGAA AAGTTTTGTC AGTGCAGTTT GGACT|GTCAA AATCGCTTTC 
       N  F  C  E   K  F  C   Q  C  S   L  D     C  Q   N  R  F 
 1601  CCGGTTGTCG TTGTAAAGCT CAATGTTGCA CTAAAGCATG CCCATGTTAT 
        P  G  C   R  C  K  A   Q  C  C   T  K  A   C  P  C  Y 
                                                          Exon 15  
 1651  TTAGCTGTTC GAGAGTGTGA CCCTGACATA TGTAAAACTT GTGGTGCAG|A 
         L  A  V   R  E  C   D  P  D  I   C  K  T   C  G  A 
 1701  CAACTTTGAA GTTGAAAGTC ACGAGTCTTC TTGTAAAAAT GTGGGTTTAC 
       D  N  F  E   V  E  S   H  E  S   S  C  K  N   V  G  L 
                       Exon 16  
 1751  AAAGAAGTTG GCGAATG|AAC TTGTTGCTGG CTCCTTCCGA TATTGCAGGT 
        Q  R  S   W  R  M     N   L  L  L   A  P  S   D  I  A  G 
SET domain 
 1801  TGGGGTATAT ACTTGAAAAA TGATGTAACA AAAAATACAT TAATAAGTGA 
         W  G  I   Y  L  K   N  D  V  T   K  N  T   L  I  S 
                   Exon 17  
 1851  ATATTGTGGA GAG|TTAATCT CTCAAGATGA AGCTGAACGT AGGGGAAAAG 
       E  Y  C  G   E     L  I   S  Q  D   E  A  E  R   R  G  K 
                                                      Exon 18  
 1901  TTTATGATAA AACTATGTGT AGTTTCTTAT TTAATTTAAA TCATG|AGTTT 
        V  Y  D   K  T  M  C   S  F  L   F  N  L   N  H     E  F 
 1951  GTTGTTGATG CCACAAGGAA AGGCAACAAG ATTCGATTTG CAAACCATTC 
         V  V  D   A  T  R   K  G  N  K   I  R  F   A  N  H   
                                 Exon 19      
 2001  TATTAATCCA AACTGTTATG CAAAAG|TTAT GATGGTTAAC GGTGATCATC 
       S  I  N  P   N  C  Y   A  K     V   M  M  V  N   G  D  H 
 2051  GAATTGGTAT ATTTGCTAAG AGAAATATTG TAACTGGTGA AGAACTTTTC 
        R  I  G   I  F  A  K   R  N  I   V  T  G   E  E  L  F                
                 Exon 20  
 2101  TTTGATTACA G|GTACGGACC AACCGATTCT CTTAGATATG TCGGCATCGA 
         F  D  Y      R  Y  G   P  T  D  S   L  R  Y   V  G  I 
 2151  AAAAGATACT CGGTTTCCTG ATTCTACTAC AGGTGTTGCA AAGAAATGGA 
       E  K  D  T   R  F  P   D  S  T   T  G  V  A   K  K  W 
3‘ UTR 
 2201  CAGTGTGAtt tctgttgttc ttcaacacta aaattattct atacgttgag 
        T  V  *    
 2251  atcatgggcg cccgtagtaa ccatagggtg aaacaagaat ttatttcatt 
 2301  ttcgccttac gaacactggt gatgtatctt agtgctttat gatttgtagt                      
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                                         polyA site 
 2351  ttttatttag aatatgaaac gtacacacaa aaaaaaaaaa aaaaaaaa 
 
 
Protein alignment: 
Comparison of HyEZH2 with EZH2 protein  sequences  from other  species  reveals  significant 
conservation on the amino acid level (45%). Areas of high matches are highlighted in grey. The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
hydra EZH2        1 MQEDIEAKERHLDPAYLEKINHFKKVIQLEYVRICRKRKQNKTEEAKSIYKSSREELLN- 
human EZH2        1 MGQ--TGKKSEKGPVC------WRKRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILER 
mouse Ezh2        1 MGQ--TGKKSEKGPVC------WRKRVKSEYMRLRQLKRFRRADEVKTMFSSNRQKILER 
xenopus EZH2      1 MGQ--TGKKSEKGPVC------WRKRVKSEYMRLRQLKRFRRADEVKSMFNTNRQKIMER 
zebrafish EZH2    1 MGL--TGRKSEKGPVC------WRRRVKSEYMRLRQLKRFRRADEVKSMFSSNRQKILER 
drosophila E(Z)   1 -------MNSTKVPPE------WKRRVKSEYIKIRQQKRYKRADEIKEAWIRNWDEHNHN 
 
hydra EZH2       60 --VLKKRQQILKEKKREPLTTIPIAIVTEASTRKAQVQSG---FNYLSQNVTLQTIYSPP 
human EZH2       53 TEILNQE---WKQRRIQPVH-ILTSVSSLRGTRECSVTSDL-DFPT--QVIPLKTLNAVA 
mouse Ezh2       53 TETLNQE---WKQRRIQPVH-IMTSVSSLRGTRECSVTSDL-DFPA--QVIPLKTLNAVA 
xenopus EZH2     53 TEILNQE---WKQRRIQPVH-IMTTVSSLRGTRECSVTSDL-DFPK--QVIPLKTLTAVA 
zebrafish EZH2   53 TDILNQE---WKLRRIQPVH-IMTPVSSLRGTRECTVDSGFSEFSR--QVIPLKTLNAVA 
drosophila E(Z)  48 VQDLYCESKVWQAKPYDPPH-VDC-------VKRAEVTS-YNGIPSGPQKVPICVINAVT 
 
hydra EZH2      115 ALPTMISWAPLQQNFIVDDETVLHNIPYMGEDVIDQDGQFIEELIKNYDGKVHTSSSLDS 
human EZH2      106 SVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDREC-G 
mouse Ezh2      106 SVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDREC-G 
xenopus EZH2    106 SVPIMYSWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDREC-G 
zebrafish EZH2  107 SVPVMYSWSPLQQNFMVEDETVLHNIPYMGDEILDQDGTFIEELIKNYDGKVHGDREC-G 
drosophila E(Z)  99 PIPTMYTWAPTQQNFMVEDETVLHNIPYMGDEVLDKDGKFIEELIKNYDGKVHGDKDP-S 
 
hydra EZH2      175 IMDDELFLELIKA---------------------------GIVYQDEYRSSENYKEQFSD 
human EZH2      165 FINDEIFVELVNAL--------------------------GQYNDDDD--DDDGDD--PE 
mouse Ezh2      165 FINDEIFVELVNAL--------------------------GQYNDDDD--DDDGDD--PD 
xenopus EZH2    165 FINDEIFVELVNAL--------------------------AQYSDYED--DEDGDDNQDD 
zebrafish EZH2  166 FINDEIFVELVNAL--------------------------NQYSDNEE--DDEEDDHH-D 
drosophila E(Z) 158 FMDDAIFVELVHALMRSYSKELEEAAPSTSTAIKTEPLAKSKQGEDDGVVDVDADCESPM 
 
hydra EZH2      208 ESLTKKLSNDLKFQTND---------------------------PSELLFDTIAHYFSEQ 
human EZH2      195 --EREEKQKDLEDHRDDKESRPP------------RK------FPSDKILEAISSMFPDK 
mouse Ezh2      195 --EREEKQKDLEDNRDDKETCPP------------RK------FPADKIFEAISSMFPDK 
xenopus EZH2    197 --EQDDTAKDQDDNMEDKETQPL------------RK------FPSDKIFEAISSMFPDK 
zebrafish EZH2  197 --YKFEKM-DLCDGKDDAEDHKEQLSSESHNNDGSKK------FPSDKIFEAISSMFPDK 
drosophila E(Z) 218 KLEKTESKGDLTD-VEKKETEEPVETEDADVKPAVEEVKDKLPFPAPIIFQAISANFPDK 
 
hydra EZH2      241 GVTAKEVKQRHMLLKEKE-SSQPPAECTPNIDGPDVITTNRERTMHSYHTLFCRRCYKYD 
human EZH2      235 G-TAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYD 
mouse Ezh2      235 G-TAEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYD 
xenopus EZH2    237 G-TSEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYD 
zebrafish EZH2  248 G-STEELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRRCFKYD 
drosophila E(Z) 277 G-TAQELKEKYIELTEHQDP-ERPQECTPNIDGIKAESVSRERTMHSFHTLFCRRCFKYD 
 
hydra EZH2      300 CFLHAV--RPGPVKVQRKQLMDIQNIEPCGENCYMHLER---------SLTIQDTKDLPK 
human EZH2      294 CFLHPF--HATPNTYKRKNTETALDNKPCGPQCYQHL--EG-AKEFAAALTAERIKTPPK 
mouse Ezh2      294 CFLHPF--HATPNTYKRKNTETALDNKPCGPQCYQHL--EG-AKEFAAALTAERIKTPPK 
xenopus EZH2    296 CFLHPF--HATPNTYKRKNNEAANDGKPCGPHCYQLL--EG-AREFAAALTAERIKTPPK 
zebrafish EZH2  307 CFLHPF--QATPNTYKRKNMENLVDSKPCGIYCYMYMVQDGMVREYPAGVVPERAKTPSK 
drosophila E(Z) 335 CFLHRLQGHAGPNLQKRRYPELKPFAEPCSNSCY--MLIDGMKEKLAA------------ 
 
hydra EZH2      349 --------------SLPET-------------DR---------NEDSKMKKFKRKKSFNK 
human EZH2      349 RPGGRRRGRLPNNSSRPSTPTINVLESKDTDSDREAGTETGGENNDKEEEEKKDE-TSSS 
mouse Ezh2      349 RPGGRRRGRLPNNSSRPSTPTISVLESKDTDSDREAGTETGGENNDKEEEEKKDE-TSSS 
xenopus EZH2    351 RPSGRRRGRLPNNTSRPSTPTVNVSEAKDTDSDREAGTETGGESNDKEEEEKKDE-TSSS 
zebrafish EZH2  365 RSTGRRRGRLPNSNSRPSTPTVN-SETKDTDSDREGGAD-GNDSNDKDDDDKKDE-TTSS 
drosophila E(Z) 381 ------------DSKTPPIDSCNEASSEDSND-----SNSQFSNKDFNHENSKDNGLTVN 
                                        -----------S A N T  d o m a i n--------- 
hydra EZH2      373 AETSVEVLAPVKSTYLIEDTNDEPWTSSDLSMFRVLIKNFPNNYCTIAQLLNYSHTCKQI 
human EZH2      408 SEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIG-TKTCRQV 
mouse Ezh2      408 SEANSRCQTPIKMKPNIEPPENVEWSGAEASMFRVLIGTYYDNFCAIARLIG-TKTCRQV 
xenopus EZH2    410 SEANSRCQTPIKMKPNIEPPENVEWSGAEASLFRVLIGTYYDNFCAIARLIG-TKTCRQV 
zebrafish EZH2  422 SEANSRCQTPVKLKLSSEPPENVDWSGAEASLFRVLIGTYYDNFCAIARLIG-TKTCRQV 
drosophila E(Z) 424 SAAVAEINSIMAGMMNITSTQCV-WTGADQALYRVLHKVYLKNYCAIAHNML-TKTCRQV 
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                    ------------ 
hydra EZH2      433 YRHAMLEPR--DENPSNDVMTPPTKKKKQTVRSWANHCKKVQMKKENSASMLIGYYPCEH 
human EZH2      467 YEFRVKESSIIAPAPAEDVDTPPRKKKRKH-RLWAAHCRKIQLKKDGSSNHVYNYQPCDH 
mouse Ezh2      467 YEFRVKESSIIAPVPTEDVDTPPRKKKRKH-RLWAAHCRKIQLKKDGSSNHVYNYQPCDH 
xenopus EZH2    469 YEFRVKESSIISPVIAEDVDTPPRKKKRKH-RLWAAHCRKIQLKKDGSSNHVYNYQPCDH 
zebrafish EZH2  481 YEFRVKESSIIARAPAVDENTPQRKKKRKH-RLWATHCRKIQLKKDGSSNHVYNYQPCDH 
drosophila E(Z) 482 YEFAQKEDAEFSFEDLRQDFTPPRKKKKKQ-RLWSLHCRKIQLKKDSSSNHVYNYTPCDH 
 
hydra EZH2      491 PGQPCNASCPCIFNHNFCEKFCQCSLDCQNRFPGCRCKAQCCTKACPCYLAVRECDPDIC 
human EZH2      526 PRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLC 
mouse Ezh2      526 PRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLC 
xenopus EZH2    528 PRQPCDSSCPCVIAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLC 
zebrafish EZH2  540 PRQPCDSSCPCVTAQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLC 
drosophila E(Z) 541 PGHPCDMNCSCIQTQNFCEKFCNCSSDCQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLC 
                                               --------S E T  d o m a i n------- 
hydra EZH2      551 KTCGADNFEVESHESSCKNVGLQRSWRMNLLLAPSDIAGWGIYLKNDVTKNTLISEYCGE 
human EZH2      586 LTCGAAD-HWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGE 
mouse Ezh2      586 LTCGAAD-HWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFIKDPVQKNEFISEYCGE 
xenopus EZH2    588 LTCGAAD-HWDSKNVSCKNCSIQRGSKKHLLLAPSDVAGWGIFINDTVQKNEFISEYCGE 
zebrafish EZH2  600 LTCGAAE-HWDSKNVSCKNCSIQRGAKKHLLLAPSDVAGWGIFIKEPVQKNEFISEYCGE 
drosophila E(Z) 601 QACG-AD-QFKLTKITCKNVCVQRGLHKHLLMAPSDIAGWGIFLKEGAQKNEFISEYCGE 
                                       S E T  d o m a i n-------           ----- 
hydra EZH2      611 LISQDEAERRGKVYDKTMCSFLFNLNHEFVVDATRKGNKIRFANHSINPNCYAKVMMVNG 
human EZH2      645 IISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNG 
mouse Ezh2      645 IISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNG 
xenopus EZH2    647 IISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNG 
zebrafish EZH2  659 IISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMMVNG 
drosophila E(Z) 659 IISQDEADRRGKVYDKYMCSFLFNLNNDFVVDATRKGNKIRFANHSINPNCYAKVMMVTG 
                                 S E T  d o m a i n------- ----- 
hydra EZH2      671 DHRIGIFAKRNIVTGEELFFDYRYGPTDSLRYVGIEKDTRFPDSTTGVAKKWTV 
human EZH2      705 DHRIGIFAKRAIQTGEELFVDYRYSQADALKYVGIEREMEIP------------ 
mouse Ezh2      705 DHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP------------ 
xenopus EZH2    707 DHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP------------ 
zebrafish EZH2  719 DHRIGIFAKRAIQTGEELFFDYRYSQADALKYVGIEREMEIP------------ 
drosophila E(Z) 719 DHRIGIFAKRAIQPGEELFFDYRYGPTEQLKFVGIEREMEIV------------ 
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HyEED     
 
From gene to protein: 
The HyEED gene is composed of 17 exons and spans a genomic region of > 38 kb. The respective 
exon and intron lengths are indicated. Undetermined lengths are indicated by a question mark. 
Based on a ~ 1.5 kb mRNA, a protein of 420 aa is translated. 
 
 
 
 
Sequence information: 
Nucleotide  and derived  amino  acid  sequence of HyEED  from Hydra magnipapillata  105.   The 
beginning  of  the  respective  exons  is  indicated. No  5’  and  3’  untranslated  region  have  been 
determined for this gene. The translation initiation start and stop codons are highlighted in red. 
The coding sequence and the derived amino acid sequence are indicated by capital letters. The 
protein domains are indicated. The six WD40 domains are highlighted in light green, red, blue, 
yellow, brown and blue lilac. 
 
 
  Exon 1                                                  Exon 2  
    1  ATGGATACTG TTAATGATTT TATCGACGAT AGTTATCGTG|ATAATGATGA 
         M  D  T   V  N  D   F  I  D  D   S  Y  R    D  N  D 
   51  CGATACTGAC AGTAGTCAAA CTTATTCAAC ATCCAGTAAA ACAAAAGGAA 
       D  D  T  D   S  S  Q   T  Y  S   T  S  S  K   T  K  G 
  101  GAAAGGTATA CAAAAAAAAA TGGAAAAAGC AAAATAAACA TGATGAGAAT 
        R  K  V   Y  K  K  K   W  K  K   Q  N  K   H  D  E  N 
                                                         Exon 3  
  151  TCAACTGGAA AATCAAAACT AAATTTTAAA TGCACTAATT TTATTAAG|GA 
         S  T  G   K  S  K   L  N  F  K   C  T  N   F  I  K 
WD40 repeat 
  201  GGATCACAAA CAACCGATTT TTGGTGTTCA ATTTTACCAA CAATGCTCCA 
       E  D  H  K   Q  P  I   F  G  V   Q  F  Y  Q   Q  C  S 
                                                        Exon 4  
  251  GTGGAGAAGA TGATCCATTA ATTTTTGGAA CTGTTGGAAG CAATAGG|GTT 
        S  G  E   D  D  P  L   I  F  G   T  V  G   S  N  R    V 
  301  TCAATTTACA AATGTGCTGA AGATTCTGGA CAAATTATAT TGCTTCAAAG 
         S  I  Y   K  C  A   E  D  S  G   Q  I  I   L  L  Q 
                      Exon 5  
  351  CTATGCTGAT AGTGAT|CCAG AAGAAAGTTT CTATGCATGT TCATGGACAT 
       S  Y  A  D   S  D     P   E  E  S   F  Y  A  C   S  W  T 
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  401  ATGATCCTGA TAACAGAAAT CCTTTGTTTT GTTTTGCTGG AGCTAAAGGA 
        Y  D  P   D  N  R  N   P  L  F   C  F  A   G  A  K  G 
                       Exon 6                             Exon 7  
  451  ATCATTCATA TACTTAA|CCC ATGCATACGT CAAGTTGCTA CT|TATCTTCA 
         I  I  H   I  L     N   P  C  I  R   Q  V  A   T    Y  L 
WD40 repeat 
  501  AGGACATGGC AGTGCGATCA ATGAGTTAAA GACACACCCC ATTGAACCAT 
       Q  G  H  G   S  A  I   N  E  L   K  T  H  P   I  E  P                       
  
                              Exon 8  
  551  CAATAATTCT CAGTGCAAGT AAAG|ATCACA CTATTAGAAT GTGGAACATT 
        S  I  I   L  S  A  S   K     D  H   T  I  R   M  W  N  I 
  601  AAAACAGAAG TTTGTGTTGC AATCTTTGGT GGTGTAGATG GTCACAGAGA 
         K  T  E   V  C  V   A  I  F  G   G  V  D   G  H  R 
                  WD40 repeat          Exon 9  
  651  TGAAGTTCTG GGTATTGATT TTGATGTACT T|GGTACAAAA ATAGTATCTT 
       D  E  V  L   G  I  D   F  D  V   L     G  T  K   I  V  S 
  701  GTGGAATGGA TCATTCTTTA AAATTTTGGT CACTTGAGAC AGAAAAATGC 
        C  G  M   D  H  S  L   K  F  W   S  L  E   T  E  K  C 
           Exon 10                                                Exon 11  
  751  AAAAAA|GTAA TCAATGATTC GCACACTTAC TTAAATACAG AAAGG|ATCTT 
         K  K     V   I  N  D   S  H  T  Y   L  N  T   E  R    I 
  801  TCATACATTA AATGTTCATT ATCCTGAGTA TACTACTCGA GAAGTTCATC 
       F  H  T  L   N  V  H   Y  P  E   Y  T  T  R   E  V  H 
WD40 repeat 
  851  GTAATTACGT TGATTGTTGT GTTTGGTTAG GTGATCTTGT TATATCAAAA 
        R  N  Y   V  D  C  C   V  W  L   G  D  L   V  I  S  K 
     Exon 12  
  901  |TCTTGTGACA ATCAAGTTGT ATGTTGGAAA ACAAAGCAAC CAATAGAAAC 
             S  C  D   N  Q  V   V  C  W  K   T  K  Q   P  I  E 
                   Exon 13  
  951  AGTTATGAAA AGG|AAAAATA ACTCTGATGT TGGTGTGTTT GTGCTACACA 
       T  V  M  K   R     K  N   N  S  D   V  G  V  F   V  L  H 
      Exon 14                        WD40 repeat 
 1001  A|GTTTGATAT TGATTTGTGC GACATTTGGT TCATCAGATT TGCAGTAGAC 
           K  F  D   I  D  L  C   D  I  W   F  I  R   F  A  V  D 
                  Exon 15  
 1051  CTGAATCAAA CG|ATTTTAGC CCTTGGAAAT CAAATTGGTA AAGTTTATCT 
         L  N  Q   T     I  L   A  L  G  N   Q  I  G   K  V  Y 
                                            Exon 16  
 1101  CTATGATTTA GAAGGAGAAC ATCCTGCCCA TGCCAA|ACCA ACGATACTTT 
       L  Y  D  L   E  G  E   H  P  A   H  A     K  P   T  I  L 
WD40 repeat 
 1151  TTCATTCCAA GTGTACAACA GTTGTTCGCC AAATTTCGTT TAATAGTTCA 
        F  H  S   K  C  T  T   V  V  R   Q  I  S   F  N  S  S 
          Exon 17  
 1201  GCTAA|AGTAC TAATTGCTGT TTGTGATGAT GGCTCTGTAT GGAGATGGGA 
         A     K  V   L  I  A   V  C  D  D   G  S  V   W  R  W 
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                                      3’ UTR 
 1251  CAAGCAGACA TAAtgaaaaa atcttgtgta aatagtaaaa atgaagctat 
       D  K  Q  T   *   
 1301  aatgacgaaa ctgctagacg ctgtgaaaat cgcaatattt tcagaggaga 
 1351  ataacaaaca attgattgtt agtatgaaaa taattaatgc gaaaatgttt 
 1401  caaaggaata aaatcagttt ttaataataa ctgtataaga taagaaaaat 
 1451  gtacattttt tagtaaataa aataaagtt 
 
 
Protein alignment: 
Comparison  of  HyEED  with  EED  protein  sequences  from  other  species  reveals  significant 
conservation on the amino acid level (47%). Areas of high matches are highlighted in grey. The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
   
hydra EED         1 -------------------------MDTVNDFIDDSYRDNDDD----------TDSSQTY 
mouse Eed         1 MSEREVSTAPAGTDMPAAKKQKLSSDE--NSNPDLSGDEN--DDAVSIESGTNTERPDTP 
human EED         1 MSEREVSTAPAGTDMPAAKKQKLSSDE--NSNPDLSGDEN--DDAVSIESGTNTERPDTP 
xenopus EED       1 --------------MP-AKKQKLSSDE--NSNPELSGDEN--DDSVSIESGTNTERPDTP 
zebrafish EED     1 --------------MP-NKKQKLSSDE--NSNPDLSGDDN--DDAVSVESGTHPERPDTP 
drosophila ESC    1 ----------------------MSSDKVKNGNEPEESEESCGDESASYTTNSTTSRSKSP 
                                                     ---W D 4 0  r e p e a t---- 
hydra EED        26 STSSKTKGRKVYKK-KWKKQNKHDENSTGKSKLNFKCTNFIKEDHKQPIFGVQFYQQCSS 
mouse Eed        57 TNTPNAPGRKSWGKGKWK--------SK-KCKYSFKCVNSLKEDHNQPLFGVQF--NWHS 
human EED        57 TNTPNAPGRKSWGKGKWK--------SK-KCKYSFKCVNSLKEDHNQPLFGVQF--NWHS 
xenopus EED      42 TNAANAPGRKGWGKGKWK--------SK-KCKYSFKCVNSLKEDHNQPLFGVQF--NWHS 
zebrafish EED    42 TNTASAPGRKSWGKGKWK--------SK-KCKYSFKCVNSLKEDHGQPLFGVQF--NWHS 
drosophila ESC   39 SSSTRSKRR---GRRSTK--------SKPKSRAAYKYDTHVKENHGANIFGVAF--NTLL 
                    W D 4 0  r e p e a t 
hydra EED        85 GEDDPLIFGTVGSNRVSIYKCAEDSGQIILLQSYADSDPEESFYACSWTYDPDNRNPLFC 
mouse Eed       106 KEGDPLVFATVGSNRVTLYEC-HSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLA 
human EED       106 KEGDPLVFATVGSNRVTLYEC-HSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLA 
xenopus EED      91 KEGDPLVFATVGSNRVTLYEC-HPQGDIRLLQSYVDADADENFYTCAWTYDSNTSHPLLA 
zebrafish EED    91 KEGDPLVFATVGSNRVTLYEC-HSQGEIRLLQSYVDADADENFYTCAWTFDCSSSHPLLA 
drosophila ESC   86 GKDEPQVFATAGSNRVTVYEC-PRQGGMQLLHCYADPDPDEVFYTCAWSYDLKTSSPLLA 
                                  ---------W D 4 0  r e p e a t------------  ---  
hydra EED       145 FAGAKGIIHILNPCIRQVATYLQGHGSAINELKTHPIEPSIILSASKDHTIRMWNIKTEV 
mouse Eed       165 VAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDT 
human EED       165 VAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDT 
xenopus EED     150 VAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDT 
zebrafish EED   150 VAGSRGIIRIINHITMQCVKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDT 
drosophila ESC  145 AAGYRGVIRVIDVEQNEAVGNYIGHGQAINELKFHPHKLQLLLSGSKDHAIRLWNIQSHV 
                    ---------W D 4 0  r e p e a t--------- - 
hydra EED       205 CVAIFGGVDGHRDEVLGIDFDVLGTKIVSCGMDHSLKFWSLETEKCKKVINDSHTYL--N 
mouse Eed       225 LVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNK 
human EED       225 LVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNK 
xenopus EED     210 LVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSLRMKTAIKESYDYNPNK 
zebrafish EED   210 LVAIFGGVEGHRDEVLSADFDLLGEKIMSCGMDHSLKLWRLDSERLQRAIRGSYEYNPSK 
drosophila ESC  205 CIAILGGVEGHRDEVLSIDFNMRGDRIVSSGMDHSLKLWCLNTPEFHHKIELSNTFSQEK 
                              ---------W D 4 0  r e p e a t--------- 
hydra EED       263 TERIFHTLNVHYPEYTTREVHRNYVDCCVWLGDLVISKSCDNQVVCWKTKQPIETVMKRK 
mouse Eed       285 TNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIK 
human EED       285 TNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIK 
xenopus EED     270 TNRPFVSQKVHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIEKIK 
zebrafish EED   270 TNRPFVSQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGRMEDDIDRIK 
drosophila ESC  265 STLPFPTVTKHFPDFSTRDIHRNYVDCVQWFGNFVLSKSCENAIVCWKPGQLHQSFEQVK 
                            ---------W D 4 0  r e p e a t----------      ------- 
hydra EED       323 NNSDVGVFVLHKFDIDLCDIWFIRFAVDLNQTILALGNQIGKVYLYDLEGEHPAHAKPTI 
mouse Eed       345 P-SESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTT 
human EED       345 P-SESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTT 
xenopus EED     330 A-SESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTT 
zebrafish EED   330 P-NESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTT 
drosophila ESC  325 P-SDSSCTIIAEFEYDECEIWFVRFGFNPWQKVIALGNQQGKVYVWELDPSDPEGAHMTT 
                    -------W D 4 0  r e p e a t-------- 
hydra EED       383 LFHSKCTTVVRQISFNSSAKVLIAVCDDGSVWRWDKQT---- 
mouse Eed       404 LTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR---- 
human EED       404 LTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR---- 
xenopus EED     389 LTYPKCASAIRQTSFSRDSSVLIAVCDDSTIWRWDRLR---- 
zebrafish EED   389 LTLPRCTSAIRQTSFSRDSSILIAVCDDASIWRWDRLR---- 
drosophila ESC  384 LHNSRSVATVRQIAFSRDASVLVYVCDDATVWRWNRRQTTSI 
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HySUZ12     
 
 
From gene to protein: 
The HySUZ12  gene  is  composed  of  14  exons  and  spans  a  genomic  region  of  >  30  kb.  The 
respective  exon  and  intron  lengths  are  indicated.  ‘Exon  10’  cannot  be  found  in  any Contig. 
Undetermined lengths are indicated by a question mark. Based on a ~ 2 kb mRNA, a protein of 
638 aa is translated. 
 
 
 
 
Sequence information: 
Nucleotide and derived amino acid sequence of HySUZ12 from Hydra magnipapillata 105.   The 
beginning of the respective exons is indicated. The  5’ untranslated region is highlighted in grey. 
No  3’ untranslated region has been determined for this gene. The translation initiation start and 
stop codons are highlighted in red. The coding sequence and the derived amino acid sequence 
are  indicated  by  capital  letters.  The  protein  domains  are  indicated.  The C2H2‐zinc  finger  is 
highlighted in yellow, the VEFS‐box is  highlighted in light blue. 
 
 
Exon 1                        5‘ UTR 
    1  aggaataaat acaaaaaaaa aaaaaaaaga tattaacatc atacaagtat 
   51  atatatatta tatgtataaa tataATGACT TCTTTAAATC AAAAGGTGGA 
                                   M  T   S  L  N   Q  K  V      
  101  ATCTTCACTT GGTACACCCA GAAAACTGAA GTTTGAACAA CTACGAGCAG 
       E  S  S  L   G  T  P   R  K  L   K  F  E  Q   L  R  A 
                                     Exon 2  
  151  ACTATGAACT TTTTTTGCAT ACATATGAAA|AACCAACATG GATCTATAGA 
        D  Y  E   L  F  L  H   T  Y  E    K  P  T   W  I  Y  R 
                                  Exon 3  
  201  TTTATACAAC GAAGACATCA ATTATCG|CCT TTTATGCTAC ACAGAAATTT 
         F  I  Q   R  R  H   Q  L  S    P   F  M  L   H  R  N 
  251  GTCTTATTTT AAAGATCGAA GAACAAAGAG ACCACAGCTG CAGCAAGTTA 
       L  S  Y  F   K  D  R   R  T  K   R  P  Q  L   Q  Q  V 
         Exon 4  
  301  AAAG|GAAAAA TTTTCAATTG GACCTGTTAT TAAAAGACTT TAAATCAACT 
        K     R  K   N  F  Q  L   D  L  L   L  K  D   F  K  S  T 
                                        Exon 5  
  351  GAATTGAATG TTAAAAGTGA AAGTAATGAG GA|AAATCATT ATCTGAATAT 
         E  L  N   V  K  S   E  S  N  E      E  N  H   Y  L  N 
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                                    Exon 6  
  401  ATCTTTTAAT GGATTCTTTC ATGGTCCAG|G TTTTGCTGAA GAAATATTTG 
       I  S  F  N   G  F  F   H  G  P       G  F  A  E   E  I  F 
  451  AAACAAATGA ACCGAAAGAA CAAGAACTGT TTAAAGACGA CTTTGTCAAA 
        E  T  N   E  P  K  E   Q  E  L   F  K  D   D  F  V  K 
                                                   Exon 7  
  501  GTAGAAATAC ACTTATGTCA AGTATACCAT AAAAAGAAAA AG|TGCCAAGA 
         V  E  I   H  L  C   Q  V  Y  H   K  K  K   K     C  Q 
  551  TTCTGAACAA ATGGATCTTA TTCCTCTTGG GTCTTGTAAA GCTCCTTGGA 
       D  S  E  Q   M  D  L   I  P  L   G  S  C  K   A  P  W 
  601  ATCCACGCAC TCAACTTCTT CTGCCATGTT CATCTGTTAA TCTCACTGTT 
        N  P  R   T  Q  L  L   L  P  C   S  S  V   N  L  T  V 
  651  CCTCCTAATG CTTTTGTTGA AAATGGTCGT GCTGTAAAAG CACACATATT 
         P  P  N   A  F  V   E  N  G  R   A  V  K   A  H  I 
  701  ATCTTTCACA GTCATTATTA CAGTGCCTAA AAAAGGTTCA TCAAAAAACA 
       L  S  F  T   V  I  I   T  V  P   K  K  G  S   S  K  N 
                            Exon 8  
  751  TAAAATCAGA CCGAACTGAA G|AAAATGGAT TACATCGCCC ATTAAAACGT 
        I  K  S   D  R  T  E      E  N  G   L  H  R   P  L  K  R 
  801  CAAAAGTGTG ACAATTCTGA TGCTGACAGT GAAACTAATA GTTTAACTTA 
         Q  K  C   D  N  S   D  A  D  S   E  T  N   S  L  T 
  851  TCCAGCTGAT GTATGTGTAG CATCATTTTC GGCAGAAATG ATTCTCTATG 
       Y  P  A  D   V  C  V   A  S  F   S  A  E  M   I  L  Y 
  901  ACCGTCTTAA AAATTGCTTG TTGACAGATG GGGATTATGA GTTACTCTTA 
        D  R  L   K  N  C  L   L  T  D   G  D  Y   E  L  L  L       
  951  CATGAAAATT CACCGACAAT TCGAAAATCA AACAGTTGGG AAAGCAAGTT 
         H  E  N   S  P  T   I  R  K  S   N  S  W   E  S  K 
               Exon 9  
 1001  CAAATCAAAG|CTGGGACCGT TTGCAGCATT TTCTTTTGGT CCGACTATAA 
       F  K  S  K    L  G  P   F  A  A   F  S  F  G   P  T  I 
 1051  AGTTTAACCT CACCTGGGGA ACAAAACCAA TAGCACCACT GGCAGCTGCC 
        K  F  N   L  T  W  G   T  K  P   I  A  P   L  A  A  A 
 1101  TATAAATGTC TTGCATCTCC TTATCAAGAC AATTCCAATA TAAAGATTGA 
         Y  K  C   L  A  S   P  Y  Q  D   N  S  N   I  K  I 
 1151  GTTAGAAATG TCAAAAGAAA CAAAGTCTGT TGCAGTAACT TCTGCAGAAA 
       E  L  E  M   S  K  E   T  K  S   V  A  V  T   S  A  E 
 1201  AGAATATGCG AATGTTTTAT CGGTTTATTT ATAATGGATC CACTAGACAA 
        K  N  M   R  M  F  Y   R  F  I   Y  N  G   S  T  R  Q 
 1251  CAAACTGAAG CCAAAGAAGG TATGGCCTGT CCTTGGTGTG CATTGGACTG 
         Q  T  E   A  K  E   G  M  A  C   P  W  C   A  L  D 
C2H2 zinc finger 
 1301  CAAAAGATTA TATGTTTTGT TAAAGCATTT TAAAACTTGT CATCCTCGAT 
       C  K  R  L   Y  V  L   L  K  H   F  K  T  C   H  P  R 
                      ‘Exon 10‘  
 1351  TTTCTTTTGT ATACACA|GCT ATAAAAAAAG GGCACCTAAT AGATGTACGT 
        F  S  F   V  Y  T     A   I  K  K   G  H  L   I  D  V  R 
 1401  ATCAAAGAGA ATTTTGAAAA TTCATTAGAG ATTGATGGTA TTAAAGATAT 
         I  K  E   N  F  E   N  S  L  E   I  D  G   I  K  D 
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 1451  TGGATTTATT GATATTGCAA ATGCTCCAAA GAAAAGGAAT TCAGAAACAG 
       I  G  F  I   D  I  A   N  A  P   K  K  R  N   S  E  T 
                     Exon 11  
 1501  AAATTATTGT TGGACG|GCCT TACAAACATC AAGAAGATTT AAAAGAGTTT 
        E  I  I   V  G     R  P   Y  K  H   Q  E  D   L  K  E  F 
                          VEFS-Box                      Exon 12  
 1551  ACAGAACTTG ATCAGTTAGA AAATGCATCA CAAATGAATC ATGACAG|GTC 
         T  E  L   D  Q  L   E  N  A  S   Q  M  N   H  D     R 
 1601  TTATTACCAC ACGCTTAACA ACCAGCTATT ACCTAGTCTG GCACATCATG 
       S  Y  Y  H   T  L  N   N  Q  L   L  P  S  L   A  H  H 
 1651  ATATAAAAGC TGAAGATGAT ATCGCTCCAG AGTGGTTAAA GGAGAAAACT 
        D  I  K   A  E  D  D   I  A  P   E  W  L   K  E  K  T 
           Exon 13  
 1701  TTAGAG|ATGA TTGAAGAATT TACTGATTTA AATGCTGGTG AGAAGCAACT 
         L  E     M   I  E  E   F  T  D  L   N  A  G   E  K  Q 
                                            Exon 14  
 1751  GATGAAATTG TGGAACATTC ATGTTTTAGA AAAAAA|TTAT ATTGCTGACT 
       L  M  K  L   W  N  I   H  V  L   E  K     N  Y   I  A  D 
 1801  TCACTTGTGC TAGAGGGTGC ATATCTTTTG CCGAGGAATA TGGTAAAGAA 
        F  T  C   A  R  G  C   I  S  F   A  E  E   Y  G  K  E 
 1851  ATTATTCAAA ACAATCTAAT CAAAAATTTT ATGCTTCATC TAAATAACTT 
         I  I  Q   N  N  L   I  K  N  F   M  L  H   L  N  N 
 1901  AATTGATTTT CATATTATAC CACAATCTGT GCTGGTTAAG TCGATGGCTA 
       L  I  D  F   H  I  I   P  Q  S   V  L  V  K   S  M  A 
 1951  TCATCTACAA GTTGAAAGAA GAACTTTTAC CAAAAATGTA G 
        I  I  Y   K  L  K  E   E  L  L   P  K  M   * 
 
 
Protein alignment: 
Comparison  of  HySUZ12  with  SUZ12  protein  sequences  from  other  species  reveals  a 
conservation of 28% on the amino acid level. Areas of high matches are highlighted in grey. The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
zebrafish SUZ12      1 MAPQKHG------------SGGNGFYGNSASKAA-------------NGGAHASS----- 
xenopus SUZ12        1 MAPQKHGGS----SGPTSKSN--------------------------------------- 
mouse Suz12          1 MAPQKHGGGGGGGSGPSAGSGGGGFGGSAAAVAAAASGGKSGGGGCGGGGSYSASSSSAA 
human SUZ12          1 MAPQKHGGGGGGGSGPSAGSGGGGFGGSAAVAAATASGGKSGGGSCGGGGSYSASSSS-- 
drosophila Su(z)12   1 MAPAKK---REKDSNPD-GSAANGIIGLT-------------------HGAPDASNAGST 
hydra SUZ12          1 ------------------------------------------------------MTSLNQ 
 
zebrafish SUZ12     31 ------GVVMTSVKRLKMEQIQADHQLFLEAFEKPTQIYRFLRTRNLITPIFLHRSLTYM 
xenopus SUZ12       18 -----ATASLLPVRKPKMEQIQADHELFLQAFEKPTQIYRFLRTRNLIAPIFLHRTLTYM 
mouse Suz12         61 AAAAAAGAAVLPVKKPKMEHVQADHELFLQAFEKPTQIYRFLRTRNLIAPIFLHRTLTYM 
human SUZ12         59 SAAAAAGAAVLPVKKPKMEHVQADHELFLQAFEKPTQIYRFLRTRNLIAPIFLHRTLTYM 
drosophila Su(z)12  38 VPPTAEG-------QVKLNGHQQEQELFLQAFEKPTQIYRYLRNRHETNPIFLNRTLSYM 
hydra SUZ12          7 KVESSLGTP----RKLKFEQLRADYELFLHTYEKPTWIYRFIQRRHQLSPFMLHRNLSYF 
 
zebrafish SUZ12     85 SHRNSRT----NSKRKSFSLNDLLFKVEKSKVDPESHNLAS-N-LQLTFTGFFHKTEKQL 
xenopus SUZ12       73 SHRNSRS----NAKRKSFKVNDLLLKVEKMKGDQESHSVSA-H-LQLTFTGFFHKIDKPS 
mouse Suz12        121 SHRNSRT----SIKRKTFKVDDMLSKVEKMKGEQESHSLSA-H-LQLTFTGFFHKNDKPS 
human SUZ12        119 SHRNSRT----NIKRKTFKVDDMLSKVEKMKGEQESHSLSA-H-LQLTFTGFFHKNDKPS 
drosophila Su(z)12  91 KERMSRN----NKKRISFQVNSMLESI-----TQKSEAVSQNY-LHVIYDSLHEKLPARL 
hydra SUZ12         63 KDRRTKRPQLQQVKRKNFQLDLLLKDFKSTELNVKSESNEENHYLNISFNGFFHGPGFAE 
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zebrafish SUZ12    139 QNSENEE-----------NSVSVEVLLVKLCHKKRK-DVTCPVKQVPTGKKQVPLNPDIS 
xenopus SUZ12      127 QNSENDQ-----------SSVTLEVLLVKVCHKKRK-DVNCPIRQVPTGKKQVPLNPELN 
mouse Suz12        175 QNSENEQ-----------NSVTLEVLLVKVCHKKRK-DVSCPIRQVPTGKKQVPLNPDLN 
human SUZ12        173 PNSENEQ-----------NSVTLEVLLVKVCHKKRK-DVSCPIRQVPTGKKQVPLNPDLN 
drosophila Su(z)12 141 DNESGEDLLQEQLLCEAGESVSVETTLYKITRSKRK-DSTLDFQELLSKCSQIVYNP--- 
hydra SUZ12        123 EIFETNE--PKEQELFKDDFVKVEIHLCQVYHKKKKCQDSEQMDLIPLGSCKAPWNPRTQ 
 
zebrafish SUZ12    187 PTKLGAFPTLVVPSHEFEP-VNSNTVKSYSLLFRA--SRPWGREHNGMTTRDTN----VI 
xenopus SUZ12      175 PAKPSSFPSLAVSSNEFEP-SNSHMVKSYSLLFRV--TRQGRRDFNGLTNGETNENIDVS 
mouse Suz12        223 QTKPGNFPSLAVSSNEFEP-SNSHMVKSYSLLFRV--TRPGRREFNGMINGETNENIDVS 
human SUZ12        221 QTKPGNFPSLAVSSNEFEP-SNSHMVKSYSLLFRV--TRPGRREFNGMINGETNENIDVN 
drosophila Su(z)12 197 KDRVGEHATISIPLQTMRPMGEQHTL--YKLLFRI------------KVLSPSTCNDENA 
hydra SUZ12        181 LLLPCSSVNLTVPPNAF--VENGRAVKAHILSFTVIITVPKKGSSKNIKSDRTEEN---G 
 
zebrafish SUZ12    240 EELSNRKKRYCSRQDDGET------------TFVAQMTVFDKNRRLQLLDGEYEVSMQEI 
xenopus SUZ12      232 EELPTRRKRNSSSIDEGEK------------TFVAQMTVFDKNRRLQLLDGEYEVAMQEM 
mouse Suz12        280 EELPARRKRNR---EDGEK------------TFVAQMTVFDKNRRLQLLDGEYEVAMQEM 
human SUZ12        278 EELPARRKRNR---EDGEK------------TFVAQMTVFDKNRRLQLLDGEYEVAMQEM 
drosophila Su(z)12 243 ETPPNKRSR------PNEK------------MFGSELILYEKSSGF-ITEGEYEAMLQPL 
hydra SUZ12        236 LHRPLKRQKCDNSDADSETNSLTYPADVCVASFSAEMILYDRLKNCLLTDGDYELLLH-- 
 
zebrafish SUZ12    288 EESPV---GKKRATWETILDEKWVP---PFETFSQGPTLQFTLRWTNDTADKATAPVAKP 
xenopus SUZ12      280 EDCPV---NKKRASWETILDGKRLP---PFETFSHGPTLQFTLRWTSDTPDKSTAPIAKP 
mouse Suz12        325 EECPI---SKKRATWETILDGKRLP---PFETFSQGPTLQFTLRWTGETNDKSTAPVAKP 
human SUZ12        323 EECPI---SKKRATWETILDGKRLP---PFETFSQGPTLQFTLRWTGETNDKSTAPIAKP 
drosophila Su(z)12 284 NSTSIKSFSPKKCTWETMPD-SYIPLSLTYDVYQQSPMLKFHLTL---SNEQLPEMISAP 
hydra SUZ12        294 ENSPTI---RKSNSWESKFKSK----LGPFAAFSFGPTIKFNLTW----GTKPIAPLA-- 
 
zebrafish SUZ12    342 -----------LATRNSESSTVDSS------KTSNVKPPQAVAVNDSLGTDLPVRREQTH 
xenopus SUZ12      334 -----------LATRNSES-LPQEH------KPSSVKPAQTIAVKESFSSDLQARKERDV 
mouse Suz12        379 -----------LATRNSES-LHQEN------KPGSVKPAQTIAVKETLTTELQTRKEKDN 
human SUZ12        377 -----------LATRNSES-LHQEN------KPGSVKPTQTIAVKESLTTDLQTRKEKDT 
drosophila Su(z)12 340 ELQRYVQHLDAVAEMNYNNNNYNNNNNCSGLKNGSGGGNSTVC-----------KTTPEH 
hydra SUZ12        341 ------------AAYKCLASPYQDNSNIKIELEMS-KETKSVAV---------TSAEKN- 
                                                    --C 2 H 2  zinc finger-- 
zebrafish SUZ12    385 I-EPCQKLRVCYQFLYNNNTRQQTEAREDLHCPWCTLNCRKLYSLLKHLKLSHSRFIFNY 
xenopus SUZ12      376 STEQRQKLRIFYQFLYNNNTRQQTEARDDLHCPWCTLNCRKLYSLIKHLKLCHSRFIFNY 
mouse Suz12        421 SNESRQKLRIFYQFLYNNNTRQQTEARDDLHCPWCTLNCRKLYSLLKHLKLCHSRFIFNY 
human SUZ12        419 PNENRQKLRIFYQFLYNNNTRQQTEARDDLHCPWCTLNCRKLYSLLKHLKLCHSRFIFNY 
drosophila Su(z)12 389 -------IQIVYNFMYSNNTRQQTEYTQELNCPWCGLDCLRLYALLKHLKLCHARFNFTY 
hydra SUZ12        378 -------MRMFYRFIYNGSTRQQTEAKEGMACPWCALDCKRLYVLLKHFKTCHPRFSFVY 
 
zebrafish SUZ12    444 VPHSKGARIDVSINECYDGSYVGNPQDILCQPGFAFSRN-GPVKRTPVTQILVCRPKRSK 
xenopus SUZ12      436 VYHPKGARIDVSINECYDGSYAGNPQDIHRQPGFAFSRN-GPVKRTPITHILVCRPKRTK 
mouse Suz12        481 VYHPKGARIDVSINECYDGSYAGNPQDIHRQPGFAFSRN-GPVKRTPITHILVCRPKRTK 
human SUZ12        479 VYHPKGARIDVSINECYDGSYAGNPQDIHRQPGFAFSRN-GPVKRTPITHILVCRPKRTK 
drosophila Su(z)12 442 QPAGSGARIDVTINDAYDGSYAGSPYDLAGPSGSSFARTCGPVRRTSVTSLMVCRPRRQK 
hydra SUZ12        431 TAIKKGHLIDVRIKENFENSL---EIDGIKDIGFIDIAN-APKKRNSETEIIVGRPYKHQ 
                          --------------------V E F S  b o x----------------------- 
zebrafish SUZ12    503 PSLSEFLEPEDGEQEQQRTYISGHNRLYFHS--DSCTPLRPQEMEVDSEDERDPDWLREK 
xenopus SUZ12      495 ASMSEFLESEDGEVEQQRTYSSGHNRLYFHS--DTCLPLRPQEMEVDSEDEKDPEWLREK 
mouse Suz12        540 ASMSEFLESEDGEVEQQRTYSSGHNRLYFHS--DTCLPLRPQEMEVDSEDEKDPEWLREK 
human SUZ12        538 ASMSEFLESEDGEVEQQRTYSSGHNRLYFHS--DTCLPLRPQEMEVDSEDEKDPEWLREK 
drosophila Su(z)12 502 TCLDEFLELDEDEISNQRSYITGHNRLYHHT--ETCLPVHPKELDIDSEGESDPLWLRQK 
hydra SUZ12        487 EDLKEFTELDQLENASQ----MNHDRSYYHTLNNQLLPSLAHH-DIKAEDDIAPEWLKEK 
                       -----------------------V E F S  b o x----------------------- 
zebrafish SUZ12    561 TAMQIEEFTDVNEGEKEIMKLWNLLVMKHGFIADNQMNQACMSFVEQHGTIMVEKNLCRN 
xenopus SUZ12      553 TITQIEEFSDVNEGEKEVMKMWNLHVMKHGFIADNQMNHGCMQFVENYGPEIVQKNLCRN 
mouse Suz12        598 TITQIEEFSDVNEGEKEVMKLWNLHVMKHGFIADNQMNHACMLFVENYGQKIIKKNLCRN 
human SUZ12        596 TITQIEEFSDVNEGEKEVMKLWNLHVMKHGFIADNQMNHACMLFVENYGQKIIKKNLCRN 
drosophila Su(z)12 560 TIQMIDEFSDVNEGEKELMKLWNLHVMRHGFVGDCQLPIACEMFLDAKGTEIVRKNLYRN 
hydra SUZ12        542 TLEMIEEFTDLNAGEKQLMKLWNIHVLEKNYIADFTCARGCISFAEEYGKEIIQNNLIKN 
                       ------V E F S  b o x------ 
zebrafish SUZ12    621 ALLHLINMHDFGLITTATIDKAMTHLRDLTQ----------------------------- 
xenopus SUZ12      613 FMLHLVSMHDFNLISIATIDKAVTRLREIQQKLEKDVC---------------------- 
mouse Suz12        658 FMLHLVSMHDFNLISIMSIDKAVTKLREMQQKLEKGES---------------------- 
human SUZ12        656 FMLHLVSMHDFNLISIMSIDKAVTKLREMQQKLEKGES---------------------- 
drosophila Su(z)12 620 FILHMCSLFDYGLIAAETVYKTVQKLQGLLSKYAAGQELMQRQREEQLKYWLDVGMHKKQ 
hydra SUZ12        602 FMLHLNNLIDFHIIPQSVLVKSMAIIYKLKEEL--------------------------- 
 
zebrafish SUZ12    652 -----------------QSIAQ-----------------------------------D-- 
xenopus SUZ12      651 ------------VAPPSEEPPE-----------------------------------EPN 
mouse Suz12        696 ------------ATPSNEEIAE-----------------------------------EQN 
human SUZ12        694 ------------ASPANEEITE-----------------------------------EQN 
drosophila Su(z)12 680 EDPKTLKSPQKPAPPADQASTSSASTSGSGSGSSSMQPPKRMPAHLKRGSAASSPGVQSK 
hydra SUZ12            ------------------------------------------------------------ 
zebrafish SUZ12        ------------------------------------------------------------ 
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xenopus SUZ12      664 RTTNSFMESNGK------------DQALENDC--------------VSG---PPKHSKKQ 
mouse Suz12        709 GTANGFSETNSK------------EKALETDG--------------VSG---VPKQSKKQ 
human SUZ12        707 GTANGFSEINSK------------EKALETDS--------------VSG---VSKQSKKQ 
drosophila Su(z)12 740 GTENGTNGSNSSSSNSKNVAKKSADQPLSTLANTRERRSEYGQKRNVSGSRLAATPASKR 
hydra SUZ12        635 ----------------------------------------------------LPKM---- 
 
zebrafish SUZ12        ------------------------------------------------------------ 
xenopus SUZ12      695 KP---------------------------------------------------------- 
mouse Suz12        740 KL---------------------------------------------------------- 
human SUZ12        738 KL---------------------------------------------------------- 
drosophila Su(z)12 800 KLSSKDNTVLNKRQRYSDGSPGTGIGNGHGGGSGSGANRNKSNNHSLPATSNNASSSSSN 
hydra SUZ12            ------------------------------------------------------------ 
 
zebrafish SUZ12        ----------------------------------------- 
xenopus SUZ12          ----------------------------------------- 
mouse Suz12            ----------------------------------------- 
human SUZ12            ----------------------------------------- 
drosophila Su(z)12 860 SKRAIARRRSTSERTKASGSTGGGAGGVRTRLSVPAKYERR 
hydra SUZ12            ----------------------------------------- 
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Hyp55     
 
 
From gene to protein: 
The Hyp55 gene is composed of 14 exons and spans a genomic region of > 29 kb. The respective 
exon and intron lengths are indicated.  ‘Exon 2’ cannot be found in any Contig. Undetermined 
lengths are  indicated by a question mark. Based on a ~ 1.4 kb mRNA, a protein of 434 aa  is 
translated. 
 
 
 
Sequence information: 
Nucleotide  and  derived  amino  acid  sequence  of Hyp55  from Hydra magnipapillata  105.    The 
beginning of the respective exons is indicated. The  5’ untranslated region is highlighted in grey. 
No  3’ untranslated region has been determined for this gene. The translation initiation start and 
stop codons are highlighted in red. The coding sequence and the derived amino acid sequence 
are indicated by capital letters. The protein domains are indicated. The six WD40 domains are 
highlighted in light green, red, blue, yellow, brown and blue lilac. 
 
  Exon 1                             5‘ UTR 
1 ttttcccgcc atcaggaatt aggtgtcaac aaaaagtctc ataacctgca 
                                                Exon 2  
   51  actaaataac cttatATGGC TGCTTTAAGT GCTCCAAACG TACCAG|ATGT 
                         M   A  A  L  S   A  P  N   V  P    D 
  101  TTATGATGAT GCTGCTGAGG AGAGAATCAT TAATGAAGAG TACAAAATAT 
       V  Y  D  D   A  A  E   E  R  I   I  N  E  E   Y  K  I 
  151  GGAAAAAAAA TACTCCTTTT TTATATGACC TTGTTATGAC GCATGCCTTA 
        W  K  K   N  T  P  F   L  Y  D   L  V  M   T  H  A  L 
                                                     Exon 3  
  201  GAATGGCCTA GTCTAACTGT ACAATGGCTT CCTGATGTCA CAAG|ACCTGA 
         E  W  P   S  L  T   V  Q  W  L   P  D  V   T    R  P 
                                                      Exon 4  
  251  AGGTAAAGAC TATTCTGTTC ATCGTTTGAT ATTAGGAACA CACAC|TTCTG 
       E  G  K  D   Y  S  V   H  R  L   I  L  G  T   H    T  S 
  301  ATGAGCAAAA CCATCTTGTA ATAGCAACTG TACAATTACC AAATGATGAA 
        D  E  Q   N  H  L  V   I  A  T   V  Q  L   P  N  D  E 
                                                Exon 5  
  351  ACTCATTTTG ATGCCAGTCA TTATGATCAT GATAGAGGAG|AGTTTGGTGG 
         T  H  F   D  A  S   H  Y  D  H   D  R  G    E  F  G 
                                         WD40 repeat 
  401  ATTTGGTACT GTAAGCGGAA AAATTGACGT AGAAATTAAA ATTAATCATG 
       G  F  G  T   V  S  G   K  I  D   V  E  I  K   I  N  H 
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                           Exon 6  
  451  AAGGTGAAGT AAACAG|AGCT CGTTATATGC CTCAAAATCC GTGTGTCATA 
        E  G  E   V  N    R  A   R  Y  M   P  Q  N   P  C  V  I 
  501  GCAACTAAGA CTCCAACTTC TGATGTTTTG ATATTTGATT ATACAAAACA 
         A  T  K   T  P  T   S  D  V  L   I  F  D   Y  T  K 
                    Exon 7                        
  551  TCCTTCTAAA CCAG|ATCCTT CCACAGGATG CACTCCAGAG CTACGCTTAA 
       H  P  S  K   P    D  P   S  T  G   C  T  P  E   L  R  L 
                              WD40 repeat 
  601  AAGGTCATTC TAAAGAAGGT TATGGCTTGT CATGGAACCC TAATTTATCA 
        K  G  H   S  K  E  G   Y  G  L   S  W  N   P  N  L  S 
  651  GGACATTTAT TAAGTGCATC TGATGATCAC ACAATTTGTT TATGGGATCT 
         G  H  L   L  S  A   S  D  D  H   T  I  C   L  W  D 
  701  TAATAATGCT GCAAAAGAAG CTAAGATGCT TGATGCATCA CGTATTTTCA 
       L  N  N  A   A  K  E   A  K  M   L  D  A  S   R  I  F 
                              WD40 repeat 
  751  ATGGTCATTC AGATGTTGTA GAAGATGTGT CATGGCATTT GCTTCATGAA 
        N  G  H   S  D  V  V   E  D  V   S  W  H   L  L  H  E 
                                                  Exon 8  
  801  AGTTTATTTG GTTCAGTTGC TGATGATCAC AAGCTTATGA T|TTGGGACAC 
         S  L  F   G  S  V   A  D  D  H   K  L  M     I  W  D 
                                       WD40 repeat 
  851  AAGGAGGAGC AGCAACAATA AACCAAGTCA CACTGTAGAT GCTCATACTG 
       T  R  R  S   S  N  N   K  P  S   H  T  V  D   A  H  T 
          Exon 9  
  901  CTGAG|GTTAA TTGTCTTTCA TTTAACCCCT ACAGTGAGTT CATACTTGCA 
        A  E  V   N  C  L  S   F  N  P   Y  S  E   F  I  L  A 
                        Exon 10  
  951  ACTGGTTCTG CTGATAAG|AC TGTTGCATTA TGGGATTTAA GAAATTTACG 
         T  G  S   A  D  K     T  V  A  L   W  D  L   R  N  L 
                                                        Exon 11  
 1001  TTTAAAACTT CATTCATTTG AATCTCATAA AGATGAAATA TTTCAGG|TTC 
       R  L  K  L   H  S  F   E  S  H   K  D  E  I   F  Q    V 
                              WD40 repeat 
 1051  AATGGTCACC TCATAATGAA ACAATTTTAG CATCAAGTGG AACAGATAGA 
        Q  W  S   P  H  N  E   T  I  L   A  S  S   G  T  D  R 
                              Exon 12  
1101  AGACTCCATG TTTGGGATTT AAGC|AAAATT GGTGAAGAAC AGACAGCAGA 
         R  L  H   V  W  D   L    S  K  I   G  E  E   Q  T  A 
                                       Exon 13  
1151  AGATGCAGAA GATGGTCCTC CAGAATTATT AT|TTATACAT GGTGGCCATA 
       E  D  A  E   D  G  P   P  E  L   L  F  I  H   G  G  H 
                              WD40 repeat 
1201  CAGCTAAAAT ATCAGACTTT GCATGGAATC CAAATGAGCC ATGGGTCATA 
        T  A  K   I  S  D  F   A  W  N   P  N  E   P  W  V  I 
                                                   Exon 14  
1251  TGTAGTGTTT CTGAAGATAA TATCATGCAA GTGTGGCAAA TGG|CTGAAAA 
         C  S  V   S  E  D   N  I  M  Q   V  W  Q   M    A  E 
1301  CATCTACAAT GATGAGGAAA TTGATACTCT TGCAACTGAT TTAGAACCAA 
       N  I  Y  N   D  E  E   I  D  T   L  A  T  D   L  E  P 
1351  GGCACCAATC GAAACCTTGA 
        R  H  Q   S  K  P  * 
A. MOLECULE INFORMATION ON Hydra PCG GENES 241
Protein alignment: 
Comparison  of  Hyp55  with  p55  protein  sequences  from  other  species  reveals  significant 
conservation on the amino acid level (82%).  Areas of high matches are highlighted in grey. The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
hydra p55         1 MAALSAPNVPDVYDDAAEERIINEEYKIWKKNTPFLYDLVMTHALEWPSLTVQWLPDVTR 
human RBBP4       1 -MADKE----AAFDDAVEERVINEEYKIWKKNTPFLYDLVMTHALEWPSLTAQWLPDVTR 
mouse Rbbp4       1 -MADKE----AAFDDAVEERVINEEYKIWKKNTPFLYDLVMTHALEWPSLTAQWLPDVTR 
xenopus RBBP4     1 -MADKE----AAFDDAVEERVINEEYKIWKKNTPFLYDLVMTHALEWPSLTAQWLSDVTR 
zebrafish RBBP4   1 -MADKE----AAFDDAVEERVINEEYKIWKKNTPFLYDLVMTHALEWPSLTAQWLPDVTR 
drosophila p55    1 -MVDRSDNAAESFDDAVEERVINEEYKIWKKNTPFLYDLVMTHALEWPSLTAQWLPDVTK 
                                                                            ---- 
hydra p55        61 PEGKDYSVHRLILGTHTSDEQNHLVIATVQLPNDETHFDASHYDHDRGEFGGFGTVSGKI 
human RBBP4      56 PEGKDFSIHRLVLGTHTSDEQNHLVIASVQLPNDDAQFDASHYDSEKGEFGGFGSVSGKI 
mouse Rbbp4      56 PEGKDFSIHRLVLGTHTSDEQNHLVIASVQLPNDDAQFDASHYDSEKGEFGGFGSVSGKI 
xenopus RBBP4    56 PDGKDFSIHRLVLGTHTSDEQNHLVIASVQLPNDDAQFDASHYDSEKGEFGGFGSVSGKI 
zebrafish RBBP4  56 PEGKDFSVHRLVLGTHTSDEQNHLVIASVQLPNDDAQFDASHYDSEKGEFGGFGSVSGKI 
drosophila p55   60 QDGKDYSVHRLILGTHTSDEQNHLLIASVQLPSEDAQFDGSHYDNEKGEFGGFGSVCGKI 
                    -------W D 4 0  r e p e a t-----------            --------- 
hydra p55       121 DVEIKINHEGEVNRARYMPQNPCVIATKTPTSDVLIFDYTKHPSKPDPSTGCTPELRLKG 
human RBBP4     116 EIEIKINHEGEVNRARYMPQNPCIIATKTPSSDVLVFDYTKHPSKPDPSGECNPDLRLRG 
mouse Rbbp4     116 EIEIKINHEGEVNRARYMPQNPCIIATKTPSSDVLVFDYTKHPSKPDPSGECNPDLRLRG 
xenopus RBBP4   116 EIEIKITHDGEVNRARYMPQNPCIIATKTPTSDVLVFDYTKHPSKPDPSGECNPNLRLRG 
zebrafish RBBP4 116 EIEIKINHEGEVNRARYMPQNPCIIATKTPTSDVLVFDYTKHPSKPDPSGECTPDLRLRG 
drosophila p55  120 EIEIKINHEGEVNRARYMPQNACVIATKTPSSDVLVFDYTKHPSKPEPSGECQPDLRLRG 
                    ------W D 4 0  r e p e a t-----        -------------------- 
hydra p55       181 HSKEGYGLSWNPNLSGHLLSASDDHTICLWDLNNAAKEAKMLDASRIFNGHSDVVEDVSW 
human RBBP4     176 HQKEGYGLSWNPNLSGHLLSASDDHTICLWDISAVPKEGKVVDAKTIFTGHTAVVEDVSW 
mouse Rbbp4     176 HQKEGYGLSWNPNLSGHLLSASDDHTICLWDISAVPKEGKVVDAKTIFTGHTAVVEDVSW 
xenopus RBBP4   176 HQKEGYGLSWNPNLSGNLLSASDDHTICLWDISAVPKEGKVVDAKTIFTGHTAVVEDVSW 
zebrafish RBBP4 176 HQKEGYGLSWNPNLSGCLLSASDDHTICLWDISTVPKEGKIVDAKTIFTGHTAVVEDVSW 
drosophila p55  180 HQKEGYGLSWNPNLNGYLLSASDDHTICLWDINATPKEHRVIDAKNIFTGHTAVVEDVAW 
                    W D 4 0  r e p e a t-     ------W D 4 0  r e p e a t------- 
hydra p55       241 HLLHESLFGSVADDHKLMIWDTRRSSNNKPSHTVDAHTAEVNCLSFNPYSEFILATGSAD 
human RBBP4     236 HLLHESLFGSVADDQKLMIWDTRSNNTSKPSHSVDAHTAEVNCLSFNPYSEFILATGSAD 
mouse Rbbp4     236 HLLHESLFGSVADDQKLMIWDTRSNNTSKPSHSVDAHTAEVNCLSFNPYSEFILATGSAD 
xenopus RBBP4   236 HLLHESLFGSVADDQKLMIWDTRSNNTSKPSHSVDAHTAEVNCLSFNPYSEFILATGSAD 
zebrafish RBBP4 236 HLLHESLFGSVADDQKLMIWDTRSNNTSKPSQAVDAHTAEVNCLSFNPYSEFILATGSAD 
drosophila p55  240 HLLHESLFGSVADDQKLMIWDTRNNNTSKPSHTVDAHTAEVNCLSFNPYSEFILATGSAD 
                    -------     ----------W D 4 0  r e p e a t--------- 
hydra p55       301 KTVALWDLRNLRLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLHVWDLSKIGEEQT 
human RBBP4     296 KTVALWDLRNLKLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLNVWDLSKIGEEQS 
mouse Rbbp4     296 KTVALWDLRNLKLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLNVWDLSKIGEEQS 
xenopus RBBP4   296 KTVALWDLRNLKLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLNVWDLSKIGEEQS 
zebrafish RBBP4 296 KTVALWDLRNLKLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLNVWDLSKIGEEQS 
drosophila p55  300 KTVALWDLRNLKLKLHSFESHKDEIFQVQWSPHNETILASSGTDRRLHVWDLSKIGEEQS 
                           ----------W D 4 0  r e p e a t----------- 
hydra p55       361 AEDAEDGPPELLFIHGGHTAKISDFAWNPNEPWVICSVSEDNIMQVWQMAENIYNDEEID 
human RBBP4     356 PEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWVICSVSEDNIMQVWQMAENIYNDEDPE 
mouse Rbbp4     356 PEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWVICSVSEDNIMQVWQMAENIYNDEDPE 
xenopus RBBP4   356 PEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWVICSVSEDNIMQVWQMAENIYNDEDTE 
zebrafish RBBP4 356 PEDAEDGPPELLFIHGGHTAKISDFSWTPNEPWVICSVSEDNIMQVWQMAENIYNDEDPE 
drosophila p55  360 TEDAEDGPPELLFIHGGHTAKISDFSWNPNEPWIICSVSEDNIMQVWQMAENVYNDEEPE 
 
hydra p55       421 TLATDLEPRHQSKP 
human RBBP4     416 ---GSVDPEGQGS- 
mouse Rbbp4     416 ---GSVDPEGQGS- 
xenopus RBBP4   416 ---GGVDPEGQGS- 
zebrafish RBBP4 416 ---GAADTEVQG-- 
drosophila p55  420 ---IPASELETNTA 
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HyYY1  
 
     
From gene to protein: 
The  HyYY1  gene  is  composed  of  6  exons  and  spans  a  genomic  region  of  ~  10.5  kb.  The 
respective  exon  and  intron  lengths  are  indicated.  Undetermined  lengths  are  indicated  by  a 
question mark. Based on a ~ 1.5 kb mRNA, a protein of 361 aa is translated. 
 
 
 
 
Sequence information: 
Nucleotide  and derived  amino  acid  sequence  of HyYY1  from Hydra magnipapillata  105.   The 
beginning of the respective exons is indicated. The untranslated regions are highlighted in grey; 
the Kozak sequence and the polyadenylation site are indicated by underlined nucleotides. The 
translation initiation start and stop codons are highlighted in red. The coding sequence and the 
derived amino acid sequence are indicated by capital letters. The protein domains are indicated. 
The REPO domain  is highlighted  in blue  lilac,  the  four C2H2‐zinc  fingers are highlighted  in 
light red, blue, green and yellow. 
 
 
     Exon 1            5‘ UTR                 Kozak sequence 
    1  ccggtacaaa ttggacctaa gttaatgccg taaaaaaATG GCTGACGATT 
                                                 M   A  D  D  
   51  TAACGATAGA TGGAGTTGAA AGTAATTCTT TTCTTTCTGT CGATGAAGAC 
        L  T  I   D  G  V  E   S  N  S   F  L  S   V  D  E  D 
  101  AATCTTAGCA TCATCGATGA GAATTTTTAT AATCAACCTT TGATAGCACT 
         N  L  S   I  I  D   E  N  F  Y   N  Q  P   L  I  A 
  151  ACAACCTAAT TCTCATTTAG GTGGCAATGA AACAGTTTCA GATGGGTTCT 
       L  Q  P  N   S  H  L   G  G  N   E  T  V  S   D  G  F 
  201  TTGAAGATTC TTTAGTTGAT ATCCCTTTAG TTGGGGAAGG GCAAGAAATT 
        F  E  D   S  L  V  D   I  P  L   V  G  E   G  Q  E  I 
  251  TCAACTGAAG CAGCGATACA ACAAACCCCT GAAAAATCAG GTATTAAGCG 
         S  T  E   A  A  I   Q  Q  T  P   E  K  S   G  I  K 
  301  AAAAAATAAT AAAAAATCAA AACCAAAACT CAAGGTAAAA AATAAATTGA 
       R  K  N  N   K  K  S   K  P  K   L  K  V  K   N  K  L 
  351  CAACATCCAA TCTTGATAAC GAGGACAGTA ACGATATCGA TGTTCCTCGT 
        T  T  S   N  L  D  N   E  D  S   N  D  I   D  V  P  R 
                                  REPO domain 
  401  AAATGGTCAA GAAAAAAGGT TCAGATTAAA ACATTTGAAG GAGAGTTCTC 
         K  W  S   R  K  K   V  Q  I  K   T  F  E   G  E  F 
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                         Exon 2   
  451  AGTTATTGTA TGGGCTTCA|G ATGGGAATGA GACTAACAAT GAGAATCAAA 
       S  V  I  V   W  A  S l  |D  G  N   E  T  N  N   E  N  Q                          
  501  GTGAAGAAGA TAAAAAATTT GTAGATCAGG TGGATTTTAC TTTAAATAGT 
      S  E  E   D  K  K  F   V  D  Q   V  D  F   T  L  N  S  
  551  TCCCCTTCTA AAGATGTTGA TCTTAGTGAT CCAAAACAGT TGACAGAGTT 
         S  P  S   K  D  V   D  L  S  D   P  K  Q   L  T  E 
         Exon 3         
  601  AACT|AGAAAA TCTAAAAAAC AAAAAAAAGT TACTGAAGAA GTTCCTAAAA 
       L  T|i  R  K   S  K  K   Q  K  K   V  T  E  E   V  P  K 
                          Exon 4           C2H2 zinc finger 
  651  GCATTTCATG TCCTCATAGC|GGTTGTTTGA AGTTATTCAG AGATAATTCG 
        S  I  S   C  P  H  S l |G  C  L   K  L  F   R  D  N  S 
  701  GCAATGCGAA AACATTTGCA TACTCATGGT CCTCGTGTTC ATGTTTGTGC 
         A  M  R   K  H  L   H  T  H  G   P  R  V   H  V  C 
                   Exon 5             C2H2 zinc finger 
  751  TGAATGCGGG AAG|GCGTTTA CAGAAAGTTC AAAATTAAAA AGGCATCAGC 
       A  E  C  G   K|   A  F   T  E  S   S  K  L  K   R  H  Q 
                                    Exon 6  
  801  TTGTCCATAC TGGTGAAAAA CCATTTCAG|T GTACATTTGA GGGTTGTGGT 
        L  V  H   T  G  E  K   P  F  Q|    C  T  F   E  G  C  G 
                     C2H2 zinc finger 
  851  AAAAGATTTA GTCTAGACTT TAATCTCCGA ACACATGTCC GTATACATAC 
         K  R  F   S  L  D   F  N  L  R   T  H  V   R  I  H 
                          C2H2 zinc finger 
  901  AGGTGACAGG CCTTATGTAT GTCCTTTTGA CTCATGTAAT AAATGTTTCG 
       T  G  D  R   P  Y  V   C  P  F   D  S  C  N   K  C  F                          
  951  CGCAATCTAC CAACCTAAAA AGTCATATCT TAACTCATGC AAAATCAAAT 
        A  Q  S   T  N  L  K   S  H  I   L  T  H   A  K  S  N 
 1001  TCTAAAAGAG ACTCTTCACC ATCAGAAAGT TTTGCTGAAG AAGAGCTTGT 
         S  K  R   D  S  S   P  S  E  S   F  A  E   E  E  L 
 1051  AATAGATCAA GGAGAAACTG GTATACCTGA TAATCTAGTT ATTTATGAAG 
       V  I  D  Q   G  E  T   G  I  P   D  N  L  V   I  Y  E 
                                         3’ UTR 
 1101  ACATAGAAGA AGATGCTGTG TAGctacaga agatatagct gtgcaaatcg 
        D  I  E   E  D  A  V   *               
 1151  caattgtata aataccataa aaatctgcat cagatattcg aatgtttttc 
 1201  atattttgtt gatacaattt ttttctattt aaaagaagaa ttggacaatt 
 1251  tataaacatt aaagtggact atatctagtt taaagcaaga aaactagaac 
 1301  ttgttaaagg acttcttcat aaaatatcaa cagacagttg tttataaata 
 1351  tatttagtgt gaataaaaga atcaataata ttgatgagtt ttataattta 
 1401  atttttcaac tgtaattttt tttttttcta tacatttatt gagttttttt 
 1451  tttctttttt tttctgtttt ttttaatgca aactttaagc gatcttagaa 
 1501  gattttataa atagtttttt gaaataaaat ttaatgtggc ttactcaaaa 
                 polyA site       
 1551  aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aa 
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Protein alignment: 
Comparison  of  HyYY1  with  YY1  protein  sequences  from  other  species  reveals  significant 
conservation on the amino acid level (39%). Areas of high matches are highlighted in grey. The 
BLOSUM62 matrix was used for the multi‐way protein sequence alignment. 
 
hydra YY1         1 MADDLTI----DGVESNS-----------FLSVDEDNLSIIDE----------------- 
human YY1         1 MASGDTLYIATDGSEMPAEIVELHEIEVETIPVETIETTVVGEEEEEDDDDEDGGGGDHG 
mouse Yy1         1 MASGDTLYIATDGSEMPAEIVELHEIEVETIPVETIETTVVGEEEEEDDDDEDGGGGDHG 
xenopus YY1       1 MASGDTLYIASDGSEMPAEIVELHEIEVECIPVETIETTVVG---DDEDDDDDQG----- 
zebrafish YY1     1 MASGETLYIEADGSEMPAEIVELHEIE-----VETIETTVVG---GDDDE---------- 
drosophila Pho    1 MA-----------YERFGIILQSEQYD------EDIGNTKVNQKMNEGNHYD-------- 
 
hydra YY1        29 ------------------NFYNQPLIALQP---------NSH------------LGGNE- 
human YY1        61 GGGG-HGHAGHHHHHHHHHHH-PPMIALQPLVTDDPTQVHHHQEVILVQTREEVVGGDD- 
mouse Yy1        61 GGGGGHGHAGHHHHHHHHHHHHPPMIALQPLVTDDPTQVHHHQEVILVQTREEVVGGDD- 
xenopus YY1      53 -------------------HHQQPMIALQPLDSDDLVHP-HHQEVILVQTREEVVGGDD- 
zebrafish YY1    43 ---------------------HQPMIALQPLVTDDPNHV-NHQEVILVQTREEVVGCDD- 
drosophila Pho   36 ---------------LHRKNAFDRIIHSESKKGDNVINYNIHE-------NDKIKAADNI 
 
hydra YY1        49 -T----VSDGFFEDSLVDIPLVGEG------QEISTEAAIQQTP-----EKSG--IKRKN 
human YY1       118 -SDGLRAEDGFEDQILIPVPAPAGGDDDYIEQTLVTVAAAGKSGGGGSSSSGGGRVKKGG 
mouse Yy1       120 -SDGLRAEDGFEDQILIPVPAPAGGDDDYIEQTLVTVAAAGKSGGG--ASSGGGRVKKGG 
xenopus YY1      92 -SD-LRADDGYEDQILIPVPVPA-GEDEYIEQTLVTV--AGKSSSGGRMKKGGG----GS 
zebrafish YY1    80 -SD-LHADDSFEDQILIPVPVPV-AEEEYIEQTLVTV--SGKNPSG-RMKKG-G----GS 
drosophila Pho   74 FSSKLKMNPNMSYEMNINCFKNIG----YGENQETSKVLTNSLSNNDINTEESGVVDK-- 
                                                    R E P O    d o m a i n 
hydra YY1        91 NKKSKPKLKVKNKLTTSNLDNEDSNDIDVPRKWSRKKVQIKTFEGEFSVIVWASDG---- 
human YY1       177 GKKSGKKSYLSGGAGAAGGGGADPGN----KKWEQKQVQIKTLEGEFSVTMWSSDEKKDI 
mouse Yy1       177 GKKSGKKSYLGGGAGAAGGGGADPGN----KKWEQKQVQIKTLEGEFSVTMWSSDEKKDI 
xenopus YY1     143 GKKSSKKSYL---------SGTEPSG----RKWEQKQVQIKTLEGEFSVTMWASDDKKDI 
zebrafish YY1   129 GKRVVKKSFL---------NSAEASG----RKWEQKQVQIKTLEGEFSVTMWASDDKKDV 
drosophila Pho  128 -----NSPFLTLGTTILNSNGKS-------RRWEQKLVHIKTMEGEFSVTMWASGIS--- 
 
hydra YY1       147 -NETNNENQSEEDKK-----------------FVDQ----VDFT----LN-SSPSKDV-- 
human YY1       233 DHETVVEEQIIGENS-----------------PPDY----SEYMTGKKLP-PGGIPGI-- 
mouse Yy1       233 DHETVVEEQIIGENS-----------------PPDY----SEYMTGKKLP-PGGIPGI-- 
xenopus YY1     190 DHETVVEEQIIGENS-----------------PPDY----SEYMTGKKLP-PGGIPGI-- 
zebrafish YY1   176 DHETVVEEQIIGENS-----------------PPDY----SEYMTGKKLP-PGGIPGI-- 
drosophila Pho  173 DDEYSGSDQIVGASDLLKGKEEFGIDGFTSQQNKEYQKMESKFTNAQTLEMPHPISSVQI 
 
hydra YY1       178 ---------DLSDPKQLTE----------------------------LTR---------- 
human YY1       269 ---------DLSDPKQLAE----------------------------FA----------- 
mouse Yy1       269 ---------DLSDPKQLAE----------------------------FA----------- 
xenopus YY1     226 ---------DLSDPKQLAE----------------------------FASETRCTNNING 
zebrafish YY1   212 ---------DLSDPKQLAE----------------------------FA----------- 
drosophila Pho  233 MDHLIKERGNLSQENNISERILSKTTLSFEEPILLPDSSSIELVNETAAMTINNHRTLSN 
 
hydra YY1       191 --------KSKKQKKV----------------------TEEVPKS--------------- 
human YY1       281 --------RMKPRKIK----------------------EDDAPRT--------------- 
mouse Yy1       281 --------RMKPRKIK----------------------EDDAPRT--------------- 
xenopus YY1     249 RKKQAPSWRMKPRKIK----------------------EDDAPRT--------------- 
zebrafish YY1   224 --------RMKPRKIK----------------------EDDSPRT--------------- 
drosophila Pho  293 HTGNTGDLHALPSSVPFRIGLHEGQVNDCLSTISQSTHQDNTDSTGCGEMNLSEVTVSYT 
                        C 2 H 2    zinc    finger     C 2 H 2  zinc  finger    
hydra YY1       206 ----ISCPHSGCLKLFRDNSAMRKHLHTHGPRVHVCAECGKAFTESSKLKRHQLVHTGEK 
human YY1       296 ----IACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEK 
mouse Yy1       296 ----IACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEK 
xenopus YY1     272 ----IACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEK 
zebrafish YY1   239 ----IACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEK 
drosophila Pho  353 NDKKIACPHKGCNKHFRDSSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEK 
                     C 2 H 2    zinc    finger     C 2 H 2    zinc    finger    
hydra YY1       262 PFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDSCNKCFAQSTNLKSHILTHAKSN 
human YY1       352 PFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAK 
mouse Yy1       352 PFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAK 
xenopus YY1     328 PFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAK 
zebrafish YY1   295 PFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAK 
drosophila Pho  413 PFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPFVCPFDACNKKFAQSTNLKSHILTHAKAK 
 
hydra YY1       322 SKRDSSPSESFAEEELVIDQGETGIPDNLVIYEDIEEDAV-------- 
human YY1       412 NNQ--------------------------------------------- 
mouse Yy1       412 NNQ--------------------------------------------- 
xenopus YY1     388 NNQ--------------------------------------------- 
zebrafish YY1   355 NNQ--------------------------------------------- 
drosophila Pho  473 RNTSISGKSGCSNAESNSQSEDTSANYVKVELQDSVTENHVPFVVYAD 
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B. Histone modifications and Hydra histones
B.1. Histone posttranslational modifications
Histone are subjected to many posttranslational modifications. These modifications can alter the
chromatin structure, disrupt the binding of associated proteins or provide a binding platform for
effector proteins. The recruitment of proteins or protein complexes can activate or repress tran-
scription. Whereas certain modifications are associated with transcriptional activation, others are
linked to transcriptional repression. Histone modifications include the acetylation, phosphoryla-
tion, methylation, sumoylation and ubiquitylation of histone residues. Jenuwein and Allis (2001)
proposed that modifications of histone tails form a kind of language, which became known as the
’histone code’ hypothesis. An overview of known histone modifications is depicted in figure 1.14
on page 17. Table ?? gives an overview of histone posttranslational modifications and their role
in transcription. In more recent studies, the existence of a histone ’cross-talk’ is proposed where
one histone modification promotes the generation of another (for a review see Suganuma and
Workman (2008)). For example, the PcG complexes catalyze the modification of H3K27 followed
by the modification of H2AK119.
TABLE B.1 List of histone posttranslational modifications. The table was adapted from Allis et al.
(2006).
modification role in transcription modified residue
Acetylation activation H3 (K9, K14, K18, K56)
H4 (K5, K8, K12, K16)
H2B (K6, K7, K16, K17)
Phosphorylation activation H3 (S10)
Methylation activation
repression
H3 (K4, K36, K79)
H3 (K9, K27)
H4 (K20)
Ubiquitylation activation
repression
H2B (K123)
H2A (K119)
Sumoylation repression H4 (K5, K8, K12, K16)
H2A (K126)
H2B (K6, K7, K16, K17)
B.2. Hydra histones
Histone proteins are highly conserved. By genome searches with histone proteins from human
and by the comparison of Hydra gene models, homologs could be identified in the Hydra genome.
All putative Hydra histone proteins differ only in a few residues from the human histone proteins.
In figure B.1, the sequences of the Hydra histone proteins are aligned with human histone vari-
ants. For histone H3, the tail region is one hundred per cent identical to its human counterpart -
including lysine 27, the site trimethylated by the PRC2 complex.
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Histone H2A variants 
 
human H2A         1 MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYMAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYMAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYMAAVLEYLTAEILELAGNA 
Hma2.207221       1 MSGRGK-GGKKSGKSKTRSSRAGLQFPVGRIHRFLRKGHYAERIGSGAPVYLAAVLEYLSAEILELAGNA 
Hma2.209449       1 MS-RGK-GGKAKGKSVTRSSRAGLQFPVGRIHRFLRKGHYANRIGSGAPVYLAAVMEYLSAEILELAGNA 
Hma2.209450       1 MS-RGK-GGKTKEKSKTRSSRAGLQFPVGRIHRFLRKGHYANRIGSGAPVYLAAVMEYLSAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKSKSRSSRAGLQFPVGRIHRLLRKGNYAERIGAGAPVYLAAVLEYLTAEILELAGNA 
human H2A         1 MSGRGKQGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYMAAVLEYLTAEILELAGNA 
         K 119 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKT-ESHHKAKGK--- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKT-ESHHKTK----- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKT-ESHHKAK----- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGRVTIAQGGVLPNIQAVLLPKKT-ESHHKAKGK--- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGRVTIAQGGVLPNIQAVLLPKKT-ESHHKAKGK--- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKT-ESHHKAKSK--- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKT-ESHHKAKGK--- 
human H2A        71 ARDNKKTRIIPRHLQLAIRNDEELNKLLGRVTIAQGGVLPNIQAVLLPKKT-ESHHKAKGK--- 
Hma2.207221      70 ARDNKKSRIVPRHLQLAVRNDEELNKLLSGVTIASGGVLPNIQAVLLPKKTKEPQSKSSQSQEY 
Hma2.209449      69 ARDNKKSRINPRHLQLAVRNDEELNKLLAGVTIANGGVLPNIQAALLPKH-NEKVHKSPHKH-- 
Hma2.209450      69 ARDNKKSRINPRHLQLAVRNDEELNKLLAGVTIANGGVLPNIQAALLPKH-NEKVHKSPHKH-- 
human H2A        71 SRDNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTESHHHKAQSK--- 
human H2A        71 ARDNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTESH--KPGPNK--- 
 
Histone H2B variants 
 
human H2B         1 MPEP----VKSAP-VPKKGSKKAINKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPE----LAKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPEP----AKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPEP----AKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPEP----TKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPEP----SKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPDP----SKSAP-APKKGSKKAVTKAQKKDG---KKRKRGRKESYSIYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPVS----SAKGATISKKGFKKAVVKTQKKEG---KKRKRTRKESYSIYIYKVLKQVHPDTGISSKAMSI 
Hma2.232238       1 MSDAPKTGGKQAPKVAKKGEKRAGKKGGKIAGTGDKKRKKKRRESYAIYIYNVLKQVHPDVGVSSKAMSI 
Hma2.216535       1 MSDAPKTGEKQALKVAKKGEKRAGKKSGKIAGIGDKKRKKRRRESYAIYIYKVLKQVHSDVGVLSKAMSI 
Hma2.201924       1 MYKE---SKAVNPNVAKKGEIRVNNKI-KDAVEGDSQRKKKRRESYAVYIYNVLKQVHPDVGVSSKAMTI 
human H2B         1 MPDP----AKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSVYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPDP----AKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPEP----AKSAP-APKKGSKKAITKAQKKDG---KKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGI 
human H2B         1 MPEP----AKSAP-APKKGSKKAVTKAQKKDG---KKRKRSRKESYSIYVYKVLKQVHPDTGISSKAMGI 
 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIASEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSAK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIASEASRLAHYNKRSTITSREVQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        64 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
Hma2.232238      71 MNSFVNDIFERIASEASRLALQNKKSTISSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
Hma2.216535      71 MNSFVNDIFEKIASEASRLALQNKKSTISSREIQTAVRLLLPGELAKHTVSEGTKAVTKYTSSK 
Hma2.201924      67 MNTFVNDIFERIASEASTLSNQSRKSTISSREIQTAVRLILPGELAKHAVNEGTKCVTKYASTK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
human H2B        63 MNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK 
 
Histone H3 variants 
             K27 
human H3.1        1 MARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQR 
human H3.2        1 MARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQR 
Hma2.200509       1 MARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQR 
human H3.3        1 MARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQR 
Hma2.203617       1 MARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKKPHRYRPGTVALREIRRYQKSTELLIRKLPFQR 
 
human H3.1       71 LVREIAQDFKTDLRFQSSAVMALQEACEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA 
human H3.2       71 LVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA 
Hma2.200509      71 LVREIAQDFKTDLRFQSTAVMALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA 
human H3.3       71 LVREIAQDFKTDLRFQSAAIGALQEASEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA 
Hma2.203617      71 LVREIAQDFKTDLRFQSAAIGALQEAAEAYLVGLFEDTNLCAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H4 
 
human H4          1 MSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLK 
Hma2.234344       1 MSGRGKGGKGLGKGGAKRHRKILRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLK 
Hma2.202246       1 MSGRGKGGKGLGKGGAKRHRKILRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLK 
 
human H4         61 VFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG 
Hma2.234344      61 VFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG 
Hma2.202246      61 VFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG 
FIGURE B.1 Hydra histones. Alignment of human histone genes with gene models of putative Hydra
histones. Sites of epigenetic modifications involved in PcG repression are marked.
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C. Chromatin remodeling complexes
Chromatin remodeling complexes disrupt DNA-histone interactions and thus alter the chromatin
structure. The topic is reviewed by (Clapier and Cairns, 2009). Whereas some of the remodel-
ers promote the dense packaging of chromatin, others allow the access to the packaged DNA.
Some of the complexes act as transcriptional activators and have TrxG-like functions. To alter
histone-DNA contacts, the chromatin remodeling complexes use the energy of ATP-hydrolysis.
Figure C.1 gives an overview of the mechanisms for the ATP-dependent chromatin remodeling.
Dependent on their ATPase subunit, the chromatin remodelers are classified into four different
families: SWI/SNF (switching defective/sucrose nonfermenting), ISWI (imitation SWI), CHD
(chromodomain, helicase, DNA binding) and INO80 (inositol requiring 80). Like PcG mediated
gene regulation, chromatin remodeling is accompanied by certain histone modifications, which
are recognized by conserved domains like the Chromodomain or Bromodomain.
Subunits of the PcG complexes have been found to be associated with chromatin remodeling com-
plexes. For example, p55 is can be found in an ISWI-family complex (NURF) and a CHD-family
complex (NuRD), the Drosophila YY1 homolog Pho is found in a complex of the INO80-family
called Pho-dINO80. The table on the next page gives an overview of the chromatin remodeling
complexes. Members, which are also found in the PcG group complexes are highlighted.
FIGURE C.1 Chromatin remodeling by ATP-dependent chromatin remodeling complexes. A Nucle-
osome ’sliding’ allows the exposure of a region (marked in red) that was occluded. B A variant nucleosome
is created by the exchange of a variant histone for a standard histone. C A large region of DNA is opened by
nucleosome eviction. D By creating a loop on the surface of the nucleosome, the nucleosome structure gets
altered and sites get available (marked in red). The figure was adapted from Allis et al. (2006)
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TABLE C.1 Chromatin remodeling complexes. Subunits, which also belong to the PcG complexes are
highlighted. The table was taken from Clapier and Cairns (2009) and modified.
Family  Drosophila Human
SWI/SNIF 
  
  
  
  
  
  
  
  
  
  
   BAP PBAP BAF PBAF 
ATPase  Brahma  Brahma     hBRM or BRG1  BRG1    
non‐catalytic   Osa  Osa     BAF250/hOSA1       
subunits  Moira/BAP155  Moira/BAP155     BAF155, BAF170  BAF180/BAF200    
   BAP60  BAP60     BAF60a, b or c       
   SNR1/BAP45  SNR1/BAP45     hSNF5/BAF47/INI1       
   BAP111  BAP111     BAF57       
   BAP55 or BAP47 BAP55 or BAP47     BAF53a or b       
   Actin  Actin     β‐actin       
     Polybromo/ 
BAP170 
          
                   
ISWI 
  
  
  
  
  
   NURF CHRAC ACF NURF CHRAC  ACF 
ATPase  ISWI  ISWI  ISWI  SNF2L  SNF2H  SNF2H 
non‐catalytic 
subunits  
NURF301  ACF1  ACF1  BPTF  hACF1/ 
WCRF180 
hACF1/WCRF180
  NURF55/p55  CHRAC14     RbAP46 or 48  hCHRAC17    
   NURF38  CHRAC16        hCHAC15    
               
CHD 
  
  
  
  
  
  
  
  
   CHD1 Mi‐2/NuRD CHD1 NuRD 
ATPase  dCHD1  dMi‐2     CHD1  Mi‐2α/CHD3,  
Mi‐2β/CHD4 
  
non‐catalytic      dMBD2/3        MBD3    
subunits     dMTA        MTA1, 2, 3    
      dRPD3        HDAC1, 2    
      p55        RbAP46 or 48    
      p66/68        p66α, β    
               DOC‐1?    
                    
INO80 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   Pho‐dN80 Tip60 INO80 SRCAP  TRAP/Tip60 
ATPase  dIno80  Domino    hINO80  SCRAP  p400 
non‐catalytic 
subunits  
Reptin, Pontin  Reptin, Pontin     RUVBL1, 2/ 
TIP49a, b 
RUVBL1, 2/ 
TIP49a, b 
RUVBL1, 2/ 
TIP49a, b 
  dArp5,8/dActin1 BAP55/Actin87E     BAF53a  BAF53a  BAF53a 
   Pho  dGAS41     Arp5, 8  Arp6  Actin 
      dYL‐1     hIes2, 6  GAS41  GAS41 
      dBrd8        DMAP1  DMAP1 
      H2Av, H2B        YL‐1  YL‐1 
      dTra1        H2AZ, H2B  Brd8/TRC/p120
      dTip60        ZnF‐HIT1  TRRAP 
      dMRG15           Tip60 
      dEaf6           MRG15/MRGX 
      dMRGBP           FLJ11730 
      E(Pc)           MRGBP 
      dING3           EPC1, EPC‐like
                  ING3 
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